{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "89757eff",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  Patient ID  Age at Diagnosis Type of Breast Surgery    Cancer Type  \\\n",
      "0    MB-0000             75.65             Mastectomy  Breast Cancer   \n",
      "1    MB-0002             43.19      Breast Conserving  Breast Cancer   \n",
      "2    MB-0005             48.87             Mastectomy  Breast Cancer   \n",
      "3    MB-0006             47.68             Mastectomy  Breast Cancer   \n",
      "4    MB-0008             76.97             Mastectomy  Breast Cancer   \n",
      "\n",
      "                        Cancer Type Detailed Cellularity Chemotherapy  \\\n",
      "0           Breast Invasive Ductal Carcinoma         NaN           No   \n",
      "1           Breast Invasive Ductal Carcinoma        High           No   \n",
      "2           Breast Invasive Ductal Carcinoma        High          Yes   \n",
      "3  Breast Mixed Ductal and Lobular Carcinoma    Moderate          Yes   \n",
      "4  Breast Mixed Ductal and Lobular Carcinoma        High          Yes   \n",
      "\n",
      "  Pam50 + Claudin-low subtype  Cohort ER status measured by IHC  ...  \\\n",
      "0                 claudin-low     1.0                   Positve  ...   \n",
      "1                        LumA     1.0                   Positve  ...   \n",
      "2                        LumB     1.0                   Positve  ...   \n",
      "3                        LumB     1.0                   Positve  ...   \n",
      "4                        LumB     1.0                   Positve  ...   \n",
      "\n",
      "  Overall Survival Status  PR Status Radio Therapy  \\\n",
      "0                  Living   Negative           Yes   \n",
      "1                  Living   Positive           Yes   \n",
      "2                Deceased   Positive            No   \n",
      "3                  Living   Positive           Yes   \n",
      "4                Deceased   Positive           Yes   \n",
      "\n",
      "  Relapse Free Status (Months) Relapse Free Status     Sex  \\\n",
      "0                       138.65        Not Recurred  Female   \n",
      "1                        83.52        Not Recurred  Female   \n",
      "2                       151.28            Recurred  Female   \n",
      "3                       162.76        Not Recurred  Female   \n",
      "4                        18.55            Recurred  Female   \n",
      "\n",
      "  3-Gene classifier subtype Tumor Size Tumor Stage  Patient's Vital Status  \n",
      "0                 ER-/HER2-       22.0         2.0                  Living  \n",
      "1     ER+/HER2- High Prolif       10.0         1.0                  Living  \n",
      "2                       NaN       15.0         2.0         Died of Disease  \n",
      "3                       NaN       25.0         2.0                  Living  \n",
      "4     ER+/HER2- High Prolif       40.0         2.0         Died of Disease  \n",
      "\n",
      "[5 rows x 34 columns]\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# Load the dataset\n",
    "df = pd.read_csv(r'C:\\Users\\Md Shoaib\\c tutorials course\\Downloads\\Breast Cancer METABRIC.csv')\n",
    "\n",
    "# Display the first few rows\n",
    "print(df.head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "55562529",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of columns is: 34\n"
     ]
    }
   ],
   "source": [
    "# Get the list of column names and find the number of columns\n",
    "num_columns = len(df.columns)\n",
    "\n",
    "print(f\"The number of columns is: {num_columns}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "083f1697",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0    75.65\n",
      "1    43.19\n",
      "2    48.87\n",
      "3    47.68\n",
      "4    76.97\n",
      "Name: Age at Diagnosis, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "# Get the first 5 ages from the 'Age' column\n",
    "first_5_ages = df['Age at Diagnosis'].head(5)\n",
    "\n",
    "print(first_5_ages)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "f44f7cc2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Patient ID', 'Age at Diagnosis', 'Type of Breast Surgery', 'Cancer Type', 'Cancer Type Detailed', 'Cellularity', 'Chemotherapy', 'Pam50 + Claudin-low subtype', 'Cohort', 'ER status measured by IHC', 'ER Status', 'Neoplasm Histologic Grade', 'HER2 status measured by SNP6', 'HER2 Status', 'Tumor Other Histologic Subtype', 'Hormone Therapy', 'Inferred Menopausal State', 'Integrative Cluster', 'Primary Tumor Laterality', 'Lymph nodes examined positive', 'Mutation Count', 'Nottingham prognostic index', 'Oncotree Code', 'Overall Survival (Months)', 'Overall Survival Status', 'PR Status', 'Radio Therapy', 'Relapse Free Status (Months)', 'Relapse Free Status', 'Sex', '3-Gene classifier subtype', 'Tumor Size', 'Tumor Stage', \"Patient's Vital Status\"]\n"
     ]
    }
   ],
   "source": [
    "# Get a list of column names\n",
    "column_names = df.columns.tolist()\n",
    "\n",
    "print(column_names)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "2aa62d63",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row 0:\n",
      "Patient ID: MB-0000\n",
      "Age at Diagnosis: 75.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1:\n",
      "Patient ID: MB-0002\n",
      "Age at Diagnosis: 43.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 84.63333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 83.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 2:\n",
      "Patient ID: MB-0005\n",
      "Age at Diagnosis: 48.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 151.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 3:\n",
      "Patient ID: MB-0006\n",
      "Age at Diagnosis: 47.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 164.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 4:\n",
      "Patient ID: MB-0008\n",
      "Age at Diagnosis: 76.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 41.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 18.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 5:\n",
      "Patient ID: MB-0010\n",
      "Age at Diagnosis: 78.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 7.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 2.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 6:\n",
      "Patient ID: MB-0014\n",
      "Age at Diagnosis: 56.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 7:\n",
      "Patient ID: MB-0020\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.13\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 22.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 8:\n",
      "Patient ID: MB-0022\n",
      "Age at Diagnosis: 89.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 99.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 98.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 9:\n",
      "Patient ID: MB-0025\n",
      "Age at Diagnosis: 76.24\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.68\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 126.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 10:\n",
      "Patient ID: MB-0028\n",
      "Age at Diagnosis: 86.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 36.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 11:\n",
      "Patient ID: MB-0035\n",
      "Age at Diagnosis: 84.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.056\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 36.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 35.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 12:\n",
      "Patient ID: MB-0036\n",
      "Age at Diagnosis: 85.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 13:\n",
      "Patient ID: MB-0039\n",
      "Age at Diagnosis: 70.91\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 14:\n",
      "Patient ID: MB-0045\n",
      "Age at Diagnosis: 45.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 105.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 15:\n",
      "Patient ID: MB-0046\n",
      "Age at Diagnosis: 83.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 24.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.072\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 16:\n",
      "Patient ID: MB-0048\n",
      "Age at Diagnosis: 51.46\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 103.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 17:\n",
      "Patient ID: MB-0050\n",
      "Age at Diagnosis: 44.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.066\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 75.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 74.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 18:\n",
      "Patient ID: MB-0053\n",
      "Age at Diagnosis: 70.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 161.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 158.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 19:\n",
      "Patient ID: MB-0054\n",
      "Age at Diagnosis: 66.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.072\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 160.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 119.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 20:\n",
      "Patient ID: MB-0056\n",
      "Age at Diagnosis: 62.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.058\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 62.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.04\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 21:\n",
      "Patient ID: MB-0059\n",
      "Age at Diagnosis: 75.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 160.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 158.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 22:\n",
      "Patient ID: MB-0060\n",
      "Age at Diagnosis: 45.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 23:\n",
      "Patient ID: MB-0062\n",
      "Age at Diagnosis: 52.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 151.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 24:\n",
      "Patient ID: MB-0064\n",
      "Age at Diagnosis: 69.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 107.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 25:\n",
      "Patient ID: MB-0066\n",
      "Age at Diagnosis: 61.49\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 157.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 155.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 26:\n",
      "Patient ID: MB-0068\n",
      "Age at Diagnosis: 51.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 103.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 101.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 27:\n",
      "Patient ID: MB-0071\n",
      "Age at Diagnosis: 68.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 131.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 28:\n",
      "Patient ID: MB-0079\n",
      "Age at Diagnosis: 50.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 29:\n",
      "Patient ID: MB-0081\n",
      "Age at Diagnosis: 49.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 69.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 68.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 30:\n",
      "Patient ID: MB-0083\n",
      "Age at Diagnosis: 64.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 86.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 31:\n",
      "Patient ID: MB-0093\n",
      "Age at Diagnosis: 43.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.028\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 153.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 151.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 32:\n",
      "Patient ID: MB-0095\n",
      "Age at Diagnosis: 80.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 49.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 33:\n",
      "Patient ID: MB-0097\n",
      "Age at Diagnosis: 78.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.4\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 34:\n",
      "Patient ID: MB-0099\n",
      "Age at Diagnosis: 51.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 80.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 35:\n",
      "Patient ID: MB-0100\n",
      "Age at Diagnosis: 68.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 8.066666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 7.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 36:\n",
      "Patient ID: MB-0101\n",
      "Age at Diagnosis: 46.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.068\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 148.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 37:\n",
      "Patient ID: MB-0102\n",
      "Age at Diagnosis: 51.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 140.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 38:\n",
      "Patient ID: MB-0106\n",
      "Age at Diagnosis: 49.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 39:\n",
      "Patient ID: MB-0107\n",
      "Age at Diagnosis: 65.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 158.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 155.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 40:\n",
      "Patient ID: MB-0108\n",
      "Age at Diagnosis: 43.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 41:\n",
      "Patient ID: MB-0109\n",
      "Age at Diagnosis: 82.53\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 112.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 42:\n",
      "Patient ID: MB-0110\n",
      "Age at Diagnosis: 45.73\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.14\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 157.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.17\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 43:\n",
      "Patient ID: MB-0111\n",
      "Age at Diagnosis: 54.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 127.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 125.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 44:\n",
      "Patient ID: MB-0112\n",
      "Age at Diagnosis: 83.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.3\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 39.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 150.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 45:\n",
      "Patient ID: MB-0113\n",
      "Age at Diagnosis: 36.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.16666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 46:\n",
      "Patient ID: MB-0114\n",
      "Age at Diagnosis: 48.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 13.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 13.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 47:\n",
      "Patient ID: MB-0115\n",
      "Age at Diagnosis: 39.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 66.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 31.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 48:\n",
      "Patient ID: MB-0116\n",
      "Age at Diagnosis: 42.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 122.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 49:\n",
      "Patient ID: MB-0117\n",
      "Age at Diagnosis: 60.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 2.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 2.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 50:\n",
      "Patient ID: MB-0119\n",
      "Age at Diagnosis: 82.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 95.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 94.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 51:\n",
      "Patient ID: MB-0120\n",
      "Age at Diagnosis: 72.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 52:\n",
      "Patient ID: MB-0121\n",
      "Age at Diagnosis: 78.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 152.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 150.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 53:\n",
      "Patient ID: MB-0122\n",
      "Age at Diagnosis: 58.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 138.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 137.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 54:\n",
      "Patient ID: MB-0123\n",
      "Age at Diagnosis: 76.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 25.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 55:\n",
      "Patient ID: MB-0124\n",
      "Age at Diagnosis: 43.46\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 118.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 116.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 56:\n",
      "Patient ID: MB-0125\n",
      "Age at Diagnosis: 73.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.018\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 1.266666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 1.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 57:\n",
      "Patient ID: MB-0126\n",
      "Age at Diagnosis: 61.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 127.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 41.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 58:\n",
      "Patient ID: MB-0127\n",
      "Age at Diagnosis: 52.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 130.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 59:\n",
      "Patient ID: MB-0128\n",
      "Age at Diagnosis: 57.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 137.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 135.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 60:\n",
      "Patient ID: MB-0129\n",
      "Age at Diagnosis: 63.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 38.06\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 61:\n",
      "Patient ID: MB-0130\n",
      "Age at Diagnosis: 56.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 151.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 62:\n",
      "Patient ID: MB-0131\n",
      "Age at Diagnosis: 69.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 66.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 63:\n",
      "Patient ID: MB-0133\n",
      "Age at Diagnosis: 58.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.16\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 151.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 149.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 64:\n",
      "Patient ID: MB-0134\n",
      "Age at Diagnosis: 73.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 12.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 65:\n",
      "Patient ID: MB-0135\n",
      "Age at Diagnosis: 74.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 116.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 115.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 66:\n",
      "Patient ID: MB-0136\n",
      "Age at Diagnosis: 72.3\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 87.04\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 67:\n",
      "Patient ID: MB-0138\n",
      "Age at Diagnosis: 51.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 150.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 148.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 68:\n",
      "Patient ID: MB-0139\n",
      "Age at Diagnosis: 47.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 109.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 107.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 69:\n",
      "Patient ID: MB-0140\n",
      "Age at Diagnosis: 74.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 147.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 145.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 70:\n",
      "Patient ID: MB-0142\n",
      "Age at Diagnosis: 57.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 12.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 71:\n",
      "Patient ID: MB-0143\n",
      "Age at Diagnosis: 85.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 54.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 53.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 72:\n",
      "Patient ID: MB-0144\n",
      "Age at Diagnosis: 79.73\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 152.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 116.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 73:\n",
      "Patient ID: MB-0145\n",
      "Age at Diagnosis: 62.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 147.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 145.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 74:\n",
      "Patient ID: MB-0146\n",
      "Age at Diagnosis: 81.0\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 75:\n",
      "Patient ID: MB-0147\n",
      "Age at Diagnosis: 79.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.076\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 51.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 50.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 76:\n",
      "Patient ID: MB-0148\n",
      "Age at Diagnosis: 53.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 1.766666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 1.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 77:\n",
      "Patient ID: MB-0149\n",
      "Age at Diagnosis: 77.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 51.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 78:\n",
      "Patient ID: MB-0150\n",
      "Age at Diagnosis: 70.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 109.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 79:\n",
      "Patient ID: MB-0151\n",
      "Age at Diagnosis: 67.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 47.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 80:\n",
      "Patient ID: MB-0152\n",
      "Age at Diagnosis: 63.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.03333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 81:\n",
      "Patient ID: MB-0153\n",
      "Age at Diagnosis: 67.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.056\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 148.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 146.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 82:\n",
      "Patient ID: MB-0154\n",
      "Age at Diagnosis: 62.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 113.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 83:\n",
      "Patient ID: MB-0155\n",
      "Age at Diagnosis: 62.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.018\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 59.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 84:\n",
      "Patient ID: MB-0156\n",
      "Age at Diagnosis: 60.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.004\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 2.866666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 2.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 2.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 85:\n",
      "Patient ID: MB-0157\n",
      "Age at Diagnosis: 71.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 113.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 86:\n",
      "Patient ID: MB-0158\n",
      "Age at Diagnosis: 50.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 192.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 40.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 87:\n",
      "Patient ID: MB-0159\n",
      "Age at Diagnosis: 51.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.046\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 75.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 74.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 88:\n",
      "Patient ID: MB-0160\n",
      "Age at Diagnosis: 36.66\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.046\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 143.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 141.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 89:\n",
      "Patient ID: MB-0162\n",
      "Age at Diagnosis: 57.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 55.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 55.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 90:\n",
      "Patient ID: MB-0163\n",
      "Age at Diagnosis: 84.73\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 96.81\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 91:\n",
      "Patient ID: MB-0164\n",
      "Age at Diagnosis: 37.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 10.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 92:\n",
      "Patient ID: MB-0165\n",
      "Age at Diagnosis: 53.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 22.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.104\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 47.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 52.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 93:\n",
      "Patient ID: MB-0166\n",
      "Age at Diagnosis: 44.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 103.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 94:\n",
      "Patient ID: MB-0167\n",
      "Age at Diagnosis: 76.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 95:\n",
      "Patient ID: MB-0168\n",
      "Age at Diagnosis: 60.26\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 96:\n",
      "Patient ID: MB-0169\n",
      "Age at Diagnosis: 79.28\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.078\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 145.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 143.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 97:\n",
      "Patient ID: MB-0170\n",
      "Age at Diagnosis: 83.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 93.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 98:\n",
      "Patient ID: MB-0171\n",
      "Age at Diagnosis: 64.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 5.433333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 5.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 99:\n",
      "Patient ID: MB-0172\n",
      "Age at Diagnosis: 48.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 138.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 136.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 100:\n",
      "Patient ID: MB-0173\n",
      "Age at Diagnosis: 83.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.088\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 3.766666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 3.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 44.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 101:\n",
      "Patient ID: MB-0174\n",
      "Age at Diagnosis: 59.18\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 78.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 77.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 102:\n",
      "Patient ID: MB-0175\n",
      "Age at Diagnosis: 69.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.36666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 103:\n",
      "Patient ID: MB-0176\n",
      "Age at Diagnosis: 38.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.072\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 113.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 77.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 104:\n",
      "Patient ID: MB-0177\n",
      "Age at Diagnosis: 85.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.088\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 45.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 45.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 44.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 105:\n",
      "Patient ID: MB-0178\n",
      "Age at Diagnosis: 74.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 103.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 106:\n",
      "Patient ID: MB-0179\n",
      "Age at Diagnosis: 56.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 17.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 107:\n",
      "Patient ID: MB-0180\n",
      "Age at Diagnosis: 51.69\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 62.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 61.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 108:\n",
      "Patient ID: MB-0181\n",
      "Age at Diagnosis: 68.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.96666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 109:\n",
      "Patient ID: MB-0184\n",
      "Age at Diagnosis: 68.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 109.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 107.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 110:\n",
      "Patient ID: MB-0185\n",
      "Age at Diagnosis: 76.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 35.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 111:\n",
      "Patient ID: MB-0188\n",
      "Age at Diagnosis: 82.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 31.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 112:\n",
      "Patient ID: MB-0189\n",
      "Age at Diagnosis: 57.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.096\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 9.066666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 1.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 48.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 113:\n",
      "Patient ID: MB-0191\n",
      "Age at Diagnosis: 81.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 114:\n",
      "Patient ID: MB-0192\n",
      "Age at Diagnosis: 62.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.026\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 144.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 142.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 115:\n",
      "Patient ID: MB-0193\n",
      "Age at Diagnosis: 51.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 116:\n",
      "Patient ID: MB-0194\n",
      "Age at Diagnosis: 56.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 90.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 117:\n",
      "Patient ID: MB-0195\n",
      "Age at Diagnosis: 75.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 21.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 118:\n",
      "Patient ID: MB-0197\n",
      "Age at Diagnosis: 50.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.73333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 69.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 119:\n",
      "Patient ID: MB-0198\n",
      "Age at Diagnosis: 43.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 144.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 142.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 120:\n",
      "Patient ID: MB-0199\n",
      "Age at Diagnosis: 57.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 144.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 142.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 121:\n",
      "Patient ID: MB-0200\n",
      "Age at Diagnosis: 69.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 122:\n",
      "Patient ID: MB-0201\n",
      "Age at Diagnosis: 49.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 123:\n",
      "Patient ID: MB-0202\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 124:\n",
      "Patient ID: MB-0203\n",
      "Age at Diagnosis: 86.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 125:\n",
      "Patient ID: MB-0204\n",
      "Age at Diagnosis: 79.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 23.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 126:\n",
      "Patient ID: MB-0205\n",
      "Age at Diagnosis: 53.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 144.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 142.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 127:\n",
      "Patient ID: MB-0206\n",
      "Age at Diagnosis: 55.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 141.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 128:\n",
      "Patient ID: MB-0207\n",
      "Age at Diagnosis: 48.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 173.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 171.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 129:\n",
      "Patient ID: MB-0209\n",
      "Age at Diagnosis: 67.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.006\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 82.36666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 81.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 3.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 130:\n",
      "Patient ID: MB-0210\n",
      "Age at Diagnosis: 63.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.01\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 144.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 143.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 131:\n",
      "Patient ID: MB-0211\n",
      "Age at Diagnosis: 42.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 44.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 132:\n",
      "Patient ID: MB-0214\n",
      "Age at Diagnosis: 41.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 144.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 133:\n",
      "Patient ID: MB-0215\n",
      "Age at Diagnosis: 75.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 122.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 134:\n",
      "Patient ID: MB-0218\n",
      "Age at Diagnosis: 43.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 135:\n",
      "Patient ID: MB-0220\n",
      "Age at Diagnosis: 37.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 39.31\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 136:\n",
      "Patient ID: MB-0221\n",
      "Age at Diagnosis: 77.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 20.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 19.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 137:\n",
      "Patient ID: MB-0222\n",
      "Age at Diagnosis: 50.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 212.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 209.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 138:\n",
      "Patient ID: MB-0223\n",
      "Age at Diagnosis: 50.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 43.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 139:\n",
      "Patient ID: MB-0224\n",
      "Age at Diagnosis: 44.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 176.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 174.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 140:\n",
      "Patient ID: MB-0225\n",
      "Age at Diagnosis: 59.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 212.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 135.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 141:\n",
      "Patient ID: MB-0226\n",
      "Age at Diagnosis: 58.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.63333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 56.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 142:\n",
      "Patient ID: MB-0227\n",
      "Age at Diagnosis: 52.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 143:\n",
      "Patient ID: MB-0228\n",
      "Age at Diagnosis: 63.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 10.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.69\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 144:\n",
      "Patient ID: MB-0229\n",
      "Age at Diagnosis: 45.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 71.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 70.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 145:\n",
      "Patient ID: MB-0230\n",
      "Age at Diagnosis: 41.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 197.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 146:\n",
      "Patient ID: MB-0231\n",
      "Age at Diagnosis: 71.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 1.06\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 19.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 19.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 147:\n",
      "Patient ID: MB-0232\n",
      "Age at Diagnosis: 44.73\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 207.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 204.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 148:\n",
      "Patient ID: MB-0233\n",
      "Age at Diagnosis: 77.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 149:\n",
      "Patient ID: MB-0234\n",
      "Age at Diagnosis: 56.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 94.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 150:\n",
      "Patient ID: MB-0235\n",
      "Age at Diagnosis: 52.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 142.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 127.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 151:\n",
      "Patient ID: MB-0236\n",
      "Age at Diagnosis: 43.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 205.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 202.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 152:\n",
      "Patient ID: MB-0238\n",
      "Age at Diagnosis: 52.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 190.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 153:\n",
      "Patient ID: MB-0239\n",
      "Age at Diagnosis: 77.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.092\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 85.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.44\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 46.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 154:\n",
      "Patient ID: MB-0241\n",
      "Age at Diagnosis: 55.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 73.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 72.17\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 155:\n",
      "Patient ID: MB-0242\n",
      "Age at Diagnosis: 51.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 196.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 156:\n",
      "Patient ID: MB-0243\n",
      "Age at Diagnosis: 53.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 157:\n",
      "Patient ID: MB-0244\n",
      "Age at Diagnosis: 67.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 147.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 158:\n",
      "Patient ID: MB-0245\n",
      "Age at Diagnosis: 54.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 1.028\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 164.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 162.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 159:\n",
      "Patient ID: MB-0247\n",
      "Age at Diagnosis: 66.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 183.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 160:\n",
      "Patient ID: MB-0248\n",
      "Age at Diagnosis: 45.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 70.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 161:\n",
      "Patient ID: MB-0249\n",
      "Age at Diagnosis: 53.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 188.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 185.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 162:\n",
      "Patient ID: MB-0253\n",
      "Age at Diagnosis: 69.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 152.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 150.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 163:\n",
      "Patient ID: MB-0256\n",
      "Age at Diagnosis: 53.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 156.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 164:\n",
      "Patient ID: MB-0257\n",
      "Age at Diagnosis: 57.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 165:\n",
      "Patient ID: MB-0258\n",
      "Age at Diagnosis: 62.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.13333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 166:\n",
      "Patient ID: MB-0259\n",
      "Age at Diagnosis: 38.99\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 11.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 11.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 167:\n",
      "Patient ID: MB-0260\n",
      "Age at Diagnosis: 78.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 1.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 169.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 167.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 168:\n",
      "Patient ID: MB-0261\n",
      "Age at Diagnosis: 63.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 86.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 169:\n",
      "Patient ID: MB-0262\n",
      "Age at Diagnosis: 55.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 179.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 170:\n",
      "Patient ID: MB-0263\n",
      "Age at Diagnosis: 76.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 1.054\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 176.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 173.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 171:\n",
      "Patient ID: MB-0264\n",
      "Age at Diagnosis: 83.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 42.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 172:\n",
      "Patient ID: MB-0265\n",
      "Age at Diagnosis: 46.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 189.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 186.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 173:\n",
      "Patient ID: MB-0266\n",
      "Age at Diagnosis: 84.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 1.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 90.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 89.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 174:\n",
      "Patient ID: MB-0268\n",
      "Age at Diagnosis: 66.54\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 175:\n",
      "Patient ID: MB-0269\n",
      "Age at Diagnosis: 45.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 176:\n",
      "Patient ID: MB-0270\n",
      "Age at Diagnosis: 29.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 337.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 139.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 177:\n",
      "Patient ID: MB-0272\n",
      "Age at Diagnosis: 55.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 120.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 178:\n",
      "Patient ID: MB-0273\n",
      "Age at Diagnosis: 68.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 184.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 179:\n",
      "Patient ID: MB-0275\n",
      "Age at Diagnosis: 61.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.018\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 183.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 180:\n",
      "Patient ID: MB-0278\n",
      "Age at Diagnosis: 34.3\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.106\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 5.833333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 5.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 53.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 181:\n",
      "Patient ID: MB-0279\n",
      "Age at Diagnosis: 69.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.042\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 192.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 189.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 182:\n",
      "Patient ID: MB-0280\n",
      "Age at Diagnosis: 47.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 172.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 170.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 183:\n",
      "Patient ID: MB-0281\n",
      "Age at Diagnosis: 52.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Sarcoma\n",
      "Cancer Type Detailed: Breast Angiosarcoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.0\n",
      "Oncotree Code: PBS\n",
      "Overall Survival (Months): 72.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 184:\n",
      "Patient ID: MB-0282\n",
      "Age at Diagnosis: 51.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 194.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 175.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 185:\n",
      "Patient ID: MB-0283\n",
      "Age at Diagnosis: 60.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.066\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 186:\n",
      "Patient ID: MB-0284\n",
      "Age at Diagnosis: 51.42\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Sarcoma\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 0.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 187:\n",
      "Patient ID: MB-0285\n",
      "Age at Diagnosis: 48.07\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 3.366666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 3.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 188:\n",
      "Patient ID: MB-0286\n",
      "Age at Diagnosis: 62.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 192.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 190.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 189:\n",
      "Patient ID: MB-0287\n",
      "Age at Diagnosis: 77.54\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 94.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 93.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 190:\n",
      "Patient ID: MB-0288\n",
      "Age at Diagnosis: 55.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 25.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 191:\n",
      "Patient ID: MB-0289\n",
      "Age at Diagnosis: 75.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 70.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 192:\n",
      "Patient ID: MB-0290\n",
      "Age at Diagnosis: 49.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 196.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 193:\n",
      "Patient ID: MB-0291\n",
      "Age at Diagnosis: 51.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 38.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 194:\n",
      "Patient ID: MB-0292\n",
      "Age at Diagnosis: 80.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 48.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 195:\n",
      "Patient ID: MB-0293\n",
      "Age at Diagnosis: 51.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 64.36666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 63.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 196:\n",
      "Patient ID: MB-0294\n",
      "Age at Diagnosis: 46.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 71.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 197:\n",
      "Patient ID: MB-0295\n",
      "Age at Diagnosis: 47.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.018\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 162.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 198:\n",
      "Patient ID: MB-0299\n",
      "Age at Diagnosis: 68.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.05\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 188.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 185.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 199:\n",
      "Patient ID: MB-0301\n",
      "Age at Diagnosis: 82.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 200:\n",
      "Patient ID: MB-0302\n",
      "Age at Diagnosis: 81.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.058\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 84.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 83.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 201:\n",
      "Patient ID: MB-0303\n",
      "Age at Diagnosis: 47.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 60.13333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 59.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 202:\n",
      "Patient ID: MB-0304\n",
      "Age at Diagnosis: 84.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 110.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 203:\n",
      "Patient ID: MB-0305\n",
      "Age at Diagnosis: 60.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 204:\n",
      "Patient ID: MB-0306\n",
      "Age at Diagnosis: 82.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 21.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 37.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 205:\n",
      "Patient ID: MB-0307\n",
      "Age at Diagnosis: 41.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 177.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 175.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 206:\n",
      "Patient ID: MB-0308\n",
      "Age at Diagnosis: 51.21\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.038\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 183.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 180.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 207:\n",
      "Patient ID: MB-0309\n",
      "Age at Diagnosis: 89.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 208:\n",
      "Patient ID: MB-0310\n",
      "Age at Diagnosis: 67.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 182.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 209:\n",
      "Patient ID: MB-0311\n",
      "Age at Diagnosis: 77.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.094\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 151.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 149.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 210:\n",
      "Patient ID: MB-0312\n",
      "Age at Diagnosis: 70.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.066\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 169.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 211:\n",
      "Patient ID: MB-0313\n",
      "Age at Diagnosis: 55.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 184.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 182.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 212:\n",
      "Patient ID: MB-0314\n",
      "Age at Diagnosis: 73.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 4.433333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 4.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 213:\n",
      "Patient ID: MB-0315\n",
      "Age at Diagnosis: 56.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 183.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 214:\n",
      "Patient ID: MB-0316\n",
      "Age at Diagnosis: 50.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 180.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 215:\n",
      "Patient ID: MB-0317\n",
      "Age at Diagnosis: 76.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 151.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 149.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 216:\n",
      "Patient ID: MB-0318\n",
      "Age at Diagnosis: 58.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 1.036\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 168.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 166.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 217:\n",
      "Patient ID: MB-0319\n",
      "Age at Diagnosis: 92.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.064\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 40.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 39.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 218:\n",
      "Patient ID: MB-0320\n",
      "Age at Diagnosis: 50.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 2.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 63.73333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 62.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 219:\n",
      "Patient ID: MB-0321\n",
      "Age at Diagnosis: 46.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 172.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 220:\n",
      "Patient ID: MB-0322\n",
      "Age at Diagnosis: 86.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 49.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 221:\n",
      "Patient ID: MB-0324\n",
      "Age at Diagnosis: 47.64\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 144.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 73.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 222:\n",
      "Patient ID: MB-0325\n",
      "Age at Diagnosis: 79.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 177.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 175.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 223:\n",
      "Patient ID: MB-0326\n",
      "Age at Diagnosis: 51.45\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.24\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 191.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 224:\n",
      "Patient ID: MB-0327\n",
      "Age at Diagnosis: 66.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 187.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 185.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 225:\n",
      "Patient ID: MB-0328\n",
      "Age at Diagnosis: 69.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.068\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 125.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 226:\n",
      "Patient ID: MB-0329\n",
      "Age at Diagnosis: 76.84\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 25.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 227:\n",
      "Patient ID: MB-0333\n",
      "Age at Diagnosis: 62.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Metaplastic Breast Cancer\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Metaplastic\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.0\n",
      "Oncotree Code: MBC\n",
      "Overall Survival (Months): 26.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 26.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 228:\n",
      "Patient ID: MB-0336\n",
      "Age at Diagnosis: 74.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 170.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 166.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 229:\n",
      "Patient ID: MB-0339\n",
      "Age at Diagnosis: 90.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.048\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 26.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 26.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 230:\n",
      "Patient ID: MB-0340\n",
      "Age at Diagnosis: 79.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 231:\n",
      "Patient ID: MB-0341\n",
      "Age at Diagnosis: 67.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 173.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 167.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 232:\n",
      "Patient ID: MB-0342\n",
      "Age at Diagnosis: 54.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.058\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 125.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 123.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 233:\n",
      "Patient ID: MB-0343\n",
      "Age at Diagnosis: 70.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 86.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 234:\n",
      "Patient ID: MB-0344\n",
      "Age at Diagnosis: 59.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 152.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 150.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 235:\n",
      "Patient ID: MB-0345\n",
      "Age at Diagnosis: 37.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.66666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 236:\n",
      "Patient ID: MB-0346\n",
      "Age at Diagnosis: 32.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 20.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 20.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 237:\n",
      "Patient ID: MB-0347\n",
      "Age at Diagnosis: 52.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 205.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 182.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 238:\n",
      "Patient ID: MB-0348\n",
      "Age at Diagnosis: 81.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 239:\n",
      "Patient ID: MB-0349\n",
      "Age at Diagnosis: 72.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 144.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 240:\n",
      "Patient ID: MB-0350\n",
      "Age at Diagnosis: 49.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 45.46\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 241:\n",
      "Patient ID: MB-0351\n",
      "Age at Diagnosis: 69.53\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.0\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 195.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 192.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 242:\n",
      "Patient ID: MB-0352\n",
      "Age at Diagnosis: 61.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 45.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 243:\n",
      "Patient ID: MB-0353\n",
      "Age at Diagnosis: 86.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 41.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 41.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 244:\n",
      "Patient ID: MB-0354\n",
      "Age at Diagnosis: 73.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 11.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 11.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 245:\n",
      "Patient ID: MB-0356\n",
      "Age at Diagnosis: 58.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 213.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 210.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 246:\n",
      "Patient ID: MB-0358\n",
      "Age at Diagnosis: 57.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 247:\n",
      "Patient ID: MB-0359\n",
      "Age at Diagnosis: 44.21\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 248:\n",
      "Patient ID: MB-0360\n",
      "Age at Diagnosis: 83.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 130.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 249:\n",
      "Patient ID: MB-0361\n",
      "Age at Diagnosis: 40.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 41.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 14.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 250:\n",
      "Patient ID: MB-0362\n",
      "Age at Diagnosis: 52.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 47.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 46.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 251:\n",
      "Patient ID: MB-0363\n",
      "Age at Diagnosis: 73.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 22.0\n",
      "Nottingham prognostic index: 5.134\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 89.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 88.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 67.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 252:\n",
      "Patient ID: MB-0364\n",
      "Age at Diagnosis: 48.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 176.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 253:\n",
      "Patient ID: MB-0365\n",
      "Age at Diagnosis: 76.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 87.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 86.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 254:\n",
      "Patient ID: MB-0366\n",
      "Age at Diagnosis: 51.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 64.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 63.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 255:\n",
      "Patient ID: MB-0367\n",
      "Age at Diagnosis: 70.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.018\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 142.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 140.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 256:\n",
      "Patient ID: MB-0368\n",
      "Age at Diagnosis: 74.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 31.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 257:\n",
      "Patient ID: MB-0369\n",
      "Age at Diagnosis: 65.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.054\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 144.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.9\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 258:\n",
      "Patient ID: MB-0370\n",
      "Age at Diagnosis: 64.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.094\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 93.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 259:\n",
      "Patient ID: MB-0371\n",
      "Age at Diagnosis: 78.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 260:\n",
      "Patient ID: MB-0372\n",
      "Age at Diagnosis: 39.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 62.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 46.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 261:\n",
      "Patient ID: MB-0373\n",
      "Age at Diagnosis: 63.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 262:\n",
      "Patient ID: MB-0374\n",
      "Age at Diagnosis: 34.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 1.433333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 1.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 263:\n",
      "Patient ID: MB-0375\n",
      "Age at Diagnosis: 72.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 143.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 141.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 264:\n",
      "Patient ID: MB-0377\n",
      "Age at Diagnosis: 63.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 134.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 132.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 265:\n",
      "Patient ID: MB-0378\n",
      "Age at Diagnosis: 57.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 97.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 96.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 266:\n",
      "Patient ID: MB-0379\n",
      "Age at Diagnosis: 48.22\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 135.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 117.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 267:\n",
      "Patient ID: MB-0380\n",
      "Age at Diagnosis: 83.9\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 69.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 68.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 268:\n",
      "Patient ID: MB-0381\n",
      "Age at Diagnosis: 33.65\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 128.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 269:\n",
      "Patient ID: MB-0382\n",
      "Age at Diagnosis: 59.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 134.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 270:\n",
      "Patient ID: MB-0383\n",
      "Age at Diagnosis: 65.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 84.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 271:\n",
      "Patient ID: MB-0384\n",
      "Age at Diagnosis: 74.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.086\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 55.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 43.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 272:\n",
      "Patient ID: MB-0385\n",
      "Age at Diagnosis: 66.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 273:\n",
      "Patient ID: MB-0386\n",
      "Age at Diagnosis: 66.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 138.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 274:\n",
      "Patient ID: MB-0388\n",
      "Age at Diagnosis: 46.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 97.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 96.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 275:\n",
      "Patient ID: MB-0389\n",
      "Age at Diagnosis: 46.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 19.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 96.96666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 95.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 276:\n",
      "Patient ID: MB-0390\n",
      "Age at Diagnosis: 40.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 46.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 277:\n",
      "Patient ID: MB-0391\n",
      "Age at Diagnosis: 61.23\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 142.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 140.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 278:\n",
      "Patient ID: MB-0392\n",
      "Age at Diagnosis: 56.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 8.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 279:\n",
      "Patient ID: MB-0393\n",
      "Age at Diagnosis: 68.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.106\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 20.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.65\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 53.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 280:\n",
      "Patient ID: MB-0394\n",
      "Age at Diagnosis: 56.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 64.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 281:\n",
      "Patient ID: MB-0395\n",
      "Age at Diagnosis: 80.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.48\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 282:\n",
      "Patient ID: MB-0396\n",
      "Age at Diagnosis: 56.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 60.66666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 59.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 283:\n",
      "Patient ID: MB-0397\n",
      "Age at Diagnosis: 58.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 56.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 284:\n",
      "Patient ID: MB-0398\n",
      "Age at Diagnosis: 56.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 19.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.084\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 37.73\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 42.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 285:\n",
      "Patient ID: MB-0399\n",
      "Age at Diagnosis: 68.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 137.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 66.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 286:\n",
      "Patient ID: MB-0400\n",
      "Age at Diagnosis: 55.28\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 287:\n",
      "Patient ID: MB-0401\n",
      "Age at Diagnosis: 48.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 26.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 288:\n",
      "Patient ID: MB-0402\n",
      "Age at Diagnosis: 73.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 99.73333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 98.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 289:\n",
      "Patient ID: MB-0403\n",
      "Age at Diagnosis: 58.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Sarcoma\n",
      "Cancer Type Detailed: Breast Angiosarcoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.0\n",
      "Oncotree Code: PBS\n",
      "Overall Survival (Months): 141.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 139.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 290:\n",
      "Patient ID: MB-0404\n",
      "Age at Diagnosis: 60.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 62.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 291:\n",
      "Patient ID: MB-0405\n",
      "Age at Diagnosis: 72.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 58.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 292:\n",
      "Patient ID: MB-0406\n",
      "Age at Diagnosis: 69.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 17.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.36\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 96.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 31.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 180.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 293:\n",
      "Patient ID: MB-0408\n",
      "Age at Diagnosis: 51.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.094\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 294:\n",
      "Patient ID: MB-0410\n",
      "Age at Diagnosis: 57.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 63.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 62.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 295:\n",
      "Patient ID: MB-0411\n",
      "Age at Diagnosis: 54.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 139.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 137.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 296:\n",
      "Patient ID: MB-0412\n",
      "Age at Diagnosis: 54.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 134.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 297:\n",
      "Patient ID: MB-0413\n",
      "Age at Diagnosis: 56.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.094\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 298:\n",
      "Patient ID: MB-0414\n",
      "Age at Diagnosis: 72.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 76.63333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 75.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 299:\n",
      "Patient ID: MB-0417\n",
      "Age at Diagnosis: 54.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 6.266666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 6.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 300:\n",
      "Patient ID: MB-0418\n",
      "Age at Diagnosis: 58.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 301:\n",
      "Patient ID: MB-0419\n",
      "Age at Diagnosis: 77.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 302:\n",
      "Patient ID: MB-0420\n",
      "Age at Diagnosis: 34.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 76.73333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 75.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 303:\n",
      "Patient ID: MB-0421\n",
      "Age at Diagnosis: 73.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 93.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 91.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 304:\n",
      "Patient ID: MB-0422\n",
      "Age at Diagnosis: 66.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 33.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 305:\n",
      "Patient ID: MB-0423\n",
      "Age at Diagnosis: 71.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 138.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 137.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 306:\n",
      "Patient ID: MB-0424\n",
      "Age at Diagnosis: 44.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 22.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 9.833333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 307:\n",
      "Patient ID: MB-0425\n",
      "Age at Diagnosis: 83.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 308:\n",
      "Patient ID: MB-0426\n",
      "Age at Diagnosis: 50.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.084\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 42.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 309:\n",
      "Patient ID: MB-0427\n",
      "Age at Diagnosis: 81.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 116.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 114.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 310:\n",
      "Patient ID: MB-0428\n",
      "Age at Diagnosis: 85.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.93333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 55.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 311:\n",
      "Patient ID: MB-0429\n",
      "Age at Diagnosis: 78.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 74.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 73.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 312:\n",
      "Patient ID: MB-0431\n",
      "Age at Diagnosis: 63.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.114\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 85.13333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 57.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 313:\n",
      "Patient ID: MB-0432\n",
      "Age at Diagnosis: 60.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 105.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 104.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 314:\n",
      "Patient ID: MB-0434\n",
      "Age at Diagnosis: 69.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 315:\n",
      "Patient ID: MB-0435\n",
      "Age at Diagnosis: 68.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.008\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 110.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 109.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 4.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 316:\n",
      "Patient ID: MB-0436\n",
      "Age at Diagnosis: 88.29\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 74.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 317:\n",
      "Patient ID: MB-0437\n",
      "Age at Diagnosis: 82.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 90.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 89.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 318:\n",
      "Patient ID: MB-0438\n",
      "Age at Diagnosis: 57.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 135.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 133.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 319:\n",
      "Patient ID: MB-0439\n",
      "Age at Diagnosis: 50.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 112.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 320:\n",
      "Patient ID: MB-0440\n",
      "Age at Diagnosis: 56.73\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 100.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 99.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 321:\n",
      "Patient ID: MB-0442\n",
      "Age at Diagnosis: 71.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 103.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 102.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 322:\n",
      "Patient ID: MB-0443\n",
      "Age at Diagnosis: 61.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.03333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 44.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 323:\n",
      "Patient ID: MB-0444\n",
      "Age at Diagnosis: 49.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 18.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.066\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 55.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 324:\n",
      "Patient ID: MB-0445\n",
      "Age at Diagnosis: 40.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 130.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 325:\n",
      "Patient ID: MB-0446\n",
      "Age at Diagnosis: 56.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 326:\n",
      "Patient ID: MB-0448\n",
      "Age at Diagnosis: 59.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 327:\n",
      "Patient ID: MB-0449\n",
      "Age at Diagnosis: 54.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 112.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 111.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 328:\n",
      "Patient ID: MB-0451\n",
      "Age at Diagnosis: 63.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.06666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 49.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 329:\n",
      "Patient ID: MB-0452\n",
      "Age at Diagnosis: 54.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 62.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 61.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 330:\n",
      "Patient ID: MB-0453\n",
      "Age at Diagnosis: 61.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.2\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.12\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 100.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 331:\n",
      "Patient ID: MB-0454\n",
      "Age at Diagnosis: 90.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 46.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 46.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 332:\n",
      "Patient ID: MB-0455\n",
      "Age at Diagnosis: 56.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 99.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 98.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 333:\n",
      "Patient ID: MB-0458\n",
      "Age at Diagnosis: 49.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 134.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 334:\n",
      "Patient ID: MB-0459\n",
      "Age at Diagnosis: 85.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 35.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 335:\n",
      "Patient ID: MB-0460\n",
      "Age at Diagnosis: 81.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 114.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 94.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 336:\n",
      "Patient ID: MB-0462\n",
      "Age at Diagnosis: 60.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 131.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 337:\n",
      "Patient ID: MB-0463\n",
      "Age at Diagnosis: 60.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 120.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 118.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 338:\n",
      "Patient ID: MB-0464\n",
      "Age at Diagnosis: 58.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 17.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 339:\n",
      "Patient ID: MB-0465\n",
      "Age at Diagnosis: 87.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 340:\n",
      "Patient ID: MB-0466\n",
      "Age at Diagnosis: 33.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 43.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 341:\n",
      "Patient ID: MB-0467\n",
      "Age at Diagnosis: 58.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 105.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 342:\n",
      "Patient ID: MB-0468\n",
      "Age at Diagnosis: 60.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 129.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 127.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 343:\n",
      "Patient ID: MB-0469\n",
      "Age at Diagnosis: 67.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.54\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 344:\n",
      "Patient ID: MB-0470\n",
      "Age at Diagnosis: 61.78\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 88.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 345:\n",
      "Patient ID: MB-0471\n",
      "Age at Diagnosis: 76.49\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 107.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 106.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 346:\n",
      "Patient ID: MB-0472\n",
      "Age at Diagnosis: 59.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.022\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 27.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.04\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 347:\n",
      "Patient ID: MB-0474\n",
      "Age at Diagnosis: 54.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 98.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 348:\n",
      "Patient ID: MB-0475\n",
      "Age at Diagnosis: 54.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 128.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 349:\n",
      "Patient ID: MB-0476\n",
      "Age at Diagnosis: 54.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 128.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 350:\n",
      "Patient ID: MB-0478\n",
      "Age at Diagnosis: 74.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 130.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 351:\n",
      "Patient ID: MB-0479\n",
      "Age at Diagnosis: 33.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 131.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 352:\n",
      "Patient ID: MB-0480\n",
      "Age at Diagnosis: 51.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 94.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 93.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 353:\n",
      "Patient ID: MB-0481\n",
      "Age at Diagnosis: 54.22\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.42\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 354:\n",
      "Patient ID: MB-0482\n",
      "Age at Diagnosis: 39.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 355:\n",
      "Patient ID: MB-0483\n",
      "Age at Diagnosis: 49.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 74.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 356:\n",
      "Patient ID: MB-0484\n",
      "Age at Diagnosis: 38.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 82.63333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 81.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 357:\n",
      "Patient ID: MB-0485\n",
      "Age at Diagnosis: 60.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 36.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.85\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 358:\n",
      "Patient ID: MB-0486\n",
      "Age at Diagnosis: 57.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.96666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 88.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 359:\n",
      "Patient ID: MB-0487\n",
      "Age at Diagnosis: 57.36\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 360:\n",
      "Patient ID: MB-0488\n",
      "Age at Diagnosis: 50.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 112.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 111.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 361:\n",
      "Patient ID: MB-0489\n",
      "Age at Diagnosis: 41.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 89.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 362:\n",
      "Patient ID: MB-0490\n",
      "Age at Diagnosis: 81.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 363:\n",
      "Patient ID: MB-0491\n",
      "Age at Diagnosis: 43.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 125.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 364:\n",
      "Patient ID: MB-0492\n",
      "Age at Diagnosis: 85.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 81.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 80.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 365:\n",
      "Patient ID: MB-0494\n",
      "Age at Diagnosis: 77.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 21.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 366:\n",
      "Patient ID: MB-0495\n",
      "Age at Diagnosis: 63.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 44.08\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 367:\n",
      "Patient ID: MB-0496\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 368:\n",
      "Patient ID: MB-0497\n",
      "Age at Diagnosis: 57.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 73.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 72.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 369:\n",
      "Patient ID: MB-0499\n",
      "Age at Diagnosis: 50.15\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.008\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 131.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 130.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 4.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 370:\n",
      "Patient ID: MB-0500\n",
      "Age at Diagnosis: 36.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 67.46666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 66.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 371:\n",
      "Patient ID: MB-0501\n",
      "Age at Diagnosis: 48.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 70.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 372:\n",
      "Patient ID: MB-0502\n",
      "Age at Diagnosis: 56.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 82.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 81.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 373:\n",
      "Patient ID: MB-0503\n",
      "Age at Diagnosis: 60.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 99.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 374:\n",
      "Patient ID: MB-0504\n",
      "Age at Diagnosis: 68.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 375:\n",
      "Patient ID: MB-0505\n",
      "Age at Diagnosis: 56.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 60.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 59.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 376:\n",
      "Patient ID: MB-0506\n",
      "Age at Diagnosis: 60.74\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 29.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 377:\n",
      "Patient ID: MB-0507\n",
      "Age at Diagnosis: 58.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 23.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 378:\n",
      "Patient ID: MB-0508\n",
      "Age at Diagnosis: 42.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 112.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 379:\n",
      "Patient ID: MB-0509\n",
      "Age at Diagnosis: 41.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 115.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 113.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 380:\n",
      "Patient ID: MB-0510\n",
      "Age at Diagnosis: 71.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 381:\n",
      "Patient ID: MB-0511\n",
      "Age at Diagnosis: 59.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 60.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 382:\n",
      "Patient ID: MB-0512\n",
      "Age at Diagnosis: 56.74\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 121.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 119.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 383:\n",
      "Patient ID: MB-0513\n",
      "Age at Diagnosis: 73.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 115.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 384:\n",
      "Patient ID: MB-0514\n",
      "Age at Diagnosis: 42.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 13.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 385:\n",
      "Patient ID: MB-0516\n",
      "Age at Diagnosis: 62.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 112.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 386:\n",
      "Patient ID: MB-0517\n",
      "Age at Diagnosis: 47.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 61.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 387:\n",
      "Patient ID: MB-0519\n",
      "Age at Diagnosis: 61.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 23.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.13\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 388:\n",
      "Patient ID: MB-0521\n",
      "Age at Diagnosis: 52.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 212.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 209.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 389:\n",
      "Patient ID: MB-0522\n",
      "Age at Diagnosis: 54.08\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.0\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 2.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 2.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 390:\n",
      "Patient ID: MB-0524\n",
      "Age at Diagnosis: 40.65\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 80.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 79.77\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 391:\n",
      "Patient ID: MB-0525\n",
      "Age at Diagnosis: 48.47\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 65.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 392:\n",
      "Patient ID: MB-0526\n",
      "Age at Diagnosis: 72.18\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 139.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 137.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 393:\n",
      "Patient ID: MB-0527\n",
      "Age at Diagnosis: 73.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 109.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 106.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 394:\n",
      "Patient ID: MB-0528\n",
      "Age at Diagnosis: 53.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 175.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 395:\n",
      "Patient ID: MB-0529\n",
      "Age at Diagnosis: 67.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 47.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 396:\n",
      "Patient ID: MB-0531\n",
      "Age at Diagnosis: 60.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 39.31\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 397:\n",
      "Patient ID: MB-0532\n",
      "Age at Diagnosis: 59.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 143.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 398:\n",
      "Patient ID: MB-0534\n",
      "Age at Diagnosis: 51.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 399:\n",
      "Patient ID: MB-0535\n",
      "Age at Diagnosis: 46.66\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 159.77\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 400:\n",
      "Patient ID: MB-0536\n",
      "Age at Diagnosis: 67.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 147.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 145.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 401:\n",
      "Patient ID: MB-0537\n",
      "Age at Diagnosis: 59.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 113.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 112.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 402:\n",
      "Patient ID: MB-0538\n",
      "Age at Diagnosis: 61.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 26.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 23.65\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 403:\n",
      "Patient ID: MB-0539\n",
      "Age at Diagnosis: 64.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.04\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 85.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 84.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 404:\n",
      "Patient ID: MB-0540\n",
      "Age at Diagnosis: 66.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.024\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 194.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 405:\n",
      "Patient ID: MB-0541\n",
      "Age at Diagnosis: 38.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 171.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 406:\n",
      "Patient ID: MB-0542\n",
      "Age at Diagnosis: 39.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 47.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 407:\n",
      "Patient ID: MB-0543\n",
      "Age at Diagnosis: 45.9\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 154.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 152.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 408:\n",
      "Patient ID: MB-0544\n",
      "Age at Diagnosis: 74.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.104\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 78.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 52.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 409:\n",
      "Patient ID: MB-0545\n",
      "Age at Diagnosis: 83.92\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 41.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 410:\n",
      "Patient ID: MB-0546\n",
      "Age at Diagnosis: 51.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 411:\n",
      "Patient ID: MB-0547\n",
      "Age at Diagnosis: 66.73\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.48\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 185.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 412:\n",
      "Patient ID: MB-0549\n",
      "Age at Diagnosis: 76.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.96666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 25.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 413:\n",
      "Patient ID: MB-0550\n",
      "Age at Diagnosis: 60.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 91.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 414:\n",
      "Patient ID: MB-0551\n",
      "Age at Diagnosis: 76.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 51.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 415:\n",
      "Patient ID: MB-0552\n",
      "Age at Diagnosis: 61.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 68.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 55.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 416:\n",
      "Patient ID: MB-0553\n",
      "Age at Diagnosis: 86.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 417:\n",
      "Patient ID: MB-0554\n",
      "Age at Diagnosis: 82.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 2.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 109.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 418:\n",
      "Patient ID: MB-0558\n",
      "Age at Diagnosis: 69.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 97.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 96.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 419:\n",
      "Patient ID: MB-0559\n",
      "Age at Diagnosis: 47.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 161.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 159.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 420:\n",
      "Patient ID: MB-0564\n",
      "Age at Diagnosis: 48.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 421:\n",
      "Patient ID: MB-0568\n",
      "Age at Diagnosis: 61.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 181.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 179.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 422:\n",
      "Patient ID: MB-0569\n",
      "Age at Diagnosis: 74.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 55.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 423:\n",
      "Patient ID: MB-0570\n",
      "Age at Diagnosis: 68.99\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 272.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 424:\n",
      "Patient ID: MB-0571\n",
      "Age at Diagnosis: 61.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 425:\n",
      "Patient ID: MB-0573\n",
      "Age at Diagnosis: 76.22\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.13\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 426:\n",
      "Patient ID: MB-0574\n",
      "Age at Diagnosis: 71.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 427:\n",
      "Patient ID: MB-0575\n",
      "Age at Diagnosis: 48.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 77.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 428:\n",
      "Patient ID: MB-0576\n",
      "Age at Diagnosis: 68.47\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 429:\n",
      "Patient ID: MB-0577\n",
      "Age at Diagnosis: 51.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 65.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.54\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 430:\n",
      "Patient ID: MB-0578\n",
      "Age at Diagnosis: 59.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.084\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 110.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 108.65\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 42.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 431:\n",
      "Patient ID: MB-0579\n",
      "Age at Diagnosis: 70.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 92.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 91.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 432:\n",
      "Patient ID: MB-0580\n",
      "Age at Diagnosis: 33.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 58.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 433:\n",
      "Patient ID: MB-0581\n",
      "Age at Diagnosis: 96.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 7.866666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 7.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 434:\n",
      "Patient ID: MB-0582\n",
      "Age at Diagnosis: 84.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 15.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 15.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 435:\n",
      "Patient ID: MB-0583\n",
      "Age at Diagnosis: 75.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 62.63333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 61.81\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 436:\n",
      "Patient ID: MB-0584\n",
      "Age at Diagnosis: 41.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 116.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 437:\n",
      "Patient ID: MB-0585\n",
      "Age at Diagnosis: 76.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 115.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 96.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 438:\n",
      "Patient ID: MB-0586\n",
      "Age at Diagnosis: 77.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.13\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 77.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 76.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 439:\n",
      "Patient ID: MB-0587\n",
      "Age at Diagnosis: 50.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 91.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 90.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 440:\n",
      "Patient ID: MB-0588\n",
      "Age at Diagnosis: 76.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 118.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 441:\n",
      "Patient ID: MB-0589\n",
      "Age at Diagnosis: 59.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 25.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 125.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 2.04\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 442:\n",
      "Patient ID: MB-0590\n",
      "Age at Diagnosis: 60.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 71.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 443:\n",
      "Patient ID: MB-0591\n",
      "Age at Diagnosis: 84.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 116.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 444:\n",
      "Patient ID: MB-0592\n",
      "Age at Diagnosis: 74.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.11\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 74.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 445:\n",
      "Patient ID: MB-0593\n",
      "Age at Diagnosis: 62.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.18\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 34.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 90.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 446:\n",
      "Patient ID: MB-0594\n",
      "Age at Diagnosis: 77.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 43.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 447:\n",
      "Patient ID: MB-0596\n",
      "Age at Diagnosis: 77.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 107.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 105.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 448:\n",
      "Patient ID: MB-0597\n",
      "Age at Diagnosis: 64.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 113.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 111.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 449:\n",
      "Patient ID: MB-0598\n",
      "Age at Diagnosis: 77.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 71.12\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 450:\n",
      "Patient ID: MB-0599\n",
      "Age at Diagnosis: 46.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 52.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 451:\n",
      "Patient ID: MB-0600\n",
      "Age at Diagnosis: 70.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.054\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 111.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.54\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 452:\n",
      "Patient ID: MB-0601\n",
      "Age at Diagnosis: 32.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 453:\n",
      "Patient ID: MB-0603\n",
      "Age at Diagnosis: 79.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 121.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 120.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 454:\n",
      "Patient ID: MB-0605\n",
      "Age at Diagnosis: 58.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 114.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 113.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 455:\n",
      "Patient ID: MB-0606\n",
      "Age at Diagnosis: 83.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 27.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 27.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 456:\n",
      "Patient ID: MB-0607\n",
      "Age at Diagnosis: 53.1\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 86.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 457:\n",
      "Patient ID: MB-0608\n",
      "Age at Diagnosis: 76.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 458:\n",
      "Patient ID: MB-0609\n",
      "Age at Diagnosis: 51.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 72.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 459:\n",
      "Patient ID: MB-0610\n",
      "Age at Diagnosis: 71.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 76.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 75.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 460:\n",
      "Patient ID: MB-0611\n",
      "Age at Diagnosis: 75.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 103.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 461:\n",
      "Patient ID: MB-0613\n",
      "Age at Diagnosis: 60.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.12\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 48.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 462:\n",
      "Patient ID: MB-0614\n",
      "Age at Diagnosis: 48.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 117.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 463:\n",
      "Patient ID: MB-0615\n",
      "Age at Diagnosis: 38.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.006\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 34.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 3.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 464:\n",
      "Patient ID: MB-0616\n",
      "Age at Diagnosis: 75.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 465:\n",
      "Patient ID: MB-0617\n",
      "Age at Diagnosis: 72.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.08\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 92.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 91.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 466:\n",
      "Patient ID: MB-0618\n",
      "Age at Diagnosis: 63.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 100.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 467:\n",
      "Patient ID: MB-0619\n",
      "Age at Diagnosis: 38.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 94.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 468:\n",
      "Patient ID: MB-0620\n",
      "Age at Diagnosis: 62.97\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.028\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 112.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 111.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 469:\n",
      "Patient ID: MB-0621\n",
      "Age at Diagnosis: 70.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 33.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 470:\n",
      "Patient ID: MB-0623\n",
      "Age at Diagnosis: 66.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 471:\n",
      "Patient ID: MB-0624\n",
      "Age at Diagnosis: 64.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 64.03333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 63.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 472:\n",
      "Patient ID: MB-0626\n",
      "Age at Diagnosis: 61.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 35.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 473:\n",
      "Patient ID: MB-0627\n",
      "Age at Diagnosis: 54.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 0.766666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 474:\n",
      "Patient ID: MB-0628\n",
      "Age at Diagnosis: 63.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 105.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 104.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 475:\n",
      "Patient ID: MB-0630\n",
      "Age at Diagnosis: 38.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 476:\n",
      "Patient ID: MB-0631\n",
      "Age at Diagnosis: 84.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 47.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.33\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 477:\n",
      "Patient ID: MB-0632\n",
      "Age at Diagnosis: 51.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 56.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 55.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 478:\n",
      "Patient ID: MB-0634\n",
      "Age at Diagnosis: 55.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.01\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 17.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 479:\n",
      "Patient ID: MB-0635\n",
      "Age at Diagnosis: 76.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 86.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 480:\n",
      "Patient ID: MB-0636\n",
      "Age at Diagnosis: 26.36\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 481:\n",
      "Patient ID: MB-0637\n",
      "Age at Diagnosis: 75.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 80.66666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 482:\n",
      "Patient ID: MB-0638\n",
      "Age at Diagnosis: 66.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.064\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 103.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.4\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 483:\n",
      "Patient ID: MB-0639\n",
      "Age at Diagnosis: 50.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 74.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 484:\n",
      "Patient ID: MB-0640\n",
      "Age at Diagnosis: 66.09\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 60.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 485:\n",
      "Patient ID: MB-0641\n",
      "Age at Diagnosis: 56.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 101.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 486:\n",
      "Patient ID: MB-0642\n",
      "Age at Diagnosis: 79.12\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 84.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 83.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 487:\n",
      "Patient ID: MB-0643\n",
      "Age at Diagnosis: 73.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 488:\n",
      "Patient ID: MB-0644\n",
      "Age at Diagnosis: 71.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 93.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 489:\n",
      "Patient ID: MB-0646\n",
      "Age at Diagnosis: 67.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.066\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 15.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 490:\n",
      "Patient ID: MB-0649\n",
      "Age at Diagnosis: 60.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.016\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.43333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 60.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 491:\n",
      "Patient ID: MB-0650\n",
      "Age at Diagnosis: 79.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.53333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 492:\n",
      "Patient ID: MB-0652\n",
      "Age at Diagnosis: 85.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 96.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 95.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 493:\n",
      "Patient ID: MB-0653\n",
      "Age at Diagnosis: 69.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 22.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 24.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 494:\n",
      "Patient ID: MB-0654\n",
      "Age at Diagnosis: 82.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 69.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 68.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 495:\n",
      "Patient ID: MB-0655\n",
      "Age at Diagnosis: 69.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 1.12\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 111.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 109.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 496:\n",
      "Patient ID: MB-0656\n",
      "Age at Diagnosis: 35.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.2\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 5.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 100.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 497:\n",
      "Patient ID: MB-0657\n",
      "Age at Diagnosis: 58.65\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.2\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 30.43333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 100.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 498:\n",
      "Patient ID: MB-0658\n",
      "Age at Diagnosis: 60.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 97.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 95.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 499:\n",
      "Patient ID: MB-0659\n",
      "Age at Diagnosis: 82.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.09\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 23.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 23.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 500:\n",
      "Patient ID: MB-0660\n",
      "Age at Diagnosis: 52.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 22.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.32\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 18.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 160.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 501:\n",
      "Patient ID: MB-0661\n",
      "Age at Diagnosis: 78.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.016\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 20.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 15.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 502:\n",
      "Patient ID: MB-0662\n",
      "Age at Diagnosis: 50.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 69.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 51.25\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 503:\n",
      "Patient ID: MB-0663\n",
      "Age at Diagnosis: 57.76\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.36666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 54.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 504:\n",
      "Patient ID: MB-0664\n",
      "Age at Diagnosis: 78.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.168\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 11.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.92\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 84.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 505:\n",
      "Patient ID: MB-0666\n",
      "Age at Diagnosis: 61.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.12\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 506:\n",
      "Patient ID: MB-0667\n",
      "Age at Diagnosis: 76.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 507:\n",
      "Patient ID: MB-0869\n",
      "Age at Diagnosis: 58.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 112.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 110.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 508:\n",
      "Patient ID: MB-0872\n",
      "Age at Diagnosis: 82.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 152.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 150.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 509:\n",
      "Patient ID: MB-0874\n",
      "Age at Diagnosis: 59.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 510:\n",
      "Patient ID: MB-0876\n",
      "Age at Diagnosis: 54.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.0\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 176.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 174.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 511:\n",
      "Patient ID: MB-0877\n",
      "Age at Diagnosis: 79.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 14.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 512:\n",
      "Patient ID: MB-0880\n",
      "Age at Diagnosis: 73.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 1.233333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 1.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 513:\n",
      "Patient ID: MB-0882\n",
      "Age at Diagnosis: 73.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.094\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 514:\n",
      "Patient ID: MB-0884\n",
      "Age at Diagnosis: 56.47\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 93.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 67.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 515:\n",
      "Patient ID: MB-0885\n",
      "Age at Diagnosis: 52.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.0\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 69.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 516:\n",
      "Patient ID: MB-0891\n",
      "Age at Diagnosis: 83.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 147.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 517:\n",
      "Patient ID: MB-0893\n",
      "Age at Diagnosis: 57.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 173.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 518:\n",
      "Patient ID: MB-0895\n",
      "Age at Diagnosis: 79.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 519:\n",
      "Patient ID: MB-0897\n",
      "Age at Diagnosis: 41.32\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 28.0\n",
      "Nottingham prognostic index: 4.092\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 30.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 46.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 520:\n",
      "Patient ID: MB-0899\n",
      "Age at Diagnosis: 50.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 142.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 521:\n",
      "Patient ID: MB-0901\n",
      "Age at Diagnosis: 68.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.066\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 134.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 522:\n",
      "Patient ID: MB-0904\n",
      "Age at Diagnosis: 83.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 144.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 142.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 523:\n",
      "Patient ID: MB-0906\n",
      "Age at Diagnosis: 70.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 63.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 47.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 524:\n",
      "Patient ID: MB-0907\n",
      "Age at Diagnosis: 72.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.074\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 119.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 118.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 525:\n",
      "Patient ID: MB-2513\n",
      "Age at Diagnosis: 57.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 37.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 526:\n",
      "Patient ID: MB-2517\n",
      "Age at Diagnosis: 60.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 268.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 264.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 527:\n",
      "Patient ID: MB-2536\n",
      "Age at Diagnosis: 54.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 47.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 47.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 528:\n",
      "Patient ID: MB-2556\n",
      "Age at Diagnosis: 62.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 220.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 217.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 529:\n",
      "Patient ID: MB-2564\n",
      "Age at Diagnosis: 52.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 285.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 530:\n",
      "Patient ID: MB-2610\n",
      "Age at Diagnosis: 58.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 280.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 277.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 531:\n",
      "Patient ID: MB-2613\n",
      "Age at Diagnosis: 59.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 161.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 532:\n",
      "Patient ID: MB-2614\n",
      "Age at Diagnosis: 43.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 64.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 29.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 533:\n",
      "Patient ID: MB-2616\n",
      "Age at Diagnosis: 65.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 219.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 534:\n",
      "Patient ID: MB-2617\n",
      "Age at Diagnosis: 63.3\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 535:\n",
      "Patient ID: MB-2618\n",
      "Age at Diagnosis: 66.22\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 46.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 536:\n",
      "Patient ID: MB-2624\n",
      "Age at Diagnosis: 53.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 537:\n",
      "Patient ID: MB-2626\n",
      "Age at Diagnosis: 62.54\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 165.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 538:\n",
      "Patient ID: MB-2629\n",
      "Age at Diagnosis: 61.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 279.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 275.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 539:\n",
      "Patient ID: MB-2632\n",
      "Age at Diagnosis: 36.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 540:\n",
      "Patient ID: MB-2634\n",
      "Age at Diagnosis: 70.69\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 274.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 270.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 541:\n",
      "Patient ID: MB-2642\n",
      "Age at Diagnosis: 30.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 542:\n",
      "Patient ID: MB-2643\n",
      "Age at Diagnosis: 34.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.006\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 52.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 3.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 543:\n",
      "Patient ID: MB-2645\n",
      "Age at Diagnosis: 69.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.92\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 544:\n",
      "Patient ID: MB-2669\n",
      "Age at Diagnosis: 62.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 73.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 47.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 545:\n",
      "Patient ID: MB-2686\n",
      "Age at Diagnosis: 68.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 177.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 174.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 546:\n",
      "Patient ID: MB-2705\n",
      "Age at Diagnosis: 61.78\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 547:\n",
      "Patient ID: MB-2708\n",
      "Age at Diagnosis: 66.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 133.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 72.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 548:\n",
      "Patient ID: MB-2711\n",
      "Age at Diagnosis: 48.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 201.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 27.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 549:\n",
      "Patient ID: MB-2712\n",
      "Age at Diagnosis: 54.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.022\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 234.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 105.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 550:\n",
      "Patient ID: MB-2718\n",
      "Age at Diagnosis: 47.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 278.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 274.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 551:\n",
      "Patient ID: MB-2721\n",
      "Age at Diagnosis: 44.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.018\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 251.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 248.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 552:\n",
      "Patient ID: MB-2724\n",
      "Age at Diagnosis: 60.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.016\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 102.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 553:\n",
      "Patient ID: MB-2725\n",
      "Age at Diagnosis: 44.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 236.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 233.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 554:\n",
      "Patient ID: MB-2728\n",
      "Age at Diagnosis: 28.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 555:\n",
      "Patient ID: MB-2730\n",
      "Age at Diagnosis: 61.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 133.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 131.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 556:\n",
      "Patient ID: MB-2735\n",
      "Age at Diagnosis: 49.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 274.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 270.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 557:\n",
      "Patient ID: MB-2742\n",
      "Age at Diagnosis: 48.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 558:\n",
      "Patient ID: MB-2744\n",
      "Age at Diagnosis: 45.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 275.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 53.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 559:\n",
      "Patient ID: MB-2745\n",
      "Age at Diagnosis: 46.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 168.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 154.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 560:\n",
      "Patient ID: MB-2747\n",
      "Age at Diagnosis: 68.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 234.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 231.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 561:\n",
      "Patient ID: MB-2749\n",
      "Age at Diagnosis: 60.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 97.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 96.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 562:\n",
      "Patient ID: MB-2750\n",
      "Age at Diagnosis: 47.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 145.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 55.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 563:\n",
      "Patient ID: MB-2752\n",
      "Age at Diagnosis: 51.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 81.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 80.69\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 564:\n",
      "Patient ID: MB-2753\n",
      "Age at Diagnosis: 30.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 274.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 270.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 565:\n",
      "Patient ID: MB-2754\n",
      "Age at Diagnosis: 66.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 203.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 170.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 566:\n",
      "Patient ID: MB-2758\n",
      "Age at Diagnosis: 38.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 32.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 567:\n",
      "Patient ID: MB-2760\n",
      "Age at Diagnosis: 63.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 86.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 568:\n",
      "Patient ID: MB-2763\n",
      "Age at Diagnosis: 70.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 275.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 271.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 569:\n",
      "Patient ID: MB-2764\n",
      "Age at Diagnosis: 57.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 270.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 215.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 570:\n",
      "Patient ID: MB-2765\n",
      "Age at Diagnosis: 65.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 227.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 224.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 571:\n",
      "Patient ID: MB-2767\n",
      "Age at Diagnosis: 53.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 271.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 267.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 572:\n",
      "Patient ID: MB-2769\n",
      "Age at Diagnosis: 59.9\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 160.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 157.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 573:\n",
      "Patient ID: MB-2770\n",
      "Age at Diagnosis: 60.32\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 274.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 270.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 574:\n",
      "Patient ID: MB-2771\n",
      "Age at Diagnosis: 56.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.49\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 575:\n",
      "Patient ID: MB-2772\n",
      "Age at Diagnosis: 54.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 150.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 148.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 576:\n",
      "Patient ID: MB-2774\n",
      "Age at Diagnosis: 66.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 129.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 577:\n",
      "Patient ID: MB-2778\n",
      "Age at Diagnosis: 62.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: NC\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 181.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 119.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 578:\n",
      "Patient ID: MB-2779\n",
      "Age at Diagnosis: 36.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 275.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 159.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 579:\n",
      "Patient ID: MB-2781\n",
      "Age at Diagnosis: 64.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 40.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 39.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 580:\n",
      "Patient ID: MB-2786\n",
      "Age at Diagnosis: 62.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 68.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.27\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 581:\n",
      "Patient ID: MB-2790\n",
      "Age at Diagnosis: 47.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 116.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 582:\n",
      "Patient ID: MB-2791\n",
      "Age at Diagnosis: 40.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 271.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 268.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 583:\n",
      "Patient ID: MB-2792\n",
      "Age at Diagnosis: 50.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 86.25\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 584:\n",
      "Patient ID: MB-2793\n",
      "Age at Diagnosis: 67.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 267.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 263.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 585:\n",
      "Patient ID: MB-2795\n",
      "Age at Diagnosis: 42.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 272.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 268.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 586:\n",
      "Patient ID: MB-2796\n",
      "Age at Diagnosis: 57.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 87.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 18.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 587:\n",
      "Patient ID: MB-2797\n",
      "Age at Diagnosis: 50.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 252.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 249.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 588:\n",
      "Patient ID: MB-2801\n",
      "Age at Diagnosis: 70.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 271.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 267.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 589:\n",
      "Patient ID: MB-2803\n",
      "Age at Diagnosis: 63.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 73.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 590:\n",
      "Patient ID: MB-2814\n",
      "Age at Diagnosis: 65.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 231.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 227.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 591:\n",
      "Patient ID: MB-2815\n",
      "Age at Diagnosis: 64.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.044\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 257.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 254.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 592:\n",
      "Patient ID: MB-2819\n",
      "Age at Diagnosis: 61.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.038\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 270.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 267.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 593:\n",
      "Patient ID: MB-2820\n",
      "Age at Diagnosis: 40.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 254.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 251.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 594:\n",
      "Patient ID: MB-2821\n",
      "Age at Diagnosis: 57.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Metaplastic Breast Cancer\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Metaplastic\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.032\n",
      "Oncotree Code: MBC\n",
      "Overall Survival (Months): 136.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 134.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 595:\n",
      "Patient ID: MB-2823\n",
      "Age at Diagnosis: 35.97\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.022\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 269.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 266.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 596:\n",
      "Patient ID: MB-2827\n",
      "Age at Diagnosis: 36.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 235.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 232.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 597:\n",
      "Patient ID: MB-2833\n",
      "Age at Diagnosis: 42.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 259.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 256.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 598:\n",
      "Patient ID: MB-2834\n",
      "Age at Diagnosis: 56.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.018\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 151.81\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 599:\n",
      "Patient ID: MB-2835\n",
      "Age at Diagnosis: 59.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 54.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 600:\n",
      "Patient ID: MB-2838\n",
      "Age at Diagnosis: 67.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 3.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 270.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 266.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 601:\n",
      "Patient ID: MB-2840\n",
      "Age at Diagnosis: 60.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 269.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 265.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 602:\n",
      "Patient ID: MB-2842\n",
      "Age at Diagnosis: 58.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 18.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 603:\n",
      "Patient ID: MB-2843\n",
      "Age at Diagnosis: 61.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 231.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 228.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 604:\n",
      "Patient ID: MB-2844\n",
      "Age at Diagnosis: 60.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 144.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 605:\n",
      "Patient ID: MB-2845\n",
      "Age at Diagnosis: 55.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 264.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 261.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 606:\n",
      "Patient ID: MB-2846\n",
      "Age at Diagnosis: 58.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.01\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 75.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 607:\n",
      "Patient ID: MB-2847\n",
      "Age at Diagnosis: 65.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 18.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 608:\n",
      "Patient ID: MB-2848\n",
      "Age at Diagnosis: 60.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 227.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 224.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 609:\n",
      "Patient ID: MB-2849\n",
      "Age at Diagnosis: 60.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 610:\n",
      "Patient ID: MB-2850\n",
      "Age at Diagnosis: 31.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 9.433333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 611:\n",
      "Patient ID: MB-2851\n",
      "Age at Diagnosis: 58.69\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 159.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 91.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 612:\n",
      "Patient ID: MB-2853\n",
      "Age at Diagnosis: 36.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 269.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 266.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 613:\n",
      "Patient ID: MB-2854\n",
      "Age at Diagnosis: 61.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 270.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 266.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 614:\n",
      "Patient ID: MB-2857\n",
      "Age at Diagnosis: 45.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 250.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 247.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 615:\n",
      "Patient ID: MB-2858\n",
      "Age at Diagnosis: 63.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 141.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 139.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 616:\n",
      "Patient ID: MB-2863\n",
      "Age at Diagnosis: 59.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 258.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 254.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 617:\n",
      "Patient ID: MB-2867\n",
      "Age at Diagnosis: 47.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 269.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 117.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 618:\n",
      "Patient ID: MB-2895\n",
      "Age at Diagnosis: 66.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 196.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 184.08\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 619:\n",
      "Patient ID: MB-2896\n",
      "Age at Diagnosis: 68.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 237.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 234.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 620:\n",
      "Patient ID: MB-2900\n",
      "Age at Diagnosis: 59.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 20.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 621:\n",
      "Patient ID: MB-2901\n",
      "Age at Diagnosis: 49.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 218.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 62.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 622:\n",
      "Patient ID: MB-2904\n",
      "Age at Diagnosis: 34.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 623:\n",
      "Patient ID: MB-2912\n",
      "Age at Diagnosis: 59.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 267.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 263.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 624:\n",
      "Patient ID: MB-2916\n",
      "Age at Diagnosis: 48.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 266.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 263.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 625:\n",
      "Patient ID: MB-2917\n",
      "Age at Diagnosis: 33.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 31.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 626:\n",
      "Patient ID: MB-2919\n",
      "Age at Diagnosis: 59.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 240.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 236.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 627:\n",
      "Patient ID: MB-2922\n",
      "Age at Diagnosis: 45.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 628:\n",
      "Patient ID: MB-2923\n",
      "Age at Diagnosis: 37.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 629:\n",
      "Patient ID: MB-2927\n",
      "Age at Diagnosis: 58.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.026\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 263.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 70.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 630:\n",
      "Patient ID: MB-2929\n",
      "Age at Diagnosis: 53.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 262.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 259.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 631:\n",
      "Patient ID: MB-2931\n",
      "Age at Diagnosis: 46.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 13.52\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 632:\n",
      "Patient ID: MB-2932\n",
      "Age at Diagnosis: 63.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 107.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 633:\n",
      "Patient ID: MB-2933\n",
      "Age at Diagnosis: 44.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 161.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 159.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 634:\n",
      "Patient ID: MB-2939\n",
      "Age at Diagnosis: 70.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 99.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 635:\n",
      "Patient ID: MB-2944\n",
      "Age at Diagnosis: 66.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 27.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 26.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 636:\n",
      "Patient ID: MB-2947\n",
      "Age at Diagnosis: 36.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 112.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 637:\n",
      "Patient ID: MB-2951\n",
      "Age at Diagnosis: 39.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 263.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 638:\n",
      "Patient ID: MB-2952\n",
      "Age at Diagnosis: 52.67\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 2.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 189.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 186.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 639:\n",
      "Patient ID: MB-2953\n",
      "Age at Diagnosis: 43.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 640:\n",
      "Patient ID: MB-2954\n",
      "Age at Diagnosis: 69.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 5.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 5.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 641:\n",
      "Patient ID: MB-2957\n",
      "Age at Diagnosis: 31.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 262.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 258.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 642:\n",
      "Patient ID: MB-2960\n",
      "Age at Diagnosis: 69.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 219.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 643:\n",
      "Patient ID: MB-2963\n",
      "Age at Diagnosis: 53.99\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.02\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 227.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 184.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 644:\n",
      "Patient ID: MB-2964\n",
      "Age at Diagnosis: 69.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 9.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 645:\n",
      "Patient ID: MB-2966\n",
      "Age at Diagnosis: 50.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 265.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 261.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 646:\n",
      "Patient ID: MB-2969\n",
      "Age at Diagnosis: 66.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 172.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 170.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 647:\n",
      "Patient ID: MB-2970\n",
      "Age at Diagnosis: 46.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 252.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 221.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 648:\n",
      "Patient ID: MB-2971\n",
      "Age at Diagnosis: 69.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 264.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 189.08\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 649:\n",
      "Patient ID: MB-2977\n",
      "Age at Diagnosis: 40.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 109.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 650:\n",
      "Patient ID: MB-2983\n",
      "Age at Diagnosis: 56.26\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 180.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 178.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 651:\n",
      "Patient ID: MB-2984\n",
      "Age at Diagnosis: 64.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 261.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 257.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 652:\n",
      "Patient ID: MB-2990\n",
      "Age at Diagnosis: 48.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 260.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 256.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 653:\n",
      "Patient ID: MB-2993\n",
      "Age at Diagnosis: 63.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 184.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 654:\n",
      "Patient ID: MB-2994\n",
      "Age at Diagnosis: 46.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 254.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 251.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 655:\n",
      "Patient ID: MB-2996\n",
      "Age at Diagnosis: 58.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 191.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 188.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 656:\n",
      "Patient ID: MB-2999\n",
      "Age at Diagnosis: 61.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 262.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 258.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 657:\n",
      "Patient ID: MB-3001\n",
      "Age at Diagnosis: 50.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 263.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 259.77\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 658:\n",
      "Patient ID: MB-3002\n",
      "Age at Diagnosis: 62.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 140.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 138.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 659:\n",
      "Patient ID: MB-3005\n",
      "Age at Diagnosis: 45.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 253.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 249.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 660:\n",
      "Patient ID: MB-3006\n",
      "Age at Diagnosis: 60.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 661:\n",
      "Patient ID: MB-3007\n",
      "Age at Diagnosis: 48.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 92.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 662:\n",
      "Patient ID: MB-3008\n",
      "Age at Diagnosis: 51.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.024\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 149.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 663:\n",
      "Patient ID: MB-3013\n",
      "Age at Diagnosis: 50.37\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 238.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 664:\n",
      "Patient ID: MB-3014\n",
      "Age at Diagnosis: 39.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 262.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 259.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 665:\n",
      "Patient ID: MB-3016\n",
      "Age at Diagnosis: 56.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 258.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 255.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 666:\n",
      "Patient ID: MB-3021\n",
      "Age at Diagnosis: 63.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 217.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 214.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 667:\n",
      "Patient ID: MB-3025\n",
      "Age at Diagnosis: 37.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 256.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 252.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 668:\n",
      "Patient ID: MB-3026\n",
      "Age at Diagnosis: 49.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 261.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 257.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 669:\n",
      "Patient ID: MB-3028\n",
      "Age at Diagnosis: 60.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 670:\n",
      "Patient ID: MB-3031\n",
      "Age at Diagnosis: 46.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 34.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 671:\n",
      "Patient ID: MB-3032\n",
      "Age at Diagnosis: 50.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 250.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 246.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 672:\n",
      "Patient ID: MB-3033\n",
      "Age at Diagnosis: 69.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 65.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 673:\n",
      "Patient ID: MB-3035\n",
      "Age at Diagnosis: 54.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 260.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 257.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 674:\n",
      "Patient ID: MB-3037\n",
      "Age at Diagnosis: 53.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 98.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 675:\n",
      "Patient ID: MB-3046\n",
      "Age at Diagnosis: 67.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 73.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 72.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 676:\n",
      "Patient ID: MB-3049\n",
      "Age at Diagnosis: 57.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 259.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 256.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 677:\n",
      "Patient ID: MB-3050\n",
      "Age at Diagnosis: 59.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 255.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 251.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 678:\n",
      "Patient ID: MB-3057\n",
      "Age at Diagnosis: 55.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.086\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 43.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 679:\n",
      "Patient ID: MB-3058\n",
      "Age at Diagnosis: 47.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 254.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 250.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 680:\n",
      "Patient ID: MB-3060\n",
      "Age at Diagnosis: 65.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.072\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 681:\n",
      "Patient ID: MB-3062\n",
      "Age at Diagnosis: 62.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 144.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 682:\n",
      "Patient ID: MB-3063\n",
      "Age at Diagnosis: 43.51\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 683:\n",
      "Patient ID: MB-3064\n",
      "Age at Diagnosis: 46.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 165.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 35.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 684:\n",
      "Patient ID: MB-3067\n",
      "Age at Diagnosis: 60.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 259.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 256.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 685:\n",
      "Patient ID: MB-3079\n",
      "Age at Diagnosis: 50.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 149.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 686:\n",
      "Patient ID: MB-3083\n",
      "Age at Diagnosis: 68.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 44.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 687:\n",
      "Patient ID: MB-3085\n",
      "Age at Diagnosis: 43.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 210.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 688:\n",
      "Patient ID: MB-3088\n",
      "Age at Diagnosis: 65.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 256.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 253.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 689:\n",
      "Patient ID: MB-3092\n",
      "Age at Diagnosis: 56.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.076\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 152.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 150.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 690:\n",
      "Patient ID: MB-3102\n",
      "Age at Diagnosis: 60.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 258.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 254.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 691:\n",
      "Patient ID: MB-3103\n",
      "Age at Diagnosis: 58.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.56\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 692:\n",
      "Patient ID: MB-3104\n",
      "Age at Diagnosis: 28.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 45.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 693:\n",
      "Patient ID: MB-3105\n",
      "Age at Diagnosis: 48.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 252.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 249.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 694:\n",
      "Patient ID: MB-3110\n",
      "Age at Diagnosis: 61.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 100.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 695:\n",
      "Patient ID: MB-3121\n",
      "Age at Diagnosis: 63.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 696:\n",
      "Patient ID: MB-3122\n",
      "Age at Diagnosis: 62.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 257.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 254.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 697:\n",
      "Patient ID: MB-3123\n",
      "Age at Diagnosis: 50.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 167.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 165.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 698:\n",
      "Patient ID: MB-3153\n",
      "Age at Diagnosis: 42.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 227.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 224.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 699:\n",
      "Patient ID: MB-3165\n",
      "Age at Diagnosis: 59.78\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 218.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 700:\n",
      "Patient ID: MB-3167\n",
      "Age at Diagnosis: 66.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 135.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 701:\n",
      "Patient ID: MB-3171\n",
      "Age at Diagnosis: 54.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 219.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 166.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 702:\n",
      "Patient ID: MB-3181\n",
      "Age at Diagnosis: 43.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 178.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 703:\n",
      "Patient ID: MB-3211\n",
      "Age at Diagnosis: 58.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 145.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 143.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 704:\n",
      "Patient ID: MB-3218\n",
      "Age at Diagnosis: 44.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 248.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 245.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 705:\n",
      "Patient ID: MB-3222\n",
      "Age at Diagnosis: 63.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 23.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 706:\n",
      "Patient ID: MB-3228\n",
      "Age at Diagnosis: 58.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 252.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 248.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 707:\n",
      "Patient ID: MB-3235\n",
      "Age at Diagnosis: 50.66\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 236.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 149.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 708:\n",
      "Patient ID: MB-3252\n",
      "Age at Diagnosis: 41.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 99.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 98.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 709:\n",
      "Patient ID: MB-3253\n",
      "Age at Diagnosis: 56.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 35.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 710:\n",
      "Patient ID: MB-3254\n",
      "Age at Diagnosis: 50.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 2.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 711:\n",
      "Patient ID: MB-3266\n",
      "Age at Diagnosis: 52.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 51.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 712:\n",
      "Patient ID: MB-3271\n",
      "Age at Diagnosis: 59.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 713:\n",
      "Patient ID: MB-3272\n",
      "Age at Diagnosis: 63.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 714:\n",
      "Patient ID: MB-3275\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 41.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 16.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 715:\n",
      "Patient ID: MB-3277\n",
      "Age at Diagnosis: 29.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 716:\n",
      "Patient ID: MB-3292\n",
      "Age at Diagnosis: 60.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 217.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 214.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 717:\n",
      "Patient ID: MB-3295\n",
      "Age at Diagnosis: 60.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 158.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 156.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 718:\n",
      "Patient ID: MB-3297\n",
      "Age at Diagnosis: 42.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 236.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 232.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 719:\n",
      "Patient ID: MB-3298\n",
      "Age at Diagnosis: 48.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 242.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 239.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 720:\n",
      "Patient ID: MB-3300\n",
      "Age at Diagnosis: 64.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 247.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 243.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 721:\n",
      "Patient ID: MB-3301\n",
      "Age at Diagnosis: 49.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 248.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 245.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 722:\n",
      "Patient ID: MB-3303\n",
      "Age at Diagnosis: 63.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 243.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 240.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 723:\n",
      "Patient ID: MB-3328\n",
      "Age at Diagnosis: 69.65\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 191.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 188.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 724:\n",
      "Patient ID: MB-3329\n",
      "Age at Diagnosis: 56.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 725:\n",
      "Patient ID: MB-3341\n",
      "Age at Diagnosis: 62.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 148.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 95.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 726:\n",
      "Patient ID: MB-3344\n",
      "Age at Diagnosis: 33.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 226.25\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 727:\n",
      "Patient ID: MB-3350\n",
      "Age at Diagnosis: 62.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 227.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 178.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 728:\n",
      "Patient ID: MB-3351\n",
      "Age at Diagnosis: 39.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 238.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 729:\n",
      "Patient ID: MB-3355\n",
      "Age at Diagnosis: 48.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 109.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 107.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 730:\n",
      "Patient ID: MB-3357\n",
      "Age at Diagnosis: 47.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 38.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 36.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 731:\n",
      "Patient ID: MB-3360\n",
      "Age at Diagnosis: 48.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 26.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 732:\n",
      "Patient ID: MB-3361\n",
      "Age at Diagnosis: 57.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 68.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 45.33\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 733:\n",
      "Patient ID: MB-3363\n",
      "Age at Diagnosis: 56.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 23.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 10.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 5.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 734:\n",
      "Patient ID: MB-3365\n",
      "Age at Diagnosis: 51.18\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 238.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 735:\n",
      "Patient ID: MB-3367\n",
      "Age at Diagnosis: 65.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 179.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 177.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 736:\n",
      "Patient ID: MB-3371\n",
      "Age at Diagnosis: 66.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 238.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 737:\n",
      "Patient ID: MB-3378\n",
      "Age at Diagnosis: 65.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 87.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 86.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 738:\n",
      "Patient ID: MB-3379\n",
      "Age at Diagnosis: 60.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 113.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 112.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 739:\n",
      "Patient ID: MB-3381\n",
      "Age at Diagnosis: 53.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 236.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 233.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 740:\n",
      "Patient ID: MB-3382\n",
      "Age at Diagnosis: 61.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 134.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 741:\n",
      "Patient ID: MB-3383\n",
      "Age at Diagnosis: 38.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 18.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 742:\n",
      "Patient ID: MB-3386\n",
      "Age at Diagnosis: 40.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 47.04\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 743:\n",
      "Patient ID: MB-3388\n",
      "Age at Diagnosis: 59.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 225.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 744:\n",
      "Patient ID: MB-3389\n",
      "Age at Diagnosis: 63.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 240.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 237.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 745:\n",
      "Patient ID: MB-3395\n",
      "Age at Diagnosis: 52.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 243.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 240.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 746:\n",
      "Patient ID: MB-3396\n",
      "Age at Diagnosis: 59.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 226.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 223.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 747:\n",
      "Patient ID: MB-3402\n",
      "Age at Diagnosis: 41.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 38.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 748:\n",
      "Patient ID: MB-3403\n",
      "Age at Diagnosis: 50.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 138.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 136.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 749:\n",
      "Patient ID: MB-3412\n",
      "Age at Diagnosis: 55.28\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 225.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 750:\n",
      "Patient ID: MB-3417\n",
      "Age at Diagnosis: 59.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 103.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 751:\n",
      "Patient ID: MB-3429\n",
      "Age at Diagnosis: 49.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 243.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 240.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 752:\n",
      "Patient ID: MB-3430\n",
      "Age at Diagnosis: 68.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 219.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 216.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 753:\n",
      "Patient ID: MB-3435\n",
      "Age at Diagnosis: 37.05\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.73\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 754:\n",
      "Patient ID: MB-3436\n",
      "Age at Diagnosis: 38.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 130.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 755:\n",
      "Patient ID: MB-3437\n",
      "Age at Diagnosis: 70.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 107.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 756:\n",
      "Patient ID: MB-3439\n",
      "Age at Diagnosis: 43.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 188.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 57.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 757:\n",
      "Patient ID: MB-3450\n",
      "Age at Diagnosis: 51.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 240.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 146.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 758:\n",
      "Patient ID: MB-3452\n",
      "Age at Diagnosis: 64.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 117.73\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 759:\n",
      "Patient ID: MB-3453\n",
      "Age at Diagnosis: 51.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.54\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 760:\n",
      "Patient ID: MB-3459\n",
      "Age at Diagnosis: 57.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 238.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 761:\n",
      "Patient ID: MB-3462\n",
      "Age at Diagnosis: 40.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 234.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 172.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 762:\n",
      "Patient ID: MB-3466\n",
      "Age at Diagnosis: 55.3\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 234.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 231.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 763:\n",
      "Patient ID: MB-3467\n",
      "Age at Diagnosis: 21.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 38.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 764:\n",
      "Patient ID: MB-3470\n",
      "Age at Diagnosis: 56.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 62.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 765:\n",
      "Patient ID: MB-3476\n",
      "Age at Diagnosis: 68.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 159.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 156.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 766:\n",
      "Patient ID: MB-3479\n",
      "Age at Diagnosis: 60.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 231.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 228.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 767:\n",
      "Patient ID: MB-3487\n",
      "Age at Diagnosis: 43.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 237.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 768:\n",
      "Patient ID: MB-3488\n",
      "Age at Diagnosis: 41.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 769:\n",
      "Patient ID: MB-3490\n",
      "Age at Diagnosis: 45.74\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 18.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 7.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 770:\n",
      "Patient ID: MB-3492\n",
      "Age at Diagnosis: 62.09\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 105.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 771:\n",
      "Patient ID: MB-3497\n",
      "Age at Diagnosis: 53.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 772:\n",
      "Patient ID: MB-3500\n",
      "Age at Diagnosis: 66.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 239.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 236.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 773:\n",
      "Patient ID: MB-3502\n",
      "Age at Diagnosis: 50.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 229.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 226.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 774:\n",
      "Patient ID: MB-3506\n",
      "Age at Diagnosis: 39.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 240.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 775:\n",
      "Patient ID: MB-3510\n",
      "Age at Diagnosis: 67.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 59.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 58.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 776:\n",
      "Patient ID: MB-3525\n",
      "Age at Diagnosis: 65.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 26.0\n",
      "Nottingham prognostic index: 6.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 236.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 233.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 777:\n",
      "Patient ID: MB-3526\n",
      "Age at Diagnosis: 60.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.44\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 778:\n",
      "Patient ID: MB-3528\n",
      "Age at Diagnosis: 71.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 113.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 112.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 779:\n",
      "Patient ID: MB-3530\n",
      "Age at Diagnosis: 70.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 20.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 112.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 111.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 780:\n",
      "Patient ID: MB-3536\n",
      "Age at Diagnosis: 48.12\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Undef\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 73.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 781:\n",
      "Patient ID: MB-3545\n",
      "Age at Diagnosis: 49.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 232.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 203.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 782:\n",
      "Patient ID: MB-3547\n",
      "Age at Diagnosis: 68.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 33.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 32.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 783:\n",
      "Patient ID: MB-3548\n",
      "Age at Diagnosis: 66.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 234.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 231.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 784:\n",
      "Patient ID: MB-3556\n",
      "Age at Diagnosis: 51.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 785:\n",
      "Patient ID: MB-3567\n",
      "Age at Diagnosis: 55.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 236.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 232.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 786:\n",
      "Patient ID: MB-3576\n",
      "Age at Diagnosis: 53.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.074\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 24.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 787:\n",
      "Patient ID: MB-3582\n",
      "Age at Diagnosis: 63.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 229.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 226.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 788:\n",
      "Patient ID: MB-3600\n",
      "Age at Diagnosis: 60.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 214.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 211.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 789:\n",
      "Patient ID: MB-3606\n",
      "Age at Diagnosis: 68.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 790:\n",
      "Patient ID: MB-3614\n",
      "Age at Diagnosis: 63.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 235.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 232.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 791:\n",
      "Patient ID: MB-3702\n",
      "Age at Diagnosis: 37.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.011\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 230.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 227.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 5.5\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 792:\n",
      "Patient ID: MB-3706\n",
      "Age at Diagnosis: 55.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.52\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 793:\n",
      "Patient ID: MB-3707\n",
      "Age at Diagnosis: 70.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 187.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 794:\n",
      "Patient ID: MB-3711\n",
      "Age at Diagnosis: 41.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 219.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 795:\n",
      "Patient ID: MB-3748\n",
      "Age at Diagnosis: 51.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 225.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 796:\n",
      "Patient ID: MB-3752\n",
      "Age at Diagnosis: 49.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 797:\n",
      "Patient ID: MB-3754\n",
      "Age at Diagnosis: 57.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 92.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 42.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 798:\n",
      "Patient ID: MB-3781\n",
      "Age at Diagnosis: 48.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 224.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 799:\n",
      "Patient ID: MB-3797\n",
      "Age at Diagnosis: 68.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.048\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 228.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 225.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 800:\n",
      "Patient ID: MB-3823\n",
      "Age at Diagnosis: 40.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Undef\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 5.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 801:\n",
      "Patient ID: MB-3824\n",
      "Age at Diagnosis: 49.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 99.31\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 802:\n",
      "Patient ID: MB-3838\n",
      "Age at Diagnosis: 60.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 134.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 35.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 803:\n",
      "Patient ID: MB-3840\n",
      "Age at Diagnosis: 53.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 287.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 283.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 804:\n",
      "Patient ID: MB-3842\n",
      "Age at Diagnosis: 54.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 226.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 223.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 805:\n",
      "Patient ID: MB-3850\n",
      "Age at Diagnosis: 65.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 72.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 806:\n",
      "Patient ID: MB-3852\n",
      "Age at Diagnosis: 43.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 225.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 222.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 807:\n",
      "Patient ID: MB-3854\n",
      "Age at Diagnosis: 63.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 2.024\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 99.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 97.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 808:\n",
      "Patient ID: MB-3865\n",
      "Age at Diagnosis: 49.37\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 809:\n",
      "Patient ID: MB-3866\n",
      "Age at Diagnosis: 54.29\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 225.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 222.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 810:\n",
      "Patient ID: MB-3871\n",
      "Age at Diagnosis: 62.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 172.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 170.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 811:\n",
      "Patient ID: MB-3874\n",
      "Age at Diagnosis: 35.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 183.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 812:\n",
      "Patient ID: MB-3978\n",
      "Age at Diagnosis: 57.91\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 2.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 100.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 813:\n",
      "Patient ID: MB-4000\n",
      "Age at Diagnosis: 76.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 814:\n",
      "Patient ID: MB-4001\n",
      "Age at Diagnosis: 74.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 815:\n",
      "Patient ID: MB-4003\n",
      "Age at Diagnosis: 70.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 106.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 816:\n",
      "Patient ID: MB-4004\n",
      "Age at Diagnosis: 61.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 256.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 253.49\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 817:\n",
      "Patient ID: MB-4005\n",
      "Age at Diagnosis: 66.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 188.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 185.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 818:\n",
      "Patient ID: MB-4008\n",
      "Age at Diagnosis: 64.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 14.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 819:\n",
      "Patient ID: MB-4010\n",
      "Age at Diagnosis: 73.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 11.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 11.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 820:\n",
      "Patient ID: MB-4011\n",
      "Age at Diagnosis: 72.36\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Undef\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 190.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 821:\n",
      "Patient ID: MB-4012\n",
      "Age at Diagnosis: 63.23\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 277.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 273.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 822:\n",
      "Patient ID: MB-4015\n",
      "Age at Diagnosis: 76.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 11.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 9.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 823:\n",
      "Patient ID: MB-4017\n",
      "Age at Diagnosis: 76.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 139.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 137.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 824:\n",
      "Patient ID: MB-4018\n",
      "Age at Diagnosis: 71.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 105.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 34.31\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 825:\n",
      "Patient ID: MB-4024\n",
      "Age at Diagnosis: 56.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 826:\n",
      "Patient ID: MB-4033\n",
      "Age at Diagnosis: 82.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 15.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 827:\n",
      "Patient ID: MB-4046\n",
      "Age at Diagnosis: 59.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 298.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 294.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 828:\n",
      "Patient ID: MB-4059\n",
      "Age at Diagnosis: 50.23\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 172.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 829:\n",
      "Patient ID: MB-4079\n",
      "Age at Diagnosis: 63.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 24.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 351.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 346.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 830:\n",
      "Patient ID: MB-4091\n",
      "Age at Diagnosis: 74.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 281.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 277.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 831:\n",
      "Patient ID: MB-4098\n",
      "Age at Diagnosis: 68.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 176.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 174.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 832:\n",
      "Patient ID: MB-4119\n",
      "Age at Diagnosis: 65.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 67.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.19\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 833:\n",
      "Patient ID: MB-4120\n",
      "Age at Diagnosis: 56.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 217.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.48\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 834:\n",
      "Patient ID: MB-4126\n",
      "Age at Diagnosis: 73.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 1.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 172.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 835:\n",
      "Patient ID: MB-4127\n",
      "Age at Diagnosis: 54.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 258.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 254.77\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 836:\n",
      "Patient ID: MB-4139\n",
      "Age at Diagnosis: 63.05\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 165.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 163.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 837:\n",
      "Patient ID: MB-4140\n",
      "Age at Diagnosis: 71.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 112.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 838:\n",
      "Patient ID: MB-4141\n",
      "Age at Diagnosis: 58.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 147.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 839:\n",
      "Patient ID: MB-4145\n",
      "Age at Diagnosis: 60.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 1.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 217.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 182.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 840:\n",
      "Patient ID: MB-4146\n",
      "Age at Diagnosis: 43.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 841:\n",
      "Patient ID: MB-4148\n",
      "Age at Diagnosis: 57.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 59.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 842:\n",
      "Patient ID: MB-4154\n",
      "Age at Diagnosis: 54.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 843:\n",
      "Patient ID: MB-4171\n",
      "Age at Diagnosis: 64.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.086\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 184.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 111.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 43.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 844:\n",
      "Patient ID: MB-4173\n",
      "Age at Diagnosis: 74.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 160.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 158.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 845:\n",
      "Patient ID: MB-4189\n",
      "Age at Diagnosis: 60.99\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 355.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 104.54\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 846:\n",
      "Patient ID: MB-4212\n",
      "Age at Diagnosis: 45.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 330.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 326.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 847:\n",
      "Patient ID: MB-4213\n",
      "Age at Diagnosis: 67.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 84.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 848:\n",
      "Patient ID: MB-4222\n",
      "Age at Diagnosis: 58.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 50.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 849:\n",
      "Patient ID: MB-4224\n",
      "Age at Diagnosis: 72.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: NC\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 58.19\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 850:\n",
      "Patient ID: MB-4230\n",
      "Age at Diagnosis: 75.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 115.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 114.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 851:\n",
      "Patient ID: MB-4233\n",
      "Age at Diagnosis: 54.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 852:\n",
      "Patient ID: MB-4234\n",
      "Age at Diagnosis: 68.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 253.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 250.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 853:\n",
      "Patient ID: MB-4235\n",
      "Age at Diagnosis: 67.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 335.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 290.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 854:\n",
      "Patient ID: MB-4236\n",
      "Age at Diagnosis: 73.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 203.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 201.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 855:\n",
      "Patient ID: MB-4250\n",
      "Age at Diagnosis: 80.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 100.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 856:\n",
      "Patient ID: MB-4254\n",
      "Age at Diagnosis: 68.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 178.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 176.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 857:\n",
      "Patient ID: MB-4264\n",
      "Age at Diagnosis: 72.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 858:\n",
      "Patient ID: MB-4266\n",
      "Age at Diagnosis: 28.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 33.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 859:\n",
      "Patient ID: MB-4270\n",
      "Age at Diagnosis: 37.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 91.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 860:\n",
      "Patient ID: MB-4274\n",
      "Age at Diagnosis: 74.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 47.17\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 861:\n",
      "Patient ID: MB-4276\n",
      "Age at Diagnosis: 55.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 132.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 130.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 862:\n",
      "Patient ID: MB-4278\n",
      "Age at Diagnosis: 68.32\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 244.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 240.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 863:\n",
      "Patient ID: MB-4281\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 260.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 256.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 864:\n",
      "Patient ID: MB-4282\n",
      "Age at Diagnosis: 49.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 865:\n",
      "Patient ID: MB-4283\n",
      "Age at Diagnosis: 55.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 172.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 866:\n",
      "Patient ID: MB-4289\n",
      "Age at Diagnosis: 65.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 96.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 867:\n",
      "Patient ID: MB-4292\n",
      "Age at Diagnosis: 58.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 335.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 331.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 868:\n",
      "Patient ID: MB-4293\n",
      "Age at Diagnosis: 54.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 219.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 216.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 869:\n",
      "Patient ID: MB-4298\n",
      "Age at Diagnosis: 70.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 870:\n",
      "Patient ID: MB-4300\n",
      "Age at Diagnosis: 70.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 189.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 186.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 871:\n",
      "Patient ID: MB-4303\n",
      "Age at Diagnosis: 66.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 872:\n",
      "Patient ID: MB-4306\n",
      "Age at Diagnosis: 69.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.042\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 234.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 231.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 873:\n",
      "Patient ID: MB-4310\n",
      "Age at Diagnosis: 76.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 265.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 262.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 874:\n",
      "Patient ID: MB-4313\n",
      "Age at Diagnosis: 58.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 300.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 296.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 875:\n",
      "Patient ID: MB-4317\n",
      "Age at Diagnosis: 51.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 177.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 175.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 876:\n",
      "Patient ID: MB-4318\n",
      "Age at Diagnosis: 72.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 17.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 877:\n",
      "Patient ID: MB-4322\n",
      "Age at Diagnosis: 63.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 196.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 193.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 878:\n",
      "Patient ID: MB-4323\n",
      "Age at Diagnosis: 80.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 26.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 879:\n",
      "Patient ID: MB-4324\n",
      "Age at Diagnosis: 61.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 24.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 66.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 880:\n",
      "Patient ID: MB-4328\n",
      "Age at Diagnosis: 64.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 196.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 881:\n",
      "Patient ID: MB-4329\n",
      "Age at Diagnosis: 70.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 168.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 166.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 882:\n",
      "Patient ID: MB-4331\n",
      "Age at Diagnosis: 63.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 235.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 232.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 883:\n",
      "Patient ID: MB-4332\n",
      "Age at Diagnosis: 34.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 307.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 303.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 884:\n",
      "Patient ID: MB-4333\n",
      "Age at Diagnosis: 64.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 207.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 205.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 885:\n",
      "Patient ID: MB-4339\n",
      "Age at Diagnosis: 74.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 173.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 886:\n",
      "Patient ID: MB-4341\n",
      "Age at Diagnosis: 35.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 18.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 33.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 887:\n",
      "Patient ID: MB-4342\n",
      "Age at Diagnosis: 73.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.124\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 232.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 62.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 888:\n",
      "Patient ID: MB-4343\n",
      "Age at Diagnosis: 68.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 198.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 195.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 889:\n",
      "Patient ID: MB-4348\n",
      "Age at Diagnosis: 61.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 226.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 44.9\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 890:\n",
      "Patient ID: MB-4350\n",
      "Age at Diagnosis: 35.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 891:\n",
      "Patient ID: MB-4351\n",
      "Age at Diagnosis: 70.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 68.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 36.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 892:\n",
      "Patient ID: MB-4353\n",
      "Age at Diagnosis: 59.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 63.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 893:\n",
      "Patient ID: MB-4354\n",
      "Age at Diagnosis: 55.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 894:\n",
      "Patient ID: MB-4357\n",
      "Age at Diagnosis: 77.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 17.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 112.37\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 895:\n",
      "Patient ID: MB-4360\n",
      "Age at Diagnosis: 59.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.016\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 11.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.12\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 896:\n",
      "Patient ID: MB-4362\n",
      "Age at Diagnosis: 50.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 267.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 81.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 897:\n",
      "Patient ID: MB-4368\n",
      "Age at Diagnosis: 74.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 117.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 898:\n",
      "Patient ID: MB-4374\n",
      "Age at Diagnosis: 77.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 899:\n",
      "Patient ID: MB-4375\n",
      "Age at Diagnosis: 40.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 291.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 287.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 900:\n",
      "Patient ID: MB-4381\n",
      "Age at Diagnosis: 59.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 39.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 901:\n",
      "Patient ID: MB-4390\n",
      "Age at Diagnosis: 68.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 902:\n",
      "Patient ID: MB-4395\n",
      "Age at Diagnosis: 45.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 139.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 9.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 903:\n",
      "Patient ID: MB-4407\n",
      "Age at Diagnosis: 44.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 83.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 904:\n",
      "Patient ID: MB-4408\n",
      "Age at Diagnosis: 71.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 206.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 203.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 905:\n",
      "Patient ID: MB-4416\n",
      "Age at Diagnosis: 44.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 192.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 906:\n",
      "Patient ID: MB-4417\n",
      "Age at Diagnosis: 68.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 8.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 907:\n",
      "Patient ID: MB-4418\n",
      "Age at Diagnosis: 56.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 307.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 303.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 908:\n",
      "Patient ID: MB-4421\n",
      "Age at Diagnosis: 69.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 264.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 261.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 909:\n",
      "Patient ID: MB-4426\n",
      "Age at Diagnosis: 70.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 170.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 168.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 910:\n",
      "Patient ID: MB-4434\n",
      "Age at Diagnosis: 74.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 148.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 142.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 911:\n",
      "Patient ID: MB-4442\n",
      "Age at Diagnosis: 47.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 296.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 292.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 912:\n",
      "Patient ID: MB-4484\n",
      "Age at Diagnosis: 66.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.11\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 52.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 34.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 913:\n",
      "Patient ID: MB-4529\n",
      "Age at Diagnosis: 61.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 914:\n",
      "Patient ID: MB-4548\n",
      "Age at Diagnosis: 50.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.002\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 322.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 318.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 915:\n",
      "Patient ID: MB-4557\n",
      "Age at Diagnosis: 51.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 279.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 203.85\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 916:\n",
      "Patient ID: MB-4564\n",
      "Age at Diagnosis: 74.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 210.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 207.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 917:\n",
      "Patient ID: MB-4578\n",
      "Age at Diagnosis: 72.74\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 197.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 194.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 918:\n",
      "Patient ID: MB-4591\n",
      "Age at Diagnosis: 71.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 41.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 919:\n",
      "Patient ID: MB-4593\n",
      "Age at Diagnosis: 48.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 920:\n",
      "Patient ID: MB-4598\n",
      "Age at Diagnosis: 67.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 62.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 921:\n",
      "Patient ID: MB-4599\n",
      "Age at Diagnosis: 63.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 191.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 188.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 922:\n",
      "Patient ID: MB-4601\n",
      "Age at Diagnosis: 39.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 56.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 44.67\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 923:\n",
      "Patient ID: MB-4602\n",
      "Age at Diagnosis: 58.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 54.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 924:\n",
      "Patient ID: MB-4603\n",
      "Age at Diagnosis: 42.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 239.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 236.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 925:\n",
      "Patient ID: MB-4607\n",
      "Age at Diagnosis: 55.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 121.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 926:\n",
      "Patient ID: MB-4616\n",
      "Age at Diagnosis: 71.47\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 81.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 927:\n",
      "Patient ID: MB-4618\n",
      "Age at Diagnosis: 40.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 267.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 263.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 928:\n",
      "Patient ID: MB-4621\n",
      "Age at Diagnosis: 39.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.106\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 271.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 68.42\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 53.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 929:\n",
      "Patient ID: MB-4622\n",
      "Age at Diagnosis: 40.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 282.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 279.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 930:\n",
      "Patient ID: MB-4623\n",
      "Age at Diagnosis: 61.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.02\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 292.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 288.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 931:\n",
      "Patient ID: MB-4626\n",
      "Age at Diagnosis: 64.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 143.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 95.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 932:\n",
      "Patient ID: MB-4627\n",
      "Age at Diagnosis: 55.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 186.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 184.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 933:\n",
      "Patient ID: MB-4630\n",
      "Age at Diagnosis: 67.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 95.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 33.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 934:\n",
      "Patient ID: MB-4633\n",
      "Age at Diagnosis: 67.03\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 318.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 298.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 935:\n",
      "Patient ID: MB-4634\n",
      "Age at Diagnosis: 66.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 109.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 74.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 936:\n",
      "Patient ID: MB-4639\n",
      "Age at Diagnosis: 71.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 115.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 937:\n",
      "Patient ID: MB-4640\n",
      "Age at Diagnosis: 61.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 938:\n",
      "Patient ID: MB-4641\n",
      "Age at Diagnosis: 64.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 148.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 43.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 939:\n",
      "Patient ID: MB-4642\n",
      "Age at Diagnosis: 66.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 285.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 281.94\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 940:\n",
      "Patient ID: MB-4643\n",
      "Age at Diagnosis: 78.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 41.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 941:\n",
      "Patient ID: MB-4644\n",
      "Age at Diagnosis: 59.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 74.44\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 942:\n",
      "Patient ID: MB-4648\n",
      "Age at Diagnosis: 75.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 168.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 166.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 943:\n",
      "Patient ID: MB-4649\n",
      "Age at Diagnosis: 61.67\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 944:\n",
      "Patient ID: MB-4651\n",
      "Age at Diagnosis: 69.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 945:\n",
      "Patient ID: MB-4653\n",
      "Age at Diagnosis: 44.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 20.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 946:\n",
      "Patient ID: MB-4654\n",
      "Age at Diagnosis: 80.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 64.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 947:\n",
      "Patient ID: MB-4655\n",
      "Age at Diagnosis: 64.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 99.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 97.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 948:\n",
      "Patient ID: MB-4660\n",
      "Age at Diagnosis: 37.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 949:\n",
      "Patient ID: MB-4661\n",
      "Age at Diagnosis: 81.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 234.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 231.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 950:\n",
      "Patient ID: MB-4663\n",
      "Age at Diagnosis: 61.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 239.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 236.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 951:\n",
      "Patient ID: MB-4665\n",
      "Age at Diagnosis: 54.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 260.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 256.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 952:\n",
      "Patient ID: MB-4666\n",
      "Age at Diagnosis: 57.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 78.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 953:\n",
      "Patient ID: MB-4667\n",
      "Age at Diagnosis: 65.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 40.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 295.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 291.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 954:\n",
      "Patient ID: MB-4669\n",
      "Age at Diagnosis: 68.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 117.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 955:\n",
      "Patient ID: MB-4670\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 67.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 42.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 956:\n",
      "Patient ID: MB-4671\n",
      "Age at Diagnosis: 72.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.52\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 957:\n",
      "Patient ID: MB-4672\n",
      "Age at Diagnosis: 58.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 220.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 70.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 958:\n",
      "Patient ID: MB-4673\n",
      "Age at Diagnosis: 63.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 53.42\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 959:\n",
      "Patient ID: MB-4674\n",
      "Age at Diagnosis: 75.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 64.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 960:\n",
      "Patient ID: MB-4675\n",
      "Age at Diagnosis: 59.23\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 263.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 259.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 961:\n",
      "Patient ID: MB-4679\n",
      "Age at Diagnosis: 64.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 292.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 288.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 962:\n",
      "Patient ID: MB-4681\n",
      "Age at Diagnosis: 60.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 1.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 251.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 140.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 963:\n",
      "Patient ID: MB-4682\n",
      "Age at Diagnosis: 65.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 139.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 135.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 964:\n",
      "Patient ID: MB-4685\n",
      "Age at Diagnosis: 73.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 965:\n",
      "Patient ID: MB-4686\n",
      "Age at Diagnosis: 53.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 966:\n",
      "Patient ID: MB-4687\n",
      "Age at Diagnosis: 81.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 74.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 967:\n",
      "Patient ID: MB-4688\n",
      "Age at Diagnosis: 71.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 36.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 968:\n",
      "Patient ID: MB-4691\n",
      "Age at Diagnosis: 49.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 282.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 273.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 969:\n",
      "Patient ID: MB-4692\n",
      "Age at Diagnosis: 58.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 107.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 105.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 970:\n",
      "Patient ID: MB-4694\n",
      "Age at Diagnosis: 76.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 198.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 195.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 971:\n",
      "Patient ID: MB-4695\n",
      "Age at Diagnosis: 61.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 21.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 972:\n",
      "Patient ID: MB-4696\n",
      "Age at Diagnosis: 49.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 255.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 251.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 973:\n",
      "Patient ID: MB-4697\n",
      "Age at Diagnosis: 79.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: NC\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 1.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 118.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 116.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 974:\n",
      "Patient ID: MB-4698\n",
      "Age at Diagnosis: 59.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 170.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 127.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 975:\n",
      "Patient ID: MB-4701\n",
      "Age at Diagnosis: 47.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 127.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 125.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 976:\n",
      "Patient ID: MB-4702\n",
      "Age at Diagnosis: 52.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 300.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 296.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 977:\n",
      "Patient ID: MB-4704\n",
      "Age at Diagnosis: 67.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.098\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 64.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 63.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 49.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 978:\n",
      "Patient ID: MB-4705\n",
      "Age at Diagnosis: 63.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 213.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 102.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 979:\n",
      "Patient ID: MB-4706\n",
      "Age at Diagnosis: 75.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 54.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 980:\n",
      "Patient ID: MB-4707\n",
      "Age at Diagnosis: 59.85\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 218.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 981:\n",
      "Patient ID: MB-4708\n",
      "Age at Diagnosis: 63.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 227.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 982:\n",
      "Patient ID: MB-4709\n",
      "Age at Diagnosis: 49.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 144.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 983:\n",
      "Patient ID: MB-4710\n",
      "Age at Diagnosis: 77.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.66666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 56.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 984:\n",
      "Patient ID: MB-4711\n",
      "Age at Diagnosis: 56.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.198\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 99.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 985:\n",
      "Patient ID: MB-4712\n",
      "Age at Diagnosis: 46.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 249.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 246.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 986:\n",
      "Patient ID: MB-4714\n",
      "Age at Diagnosis: 64.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.002\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 83.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 82.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 987:\n",
      "Patient ID: MB-4715\n",
      "Age at Diagnosis: 67.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.52\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 988:\n",
      "Patient ID: MB-4716\n",
      "Age at Diagnosis: 52.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 76.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 989:\n",
      "Patient ID: MB-4717\n",
      "Age at Diagnosis: 43.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 26.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 990:\n",
      "Patient ID: MB-4718\n",
      "Age at Diagnosis: 44.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.198\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 198.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 49.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 99.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 991:\n",
      "Patient ID: MB-4719\n",
      "Age at Diagnosis: 67.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 80.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 992:\n",
      "Patient ID: MB-4721\n",
      "Age at Diagnosis: 66.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 23.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 993:\n",
      "Patient ID: MB-4722\n",
      "Age at Diagnosis: 64.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 84.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 994:\n",
      "Patient ID: MB-4723\n",
      "Age at Diagnosis: 64.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 209.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 995:\n",
      "Patient ID: MB-4724\n",
      "Age at Diagnosis: 60.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 144.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 996:\n",
      "Patient ID: MB-4725\n",
      "Age at Diagnosis: 65.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 997:\n",
      "Patient ID: MB-4729\n",
      "Age at Diagnosis: 75.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 28.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 998:\n",
      "Patient ID: MB-4730\n",
      "Age at Diagnosis: 51.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.136\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 131.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 129.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 68.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 999:\n",
      "Patient ID: MB-4731\n",
      "Age at Diagnosis: 49.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 33.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1000:\n",
      "Patient ID: MB-4732\n",
      "Age at Diagnosis: 26.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1001:\n",
      "Patient ID: MB-4733\n",
      "Age at Diagnosis: 56.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1002:\n",
      "Patient ID: MB-4735\n",
      "Age at Diagnosis: 54.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 297.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 131.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1003:\n",
      "Patient ID: MB-4737\n",
      "Age at Diagnosis: 52.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.092\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 120.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 46.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1004:\n",
      "Patient ID: MB-4738\n",
      "Age at Diagnosis: 42.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 176.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 173.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1005:\n",
      "Patient ID: MB-4739\n",
      "Age at Diagnosis: 56.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 161.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1006:\n",
      "Patient ID: MB-4741\n",
      "Age at Diagnosis: 53.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 56.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1007:\n",
      "Patient ID: MB-4742\n",
      "Age at Diagnosis: 76.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 83.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 53.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1008:\n",
      "Patient ID: MB-4743\n",
      "Age at Diagnosis: 52.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 230.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 143.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1009:\n",
      "Patient ID: MB-4744\n",
      "Age at Diagnosis: 64.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 75.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1010:\n",
      "Patient ID: MB-4745\n",
      "Age at Diagnosis: 50.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 29.67\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1011:\n",
      "Patient ID: MB-4746\n",
      "Age at Diagnosis: 38.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 244.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 241.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1012:\n",
      "Patient ID: MB-4749\n",
      "Age at Diagnosis: 70.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 51.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 50.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1013:\n",
      "Patient ID: MB-4750\n",
      "Age at Diagnosis: 73.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 36.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1014:\n",
      "Patient ID: MB-4752\n",
      "Age at Diagnosis: 63.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1015:\n",
      "Patient ID: MB-4757\n",
      "Age at Diagnosis: 38.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1016:\n",
      "Patient ID: MB-4758\n",
      "Age at Diagnosis: 45.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 209.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1017:\n",
      "Patient ID: MB-4760\n",
      "Age at Diagnosis: 48.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 97.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1018:\n",
      "Patient ID: MB-4762\n",
      "Age at Diagnosis: 67.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 252.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 248.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1019:\n",
      "Patient ID: MB-4763\n",
      "Age at Diagnosis: 44.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1020:\n",
      "Patient ID: MB-4764\n",
      "Age at Diagnosis: 57.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 245.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 242.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1021:\n",
      "Patient ID: MB-4767\n",
      "Age at Diagnosis: 74.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 47.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1022:\n",
      "Patient ID: MB-4769\n",
      "Age at Diagnosis: 65.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 7.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1023:\n",
      "Patient ID: MB-4770\n",
      "Age at Diagnosis: 70.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 152.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 150.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1024:\n",
      "Patient ID: MB-4771\n",
      "Age at Diagnosis: 47.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 297.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 293.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1025:\n",
      "Patient ID: MB-4778\n",
      "Age at Diagnosis: 78.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 206.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 203.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1026:\n",
      "Patient ID: MB-4779\n",
      "Age at Diagnosis: 53.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1027:\n",
      "Patient ID: MB-4782\n",
      "Age at Diagnosis: 43.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 251.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 247.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1028:\n",
      "Patient ID: MB-4784\n",
      "Age at Diagnosis: 63.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 145.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 143.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1029:\n",
      "Patient ID: MB-4785\n",
      "Age at Diagnosis: 75.46\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 121.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1030:\n",
      "Patient ID: MB-4787\n",
      "Age at Diagnosis: 68.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 80.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1031:\n",
      "Patient ID: MB-4790\n",
      "Age at Diagnosis: 43.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1032:\n",
      "Patient ID: MB-4791\n",
      "Age at Diagnosis: 83.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 46.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 173.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 171.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1033:\n",
      "Patient ID: MB-4792\n",
      "Age at Diagnosis: 49.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 40.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 35.1\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1034:\n",
      "Patient ID: MB-4793\n",
      "Age at Diagnosis: 72.49\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 83.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 82.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1035:\n",
      "Patient ID: MB-4794\n",
      "Age at Diagnosis: 89.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 44.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1036:\n",
      "Patient ID: MB-4796\n",
      "Age at Diagnosis: 53.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 8.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1037:\n",
      "Patient ID: MB-4797\n",
      "Age at Diagnosis: 81.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 99.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 98.06\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1038:\n",
      "Patient ID: MB-4798\n",
      "Age at Diagnosis: 44.51\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 257.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 253.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1039:\n",
      "Patient ID: MB-4800\n",
      "Age at Diagnosis: 61.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 26.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1040:\n",
      "Patient ID: MB-4801\n",
      "Age at Diagnosis: 65.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 128.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1041:\n",
      "Patient ID: MB-4802\n",
      "Age at Diagnosis: 71.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1042:\n",
      "Patient ID: MB-4805\n",
      "Age at Diagnosis: 45.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 129.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 48.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1043:\n",
      "Patient ID: MB-4806\n",
      "Age at Diagnosis: 49.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 201.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 199.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1044:\n",
      "Patient ID: MB-4809\n",
      "Age at Diagnosis: 43.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 286.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 282.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1045:\n",
      "Patient ID: MB-4814\n",
      "Age at Diagnosis: 39.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 73.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 53.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1046:\n",
      "Patient ID: MB-4818\n",
      "Age at Diagnosis: 75.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.114\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 76.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 75.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 57.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1047:\n",
      "Patient ID: MB-4820\n",
      "Age at Diagnosis: 67.19\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 49.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1048:\n",
      "Patient ID: MB-4822\n",
      "Age at Diagnosis: 76.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 91.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 89.44\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1049:\n",
      "Patient ID: MB-4823\n",
      "Age at Diagnosis: 64.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.002\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 282.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 278.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1050:\n",
      "Patient ID: MB-4825\n",
      "Age at Diagnosis: 65.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 214.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 211.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1051:\n",
      "Patient ID: MB-4827\n",
      "Age at Diagnosis: 78.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 45.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1052:\n",
      "Patient ID: MB-4828\n",
      "Age at Diagnosis: 78.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 42.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.04\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1053:\n",
      "Patient ID: MB-4829\n",
      "Age at Diagnosis: 83.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 176.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 173.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1054:\n",
      "Patient ID: MB-4832\n",
      "Age at Diagnosis: 45.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 141.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 125.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1055:\n",
      "Patient ID: MB-4834\n",
      "Age at Diagnosis: 49.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1056:\n",
      "Patient ID: MB-4836\n",
      "Age at Diagnosis: 55.66\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1057:\n",
      "Patient ID: MB-4838\n",
      "Age at Diagnosis: 74.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.198\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 198.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 99.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1058:\n",
      "Patient ID: MB-4839\n",
      "Age at Diagnosis: 67.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 1.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 299.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 131.15\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1059:\n",
      "Patient ID: MB-4843\n",
      "Age at Diagnosis: 54.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 265.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 261.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1060:\n",
      "Patient ID: MB-4845\n",
      "Age at Diagnosis: 86.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 19.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 4.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1061:\n",
      "Patient ID: MB-4846\n",
      "Age at Diagnosis: 63.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 101.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1062:\n",
      "Patient ID: MB-4849\n",
      "Age at Diagnosis: 81.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1063:\n",
      "Patient ID: MB-4851\n",
      "Age at Diagnosis: 73.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 85.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1064:\n",
      "Patient ID: MB-4853\n",
      "Age at Diagnosis: 62.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 265.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 30.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1065:\n",
      "Patient ID: MB-4855\n",
      "Age at Diagnosis: 74.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 41.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 31.25\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1066:\n",
      "Patient ID: MB-4858\n",
      "Age at Diagnosis: 74.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 129.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 127.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1067:\n",
      "Patient ID: MB-4859\n",
      "Age at Diagnosis: 74.29\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 157.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 155.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1068:\n",
      "Patient ID: MB-4860\n",
      "Age at Diagnosis: 44.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 234.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 37.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1069:\n",
      "Patient ID: MB-4862\n",
      "Age at Diagnosis: 64.32\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 184.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1070:\n",
      "Patient ID: MB-4865\n",
      "Age at Diagnosis: 50.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 229.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 226.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1071:\n",
      "Patient ID: MB-4866\n",
      "Age at Diagnosis: 43.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 224.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 221.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1072:\n",
      "Patient ID: MB-4867\n",
      "Age at Diagnosis: 47.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 218.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1073:\n",
      "Patient ID: MB-4869\n",
      "Age at Diagnosis: 67.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 27.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1074:\n",
      "Patient ID: MB-4870\n",
      "Age at Diagnosis: 57.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 229.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 225.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1075:\n",
      "Patient ID: MB-4871\n",
      "Age at Diagnosis: 74.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 36.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1076:\n",
      "Patient ID: MB-4872\n",
      "Age at Diagnosis: 58.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 157.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 108.62\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1077:\n",
      "Patient ID: MB-4873\n",
      "Age at Diagnosis: 64.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 88.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1078:\n",
      "Patient ID: MB-4876\n",
      "Age at Diagnosis: 42.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.056\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 150.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1079:\n",
      "Patient ID: MB-4878\n",
      "Age at Diagnosis: 79.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1080:\n",
      "Patient ID: MB-4879\n",
      "Age at Diagnosis: 49.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 78.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1081:\n",
      "Patient ID: MB-4880\n",
      "Age at Diagnosis: 69.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 210.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 85.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1082:\n",
      "Patient ID: MB-4881\n",
      "Age at Diagnosis: 37.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 274.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 270.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1083:\n",
      "Patient ID: MB-4882\n",
      "Age at Diagnosis: 76.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.014\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 266.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 262.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 7.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1084:\n",
      "Patient ID: MB-4883\n",
      "Age at Diagnosis: 57.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 268.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 265.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1085:\n",
      "Patient ID: MB-4886\n",
      "Age at Diagnosis: 43.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 31.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1086:\n",
      "Patient ID: MB-4887\n",
      "Age at Diagnosis: 52.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.066\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 9.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1087:\n",
      "Patient ID: MB-4888\n",
      "Age at Diagnosis: 63.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 230.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 227.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1088:\n",
      "Patient ID: MB-4893\n",
      "Age at Diagnosis: 33.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 176.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 174.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1089:\n",
      "Patient ID: MB-4894\n",
      "Age at Diagnosis: 47.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 232.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 229.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1090:\n",
      "Patient ID: MB-4896\n",
      "Age at Diagnosis: 41.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 64.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 16.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1091:\n",
      "Patient ID: MB-4897\n",
      "Age at Diagnosis: 40.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.002\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 197.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 194.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1092:\n",
      "Patient ID: MB-4898\n",
      "Age at Diagnosis: 63.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1093:\n",
      "Patient ID: MB-4899\n",
      "Age at Diagnosis: 40.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 275.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1094:\n",
      "Patient ID: MB-4900\n",
      "Age at Diagnosis: 47.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 224.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 221.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1095:\n",
      "Patient ID: MB-4904\n",
      "Age at Diagnosis: 64.3\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 129.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 127.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1096:\n",
      "Patient ID: MB-4906\n",
      "Age at Diagnosis: 73.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 233.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 230.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1097:\n",
      "Patient ID: MB-4908\n",
      "Age at Diagnosis: 69.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 47.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1098:\n",
      "Patient ID: MB-4911\n",
      "Age at Diagnosis: 43.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 23.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1099:\n",
      "Patient ID: MB-4912\n",
      "Age at Diagnosis: 78.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1100:\n",
      "Patient ID: MB-4925\n",
      "Age at Diagnosis: 76.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 101.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1101:\n",
      "Patient ID: MB-4928\n",
      "Age at Diagnosis: 75.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 220.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 217.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1102:\n",
      "Patient ID: MB-4929\n",
      "Age at Diagnosis: 59.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 40.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1103:\n",
      "Patient ID: MB-4930\n",
      "Age at Diagnosis: 62.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.43333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1104:\n",
      "Patient ID: MB-4931\n",
      "Age at Diagnosis: 58.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1105:\n",
      "Patient ID: MB-4933\n",
      "Age at Diagnosis: 50.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 272.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1106:\n",
      "Patient ID: MB-4934\n",
      "Age at Diagnosis: 74.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 69.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1107:\n",
      "Patient ID: MB-4935\n",
      "Age at Diagnosis: 36.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 191.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1108:\n",
      "Patient ID: MB-4937\n",
      "Age at Diagnosis: 41.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 77.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 32.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1109:\n",
      "Patient ID: MB-4938\n",
      "Age at Diagnosis: 33.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 30.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1110:\n",
      "Patient ID: MB-4941\n",
      "Age at Diagnosis: 57.32\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 53.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1111:\n",
      "Patient ID: MB-4942\n",
      "Age at Diagnosis: 60.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1112:\n",
      "Patient ID: MB-4944\n",
      "Age at Diagnosis: 77.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 237.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 234.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1113:\n",
      "Patient ID: MB-4945\n",
      "Age at Diagnosis: 65.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 20.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 15.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1114:\n",
      "Patient ID: MB-4949\n",
      "Age at Diagnosis: 69.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 216.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 214.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1115:\n",
      "Patient ID: MB-4950\n",
      "Age at Diagnosis: 69.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 150.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 148.62\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1116:\n",
      "Patient ID: MB-4952\n",
      "Age at Diagnosis: 67.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 184.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 181.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1117:\n",
      "Patient ID: MB-4956\n",
      "Age at Diagnosis: 69.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 69.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 36.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1118:\n",
      "Patient ID: MB-4957\n",
      "Age at Diagnosis: 70.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 197.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 90.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1119:\n",
      "Patient ID: MB-4959\n",
      "Age at Diagnosis: 76.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 2.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 115.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1120:\n",
      "Patient ID: MB-4961\n",
      "Age at Diagnosis: 56.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 219.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 216.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1121:\n",
      "Patient ID: MB-4962\n",
      "Age at Diagnosis: 72.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 197.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 195.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1122:\n",
      "Patient ID: MB-4965\n",
      "Age at Diagnosis: 69.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 263.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 260.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1123:\n",
      "Patient ID: MB-4966\n",
      "Age at Diagnosis: 55.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 49.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 46.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1124:\n",
      "Patient ID: MB-4967\n",
      "Age at Diagnosis: 61.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 130.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 128.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1125:\n",
      "Patient ID: MB-4968\n",
      "Age at Diagnosis: 56.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 78.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 77.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1126:\n",
      "Patient ID: MB-4969\n",
      "Age at Diagnosis: 76.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 17.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 198.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 195.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1127:\n",
      "Patient ID: MB-4970\n",
      "Age at Diagnosis: 77.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 54.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1128:\n",
      "Patient ID: MB-4974\n",
      "Age at Diagnosis: 65.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 176.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 173.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1129:\n",
      "Patient ID: MB-4976\n",
      "Age at Diagnosis: 73.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 224.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 221.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1130:\n",
      "Patient ID: MB-4977\n",
      "Age at Diagnosis: 72.54\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 216.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 196.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1131:\n",
      "Patient ID: MB-4978\n",
      "Age at Diagnosis: 58.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 198.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 195.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1132:\n",
      "Patient ID: MB-4981\n",
      "Age at Diagnosis: 69.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 180.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 174.44\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1133:\n",
      "Patient ID: MB-4982\n",
      "Age at Diagnosis: 62.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.67\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1134:\n",
      "Patient ID: MB-4986\n",
      "Age at Diagnosis: 41.0\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1135:\n",
      "Patient ID: MB-4987\n",
      "Age at Diagnosis: 76.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 218.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1136:\n",
      "Patient ID: MB-4991\n",
      "Age at Diagnosis: 77.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 125.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1137:\n",
      "Patient ID: MB-4992\n",
      "Age at Diagnosis: 66.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.066\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 165.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 163.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1138:\n",
      "Patient ID: MB-4993\n",
      "Age at Diagnosis: 33.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1139:\n",
      "Patient ID: MB-4994\n",
      "Age at Diagnosis: 77.54\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 171.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1140:\n",
      "Patient ID: MB-4996\n",
      "Age at Diagnosis: 69.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 99.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 98.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1141:\n",
      "Patient ID: MB-4998\n",
      "Age at Diagnosis: 75.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.064\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 65.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1142:\n",
      "Patient ID: MB-4999\n",
      "Age at Diagnosis: 44.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 185.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1143:\n",
      "Patient ID: MB-5001\n",
      "Age at Diagnosis: 71.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1144:\n",
      "Patient ID: MB-5004\n",
      "Age at Diagnosis: 42.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 17.0\n",
      "Nottingham prognostic index: 5.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 216.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 213.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1145:\n",
      "Patient ID: MB-5008\n",
      "Age at Diagnosis: 65.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 223.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 220.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1146:\n",
      "Patient ID: MB-5011\n",
      "Age at Diagnosis: 67.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 80.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1147:\n",
      "Patient ID: MB-5013\n",
      "Age at Diagnosis: 68.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 251.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 247.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1148:\n",
      "Patient ID: MB-5014\n",
      "Age at Diagnosis: 69.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 213.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 210.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1149:\n",
      "Patient ID: MB-5015\n",
      "Age at Diagnosis: 44.36\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 252.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 248.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1150:\n",
      "Patient ID: MB-5017\n",
      "Age at Diagnosis: 65.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 144.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 143.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1151:\n",
      "Patient ID: MB-5018\n",
      "Age at Diagnosis: 72.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 107.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1152:\n",
      "Patient ID: MB-5019\n",
      "Age at Diagnosis: 49.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 28.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1153:\n",
      "Patient ID: MB-5020\n",
      "Age at Diagnosis: 62.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 84.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1154:\n",
      "Patient ID: MB-5022\n",
      "Age at Diagnosis: 70.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.062\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 118.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 107.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1155:\n",
      "Patient ID: MB-5027\n",
      "Age at Diagnosis: 46.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 189.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 187.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1156:\n",
      "Patient ID: MB-5033\n",
      "Age at Diagnosis: 63.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 2.086\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 52.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 43.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1157:\n",
      "Patient ID: MB-5035\n",
      "Age at Diagnosis: 56.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 19.0\n",
      "Nottingham prognostic index: 4.11\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 213.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 210.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1158:\n",
      "Patient ID: MB-5039\n",
      "Age at Diagnosis: 67.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 62.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.56\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1159:\n",
      "Patient ID: MB-5040\n",
      "Age at Diagnosis: 72.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 78.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1160:\n",
      "Patient ID: MB-5041\n",
      "Age at Diagnosis: 45.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 173.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 171.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1161:\n",
      "Patient ID: MB-5043\n",
      "Age at Diagnosis: 70.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 128.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 117.04\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1162:\n",
      "Patient ID: MB-5044\n",
      "Age at Diagnosis: 55.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 139.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 137.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1163:\n",
      "Patient ID: MB-5045\n",
      "Age at Diagnosis: 70.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 168.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 166.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1164:\n",
      "Patient ID: MB-5048\n",
      "Age at Diagnosis: 44.12\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.27\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1165:\n",
      "Patient ID: MB-5049\n",
      "Age at Diagnosis: 61.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 255.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 251.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1166:\n",
      "Patient ID: MB-5050\n",
      "Age at Diagnosis: 55.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 184.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 181.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1167:\n",
      "Patient ID: MB-5052\n",
      "Age at Diagnosis: 76.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 34.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1168:\n",
      "Patient ID: MB-5053\n",
      "Age at Diagnosis: 68.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 150.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 148.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1169:\n",
      "Patient ID: MB-5054\n",
      "Age at Diagnosis: 52.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.002\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 185.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1170:\n",
      "Patient ID: MB-5057\n",
      "Age at Diagnosis: 39.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 56.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 3.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1171:\n",
      "Patient ID: MB-5058\n",
      "Age at Diagnosis: 61.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 178.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 169.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1172:\n",
      "Patient ID: MB-5059\n",
      "Age at Diagnosis: 53.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 257.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 254.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1173:\n",
      "Patient ID: MB-5060\n",
      "Age at Diagnosis: 75.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 150.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 148.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1174:\n",
      "Patient ID: MB-5061\n",
      "Age at Diagnosis: 71.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 39.43333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 38.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1175:\n",
      "Patient ID: MB-5062\n",
      "Age at Diagnosis: 75.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 168.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 74.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1176:\n",
      "Patient ID: MB-5063\n",
      "Age at Diagnosis: 41.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 215.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 212.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1177:\n",
      "Patient ID: MB-5064\n",
      "Age at Diagnosis: 63.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 90.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1178:\n",
      "Patient ID: MB-5065\n",
      "Age at Diagnosis: 68.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 184.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 182.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1179:\n",
      "Patient ID: MB-5066\n",
      "Age at Diagnosis: 53.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 94.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 93.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1180:\n",
      "Patient ID: MB-5068\n",
      "Age at Diagnosis: 71.19\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 180.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1181:\n",
      "Patient ID: MB-5070\n",
      "Age at Diagnosis: 47.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 213.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 211.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1182:\n",
      "Patient ID: MB-5072\n",
      "Age at Diagnosis: 52.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1183:\n",
      "Patient ID: MB-5073\n",
      "Age at Diagnosis: 67.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 191.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1184:\n",
      "Patient ID: MB-5074\n",
      "Age at Diagnosis: 70.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 221.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1185:\n",
      "Patient ID: MB-5076\n",
      "Age at Diagnosis: 28.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 26.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 23.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1186:\n",
      "Patient ID: MB-5078\n",
      "Age at Diagnosis: 56.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1187:\n",
      "Patient ID: MB-5079\n",
      "Age at Diagnosis: 66.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1188:\n",
      "Patient ID: MB-5081\n",
      "Age at Diagnosis: 43.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 44.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1189:\n",
      "Patient ID: MB-5084\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 198.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1190:\n",
      "Patient ID: MB-5086\n",
      "Age at Diagnosis: 65.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 84.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 45.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1191:\n",
      "Patient ID: MB-5088\n",
      "Age at Diagnosis: 72.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 196.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1192:\n",
      "Patient ID: MB-5092\n",
      "Age at Diagnosis: 76.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 172.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1193:\n",
      "Patient ID: MB-5093\n",
      "Age at Diagnosis: 69.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 142.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 140.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1194:\n",
      "Patient ID: MB-5097\n",
      "Age at Diagnosis: 56.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 61.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 60.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1195:\n",
      "Patient ID: MB-5098\n",
      "Age at Diagnosis: 61.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 79.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1196:\n",
      "Patient ID: MB-5100\n",
      "Age at Diagnosis: 32.74\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 17.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1197:\n",
      "Patient ID: MB-5101\n",
      "Age at Diagnosis: 67.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1198:\n",
      "Patient ID: MB-5102\n",
      "Age at Diagnosis: 69.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 20.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 18.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1199:\n",
      "Patient ID: MB-5104\n",
      "Age at Diagnosis: 73.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 120.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1200:\n",
      "Patient ID: MB-5105\n",
      "Age at Diagnosis: 63.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 204.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 105.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1201:\n",
      "Patient ID: MB-5106\n",
      "Age at Diagnosis: 59.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 190.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 160.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1202:\n",
      "Patient ID: MB-5107\n",
      "Age at Diagnosis: 61.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.082\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 82.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 69.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 41.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1203:\n",
      "Patient ID: MB-5109\n",
      "Age at Diagnosis: 64.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1204:\n",
      "Patient ID: MB-5110\n",
      "Age at Diagnosis: 59.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 1.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 21.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1205:\n",
      "Patient ID: MB-5113\n",
      "Age at Diagnosis: 43.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 173.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1206:\n",
      "Patient ID: MB-5114\n",
      "Age at Diagnosis: 57.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 13.49\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1207:\n",
      "Patient ID: MB-5115\n",
      "Age at Diagnosis: 40.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 77.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 76.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1208:\n",
      "Patient ID: MB-5116\n",
      "Age at Diagnosis: 74.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 66.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1209:\n",
      "Patient ID: MB-5117\n",
      "Age at Diagnosis: 51.09\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 209.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 206.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1210:\n",
      "Patient ID: MB-5118\n",
      "Age at Diagnosis: 72.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 208.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1211:\n",
      "Patient ID: MB-5119\n",
      "Age at Diagnosis: 75.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 58.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1212:\n",
      "Patient ID: MB-5120\n",
      "Age at Diagnosis: 47.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1213:\n",
      "Patient ID: MB-5121\n",
      "Age at Diagnosis: 72.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 114.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 111.94\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1214:\n",
      "Patient ID: MB-5122\n",
      "Age at Diagnosis: 77.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 125.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1215:\n",
      "Patient ID: MB-5123\n",
      "Age at Diagnosis: 69.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 61.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1216:\n",
      "Patient ID: MB-5124\n",
      "Age at Diagnosis: 83.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1217:\n",
      "Patient ID: MB-5126\n",
      "Age at Diagnosis: 63.48\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1218:\n",
      "Patient ID: MB-5127\n",
      "Age at Diagnosis: 74.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Undef\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 191.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 188.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1219:\n",
      "Patient ID: MB-5130\n",
      "Age at Diagnosis: 58.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 255.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 251.64\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1220:\n",
      "Patient ID: MB-5131\n",
      "Age at Diagnosis: 64.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.006\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 264.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 31.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 3.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1221:\n",
      "Patient ID: MB-5134\n",
      "Age at Diagnosis: 46.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 196.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 193.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1222:\n",
      "Patient ID: MB-5135\n",
      "Age at Diagnosis: 38.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1223:\n",
      "Patient ID: MB-5136\n",
      "Age at Diagnosis: 63.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 178.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 176.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1224:\n",
      "Patient ID: MB-5137\n",
      "Age at Diagnosis: 36.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1225:\n",
      "Patient ID: MB-5138\n",
      "Age at Diagnosis: 44.59\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 6.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1226:\n",
      "Patient ID: MB-5139\n",
      "Age at Diagnosis: 69.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1227:\n",
      "Patient ID: MB-5140\n",
      "Age at Diagnosis: 77.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 134.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1228:\n",
      "Patient ID: MB-5143\n",
      "Age at Diagnosis: 78.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 127.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1229:\n",
      "Patient ID: MB-5144\n",
      "Age at Diagnosis: 57.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 213.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 210.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1230:\n",
      "Patient ID: MB-5145\n",
      "Age at Diagnosis: 61.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 159.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 61.15\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1231:\n",
      "Patient ID: MB-5147\n",
      "Age at Diagnosis: 54.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 20.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 20.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1232:\n",
      "Patient ID: MB-5148\n",
      "Age at Diagnosis: 76.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 245.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 242.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1233:\n",
      "Patient ID: MB-5150\n",
      "Age at Diagnosis: 69.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.002\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 110.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 8.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1234:\n",
      "Patient ID: MB-5152\n",
      "Age at Diagnosis: 76.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 115.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 114.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1235:\n",
      "Patient ID: MB-5154\n",
      "Age at Diagnosis: 31.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.002\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 170.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 168.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1236:\n",
      "Patient ID: MB-5155\n",
      "Age at Diagnosis: 51.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 259.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 256.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1237:\n",
      "Patient ID: MB-5157\n",
      "Age at Diagnosis: 70.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 18.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1238:\n",
      "Patient ID: MB-5158\n",
      "Age at Diagnosis: 66.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 244.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 240.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1239:\n",
      "Patient ID: MB-5160\n",
      "Age at Diagnosis: 68.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1240:\n",
      "Patient ID: MB-5161\n",
      "Age at Diagnosis: 44.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 173.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1241:\n",
      "Patient ID: MB-5162\n",
      "Age at Diagnosis: 53.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 162.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1242:\n",
      "Patient ID: MB-5163\n",
      "Age at Diagnosis: 69.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 212.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 209.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1243:\n",
      "Patient ID: MB-5164\n",
      "Age at Diagnosis: 48.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 80.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1244:\n",
      "Patient ID: MB-5166\n",
      "Age at Diagnosis: 69.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 80.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 43.65\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1245:\n",
      "Patient ID: MB-5167\n",
      "Age at Diagnosis: 60.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 208.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 205.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1246:\n",
      "Patient ID: MB-5169\n",
      "Age at Diagnosis: 62.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1247:\n",
      "Patient ID: MB-5171\n",
      "Age at Diagnosis: 46.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1248:\n",
      "Patient ID: MB-5172\n",
      "Age at Diagnosis: 49.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 184.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 181.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1249:\n",
      "Patient ID: MB-5173\n",
      "Age at Diagnosis: 69.05\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 19.54\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1250:\n",
      "Patient ID: MB-5174\n",
      "Age at Diagnosis: 54.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 151.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 149.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1251:\n",
      "Patient ID: MB-5175\n",
      "Age at Diagnosis: 50.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 192.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1252:\n",
      "Patient ID: MB-5176\n",
      "Age at Diagnosis: 53.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 19.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 112.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 111.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1253:\n",
      "Patient ID: MB-5177\n",
      "Age at Diagnosis: 68.53\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 64.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1254:\n",
      "Patient ID: MB-5178\n",
      "Age at Diagnosis: 65.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 184.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 181.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1255:\n",
      "Patient ID: MB-5179\n",
      "Age at Diagnosis: 68.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 246.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 243.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1256:\n",
      "Patient ID: MB-5182\n",
      "Age at Diagnosis: 78.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 134.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 132.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1257:\n",
      "Patient ID: MB-5183\n",
      "Age at Diagnosis: 74.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 116.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1258:\n",
      "Patient ID: MB-5184\n",
      "Age at Diagnosis: 79.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 89.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 88.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1259:\n",
      "Patient ID: MB-5185\n",
      "Age at Diagnosis: 61.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 77.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1260:\n",
      "Patient ID: MB-5186\n",
      "Age at Diagnosis: 42.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 1.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 203.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 200.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1261:\n",
      "Patient ID: MB-5188\n",
      "Age at Diagnosis: 65.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 7.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1262:\n",
      "Patient ID: MB-5189\n",
      "Age at Diagnosis: 69.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 45.33\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1263:\n",
      "Patient ID: MB-5190\n",
      "Age at Diagnosis: 53.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 242.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 239.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1264:\n",
      "Patient ID: MB-5191\n",
      "Age at Diagnosis: 54.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 142.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 140.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1265:\n",
      "Patient ID: MB-5193\n",
      "Age at Diagnosis: 88.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 54.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 53.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1266:\n",
      "Patient ID: MB-5195\n",
      "Age at Diagnosis: 72.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 196.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 194.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1267:\n",
      "Patient ID: MB-5196\n",
      "Age at Diagnosis: 52.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 94.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1268:\n",
      "Patient ID: MB-5197\n",
      "Age at Diagnosis: 62.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 223.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 220.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1269:\n",
      "Patient ID: MB-5199\n",
      "Age at Diagnosis: 65.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 204.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 201.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1270:\n",
      "Patient ID: MB-5200\n",
      "Age at Diagnosis: 70.23\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 52.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1271:\n",
      "Patient ID: MB-5201\n",
      "Age at Diagnosis: 73.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 96.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 95.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1272:\n",
      "Patient ID: MB-5204\n",
      "Age at Diagnosis: 76.91\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 191.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 158.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1273:\n",
      "Patient ID: MB-5205\n",
      "Age at Diagnosis: 50.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 73.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1274:\n",
      "Patient ID: MB-5206\n",
      "Age at Diagnosis: 67.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 205.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 203.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1275:\n",
      "Patient ID: MB-5208\n",
      "Age at Diagnosis: 52.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 151.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 149.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1276:\n",
      "Patient ID: MB-5209\n",
      "Age at Diagnosis: 79.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 172.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1277:\n",
      "Patient ID: MB-5211\n",
      "Age at Diagnosis: 68.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 247.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 244.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1278:\n",
      "Patient ID: MB-5212\n",
      "Age at Diagnosis: 80.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 179.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 176.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1279:\n",
      "Patient ID: MB-5213\n",
      "Age at Diagnosis: 74.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1280:\n",
      "Patient ID: MB-5214\n",
      "Age at Diagnosis: 66.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 107.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 37.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1281:\n",
      "Patient ID: MB-5215\n",
      "Age at Diagnosis: 74.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 115.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1282:\n",
      "Patient ID: MB-5218\n",
      "Age at Diagnosis: 42.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 254.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 251.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1283:\n",
      "Patient ID: MB-5219\n",
      "Age at Diagnosis: 55.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 252.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 249.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1284:\n",
      "Patient ID: MB-5221\n",
      "Age at Diagnosis: 63.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 129.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1285:\n",
      "Patient ID: MB-5222\n",
      "Age at Diagnosis: 76.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 110.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1286:\n",
      "Patient ID: MB-5223\n",
      "Age at Diagnosis: 42.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 144.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 134.9\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1287:\n",
      "Patient ID: MB-5224\n",
      "Age at Diagnosis: 90.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 99.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 98.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1288:\n",
      "Patient ID: MB-5225\n",
      "Age at Diagnosis: 68.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1289:\n",
      "Patient ID: MB-5226\n",
      "Age at Diagnosis: 75.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1290:\n",
      "Patient ID: MB-5227\n",
      "Age at Diagnosis: 74.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 184.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1291:\n",
      "Patient ID: MB-5228\n",
      "Age at Diagnosis: 72.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 180.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 178.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1292:\n",
      "Patient ID: MB-5229\n",
      "Age at Diagnosis: 39.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 33.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 25.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1293:\n",
      "Patient ID: MB-5230\n",
      "Age at Diagnosis: 48.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 176.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 174.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1294:\n",
      "Patient ID: MB-5231\n",
      "Age at Diagnosis: 61.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 13.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1295:\n",
      "Patient ID: MB-5232\n",
      "Age at Diagnosis: 74.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 208.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1296:\n",
      "Patient ID: MB-5233\n",
      "Age at Diagnosis: 79.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 209.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 206.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1297:\n",
      "Patient ID: MB-5235\n",
      "Age at Diagnosis: 59.04\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 3.012\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 204.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 201.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 6.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1298:\n",
      "Patient ID: MB-5236\n",
      "Age at Diagnosis: 63.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.13\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 166.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 164.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1299:\n",
      "Patient ID: MB-5238\n",
      "Age at Diagnosis: 46.03\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1300:\n",
      "Patient ID: MB-5239\n",
      "Age at Diagnosis: 69.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 192.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 163.65\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1301:\n",
      "Patient ID: MB-5240\n",
      "Age at Diagnosis: 56.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 103.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1302:\n",
      "Patient ID: MB-5243\n",
      "Age at Diagnosis: 62.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1303:\n",
      "Patient ID: MB-5244\n",
      "Age at Diagnosis: 69.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 216.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 118.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1304:\n",
      "Patient ID: MB-5251\n",
      "Age at Diagnosis: 76.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 112.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 85.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1305:\n",
      "Patient ID: MB-5253\n",
      "Age at Diagnosis: 69.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 102.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 100.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1306:\n",
      "Patient ID: MB-5255\n",
      "Age at Diagnosis: 58.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 53.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 52.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1307:\n",
      "Patient ID: MB-5256\n",
      "Age at Diagnosis: 70.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 83.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1308:\n",
      "Patient ID: MB-5258\n",
      "Age at Diagnosis: 72.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 99.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1309:\n",
      "Patient ID: MB-5259\n",
      "Age at Diagnosis: 41.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.15\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1310:\n",
      "Patient ID: MB-5260\n",
      "Age at Diagnosis: 72.23\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 202.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 199.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1311:\n",
      "Patient ID: MB-5261\n",
      "Age at Diagnosis: 66.12\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 116.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 114.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1312:\n",
      "Patient ID: MB-5264\n",
      "Age at Diagnosis: 46.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 196.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1313:\n",
      "Patient ID: MB-5266\n",
      "Age at Diagnosis: 76.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 83.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 75.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1314:\n",
      "Patient ID: MB-5267\n",
      "Age at Diagnosis: 52.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 45.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1315:\n",
      "Patient ID: MB-5268\n",
      "Age at Diagnosis: 47.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 186.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 178.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1316:\n",
      "Patient ID: MB-5270\n",
      "Age at Diagnosis: 67.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 187.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 185.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1317:\n",
      "Patient ID: MB-5271\n",
      "Age at Diagnosis: 58.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 167.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 165.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1318:\n",
      "Patient ID: MB-5272\n",
      "Age at Diagnosis: 40.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 201.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 112.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1319:\n",
      "Patient ID: MB-5273\n",
      "Age at Diagnosis: 60.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 60.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 44.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1320:\n",
      "Patient ID: MB-5275\n",
      "Age at Diagnosis: 72.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 80.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1321:\n",
      "Patient ID: MB-5277\n",
      "Age at Diagnosis: 35.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 151.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1322:\n",
      "Patient ID: MB-5278\n",
      "Age at Diagnosis: 47.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 99.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 85.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1323:\n",
      "Patient ID: MB-5279\n",
      "Age at Diagnosis: 66.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 68.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 30.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1324:\n",
      "Patient ID: MB-5280\n",
      "Age at Diagnosis: 45.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.004\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 77.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 56.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 2.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1325:\n",
      "Patient ID: MB-5281\n",
      "Age at Diagnosis: 55.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 78.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1326:\n",
      "Patient ID: MB-5284\n",
      "Age at Diagnosis: 68.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 65.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 64.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1327:\n",
      "Patient ID: MB-5287\n",
      "Age at Diagnosis: 69.46\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1328:\n",
      "Patient ID: MB-5288\n",
      "Age at Diagnosis: 70.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 22.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1329:\n",
      "Patient ID: MB-5289\n",
      "Age at Diagnosis: 65.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1330:\n",
      "Patient ID: MB-5290\n",
      "Age at Diagnosis: 69.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 36.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1331:\n",
      "Patient ID: MB-5291\n",
      "Age at Diagnosis: 67.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 151.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1332:\n",
      "Patient ID: MB-5292\n",
      "Age at Diagnosis: 82.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.01\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 9.31\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1333:\n",
      "Patient ID: MB-5293\n",
      "Age at Diagnosis: 70.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 208.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 206.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1334:\n",
      "Patient ID: MB-5294\n",
      "Age at Diagnosis: 31.71\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.198\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 193.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 99.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1335:\n",
      "Patient ID: MB-5295\n",
      "Age at Diagnosis: 60.51\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 74.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1336:\n",
      "Patient ID: MB-5296\n",
      "Age at Diagnosis: 78.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 13.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1337:\n",
      "Patient ID: MB-5298\n",
      "Age at Diagnosis: 49.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.046\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 84.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 22.04\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1338:\n",
      "Patient ID: MB-5299\n",
      "Age at Diagnosis: 53.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 16.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 4.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1339:\n",
      "Patient ID: MB-5300\n",
      "Age at Diagnosis: 55.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 190.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1340:\n",
      "Patient ID: MB-5301\n",
      "Age at Diagnosis: 64.46\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 241.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1341:\n",
      "Patient ID: MB-5302\n",
      "Age at Diagnosis: 52.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.12\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 191.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 188.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1342:\n",
      "Patient ID: MB-5305\n",
      "Age at Diagnosis: 61.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 149.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1343:\n",
      "Patient ID: MB-5306\n",
      "Age at Diagnosis: 58.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 159.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 157.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1344:\n",
      "Patient ID: MB-5308\n",
      "Age at Diagnosis: 67.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 77.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1345:\n",
      "Patient ID: MB-5310\n",
      "Age at Diagnosis: 71.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 153.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 151.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1346:\n",
      "Patient ID: MB-5311\n",
      "Age at Diagnosis: 73.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 0.69\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1347:\n",
      "Patient ID: MB-5312\n",
      "Age at Diagnosis: 50.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 3.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1348:\n",
      "Patient ID: MB-5313\n",
      "Age at Diagnosis: 79.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 46.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1349:\n",
      "Patient ID: MB-5315\n",
      "Age at Diagnosis: 52.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1350:\n",
      "Patient ID: MB-5317\n",
      "Age at Diagnosis: 69.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 53.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 48.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1351:\n",
      "Patient ID: MB-5318\n",
      "Age at Diagnosis: 60.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 6.94\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1352:\n",
      "Patient ID: MB-5322\n",
      "Age at Diagnosis: 66.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 102.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 66.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1353:\n",
      "Patient ID: MB-5323\n",
      "Age at Diagnosis: 31.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 226.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 223.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1354:\n",
      "Patient ID: MB-5324\n",
      "Age at Diagnosis: 64.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 190.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 187.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1355:\n",
      "Patient ID: MB-5325\n",
      "Age at Diagnosis: 43.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 204.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 201.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1356:\n",
      "Patient ID: MB-5326\n",
      "Age at Diagnosis: 79.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 2.096\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 96.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 94.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 48.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1357:\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Patient ID: MB-5327\n",
      "Age at Diagnosis: 66.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 163.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1358:\n",
      "Patient ID: MB-5328\n",
      "Age at Diagnosis: 74.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 14.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1359:\n",
      "Patient ID: MB-5329\n",
      "Age at Diagnosis: 64.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 6.13\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 45.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1360:\n",
      "Patient ID: MB-5330\n",
      "Age at Diagnosis: 70.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 114.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 113.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1361:\n",
      "Patient ID: MB-5331\n",
      "Age at Diagnosis: 54.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1362:\n",
      "Patient ID: MB-5332\n",
      "Age at Diagnosis: 68.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1363:\n",
      "Patient ID: MB-5334\n",
      "Age at Diagnosis: 78.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1364:\n",
      "Patient ID: MB-5335\n",
      "Age at Diagnosis: 41.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1365:\n",
      "Patient ID: MB-5338\n",
      "Age at Diagnosis: 61.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.54\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1366:\n",
      "Patient ID: MB-5339\n",
      "Age at Diagnosis: 71.78\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: NC\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 193.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1367:\n",
      "Patient ID: MB-5341\n",
      "Age at Diagnosis: 56.37\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 250.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 88.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1368:\n",
      "Patient ID: MB-5345\n",
      "Age at Diagnosis: 76.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 216.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 213.19\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1369:\n",
      "Patient ID: MB-5346\n",
      "Age at Diagnosis: 52.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1370:\n",
      "Patient ID: MB-5347\n",
      "Age at Diagnosis: 56.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 167.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1371:\n",
      "Patient ID: MB-5348\n",
      "Age at Diagnosis: 41.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 169.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 167.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1372:\n",
      "Patient ID: MB-5349\n",
      "Age at Diagnosis: 72.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 191.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 95.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1373:\n",
      "Patient ID: MB-5350\n",
      "Age at Diagnosis: 66.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 53.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 52.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1374:\n",
      "Patient ID: MB-5351\n",
      "Age at Diagnosis: 47.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.004\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 202.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 199.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 2.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1375:\n",
      "Patient ID: MB-5358\n",
      "Age at Diagnosis: 72.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.114\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 28.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 57.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1376:\n",
      "Patient ID: MB-5360\n",
      "Age at Diagnosis: 66.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.14\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 161.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 159.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1377:\n",
      "Patient ID: MB-5361\n",
      "Age at Diagnosis: 76.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1378:\n",
      "Patient ID: MB-5364\n",
      "Age at Diagnosis: 56.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1379:\n",
      "Patient ID: MB-5365\n",
      "Age at Diagnosis: 79.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1380:\n",
      "Patient ID: MB-5366\n",
      "Age at Diagnosis: 75.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 243.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 239.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1381:\n",
      "Patient ID: MB-5368\n",
      "Age at Diagnosis: 77.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 100.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 98.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1382:\n",
      "Patient ID: MB-5369\n",
      "Age at Diagnosis: 66.18\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 39.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 34.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1383:\n",
      "Patient ID: MB-5370\n",
      "Age at Diagnosis: 62.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 119.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 69.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1384:\n",
      "Patient ID: MB-5373\n",
      "Age at Diagnosis: 67.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 2.533333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 2.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1385:\n",
      "Patient ID: MB-5377\n",
      "Age at Diagnosis: 35.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1386:\n",
      "Patient ID: MB-5378\n",
      "Age at Diagnosis: 57.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 12.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1387:\n",
      "Patient ID: MB-5381\n",
      "Age at Diagnosis: 44.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 201.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 199.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1388:\n",
      "Patient ID: MB-5382\n",
      "Age at Diagnosis: 69.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 116.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 114.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1389:\n",
      "Patient ID: MB-5383\n",
      "Age at Diagnosis: 83.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.15\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 113.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 75.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 75.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1390:\n",
      "Patient ID: MB-5384\n",
      "Age at Diagnosis: 61.05\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 71.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 61.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1391:\n",
      "Patient ID: MB-5385\n",
      "Age at Diagnosis: 83.32\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 148.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 146.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1392:\n",
      "Patient ID: MB-5386\n",
      "Age at Diagnosis: 65.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 192.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 189.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1393:\n",
      "Patient ID: MB-5387\n",
      "Age at Diagnosis: 45.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.026\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 45.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 34.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1394:\n",
      "Patient ID: MB-5388\n",
      "Age at Diagnosis: 69.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 146.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 145.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1395:\n",
      "Patient ID: MB-5389\n",
      "Age at Diagnosis: 64.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1396:\n",
      "Patient ID: MB-5390\n",
      "Age at Diagnosis: 37.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.026\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 30.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 25.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1397:\n",
      "Patient ID: MB-5392\n",
      "Age at Diagnosis: 57.34\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 237.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 234.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1398:\n",
      "Patient ID: MB-5393\n",
      "Age at Diagnosis: 82.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 154.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 151.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1399:\n",
      "Patient ID: MB-5394\n",
      "Age at Diagnosis: 72.18\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 193.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1400:\n",
      "Patient ID: MB-5395\n",
      "Age at Diagnosis: 71.51\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 165.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 162.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1401:\n",
      "Patient ID: MB-5396\n",
      "Age at Diagnosis: 61.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 165.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 163.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1402:\n",
      "Patient ID: MB-5397\n",
      "Age at Diagnosis: 61.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 172.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 114.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1403:\n",
      "Patient ID: MB-5398\n",
      "Age at Diagnosis: 71.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 213.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 210.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1404:\n",
      "Patient ID: MB-5399\n",
      "Age at Diagnosis: 73.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 106.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 105.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1405:\n",
      "Patient ID: MB-5401\n",
      "Age at Diagnosis: 75.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 70.16666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1406:\n",
      "Patient ID: MB-5402\n",
      "Age at Diagnosis: 81.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 107.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 106.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1407:\n",
      "Patient ID: MB-5403\n",
      "Age at Diagnosis: 85.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 95.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 94.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1408:\n",
      "Patient ID: MB-5404\n",
      "Age at Diagnosis: 81.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 74.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1409:\n",
      "Patient ID: MB-5405\n",
      "Age at Diagnosis: 64.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 117.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 116.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1410:\n",
      "Patient ID: MB-5406\n",
      "Age at Diagnosis: 80.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 97.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 94.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1411:\n",
      "Patient ID: MB-5407\n",
      "Age at Diagnosis: 36.03\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.002\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 205.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.46\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1412:\n",
      "Patient ID: MB-5408\n",
      "Age at Diagnosis: 65.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1413:\n",
      "Patient ID: MB-5409\n",
      "Age at Diagnosis: 51.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 198.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 195.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1414:\n",
      "Patient ID: MB-5410\n",
      "Age at Diagnosis: 66.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 202.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 200.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1415:\n",
      "Patient ID: MB-5411\n",
      "Age at Diagnosis: 43.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 26.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1416:\n",
      "Patient ID: MB-5412\n",
      "Age at Diagnosis: 51.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 220.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 182.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1417:\n",
      "Patient ID: MB-5413\n",
      "Age at Diagnosis: 71.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 157.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 155.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1418:\n",
      "Patient ID: MB-5414\n",
      "Age at Diagnosis: 61.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1419:\n",
      "Patient ID: MB-5417\n",
      "Age at Diagnosis: 45.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 107.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 105.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1420:\n",
      "Patient ID: MB-5418\n",
      "Age at Diagnosis: 64.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 207.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 204.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1421:\n",
      "Patient ID: MB-5420\n",
      "Age at Diagnosis: 71.49\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1422:\n",
      "Patient ID: MB-5421\n",
      "Age at Diagnosis: 68.0\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 192.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1423:\n",
      "Patient ID: MB-5422\n",
      "Age at Diagnosis: 47.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1424:\n",
      "Patient ID: MB-5424\n",
      "Age at Diagnosis: 66.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 83.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 40.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1425:\n",
      "Patient ID: MB-5425\n",
      "Age at Diagnosis: 67.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1426:\n",
      "Patient ID: MB-5426\n",
      "Age at Diagnosis: 53.69\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1427:\n",
      "Patient ID: MB-5427\n",
      "Age at Diagnosis: 83.68\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 155.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 153.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1428:\n",
      "Patient ID: MB-5428\n",
      "Age at Diagnosis: 55.36\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 150.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 148.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1429:\n",
      "Patient ID: MB-5429\n",
      "Age at Diagnosis: 86.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 30.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1430:\n",
      "Patient ID: MB-5431\n",
      "Age at Diagnosis: 49.91\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 7.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1431:\n",
      "Patient ID: MB-5432\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1432:\n",
      "Patient ID: MB-5433\n",
      "Age at Diagnosis: 69.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 176.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 174.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1433:\n",
      "Patient ID: MB-5434\n",
      "Age at Diagnosis: 71.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 18.0\n",
      "Nottingham prognostic index: 5.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1434:\n",
      "Patient ID: MB-5435\n",
      "Age at Diagnosis: 77.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 102.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1435:\n",
      "Patient ID: MB-5440\n",
      "Age at Diagnosis: 49.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 196.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 194.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1436:\n",
      "Patient ID: MB-5441\n",
      "Age at Diagnosis: 90.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 9.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 9.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1437:\n",
      "Patient ID: MB-5442\n",
      "Age at Diagnosis: 44.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 205.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1438:\n",
      "Patient ID: MB-5444\n",
      "Age at Diagnosis: 49.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 240.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 237.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1439:\n",
      "Patient ID: MB-5446\n",
      "Age at Diagnosis: 51.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 162.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1440:\n",
      "Patient ID: MB-5447\n",
      "Age at Diagnosis: 68.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 148.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 146.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1441:\n",
      "Patient ID: MB-5450\n",
      "Age at Diagnosis: 38.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 190.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 187.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1442:\n",
      "Patient ID: MB-5451\n",
      "Age at Diagnosis: 43.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 189.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 187.4\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1443:\n",
      "Patient ID: MB-5452\n",
      "Age at Diagnosis: 66.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1444:\n",
      "Patient ID: MB-5453\n",
      "Age at Diagnosis: 36.99\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 46.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1445:\n",
      "Patient ID: MB-5454\n",
      "Age at Diagnosis: 55.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.56\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1446:\n",
      "Patient ID: MB-5455\n",
      "Age at Diagnosis: 73.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 61.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 13.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1447:\n",
      "Patient ID: MB-5457\n",
      "Age at Diagnosis: 52.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 46.12\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1448:\n",
      "Patient ID: MB-5458\n",
      "Age at Diagnosis: 54.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 183.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 181.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1449:\n",
      "Patient ID: MB-5459\n",
      "Age at Diagnosis: 64.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.1\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1450:\n",
      "Patient ID: MB-5460\n",
      "Age at Diagnosis: 55.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.01\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 218.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.73\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1451:\n",
      "Patient ID: MB-5463\n",
      "Age at Diagnosis: 71.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.096\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 58.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 48.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1452:\n",
      "Patient ID: MB-5464\n",
      "Age at Diagnosis: 65.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 116.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 115.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1453:\n",
      "Patient ID: MB-5465\n",
      "Age at Diagnosis: 69.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 18.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1454:\n",
      "Patient ID: MB-5467\n",
      "Age at Diagnosis: 36.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 16.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1455:\n",
      "Patient ID: MB-5468\n",
      "Age at Diagnosis: 48.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 99.36666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 98.06\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1456:\n",
      "Patient ID: MB-5470\n",
      "Age at Diagnosis: 48.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.0\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 42.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 30.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1457:\n",
      "Patient ID: MB-5471\n",
      "Age at Diagnosis: 67.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 183.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1458:\n",
      "Patient ID: MB-5472\n",
      "Age at Diagnosis: 74.78\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1459:\n",
      "Patient ID: MB-5473\n",
      "Age at Diagnosis: 72.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1460:\n",
      "Patient ID: MB-5474\n",
      "Age at Diagnosis: 46.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 226.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 223.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1461:\n",
      "Patient ID: MB-5475\n",
      "Age at Diagnosis: 73.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 2.533333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 2.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1462:\n",
      "Patient ID: MB-5477\n",
      "Age at Diagnosis: 59.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 110.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 109.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1463:\n",
      "Patient ID: MB-5478\n",
      "Age at Diagnosis: 72.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 21.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 34.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1464:\n",
      "Patient ID: MB-5481\n",
      "Age at Diagnosis: 57.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Undef\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1465:\n",
      "Patient ID: MB-5482\n",
      "Age at Diagnosis: 40.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 17.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1466:\n",
      "Patient ID: MB-5483\n",
      "Age at Diagnosis: 44.5\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1467:\n",
      "Patient ID: MB-5484\n",
      "Age at Diagnosis: 47.3\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 238.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 235.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1468:\n",
      "Patient ID: MB-5485\n",
      "Age at Diagnosis: 80.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1469:\n",
      "Patient ID: MB-5486\n",
      "Age at Diagnosis: 75.65\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 115.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1470:\n",
      "Patient ID: MB-5489\n",
      "Age at Diagnosis: 53.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 216.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 140.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1471:\n",
      "Patient ID: MB-5490\n",
      "Age at Diagnosis: 65.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 8.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1472:\n",
      "Patient ID: MB-5491\n",
      "Age at Diagnosis: 72.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.13\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 15.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1473:\n",
      "Patient ID: MB-5492\n",
      "Age at Diagnosis: 74.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.102\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 23.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 51.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1474:\n",
      "Patient ID: MB-5493\n",
      "Age at Diagnosis: 69.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.102\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 57.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 20.56\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 51.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1475:\n",
      "Patient ID: MB-5495\n",
      "Age at Diagnosis: 42.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 225.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1476:\n",
      "Patient ID: MB-5497\n",
      "Age at Diagnosis: 69.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 237.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1477:\n",
      "Patient ID: MB-5498\n",
      "Age at Diagnosis: 64.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 225.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 222.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1478:\n",
      "Patient ID: MB-5499\n",
      "Age at Diagnosis: 65.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 122.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1479:\n",
      "Patient ID: MB-5502\n",
      "Age at Diagnosis: 51.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 189.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 187.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1480:\n",
      "Patient ID: MB-5505\n",
      "Age at Diagnosis: 74.26\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 164.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 33.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1481:\n",
      "Patient ID: MB-5510\n",
      "Age at Diagnosis: 75.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 103.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 101.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1482:\n",
      "Patient ID: MB-5511\n",
      "Age at Diagnosis: 54.18\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 158.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 156.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1483:\n",
      "Patient ID: MB-5513\n",
      "Age at Diagnosis: 86.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 34.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1484:\n",
      "Patient ID: MB-5514\n",
      "Age at Diagnosis: 63.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 180.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1485:\n",
      "Patient ID: MB-5518\n",
      "Age at Diagnosis: 72.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1486:\n",
      "Patient ID: MB-5519\n",
      "Age at Diagnosis: 72.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 169.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 167.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1487:\n",
      "Patient ID: MB-5520\n",
      "Age at Diagnosis: 38.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 16.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1488:\n",
      "Patient ID: MB-5521\n",
      "Age at Diagnosis: 69.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1489:\n",
      "Patient ID: MB-5525\n",
      "Age at Diagnosis: 63.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 2.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 1.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1490:\n",
      "Patient ID: MB-5526\n",
      "Age at Diagnosis: 45.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 151.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 149.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1491:\n",
      "Patient ID: MB-5527\n",
      "Age at Diagnosis: 53.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.022\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 180.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 178.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1492:\n",
      "Patient ID: MB-5529\n",
      "Age at Diagnosis: 40.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.56\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1493:\n",
      "Patient ID: MB-5530\n",
      "Age at Diagnosis: 50.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 183.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1494:\n",
      "Patient ID: MB-5531\n",
      "Age at Diagnosis: 66.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 183.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 181.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1495:\n",
      "Patient ID: MB-5532\n",
      "Age at Diagnosis: 69.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 66.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1496:\n",
      "Patient ID: MB-5533\n",
      "Age at Diagnosis: 71.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 158.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 155.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1497:\n",
      "Patient ID: MB-5534\n",
      "Age at Diagnosis: 80.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 42.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1498:\n",
      "Patient ID: MB-5535\n",
      "Age at Diagnosis: 49.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 120.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 83.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1499:\n",
      "Patient ID: MB-5540\n",
      "Age at Diagnosis: 76.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 48.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 20.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1500:\n",
      "Patient ID: MB-5541\n",
      "Age at Diagnosis: 60.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1501:\n",
      "Patient ID: MB-5543\n",
      "Age at Diagnosis: 79.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 33.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1502:\n",
      "Patient ID: MB-5546\n",
      "Age at Diagnosis: 40.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.01\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 233.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 101.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1503:\n",
      "Patient ID: MB-5547\n",
      "Age at Diagnosis: 43.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.56666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1504:\n",
      "Patient ID: MB-5548\n",
      "Age at Diagnosis: 62.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 25.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1505:\n",
      "Patient ID: MB-5549\n",
      "Age at Diagnosis: 54.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 67.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1506:\n",
      "Patient ID: MB-5550\n",
      "Age at Diagnosis: 84.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 171.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 169.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1507:\n",
      "Patient ID: MB-5551\n",
      "Age at Diagnosis: 67.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 179.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1508:\n",
      "Patient ID: MB-5552\n",
      "Age at Diagnosis: 69.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1509:\n",
      "Patient ID: MB-5553\n",
      "Age at Diagnosis: 70.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 154.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 152.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1510:\n",
      "Patient ID: MB-5554\n",
      "Age at Diagnosis: 57.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.052\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 229.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 226.81\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1511:\n",
      "Patient ID: MB-5556\n",
      "Age at Diagnosis: 53.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 225.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 222.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1512:\n",
      "Patient ID: MB-5558\n",
      "Age at Diagnosis: 35.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.15\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 25.03333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 75.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1513:\n",
      "Patient ID: MB-5559\n",
      "Age at Diagnosis: 42.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.096\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 18.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 48.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1514:\n",
      "Patient ID: MB-5560\n",
      "Age at Diagnosis: 44.05\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 184.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1515:\n",
      "Patient ID: MB-5562\n",
      "Age at Diagnosis: 73.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 41.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1516:\n",
      "Patient ID: MB-5563\n",
      "Age at Diagnosis: 76.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 117.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 116.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1517:\n",
      "Patient ID: MB-5565\n",
      "Age at Diagnosis: 64.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1518:\n",
      "Patient ID: MB-5566\n",
      "Age at Diagnosis: 38.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 234.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 20.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1519:\n",
      "Patient ID: MB-5567\n",
      "Age at Diagnosis: 74.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 178.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 176.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1520:\n",
      "Patient ID: MB-5571\n",
      "Age at Diagnosis: 78.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 66.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1521:\n",
      "Patient ID: MB-5572\n",
      "Age at Diagnosis: 47.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 178.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 176.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1522:\n",
      "Patient ID: MB-5575\n",
      "Age at Diagnosis: 52.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 116.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1523:\n",
      "Patient ID: MB-5576\n",
      "Age at Diagnosis: 67.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 194.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1524:\n",
      "Patient ID: MB-5577\n",
      "Age at Diagnosis: 68.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 55.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 44.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1525:\n",
      "Patient ID: MB-5579\n",
      "Age at Diagnosis: 68.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 90.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.9\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1526:\n",
      "Patient ID: MB-5580\n",
      "Age at Diagnosis: 75.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 70.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1527:\n",
      "Patient ID: MB-5582\n",
      "Age at Diagnosis: 46.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 219.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1528:\n",
      "Patient ID: MB-5583\n",
      "Age at Diagnosis: 50.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1529:\n",
      "Patient ID: MB-5584\n",
      "Age at Diagnosis: 69.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 23.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 89.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1530:\n",
      "Patient ID: MB-5585\n",
      "Age at Diagnosis: 75.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 53.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 49.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1531:\n",
      "Patient ID: MB-5588\n",
      "Age at Diagnosis: 66.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 81.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.31\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1532:\n",
      "Patient ID: MB-5589\n",
      "Age at Diagnosis: 70.86\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 182.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1533:\n",
      "Patient ID: MB-5590\n",
      "Age at Diagnosis: 64.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 17.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1534:\n",
      "Patient ID: MB-5591\n",
      "Age at Diagnosis: 46.28\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 155.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1535:\n",
      "Patient ID: MB-5592\n",
      "Age at Diagnosis: 66.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 26.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1536:\n",
      "Patient ID: MB-5593\n",
      "Age at Diagnosis: 40.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 92.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1537:\n",
      "Patient ID: MB-5596\n",
      "Age at Diagnosis: 54.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 20.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 167.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 123.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1538:\n",
      "Patient ID: MB-5597\n",
      "Age at Diagnosis: 75.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 32.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1539:\n",
      "Patient ID: MB-5599\n",
      "Age at Diagnosis: 62.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 224.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 221.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1540:\n",
      "Patient ID: MB-5601\n",
      "Age at Diagnosis: 61.73\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 214.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 211.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1541:\n",
      "Patient ID: MB-5602\n",
      "Age at Diagnosis: 39.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 224.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 221.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1542:\n",
      "Patient ID: MB-5603\n",
      "Age at Diagnosis: 70.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 171.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 169.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1543:\n",
      "Patient ID: MB-5604\n",
      "Age at Diagnosis: 66.88\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 145.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 143.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1544:\n",
      "Patient ID: MB-5605\n",
      "Age at Diagnosis: 40.37\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1545:\n",
      "Patient ID: MB-5613\n",
      "Age at Diagnosis: 80.21\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 212.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 209.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1546:\n",
      "Patient ID: MB-5614\n",
      "Age at Diagnosis: 62.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 116.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 82.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1547:\n",
      "Patient ID: MB-5616\n",
      "Age at Diagnosis: 41.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 180.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 178.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1548:\n",
      "Patient ID: MB-5617\n",
      "Age at Diagnosis: 81.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1549:\n",
      "Patient ID: MB-5620\n",
      "Age at Diagnosis: 79.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1550:\n",
      "Patient ID: MB-5622\n",
      "Age at Diagnosis: 62.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 180.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1551:\n",
      "Patient ID: MB-5623\n",
      "Age at Diagnosis: 44.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 137.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 135.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1552:\n",
      "Patient ID: MB-5624\n",
      "Age at Diagnosis: 55.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 17.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 134.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1553:\n",
      "Patient ID: MB-5625\n",
      "Age at Diagnosis: 45.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 30.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1554:\n",
      "Patient ID: MB-5626\n",
      "Age at Diagnosis: 73.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 82.96666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 81.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1555:\n",
      "Patient ID: MB-5628\n",
      "Age at Diagnosis: 65.06\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1556:\n",
      "Patient ID: MB-5629\n",
      "Age at Diagnosis: 71.36\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 103.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 102.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1557:\n",
      "Patient ID: MB-5632\n",
      "Age at Diagnosis: 78.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 19.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1558:\n",
      "Patient ID: MB-5633\n",
      "Age at Diagnosis: 62.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 29.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1559:\n",
      "Patient ID: MB-5634\n",
      "Age at Diagnosis: 55.53\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 62.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 54.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1560:\n",
      "Patient ID: MB-5635\n",
      "Age at Diagnosis: 57.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1561:\n",
      "Patient ID: MB-5636\n",
      "Age at Diagnosis: 68.49\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1562:\n",
      "Patient ID: MB-5638\n",
      "Age at Diagnosis: 65.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 193.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1563:\n",
      "Patient ID: MB-5640\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.002\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 172.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 170.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1564:\n",
      "Patient ID: MB-5641\n",
      "Age at Diagnosis: 78.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 181.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 179.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1565:\n",
      "Patient ID: MB-5642\n",
      "Age at Diagnosis: 68.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 156.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 154.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1566:\n",
      "Patient ID: MB-5645\n",
      "Age at Diagnosis: 71.31\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 21.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1567:\n",
      "Patient ID: MB-5646\n",
      "Age at Diagnosis: 58.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 167.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 164.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1568:\n",
      "Patient ID: MB-5647\n",
      "Age at Diagnosis: 65.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1569:\n",
      "Patient ID: MB-5648\n",
      "Age at Diagnosis: 74.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1570:\n",
      "Patient ID: MB-5651\n",
      "Age at Diagnosis: 51.98\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 21.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.62\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1571:\n",
      "Patient ID: MB-5652\n",
      "Age at Diagnosis: 68.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 103.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1572:\n",
      "Patient ID: MB-5653\n",
      "Age at Diagnosis: 60.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 192.04\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1573:\n",
      "Patient ID: MB-5654\n",
      "Age at Diagnosis: 82.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 173.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 170.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1574:\n",
      "Patient ID: MB-5655\n",
      "Age at Diagnosis: 67.57\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 191.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 189.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1575:\n",
      "Patient ID: MB-5656\n",
      "Age at Diagnosis: 74.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 3.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1576:\n",
      "Patient ID: MB-6001\n",
      "Age at Diagnosis: 68.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 135.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 133.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1577:\n",
      "Patient ID: MB-6006\n",
      "Age at Diagnosis: 86.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 2.032\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 63.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1578:\n",
      "Patient ID: MB-6007\n",
      "Age at Diagnosis: 70.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 20.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 70.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1579:\n",
      "Patient ID: MB-6008\n",
      "Age at Diagnosis: 80.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 69.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 29.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1580:\n",
      "Patient ID: MB-6010\n",
      "Age at Diagnosis: 70.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 218.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 215.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1581:\n",
      "Patient ID: MB-6011\n",
      "Age at Diagnosis: 59.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 1.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 208.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1582:\n",
      "Patient ID: MB-6012\n",
      "Age at Diagnosis: 67.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.066\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 144.4333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 142.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1583:\n",
      "Patient ID: MB-6014\n",
      "Age at Diagnosis: 44.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.114\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 191.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 189.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 57.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1584:\n",
      "Patient ID: MB-6016\n",
      "Age at Diagnosis: 87.32\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 143.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 141.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1585:\n",
      "Patient ID: MB-6017\n",
      "Age at Diagnosis: 72.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1586:\n",
      "Patient ID: MB-6018\n",
      "Age at Diagnosis: 65.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 143.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 141.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1587:\n",
      "Patient ID: MB-6019\n",
      "Age at Diagnosis: 67.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 13.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 13.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1588:\n",
      "Patient ID: MB-6020\n",
      "Age at Diagnosis: 75.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 48.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 47.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1589:\n",
      "Patient ID: MB-6021\n",
      "Age at Diagnosis: 51.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 301.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 297.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1590:\n",
      "Patient ID: MB-6022\n",
      "Age at Diagnosis: 90.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 52.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 8.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1591:\n",
      "Patient ID: MB-6023\n",
      "Age at Diagnosis: 60.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.068\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 232.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 229.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1592:\n",
      "Patient ID: MB-6024\n",
      "Age at Diagnosis: 65.63\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 252.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 248.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1593:\n",
      "Patient ID: MB-6026\n",
      "Age at Diagnosis: 87.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 49.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1594:\n",
      "Patient ID: MB-6029\n",
      "Age at Diagnosis: 63.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 6.02\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 278.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1595:\n",
      "Patient ID: MB-6030\n",
      "Age at Diagnosis: 66.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 145.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 65.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1596:\n",
      "Patient ID: MB-6036\n",
      "Age at Diagnosis: 44.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 287.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 284.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1597:\n",
      "Patient ID: MB-6039\n",
      "Age at Diagnosis: 65.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 73.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1598:\n",
      "Patient ID: MB-6042\n",
      "Age at Diagnosis: 70.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 263.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 259.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1599:\n",
      "Patient ID: MB-6044\n",
      "Age at Diagnosis: 70.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 219.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 216.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1600:\n",
      "Patient ID: MB-6047\n",
      "Age at Diagnosis: 72.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 37.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1601:\n",
      "Patient ID: MB-6048\n",
      "Age at Diagnosis: 58.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 168.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 165.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1602:\n",
      "Patient ID: MB-6049\n",
      "Age at Diagnosis: 62.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 20.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 264.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 260.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1603:\n",
      "Patient ID: MB-6050\n",
      "Age at Diagnosis: 51.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 192.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 189.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1604:\n",
      "Patient ID: MB-6051\n",
      "Age at Diagnosis: 65.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.072\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 182.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1605:\n",
      "Patient ID: MB-6052\n",
      "Age at Diagnosis: 36.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 255.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 252.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1606:\n",
      "Patient ID: MB-6053\n",
      "Age at Diagnosis: 69.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 250.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 247.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1607:\n",
      "Patient ID: MB-6055\n",
      "Age at Diagnosis: 33.08\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1608:\n",
      "Patient ID: MB-6058\n",
      "Age at Diagnosis: 41.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1609:\n",
      "Patient ID: MB-6059\n",
      "Age at Diagnosis: 50.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.096\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 278.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 274.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 48.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1610:\n",
      "Patient ID: MB-6060\n",
      "Age at Diagnosis: 53.79\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 38.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1611:\n",
      "Patient ID: MB-6062\n",
      "Age at Diagnosis: 31.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 282.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 278.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1612:\n",
      "Patient ID: MB-6063\n",
      "Age at Diagnosis: 58.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.24\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 120.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1613:\n",
      "Patient ID: MB-6065\n",
      "Age at Diagnosis: 76.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.096\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 188.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 186.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 48.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1614:\n",
      "Patient ID: MB-6068\n",
      "Age at Diagnosis: 43.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 180.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1615:\n",
      "Patient ID: MB-6069\n",
      "Age at Diagnosis: 75.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 258.1333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 254.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1616:\n",
      "Patient ID: MB-6071\n",
      "Age at Diagnosis: 72.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 50.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1617:\n",
      "Patient ID: MB-6075\n",
      "Age at Diagnosis: 84.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 179.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1618:\n",
      "Patient ID: MB-6077\n",
      "Age at Diagnosis: 70.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: NC\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 170.2666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 168.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1619:\n",
      "Patient ID: MB-6079\n",
      "Age at Diagnosis: 68.91\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 239.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 171.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1620:\n",
      "Patient ID: MB-6080\n",
      "Age at Diagnosis: 79.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 54.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1621:\n",
      "Patient ID: MB-6082\n",
      "Age at Diagnosis: 46.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 101.15\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1622:\n",
      "Patient ID: MB-6083\n",
      "Age at Diagnosis: 73.03\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 161.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1623:\n",
      "Patient ID: MB-6085\n",
      "Age at Diagnosis: 58.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1624:\n",
      "Patient ID: MB-6092\n",
      "Age at Diagnosis: 80.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 2.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 2.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1625:\n",
      "Patient ID: MB-6097\n",
      "Age at Diagnosis: 68.59\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.016\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 159.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 157.6\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1626:\n",
      "Patient ID: MB-6098\n",
      "Age at Diagnosis: 28.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 10.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.69\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1627:\n",
      "Patient ID: MB-6100\n",
      "Age at Diagnosis: 53.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 10.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 8.06\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1628:\n",
      "Patient ID: MB-6101\n",
      "Age at Diagnosis: 82.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 77.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 76.48\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1629:\n",
      "Patient ID: MB-6103\n",
      "Age at Diagnosis: 66.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 239.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 236.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1630:\n",
      "Patient ID: MB-6105\n",
      "Age at Diagnosis: 78.93\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.026\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 192.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 189.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1631:\n",
      "Patient ID: MB-6107\n",
      "Age at Diagnosis: 71.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.0\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 123.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 121.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1632:\n",
      "Patient ID: MB-6108\n",
      "Age at Diagnosis: 38.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 191.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1633:\n",
      "Patient ID: MB-6113\n",
      "Age at Diagnosis: 39.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.5666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 122.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1634:\n",
      "Patient ID: MB-6114\n",
      "Age at Diagnosis: 70.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 66.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 65.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1635:\n",
      "Patient ID: MB-6116\n",
      "Age at Diagnosis: 66.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 193.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 190.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1636:\n",
      "Patient ID: MB-6118\n",
      "Age at Diagnosis: 41.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 264.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 93.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1637:\n",
      "Patient ID: MB-6122\n",
      "Age at Diagnosis: 54.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 260.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 256.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1638:\n",
      "Patient ID: MB-6124\n",
      "Age at Diagnosis: 76.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 115.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 114.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1639:\n",
      "Patient ID: MB-6125\n",
      "Age at Diagnosis: 63.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 153.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 151.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1640:\n",
      "Patient ID: MB-6131\n",
      "Age at Diagnosis: 57.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.122\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 257.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 254.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 61.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1641:\n",
      "Patient ID: MB-6133\n",
      "Age at Diagnosis: 74.6\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.078\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 61.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 60.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1642:\n",
      "Patient ID: MB-6135\n",
      "Age at Diagnosis: 69.38\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 78.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 12.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1643:\n",
      "Patient ID: MB-6138\n",
      "Age at Diagnosis: 85.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.074\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 25.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1644:\n",
      "Patient ID: MB-6141\n",
      "Age at Diagnosis: 79.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.0\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 78.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 77.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1645:\n",
      "Patient ID: MB-6143\n",
      "Age at Diagnosis: 60.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.092\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 255.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 252.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 46.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1646:\n",
      "Patient ID: MB-6144\n",
      "Age at Diagnosis: 64.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 254.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 251.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1647:\n",
      "Patient ID: MB-6145\n",
      "Age at Diagnosis: 60.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.09\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 34.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 20.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1648:\n",
      "Patient ID: MB-6146\n",
      "Age at Diagnosis: 51.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.012\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 36.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 6.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1649:\n",
      "Patient ID: MB-6147\n",
      "Age at Diagnosis: 76.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 238.0666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 234.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1650:\n",
      "Patient ID: MB-6149\n",
      "Age at Diagnosis: 70.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 74.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1651:\n",
      "Patient ID: MB-6150\n",
      "Age at Diagnosis: 59.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 77.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.81\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1652:\n",
      "Patient ID: MB-6152\n",
      "Age at Diagnosis: 60.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 228.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 225.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1653:\n",
      "Patient ID: MB-6154\n",
      "Age at Diagnosis: 71.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 192.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1654:\n",
      "Patient ID: MB-6156\n",
      "Age at Diagnosis: 49.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1655:\n",
      "Patient ID: MB-6157\n",
      "Age at Diagnosis: 86.29\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1656:\n",
      "Patient ID: MB-6160\n",
      "Age at Diagnosis: 46.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 247.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 244.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1657:\n",
      "Patient ID: MB-6163\n",
      "Age at Diagnosis: 71.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 88.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 48.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1658:\n",
      "Patient ID: MB-6164\n",
      "Age at Diagnosis: 77.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 205.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 203.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1659:\n",
      "Patient ID: MB-6167\n",
      "Age at Diagnosis: 75.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 122.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 121.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1660:\n",
      "Patient ID: MB-6168\n",
      "Age at Diagnosis: 64.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 225.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 222.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1661:\n",
      "Patient ID: MB-6169\n",
      "Age at Diagnosis: 39.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 84.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 83.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1662:\n",
      "Patient ID: MB-6171\n",
      "Age at Diagnosis: 70.91\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 220.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 217.4\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1663:\n",
      "Patient ID: MB-6178\n",
      "Age at Diagnosis: 38.58\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.064\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 33.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 17.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1664:\n",
      "Patient ID: MB-6179\n",
      "Age at Diagnosis: 59.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.066\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 58.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 22.4\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1665:\n",
      "Patient ID: MB-6181\n",
      "Age at Diagnosis: 83.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 54.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 54.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1666:\n",
      "Patient ID: MB-6182\n",
      "Age at Diagnosis: 56.47\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 208.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 206.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1667:\n",
      "Patient ID: MB-6183\n",
      "Age at Diagnosis: 66.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 79.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 78.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1668:\n",
      "Patient ID: MB-6184\n",
      "Age at Diagnosis: 35.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 125.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1669:\n",
      "Patient ID: MB-6185\n",
      "Age at Diagnosis: 75.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.032\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 197.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 195.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1670:\n",
      "Patient ID: MB-6187\n",
      "Age at Diagnosis: 70.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.158\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 79.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1671:\n",
      "Patient ID: MB-6188\n",
      "Age at Diagnosis: 41.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 23.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1672:\n",
      "Patient ID: MB-6189\n",
      "Age at Diagnosis: 56.25\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.084\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 240.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 237.04\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 42.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1673:\n",
      "Patient ID: MB-6190\n",
      "Age at Diagnosis: 79.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 24.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1674:\n",
      "Patient ID: MB-6192\n",
      "Age at Diagnosis: 78.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 42.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1675:\n",
      "Patient ID: MB-6194\n",
      "Age at Diagnosis: 44.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 52.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 0.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1676:\n",
      "Patient ID: MB-6195\n",
      "Age at Diagnosis: 66.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 202.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 199.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1677:\n",
      "Patient ID: MB-6200\n",
      "Age at Diagnosis: 65.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 18.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1678:\n",
      "Patient ID: MB-6201\n",
      "Age at Diagnosis: 79.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 219.77\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1679:\n",
      "Patient ID: MB-6204\n",
      "Age at Diagnosis: 41.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 56.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 56.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1680:\n",
      "Patient ID: MB-6206\n",
      "Age at Diagnosis: 65.01\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 166.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 164.54\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1681:\n",
      "Patient ID: MB-6207\n",
      "Age at Diagnosis: 80.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 116.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1682:\n",
      "Patient ID: MB-6208\n",
      "Age at Diagnosis: 56.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 218.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1683:\n",
      "Patient ID: MB-6211\n",
      "Age at Diagnosis: 82.1\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1684:\n",
      "Patient ID: MB-6212\n",
      "Age at Diagnosis: 61.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 224.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 221.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1685:\n",
      "Patient ID: MB-6213\n",
      "Age at Diagnosis: 60.75\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 203.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 200.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1686:\n",
      "Patient ID: MB-6214\n",
      "Age at Diagnosis: 74.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 174.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 172.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1687:\n",
      "Patient ID: MB-6217\n",
      "Age at Diagnosis: 47.51\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 211.5333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 208.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1688:\n",
      "Patient ID: MB-6218\n",
      "Age at Diagnosis: 49.67\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 147.7666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 101.15\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1689:\n",
      "Patient ID: MB-6223\n",
      "Age at Diagnosis: 58.83\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 221.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 219.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1690:\n",
      "Patient ID: MB-6224\n",
      "Age at Diagnosis: 66.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 31.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 26.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1691:\n",
      "Patient ID: MB-6225\n",
      "Age at Diagnosis: 68.43\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 17.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 116.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1692:\n",
      "Patient ID: MB-6226\n",
      "Age at Diagnosis: 73.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.074\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 35.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 34.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1693:\n",
      "Patient ID: MB-6228\n",
      "Age at Diagnosis: 37.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 200.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 197.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1694:\n",
      "Patient ID: MB-6229\n",
      "Age at Diagnosis: 75.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 0.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.1\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1695:\n",
      "Patient ID: MB-6230\n",
      "Age at Diagnosis: 52.95\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 74.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 0.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1696:\n",
      "Patient ID: MB-6231\n",
      "Age at Diagnosis: 77.96\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 72.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 71.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1697:\n",
      "Patient ID: MB-6232\n",
      "Age at Diagnosis: 71.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 85.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 83.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1698:\n",
      "Patient ID: MB-6233\n",
      "Age at Diagnosis: 70.65\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 201.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 198.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1699:\n",
      "Patient ID: MB-6234\n",
      "Age at Diagnosis: 66.35\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.0\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 213.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 210.56\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1700:\n",
      "Patient ID: MB-6237\n",
      "Age at Diagnosis: 75.62\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 105.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 103.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1701:\n",
      "Patient ID: MB-6238\n",
      "Age at Diagnosis: 84.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.058\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 172.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 170.69\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1702:\n",
      "Patient ID: MB-6239\n",
      "Age at Diagnosis: 52.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 200.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 197.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1703:\n",
      "Patient ID: MB-6242\n",
      "Age at Diagnosis: 41.29\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 6.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 165.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 163.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1704:\n",
      "Patient ID: MB-6245\n",
      "Age at Diagnosis: 47.01\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 177.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 175.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1705:\n",
      "Patient ID: MB-6246\n",
      "Age at Diagnosis: 58.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 52.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 52.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1706:\n",
      "Patient ID: MB-6248\n",
      "Age at Diagnosis: 51.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 180.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1707:\n",
      "Patient ID: MB-6251\n",
      "Age at Diagnosis: 48.59\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 14.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1708:\n",
      "Patient ID: MB-6253\n",
      "Age at Diagnosis: 62.9\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.022\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 194.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.81\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1709:\n",
      "Patient ID: MB-6254\n",
      "Age at Diagnosis: 78.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.142\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 60.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 60.1\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 71.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1710:\n",
      "Patient ID: MB-6256\n",
      "Age at Diagnosis: 67.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 127.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1711:\n",
      "Patient ID: MB-6257\n",
      "Age at Diagnosis: 49.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 89.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1712:\n",
      "Patient ID: MB-6263\n",
      "Age at Diagnosis: 79.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 74.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1713:\n",
      "Patient ID: MB-6271\n",
      "Age at Diagnosis: 64.4\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 157.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 155.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1714:\n",
      "Patient ID: MB-6272\n",
      "Age at Diagnosis: 36.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 22.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 17.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1715:\n",
      "Patient ID: MB-6273\n",
      "Age at Diagnosis: 43.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 189.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 186.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1716:\n",
      "Patient ID: MB-6280\n",
      "Age at Diagnosis: 53.68\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.088\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 44.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1717:\n",
      "Patient ID: MB-6281\n",
      "Age at Diagnosis: 75.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.01\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 3.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 3.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 5.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1718:\n",
      "Patient ID: MB-6283\n",
      "Age at Diagnosis: 73.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 92.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 91.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1719:\n",
      "Patient ID: MB-6284\n",
      "Age at Diagnosis: 67.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 88.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1720:\n",
      "Patient ID: MB-6286\n",
      "Age at Diagnosis: 85.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 48.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1721:\n",
      "Patient ID: MB-6287\n",
      "Age at Diagnosis: 58.08\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.65\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1722:\n",
      "Patient ID: MB-6288\n",
      "Age at Diagnosis: 74.33\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 100.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 60.49\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1723:\n",
      "Patient ID: MB-6297\n",
      "Age at Diagnosis: 52.55\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 170.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 168.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1724:\n",
      "Patient ID: MB-6300\n",
      "Age at Diagnosis: 62.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1725:\n",
      "Patient ID: MB-6302\n",
      "Age at Diagnosis: 67.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 124.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1726:\n",
      "Patient ID: MB-6305\n",
      "Age at Diagnosis: 52.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.1\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1727:\n",
      "Patient ID: MB-6306\n",
      "Age at Diagnosis: 78.22\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 64.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 63.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1728:\n",
      "Patient ID: MB-6308\n",
      "Age at Diagnosis: 81.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 151.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 149.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1729:\n",
      "Patient ID: MB-6312\n",
      "Age at Diagnosis: 85.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.078\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 162.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 160.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1730:\n",
      "Patient ID: MB-6314\n",
      "Age at Diagnosis: 68.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 134.8333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 36.15\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1731:\n",
      "Patient ID: MB-6317\n",
      "Age at Diagnosis: 86.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.106\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 53.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1732:\n",
      "Patient ID: MB-6318\n",
      "Age at Diagnosis: 81.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 109.2333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 107.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1733:\n",
      "Patient ID: MB-6319\n",
      "Age at Diagnosis: 57.9\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.124\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 154.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 152.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 62.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1734:\n",
      "Patient ID: MB-6322\n",
      "Age at Diagnosis: 80.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 80.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 73.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1735:\n",
      "Patient ID: MB-6327\n",
      "Age at Diagnosis: 76.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 18.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 15.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1736:\n",
      "Patient ID: MB-6328\n",
      "Age at Diagnosis: 75.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 125.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1737:\n",
      "Patient ID: MB-6329\n",
      "Age at Diagnosis: 68.48\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 80.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1738:\n",
      "Patient ID: MB-6330\n",
      "Age at Diagnosis: 36.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1739:\n",
      "Patient ID: MB-6334\n",
      "Age at Diagnosis: 60.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 126.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1740:\n",
      "Patient ID: MB-6336\n",
      "Age at Diagnosis: 63.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 18.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 17.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1741:\n",
      "Patient ID: MB-6337\n",
      "Age at Diagnosis: 58.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.11\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 109.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1742:\n",
      "Patient ID: MB-6344\n",
      "Age at Diagnosis: 82.0\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 152.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 100.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1743:\n",
      "Patient ID: MB-6346\n",
      "Age at Diagnosis: 63.2\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): 281.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 277.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1744:\n",
      "Patient ID: MB-6358\n",
      "Age at Diagnosis: 57.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 37.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.37\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1745:\n",
      "Patient ID: MB-6359\n",
      "Age at Diagnosis: 73.42\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.03333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 70.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1746:\n",
      "Patient ID: MB-6363\n",
      "Age at Diagnosis: 60.77\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 5.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 0.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1747:\n",
      "Patient ID: MB-7000\n",
      "Age at Diagnosis: 69.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.022\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 97.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 96.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1748:\n",
      "Patient ID: MB-7001\n",
      "Age at Diagnosis: 72.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 101.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1749:\n",
      "Patient ID: MB-7002\n",
      "Age at Diagnosis: 74.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 57.93333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 57.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1750:\n",
      "Patient ID: MB-7003\n",
      "Age at Diagnosis: 50.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 90.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1751:\n",
      "Patient ID: MB-7004\n",
      "Age at Diagnosis: 74.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 50.46666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 49.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1752:\n",
      "Patient ID: MB-7005\n",
      "Age at Diagnosis: 70.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.33333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 44.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1753:\n",
      "Patient ID: MB-7006\n",
      "Age at Diagnosis: 58.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 109.9333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 108.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1754:\n",
      "Patient ID: MB-7007\n",
      "Age at Diagnosis: 54.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1755:\n",
      "Patient ID: MB-7008\n",
      "Age at Diagnosis: 69.94\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.048\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 50.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 50.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1756:\n",
      "Patient ID: MB-7009\n",
      "Age at Diagnosis: 68.28\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 54.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 18.85\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1757:\n",
      "Patient ID: MB-7010\n",
      "Age at Diagnosis: 70.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 74.03333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 73.06\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1758:\n",
      "Patient ID: MB-7011\n",
      "Age at Diagnosis: 68.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 70.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 69.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1759:\n",
      "Patient ID: MB-7012\n",
      "Age at Diagnosis: 60.96\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 19.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1760:\n",
      "Patient ID: MB-7013\n",
      "Age at Diagnosis: 30.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.43333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 45.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1761:\n",
      "Patient ID: MB-7014\n",
      "Age at Diagnosis: 67.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 68.7\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 67.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1762:\n",
      "Patient ID: MB-7015\n",
      "Age at Diagnosis: 63.79\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 78.16666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 77.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1763:\n",
      "Patient ID: MB-7017\n",
      "Age at Diagnosis: 36.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 135.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 133.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1764:\n",
      "Patient ID: MB-7018\n",
      "Age at Diagnosis: 72.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1765:\n",
      "Patient ID: MB-7019\n",
      "Age at Diagnosis: 68.44\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 80.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 79.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1766:\n",
      "Patient ID: MB-7020\n",
      "Age at Diagnosis: 44.47\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 38.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1767:\n",
      "Patient ID: MB-7022\n",
      "Age at Diagnosis: 70.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 84.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1768:\n",
      "Patient ID: MB-7023\n",
      "Age at Diagnosis: 66.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 6.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1769:\n",
      "Patient ID: MB-7024\n",
      "Age at Diagnosis: 54.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 70.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 69.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1770:\n",
      "Patient ID: MB-7025\n",
      "Age at Diagnosis: 65.22\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 80.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1771:\n",
      "Patient ID: MB-7026\n",
      "Age at Diagnosis: 35.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 111.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 110.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1772:\n",
      "Patient ID: MB-7027\n",
      "Age at Diagnosis: 60.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 36.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 29.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1773:\n",
      "Patient ID: MB-7028\n",
      "Age at Diagnosis: 65.94\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 88.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1774:\n",
      "Patient ID: MB-7029\n",
      "Age at Diagnosis: 43.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 76.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 75.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1775:\n",
      "Patient ID: MB-7030\n",
      "Age at Diagnosis: 74.21\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 31.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1776:\n",
      "Patient ID: MB-7031\n",
      "Age at Diagnosis: 60.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.36666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 84.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1777:\n",
      "Patient ID: MB-7032\n",
      "Age at Diagnosis: 79.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.046\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 71.46666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 70.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1778:\n",
      "Patient ID: MB-7034\n",
      "Age at Diagnosis: 78.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.086\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 75.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 74.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 43.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1779:\n",
      "Patient ID: MB-7035\n",
      "Age at Diagnosis: 45.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 32.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1780:\n",
      "Patient ID: MB-7036\n",
      "Age at Diagnosis: 54.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 120.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 118.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1781:\n",
      "Patient ID: MB-7037\n",
      "Age at Diagnosis: 68.74\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1782:\n",
      "Patient ID: MB-7038\n",
      "Age at Diagnosis: 57.62\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 5.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 81.03333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1783:\n",
      "Patient ID: MB-7039\n",
      "Age at Diagnosis: 78.19\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.124\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 49.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 47.4\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 62.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1784:\n",
      "Patient ID: MB-7040\n",
      "Age at Diagnosis: 81.32\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 71.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 70.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1785:\n",
      "Patient ID: MB-7041\n",
      "Age at Diagnosis: 79.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: 1.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 101.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 100.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1786:\n",
      "Patient ID: MB-7042\n",
      "Age at Diagnosis: 61.72\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1787:\n",
      "Patient ID: MB-7043\n",
      "Age at Diagnosis: 72.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.53333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 90.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1788:\n",
      "Patient ID: MB-7044\n",
      "Age at Diagnosis: 67.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.83333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1789:\n",
      "Patient ID: MB-7045\n",
      "Age at Diagnosis: 61.39\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 94.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 92.17\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1790:\n",
      "Patient ID: MB-7046\n",
      "Age at Diagnosis: 76.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 144.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1791:\n",
      "Patient ID: MB-7048\n",
      "Age at Diagnosis: 36.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.46666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1792:\n",
      "Patient ID: MB-7049\n",
      "Age at Diagnosis: 48.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1793:\n",
      "Patient ID: MB-7050\n",
      "Age at Diagnosis: 64.99\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.045\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.13333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 53.62\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1794:\n",
      "Patient ID: MB-7051\n",
      "Age at Diagnosis: 63.44\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 85.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 72.37\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1795:\n",
      "Patient ID: MB-7052\n",
      "Age at Diagnosis: 45.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.0358\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 106.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 104.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.9\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1796:\n",
      "Patient ID: MB-7053\n",
      "Age at Diagnosis: 45.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.029\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.1333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 14.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1797:\n",
      "Patient ID: MB-7054\n",
      "Age at Diagnosis: 73.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.0256\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 30.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 22.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 12.8\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1798:\n",
      "Patient ID: MB-7055\n",
      "Age at Diagnosis: 54.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 9.133333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 2.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1799:\n",
      "Patient ID: MB-7056\n",
      "Age at Diagnosis: 71.82\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 20.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 115.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1800:\n",
      "Patient ID: MB-7057\n",
      "Age at Diagnosis: 72.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 43.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 43.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1801:\n",
      "Patient ID: MB-7058\n",
      "Age at Diagnosis: 45.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 120.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1802:\n",
      "Patient ID: MB-7059\n",
      "Age at Diagnosis: 50.55\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 23.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.048\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 119.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 117.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1803:\n",
      "Patient ID: MB-7060\n",
      "Age at Diagnosis: 69.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 112.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 62.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1804:\n",
      "Patient ID: MB-7061\n",
      "Age at Diagnosis: 61.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 96.76666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 95.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1805:\n",
      "Patient ID: MB-7062\n",
      "Age at Diagnosis: 63.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 95.86666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 94.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1806:\n",
      "Patient ID: MB-7063\n",
      "Age at Diagnosis: 76.77\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 85.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1807:\n",
      "Patient ID: MB-7065\n",
      "Age at Diagnosis: 45.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 107.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 106.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1808:\n",
      "Patient ID: MB-7066\n",
      "Age at Diagnosis: 64.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.037\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 89.76666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 88.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1809:\n",
      "Patient ID: MB-7067\n",
      "Age at Diagnosis: 69.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.031\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 105.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 103.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1810:\n",
      "Patient ID: MB-7068\n",
      "Age at Diagnosis: 58.95\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.46666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.17\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1811:\n",
      "Patient ID: MB-7069\n",
      "Age at Diagnosis: 67.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.043\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 114.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 113.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 21.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1812:\n",
      "Patient ID: MB-7070\n",
      "Age at Diagnosis: 68.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.004\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 106.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 2.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1813:\n",
      "Patient ID: MB-7071\n",
      "Age at Diagnosis: 27.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 22.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 102.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1814:\n",
      "Patient ID: MB-7072\n",
      "Age at Diagnosis: 71.24\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.13\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 52.33333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1815:\n",
      "Patient ID: MB-7073\n",
      "Age at Diagnosis: 54.69\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 13.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 137.9333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 136.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1816:\n",
      "Patient ID: MB-7074\n",
      "Age at Diagnosis: 51.36\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 106.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1817:\n",
      "Patient ID: MB-7075\n",
      "Age at Diagnosis: 64.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 111.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1818:\n",
      "Patient ID: MB-7076\n",
      "Age at Diagnosis: 56.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 142.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 140.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1819:\n",
      "Patient ID: MB-7077\n",
      "Age at Diagnosis: 37.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 101.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 99.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1820:\n",
      "Patient ID: MB-7078\n",
      "Age at Diagnosis: 74.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 4.166666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 3.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1821:\n",
      "Patient ID: MB-7079\n",
      "Age at Diagnosis: 70.3\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.06666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 89.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1822:\n",
      "Patient ID: MB-7080\n",
      "Age at Diagnosis: 64.01\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 91.23333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 90.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1823:\n",
      "Patient ID: MB-7081\n",
      "Age at Diagnosis: 69.12\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1824:\n",
      "Patient ID: MB-7082\n",
      "Age at Diagnosis: 57.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 98.26666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 96.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1825:\n",
      "Patient ID: MB-7083\n",
      "Age at Diagnosis: 50.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 105.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 104.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1826:\n",
      "Patient ID: MB-7084\n",
      "Age at Diagnosis: 74.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 116.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 115.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1827:\n",
      "Patient ID: MB-7085\n",
      "Age at Diagnosis: 60.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1828:\n",
      "Patient ID: MB-7086\n",
      "Age at Diagnosis: 70.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 123.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1829:\n",
      "Patient ID: MB-7087\n",
      "Age at Diagnosis: 66.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.028\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 5.066666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 5.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1830:\n",
      "Patient ID: MB-7088\n",
      "Age at Diagnosis: 72.05\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 121.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1831:\n",
      "Patient ID: MB-7089\n",
      "Age at Diagnosis: 47.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 118.9\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 117.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1832:\n",
      "Patient ID: MB-7090\n",
      "Age at Diagnosis: 48.52\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 109.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 108.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1833:\n",
      "Patient ID: MB-7091\n",
      "Age at Diagnosis: 55.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 110.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 108.82\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1834:\n",
      "Patient ID: MB-7092\n",
      "Age at Diagnosis: 55.67\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 122.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 120.79\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1835:\n",
      "Patient ID: MB-7093\n",
      "Age at Diagnosis: 76.25\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.0338\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 77.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.9\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1836:\n",
      "Patient ID: MB-7094\n",
      "Age at Diagnosis: 60.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.0488\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 113.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 111.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 24.4\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1837:\n",
      "Patient ID: MB-7095\n",
      "Age at Diagnosis: 74.64\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 115.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 114.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1838:\n",
      "Patient ID: MB-7096\n",
      "Age at Diagnosis: 48.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.025\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 124.0\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1839:\n",
      "Patient ID: MB-7097\n",
      "Age at Diagnosis: 60.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 2.0806\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 65.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1840:\n",
      "Patient ID: MB-7099\n",
      "Age at Diagnosis: 80.31\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1841:\n",
      "Patient ID: MB-7100\n",
      "Age at Diagnosis: 70.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.056\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 156.3333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 154.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1842:\n",
      "Patient ID: MB-7101\n",
      "Age at Diagnosis: 49.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.031\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 124.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 122.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1843:\n",
      "Patient ID: MB-7102\n",
      "Age at Diagnosis: 73.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 104.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 102.73\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1844:\n",
      "Patient ID: MB-7104\n",
      "Age at Diagnosis: 59.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 122.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1845:\n",
      "Patient ID: MB-7106\n",
      "Age at Diagnosis: 80.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 18.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 37.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1846:\n",
      "Patient ID: MB-7107\n",
      "Age at Diagnosis: 67.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 56.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 42.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1847:\n",
      "Patient ID: MB-7109\n",
      "Age at Diagnosis: 67.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 117.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 115.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1848:\n",
      "Patient ID: MB-7111\n",
      "Age at Diagnosis: 52.12\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 30.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 29.77\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1849:\n",
      "Patient ID: MB-7112\n",
      "Age at Diagnosis: 40.74\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 64.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 37.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1850:\n",
      "Patient ID: MB-7113\n",
      "Age at Diagnosis: 66.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 136.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 134.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1851:\n",
      "Patient ID: MB-7114\n",
      "Age at Diagnosis: 55.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.2666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1852:\n",
      "Patient ID: MB-7115\n",
      "Age at Diagnosis: 80.56\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 141.7333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1853:\n",
      "Patient ID: MB-7116\n",
      "Age at Diagnosis: 77.17\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 33.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 24.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1854:\n",
      "Patient ID: MB-7118\n",
      "Age at Diagnosis: 70.15\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 138.72\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1855:\n",
      "Patient ID: MB-7119\n",
      "Age at Diagnosis: 54.53\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 126.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1856:\n",
      "Patient ID: MB-7121\n",
      "Age at Diagnosis: 49.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 88.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 87.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1857:\n",
      "Patient ID: MB-7122\n",
      "Age at Diagnosis: 83.39\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 29.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 29.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1858:\n",
      "Patient ID: MB-7123\n",
      "Age at Diagnosis: 56.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.072\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 137.6666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 135.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1859:\n",
      "Patient ID: MB-7124\n",
      "Age at Diagnosis: 71.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 139.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 137.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1860:\n",
      "Patient ID: MB-7127\n",
      "Age at Diagnosis: 52.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 135.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 133.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1861:\n",
      "Patient ID: MB-7128\n",
      "Age at Diagnosis: 71.05\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.042\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 60.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 59.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1862:\n",
      "Patient ID: MB-7130\n",
      "Age at Diagnosis: 72.28\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 101.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1863:\n",
      "Patient ID: MB-7131\n",
      "Age at Diagnosis: 58.04\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 134.7333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 132.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1864:\n",
      "Patient ID: MB-7132\n",
      "Age at Diagnosis: 69.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 131.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 129.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1865:\n",
      "Patient ID: MB-7133\n",
      "Age at Diagnosis: 71.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 23.83333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1866:\n",
      "Patient ID: MB-7135\n",
      "Age at Diagnosis: 56.93\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 26.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1867:\n",
      "Patient ID: MB-7137\n",
      "Age at Diagnosis: 64.24\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 179.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 177.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1868:\n",
      "Patient ID: MB-7138\n",
      "Age at Diagnosis: 68.16\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.044\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 123.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1869:\n",
      "Patient ID: MB-7140\n",
      "Age at Diagnosis: 58.27\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.12\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 53.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1870:\n",
      "Patient ID: MB-7141\n",
      "Age at Diagnosis: 78.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.0236\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 138.5666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 136.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 11.8\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1871:\n",
      "Patient ID: MB-7142\n",
      "Age at Diagnosis: 55.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.026\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 137.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1872:\n",
      "Patient ID: MB-7143\n",
      "Age at Diagnosis: 61.38\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 186.3666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 183.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1873:\n",
      "Patient ID: MB-7144\n",
      "Age at Diagnosis: 59.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.045\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 102.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 101.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 22.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1874:\n",
      "Patient ID: MB-7145\n",
      "Age at Diagnosis: 44.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 138.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 136.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1875:\n",
      "Patient ID: MB-7147\n",
      "Age at Diagnosis: 76.98\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 168.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 166.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1876:\n",
      "Patient ID: MB-7148\n",
      "Age at Diagnosis: 62.97\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.26\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 19.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 7.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 130.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1877:\n",
      "Patient ID: MB-7149\n",
      "Age at Diagnosis: 66.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 39.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1878:\n",
      "Patient ID: MB-7150\n",
      "Age at Diagnosis: 70.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.074\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 128.9666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 127.27\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1879:\n",
      "Patient ID: MB-7151\n",
      "Age at Diagnosis: 59.06\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 144.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 142.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1880:\n",
      "Patient ID: MB-7152\n",
      "Age at Diagnosis: 62.13\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 193.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1881:\n",
      "Patient ID: MB-7153\n",
      "Age at Diagnosis: 74.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 142.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 140.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1882:\n",
      "Patient ID: MB-7154\n",
      "Age at Diagnosis: 77.54\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.0652\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 108.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 107.04\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 32.6\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1883:\n",
      "Patient ID: MB-7155\n",
      "Age at Diagnosis: 41.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.0344\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 147.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 17.2\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1884:\n",
      "Patient ID: MB-7157\n",
      "Age at Diagnosis: 56.86\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.038\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 219.6333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.87\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1885:\n",
      "Patient ID: MB-7158\n",
      "Age at Diagnosis: 50.73\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER-\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 16.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.058\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 31.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1886:\n",
      "Patient ID: MB-7159\n",
      "Age at Diagnosis: 60.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.068\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1887:\n",
      "Patient ID: MB-7160\n",
      "Age at Diagnosis: 51.34\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 148.0666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 146.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1888:\n",
      "Patient ID: MB-7161\n",
      "Age at Diagnosis: 47.67\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.092\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 121.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 119.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 46.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1889:\n",
      "Patient ID: MB-7162\n",
      "Age at Diagnosis: 59.84\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.0276\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 13.8\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1890:\n",
      "Patient ID: MB-7163\n",
      "Age at Diagnosis: 43.81\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 52.63333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 50.92\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1891:\n",
      "Patient ID: MB-7164\n",
      "Age at Diagnosis: 49.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.0314\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 211.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 208.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.7\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1892:\n",
      "Patient ID: MB-7165\n",
      "Age at Diagnosis: 28.78\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.364\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 147.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 145.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 182.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1893:\n",
      "Patient ID: MB-7167\n",
      "Age at Diagnosis: 43.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.17\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 141.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 139.18\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 85.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1894:\n",
      "Patient ID: MB-7168\n",
      "Age at Diagnosis: 60.33\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 150.5\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 148.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1895:\n",
      "Patient ID: MB-7170\n",
      "Age at Diagnosis: 58.56\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 155.4\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 153.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1896:\n",
      "Patient ID: MB-7171\n",
      "Age at Diagnosis: 71.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.062\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 160.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 158.29\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1897:\n",
      "Patient ID: MB-7172\n",
      "Age at Diagnosis: 62.7\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.0366\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 149.3\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 131.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1898:\n",
      "Patient ID: MB-7173\n",
      "Age at Diagnosis: 67.4\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.0432\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 63.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.6\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1899:\n",
      "Patient ID: MB-7174\n",
      "Age at Diagnosis: 60.63\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 140.7666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 138.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1900:\n",
      "Patient ID: MB-7176\n",
      "Age at Diagnosis: 50.51\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.057\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 194.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 191.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 28.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1901:\n",
      "Patient ID: MB-7181\n",
      "Age at Diagnosis: 63.09\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 157.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 155.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1902:\n",
      "Patient ID: MB-7182\n",
      "Age at Diagnosis: 58.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 33.52\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1903:\n",
      "Patient ID: MB-7185\n",
      "Age at Diagnosis: 70.76\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.0324\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 125.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 123.39\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 16.2\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1904:\n",
      "Patient ID: MB-7186\n",
      "Age at Diagnosis: 48.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.066\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 4.866666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 4.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1905:\n",
      "Patient ID: MB-7187\n",
      "Age at Diagnosis: 49.35\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.0046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 146.8333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 79.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 2.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1906:\n",
      "Patient ID: MB-7188\n",
      "Age at Diagnosis: 68.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 1.05\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 188.1666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 185.69\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1907:\n",
      "Patient ID: MB-7189\n",
      "Age at Diagnosis: 58.75\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 143.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 88.19\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1908:\n",
      "Patient ID: MB-7193\n",
      "Age at Diagnosis: 76.65\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.0304\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 87.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 86.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.2\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1909:\n",
      "Patient ID: MB-7194\n",
      "Age at Diagnosis: 63.71\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 2\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.043\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 46.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 28.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 21.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1910:\n",
      "Patient ID: MB-7195\n",
      "Age at Diagnosis: 72.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 80.43333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 79.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1911:\n",
      "Patient ID: MB-7196\n",
      "Age at Diagnosis: 67.99\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.15\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 107.1\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 100.66\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 75.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1912:\n",
      "Patient ID: MB-7197\n",
      "Age at Diagnosis: 70.58\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.8666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 185.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1913:\n",
      "Patient ID: MB-7198\n",
      "Age at Diagnosis: 67.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 16.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 14.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1914:\n",
      "Patient ID: MB-7199\n",
      "Age at Diagnosis: 81.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 76.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 75.0\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1915:\n",
      "Patient ID: MB-7200\n",
      "Age at Diagnosis: 71.69\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 97.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 96.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1916:\n",
      "Patient ID: MB-7201\n",
      "Age at Diagnosis: 62.07\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 163.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 161.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1917:\n",
      "Patient ID: MB-7205\n",
      "Age at Diagnosis: 38.17\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 166.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 163.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1918:\n",
      "Patient ID: MB-7207\n",
      "Age at Diagnosis: 43.28\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 14.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1919:\n",
      "Patient ID: MB-7208\n",
      "Age at Diagnosis: 48.83\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.0622\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 45.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 11.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 31.1\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1920:\n",
      "Patient ID: MB-7212\n",
      "Age at Diagnosis: 62.26\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.0286\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 52.5\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 51.81\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 14.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1921:\n",
      "Patient ID: MB-7215\n",
      "Age at Diagnosis: 60.15\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.031\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 208.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 206.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1922:\n",
      "Patient ID: MB-7216\n",
      "Age at Diagnosis: 79.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 207.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 204.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1923:\n",
      "Patient ID: MB-7217\n",
      "Age at Diagnosis: 62.61\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 1.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 90.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 89.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1924:\n",
      "Patient ID: MB-7218\n",
      "Age at Diagnosis: 57.87\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.0252\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 165.4333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 163.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.6\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1925:\n",
      "Patient ID: MB-7219\n",
      "Age at Diagnosis: 60.07\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.025\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 165.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 106.94\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1926:\n",
      "Patient ID: MB-7220\n",
      "Age at Diagnosis: 70.97\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.0502\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 183.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 1.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.1\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1927:\n",
      "Patient ID: MB-7225\n",
      "Age at Diagnosis: 49.61\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 55.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 40.46\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1928:\n",
      "Patient ID: MB-7226\n",
      "Age at Diagnosis: 67.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.0352\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 53.36666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 41.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.6\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1929:\n",
      "Patient ID: MB-7227\n",
      "Age at Diagnosis: 72.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 63.2\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 62.27\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1930:\n",
      "Patient ID: MB-7228\n",
      "Age at Diagnosis: 58.92\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 239.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 236.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1931:\n",
      "Patient ID: MB-7229\n",
      "Age at Diagnosis: 73.52\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.058\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): 111.6\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 110.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 29.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1932:\n",
      "Patient ID: MB-7230\n",
      "Age at Diagnosis: 51.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 182.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 180.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1933:\n",
      "Patient ID: MB-7231\n",
      "Age at Diagnosis: 68.41\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 1.076\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 196.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 38.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1934:\n",
      "Patient ID: MB-7232\n",
      "Age at Diagnosis: 58.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.00424\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 177.6\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 175.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 2.12\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1935:\n",
      "Patient ID: MB-7233\n",
      "Age at Diagnosis: 74.76\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.0426\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 219.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1936:\n",
      "Patient ID: MB-7234\n",
      "Age at Diagnosis: 63.43\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.016\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 222.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 219.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1937:\n",
      "Patient ID: MB-7235\n",
      "Age at Diagnosis: 62.45\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): 170.8\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 168.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1938:\n",
      "Patient ID: MB-7236\n",
      "Age at Diagnosis: 51.46\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.04464\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): 201.4666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 129.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 22.32\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1939:\n",
      "Patient ID: MB-7237\n",
      "Age at Diagnosis: 77.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: NC\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.036\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.93333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 21.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1940:\n",
      "Patient ID: MB-7238\n",
      "Age at Diagnosis: 71.11\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.054\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 23.26666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 10.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1941:\n",
      "Patient ID: MB-7241\n",
      "Age at Diagnosis: 47.85\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 171.1\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 168.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1942:\n",
      "Patient ID: MB-7243\n",
      "Age at Diagnosis: 78.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.034\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 148.8\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 146.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1943:\n",
      "Patient ID: MB-7244\n",
      "Age at Diagnosis: 54.81\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 3.024\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 184.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 181.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1944:\n",
      "Patient ID: MB-7249\n",
      "Age at Diagnosis: 75.13\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Low\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 1.042\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 58.66666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 57.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1945:\n",
      "Patient ID: MB-7250\n",
      "Age at Diagnosis: 48.45\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.0354\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 51.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 10.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 17.7\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1946:\n",
      "Patient ID: MB-7251\n",
      "Age at Diagnosis: 54.66\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 6.03094\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.56666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 19.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 15.47\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1947:\n",
      "Patient ID: MB-7252\n",
      "Age at Diagnosis: 74.8\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 35.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 32.4\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1948:\n",
      "Patient ID: MB-7253\n",
      "Age at Diagnosis: 69.72\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 59.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 56.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1949:\n",
      "Patient ID: MB-7254\n",
      "Age at Diagnosis: 62.46\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.046\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 192.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 189.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1950:\n",
      "Patient ID: MB-7256\n",
      "Age at Diagnosis: 50.92\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 17.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 34.7\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 27.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1951:\n",
      "Patient ID: MB-7258\n",
      "Age at Diagnosis: 45.11\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 15.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.87\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1952:\n",
      "Patient ID: MB-7260\n",
      "Age at Diagnosis: 52.41\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.0483\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 31.16666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 24.15\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1953:\n",
      "Patient ID: MB-7262\n",
      "Age at Diagnosis: 83.8\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 104.0333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 102.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1954:\n",
      "Patient ID: MB-7263\n",
      "Age at Diagnosis: 63.89\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 164.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 97.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1955:\n",
      "Patient ID: MB-7264\n",
      "Age at Diagnosis: 60.57\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 42.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 22.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1956:\n",
      "Patient ID: MB-7266\n",
      "Age at Diagnosis: 59.82\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 68.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 30.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1957:\n",
      "Patient ID: MB-7267\n",
      "Age at Diagnosis: 28.37\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.041\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.3666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 136.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1958:\n",
      "Patient ID: MB-7268\n",
      "Age at Diagnosis: 34.64\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 227.4666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 72.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1959:\n",
      "Patient ID: MB-7269\n",
      "Age at Diagnosis: 36.6\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.16666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 13.19\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1960:\n",
      "Patient ID: MB-7270\n",
      "Age at Diagnosis: 50.84\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Basal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.1666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 172.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER-/HER2-\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1961:\n",
      "Patient ID: MB-7273\n",
      "Age at Diagnosis: 47.47\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 208.2\n",
      "Overall Survival Status: Living\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 205.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1962:\n",
      "Patient ID: MB-7275\n",
      "Age at Diagnosis: 30.02\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.4\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 22.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1963:\n",
      "Patient ID: MB-7276\n",
      "Age at Diagnosis: 61.27\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 185.3333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 182.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1964:\n",
      "Patient ID: MB-7277\n",
      "Age at Diagnosis: 56.78\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 187.0333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 184.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1965:\n",
      "Patient ID: MB-7278\n",
      "Age at Diagnosis: 67.89\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 241.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 238.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1966:\n",
      "Patient ID: MB-7279\n",
      "Age at Diagnosis: 86.14\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 9\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 21.3\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 19.08\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1967:\n",
      "Patient ID: MB-7280\n",
      "Age at Diagnosis: 63.5\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 7\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.08\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 195.5333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 192.96\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1968:\n",
      "Patient ID: MB-7281\n",
      "Age at Diagnosis: 51.22\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: Her2\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.032\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 49.53333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 24.54\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1969:\n",
      "Patient ID: MB-7283\n",
      "Age at Diagnosis: 54.42\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: Yes\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Loss\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 33.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 28.86666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 12.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1970:\n",
      "Patient ID: MB-7284\n",
      "Age at Diagnosis: 61.23\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 203.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 146.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1971:\n",
      "Patient ID: MB-7285\n",
      "Age at Diagnosis: 53.14\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 109.0\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 107.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1972:\n",
      "Patient ID: MB-7286\n",
      "Age at Diagnosis: 66.48\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 158.6333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 156.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1973:\n",
      "Patient ID: MB-7287\n",
      "Age at Diagnosis: 63.09\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 96.96666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 63.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1974:\n",
      "Patient ID: MB-7288\n",
      "Age at Diagnosis: 55.7\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 8\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 27.06666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 9.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1975:\n",
      "Patient ID: MB-7289\n",
      "Age at Diagnosis: 51.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: Normal\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 4ER+\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.13\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 126.6666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 53.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1976:\n",
      "Patient ID: MB-7291\n",
      "Age at Diagnosis: 53.87\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: claudin-low\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 22.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 6.833333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 6.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: HER2+\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1977:\n",
      "Patient ID: MB-7292\n",
      "Age at Diagnosis: 52.9\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 6\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 78.46666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 32.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1978:\n",
      "Patient ID: MB-7293\n",
      "Age at Diagnosis: 56.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.09\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 199.2333333\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 196.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1979:\n",
      "Patient ID: MB-7294\n",
      "Age at Diagnosis: 59.2\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 82.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 81.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1980:\n",
      "Patient ID: MB-7295\n",
      "Age at Diagnosis: 43.1\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumA\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 3\n",
      "Primary Tumor Laterality: Right\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): 196.8666667\n",
      "Overall Survival Status: Living\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 194.28\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- Low Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Living\n",
      "\n",
      "Row 1981:\n",
      "Patient ID: MB-7296\n",
      "Age at Diagnosis: 42.88\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Gain\n",
      "HER2 Status: Positive\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: No\n",
      "Inferred Menopausal State: Pre\n",
      "Integrative Cluster: 5\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 44.73333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 16.09\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1982:\n",
      "Patient ID: MB-7297\n",
      "Age at Diagnosis: 62.9\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: Left\n",
      "Lymph nodes examined positive: 45.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 175.9666667\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 121.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Disease\n",
      "\n",
      "Row 1983:\n",
      "Patient ID: MB-7298\n",
      "Age at Diagnosis: 61.16\n",
      "Type of Breast Surgery: Mastectomy\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: Moderate\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 1\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 86.23333333\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Positive\n",
      "Radio Therapy: No\n",
      "Relapse Free Status (Months): 85.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1984:\n",
      "Patient ID: MB-7299\n",
      "Age at Diagnosis: 60.02\n",
      "Type of Breast Surgery: Breast Conserving\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: High\n",
      "Chemotherapy: No\n",
      "Pam50 + Claudin-low subtype: LumB\n",
      "Cohort: 4.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: Neutral\n",
      "HER2 Status: Negative\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: Yes\n",
      "Inferred Menopausal State: Post\n",
      "Integrative Cluster: 10\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): 201.9\n",
      "Overall Survival Status: Deceased\n",
      "PR Status: Negative\n",
      "Radio Therapy: Yes\n",
      "Relapse Free Status (Months): 199.24\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: ER+/HER2- High Prolif\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: Died of Other Causes\n",
      "\n",
      "Row 1985:\n",
      "Patient ID: MTS-T0035\n",
      "Age at Diagnosis: 55.64\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 64.67\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1986:\n",
      "Patient ID: MTS-T0058\n",
      "Age at Diagnosis: 48.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.62\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 59.31\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1987:\n",
      "Patient ID: MTS-T0059\n",
      "Age at Diagnosis: 82.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 1.48\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 49.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1988:\n",
      "Patient ID: MTS-T0060\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.98\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.49\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 49.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1989:\n",
      "Patient ID: MTS-T0061\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.38\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 67.8\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1990:\n",
      "Patient ID: MTS-T0062\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 2.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 65.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1991:\n",
      "Patient ID: MTS-T0063\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 51.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1992:\n",
      "Patient ID: MTS-T0064\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 1.36\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 47.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1993:\n",
      "Patient ID: MTS-T0065\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 0.86\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1994:\n",
      "Patient ID: MTS-T0066\n",
      "Age at Diagnosis: 73.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 1.14\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 84.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 7.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1995:\n",
      "Patient ID: MTS-T0067\n",
      "Age at Diagnosis: 32.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 179.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1996:\n",
      "Patient ID: MTS-T0068\n",
      "Age at Diagnosis: 66.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 17.0\n",
      "Nottingham prognostic index: 1.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 47.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1997:\n",
      "Patient ID: MTS-T0069\n",
      "Age at Diagnosis: 78.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.52\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 0.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1998:\n",
      "Patient ID: MTS-T0070\n",
      "Age at Diagnosis: 76.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.9\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 35.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 1999:\n",
      "Patient ID: MTS-T0071\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.36\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 24.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2000:\n",
      "Patient ID: MTS-T0072\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 1.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 26.35\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2001:\n",
      "Patient ID: MTS-T0073\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 42.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2002:\n",
      "Patient ID: MTS-T0074\n",
      "Age at Diagnosis: 59.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 1.42\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 68.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2003:\n",
      "Patient ID: MTS-T0075\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 215.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2004:\n",
      "Patient ID: MTS-T0076\n",
      "Age at Diagnosis: 80.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.8\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 68.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2005:\n",
      "Patient ID: MTS-T0077\n",
      "Age at Diagnosis: 78.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.6\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 61.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2006:\n",
      "Patient ID: MTS-T0078\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.8\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 51.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 90.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2007:\n",
      "Patient ID: MTS-T0079\n",
      "Age at Diagnosis: 78.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 30.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 12.01\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 75.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2008:\n",
      "Patient ID: MTS-T0080\n",
      "Age at Diagnosis: 59.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 1.16\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2009:\n",
      "Patient ID: MTS-T0081\n",
      "Age at Diagnosis: 76.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 57.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 51.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2010:\n",
      "Patient ID: MTS-T0082\n",
      "Age at Diagnosis: 75.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.38\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 40.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 69.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2011:\n",
      "Patient ID: MTS-T0083\n",
      "Age at Diagnosis: 54.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 43.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 51.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2012:\n",
      "Patient ID: MTS-T0084\n",
      "Age at Diagnosis: 87.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 50.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 51.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2013:\n",
      "Patient ID: MTS-T0085\n",
      "Age at Diagnosis: 67.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.5\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 45.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2014:\n",
      "Patient ID: MTS-T0086\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 44.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2015:\n",
      "Patient ID: MTS-T0087\n",
      "Age at Diagnosis: 42.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.94\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 39.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2016:\n",
      "Patient ID: MTS-T0088\n",
      "Age at Diagnosis: 89.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 1.7\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.98\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2017:\n",
      "Patient ID: MTS-T0089\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 1.84\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 33.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 42.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2018:\n",
      "Patient ID: MTS-T0090\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 24.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2019:\n",
      "Patient ID: MTS-T0091\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 1.36\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 19.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2020:\n",
      "Patient ID: MTS-T0092\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 1.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 18.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2021:\n",
      "Patient ID: MTS-T0093\n",
      "Age at Diagnosis: 73.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 1.72\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 25.89\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 36.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2022:\n",
      "Patient ID: MTS-T0094\n",
      "Age at Diagnosis: 83.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 1.4\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 20.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2023:\n",
      "Patient ID: MTS-T0095\n",
      "Age at Diagnosis: 62.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 10.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 88.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2024:\n",
      "Patient ID: MTS-T0131\n",
      "Age at Diagnosis: 36.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2025:\n",
      "Patient ID: MTS-T0132\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2026:\n",
      "Patient ID: MTS-T0133\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2027:\n",
      "Patient ID: MTS-T0134\n",
      "Age at Diagnosis: 40.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2028:\n",
      "Patient ID: MTS-T0135\n",
      "Age at Diagnosis: 59.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2029:\n",
      "Patient ID: MTS-T0136\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2030:\n",
      "Patient ID: MTS-T0137\n",
      "Age at Diagnosis: 41.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2031:\n",
      "Patient ID: MTS-T0138\n",
      "Age at Diagnosis: 54.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2032:\n",
      "Patient ID: MTS-T0139\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2033:\n",
      "Patient ID: MTS-T0140\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2034:\n",
      "Patient ID: MTS-T0141\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2035:\n",
      "Patient ID: MTS-T0142\n",
      "Age at Diagnosis: 35.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2036:\n",
      "Patient ID: MTS-T0143\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2037:\n",
      "Patient ID: MTS-T0144\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2038:\n",
      "Patient ID: MTS-T0145\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2039:\n",
      "Patient ID: MTS-T0146\n",
      "Age at Diagnosis: 67.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2040:\n",
      "Patient ID: MTS-T0147\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2041:\n",
      "Patient ID: MTS-T0148\n",
      "Age at Diagnosis: 56.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2042:\n",
      "Patient ID: MTS-T0149\n",
      "Age at Diagnosis: 35.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2043:\n",
      "Patient ID: MTS-T0150\n",
      "Age at Diagnosis: 38.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2044:\n",
      "Patient ID: MTS-T0151\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2045:\n",
      "Patient ID: MTS-T0152\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2046:\n",
      "Patient ID: MTS-T0153\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2047:\n",
      "Patient ID: MTS-T0154\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2048:\n",
      "Patient ID: MTS-T0155\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2049:\n",
      "Patient ID: MTS-T0156\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2050:\n",
      "Patient ID: MTS-T0157\n",
      "Age at Diagnosis: 62.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2051:\n",
      "Patient ID: MTS-T0158\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2052:\n",
      "Patient ID: MTS-T0159\n",
      "Age at Diagnosis: 75.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2053:\n",
      "Patient ID: MTS-T0160\n",
      "Age at Diagnosis: 36.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2054:\n",
      "Patient ID: MTS-T0161\n",
      "Age at Diagnosis: 39.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 6.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 17.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.6\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2055:\n",
      "Patient ID: MTS-T0162\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2056:\n",
      "Patient ID: MTS-T0163\n",
      "Age at Diagnosis: 50.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 6.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 7.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 53.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2057:\n",
      "Patient ID: MTS-T0164\n",
      "Age at Diagnosis: 73.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 6.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2058:\n",
      "Patient ID: MTS-T0165\n",
      "Age at Diagnosis: 56.22\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 7.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 100.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2059:\n",
      "Patient ID: MTS-T0166\n",
      "Age at Diagnosis: 44.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.2\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 226.97\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2060:\n",
      "Patient ID: MTS-T0167\n",
      "Age at Diagnosis: 58.77\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 223.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2061:\n",
      "Patient ID: MTS-T0168\n",
      "Age at Diagnosis: 57.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 42.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2062:\n",
      "Patient ID: MTS-T0169\n",
      "Age at Diagnosis: 50.1\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 217.11\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2063:\n",
      "Patient ID: MTS-T0170\n",
      "Age at Diagnosis: 40.84\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.7\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 27.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2064:\n",
      "Patient ID: MTS-T0171\n",
      "Age at Diagnosis: 51.24\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 201.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2065:\n",
      "Patient ID: MTS-T0172\n",
      "Age at Diagnosis: 32.84\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 187.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 7.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2066:\n",
      "Patient ID: MTS-T0173\n",
      "Age at Diagnosis: 64.2\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.64\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 56.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2067:\n",
      "Patient ID: MTS-T0174\n",
      "Age at Diagnosis: 38.6\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.24\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 39.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2068:\n",
      "Patient ID: MTS-T0175\n",
      "Age at Diagnosis: 50.65\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.38\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 17.37\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2069:\n",
      "Patient ID: MTS-T0176\n",
      "Age at Diagnosis: 56.49\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.98\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 5.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 49.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2070:\n",
      "Patient ID: MTS-T0177\n",
      "Age at Diagnosis: 65.7\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.36\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 162.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2071:\n",
      "Patient ID: MTS-T0178\n",
      "Age at Diagnosis: 54.54\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2072:\n",
      "Patient ID: MTS-T0179\n",
      "Age at Diagnosis: 62.14\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 2.3\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 213.16\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2073:\n",
      "Patient ID: MTS-T0180\n",
      "Age at Diagnosis: 52.63\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 151.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2074:\n",
      "Patient ID: MTS-T0181\n",
      "Age at Diagnosis: 54.84\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 237.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2075:\n",
      "Patient ID: MTS-T0182\n",
      "Age at Diagnosis: 50.52\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.6\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 230.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2076:\n",
      "Patient ID: MTS-T0183\n",
      "Age at Diagnosis: 39.78\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.3\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 189.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2077:\n",
      "Patient ID: MTS-T0184\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.9\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 7.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2078:\n",
      "Patient ID: MTS-T0185\n",
      "Age at Diagnosis: 50.22\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.46\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 2.37\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2079:\n",
      "Patient ID: MTS-T0186\n",
      "Age at Diagnosis: 41.52\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.84\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 10.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 42.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2080:\n",
      "Patient ID: MTS-T0187\n",
      "Age at Diagnosis: 47.13\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 208.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2081:\n",
      "Patient ID: MTS-T0188\n",
      "Age at Diagnosis: 50.34\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 33.55\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2082:\n",
      "Patient ID: MTS-T0189\n",
      "Age at Diagnosis: 50.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 5.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 96.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2083:\n",
      "Patient ID: MTS-T0190\n",
      "Age at Diagnosis: 40.2\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 109.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2084:\n",
      "Patient ID: MTS-T0191\n",
      "Age at Diagnosis: 56.65\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 154.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.6\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2085:\n",
      "Patient ID: MTS-T0192\n",
      "Age at Diagnosis: 83.87\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 69.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2086:\n",
      "Patient ID: MTS-T0193\n",
      "Age at Diagnosis: 68.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 15.2\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2087:\n",
      "Patient ID: MTS-T0194\n",
      "Age at Diagnosis: 75.68\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 181.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2088:\n",
      "Patient ID: MTS-T0195\n",
      "Age at Diagnosis: 40.41\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.16\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 110.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2089:\n",
      "Patient ID: MTS-T0196\n",
      "Age at Diagnosis: 80.79\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 118.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2090:\n",
      "Patient ID: MTS-T0197\n",
      "Age at Diagnosis: 46.65\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 10.56\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 66.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2091:\n",
      "Patient ID: MTS-T0198\n",
      "Age at Diagnosis: 88.45\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 81.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2092:\n",
      "Patient ID: MTS-T0199\n",
      "Age at Diagnosis: 75.61\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 86.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2093:\n",
      "Patient ID: MTS-T0200\n",
      "Age at Diagnosis: 58.85\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 100.0\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2094:\n",
      "Patient ID: MTS-T0201\n",
      "Age at Diagnosis: 43.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 50.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2095:\n",
      "Patient ID: MTS-T0202\n",
      "Age at Diagnosis: 56.8\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 62.73\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.8\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2096:\n",
      "Patient ID: MTS-T0203\n",
      "Age at Diagnosis: 50.99\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 134.44\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2097:\n",
      "Patient ID: MTS-T0204\n",
      "Age at Diagnosis: 47.93\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 13.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2098:\n",
      "Patient ID: MTS-T0205\n",
      "Age at Diagnosis: 77.73\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 37.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2099:\n",
      "Patient ID: MTS-T0206\n",
      "Age at Diagnosis: 65.24\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 42.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.1\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2100:\n",
      "Patient ID: MTS-T0207\n",
      "Age at Diagnosis: 72.77\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 148.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.8\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2101:\n",
      "Patient ID: MTS-T0208\n",
      "Age at Diagnosis: 52.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 111.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 47.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2102:\n",
      "Patient ID: MTS-T0209\n",
      "Age at Diagnosis: 82.41\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 37.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2103:\n",
      "Patient ID: MTS-T0210\n",
      "Age at Diagnosis: 66.13\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 155.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2104:\n",
      "Patient ID: MTS-T0211\n",
      "Age at Diagnosis: 54.59\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 17.14\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2105:\n",
      "Patient ID: MTS-T0212\n",
      "Age at Diagnosis: 70.34\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 1.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2106:\n",
      "Patient ID: MTS-T0213\n",
      "Age at Diagnosis: 73.42\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 39.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.2\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2107:\n",
      "Patient ID: MTS-T0214\n",
      "Age at Diagnosis: 79.92\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 149.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.7\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2108:\n",
      "Patient ID: MTS-T0215\n",
      "Age at Diagnosis: 46.99\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 157.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 8.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2109:\n",
      "Patient ID: MTS-T0216\n",
      "Age at Diagnosis: 45.54\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 175.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 8.9\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2110:\n",
      "Patient ID: MTS-T0217\n",
      "Age at Diagnosis: 58.5\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 25.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2111:\n",
      "Patient ID: MTS-T0218\n",
      "Age at Diagnosis: 70.5\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 166.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2112:\n",
      "Patient ID: MTS-T0219\n",
      "Age at Diagnosis: 50.78\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 149.9\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.1\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2113:\n",
      "Patient ID: MTS-T0220\n",
      "Age at Diagnosis: 44.19\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 160.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 7.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2114:\n",
      "Patient ID: MTS-T0221\n",
      "Age at Diagnosis: 40.48\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 81.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2115:\n",
      "Patient ID: MTS-T0222\n",
      "Age at Diagnosis: 52.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 164.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.4\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2116:\n",
      "Patient ID: MTS-T0223\n",
      "Age at Diagnosis: 74.4\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 112.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.9\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2117:\n",
      "Patient ID: MTS-T0224\n",
      "Age at Diagnosis: 56.09\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 81.64\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.4\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2118:\n",
      "Patient ID: MTS-T0225\n",
      "Age at Diagnosis: 66.04\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 10.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 100.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2119:\n",
      "Patient ID: MTS-T0226\n",
      "Age at Diagnosis: 65.22\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 160.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.33\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2120:\n",
      "Patient ID: MTS-T0227\n",
      "Age at Diagnosis: 63.19\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 173.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.06\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2121:\n",
      "Patient ID: MTS-T0228\n",
      "Age at Diagnosis: 65.71\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 102.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.95\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2122:\n",
      "Patient ID: MTS-T0229\n",
      "Age at Diagnosis: 62.29\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 20.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 185.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2123:\n",
      "Patient ID: MTS-T0230\n",
      "Age at Diagnosis: 47.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 41.94\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.7\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2124:\n",
      "Patient ID: MTS-T0231\n",
      "Age at Diagnosis: 42.57\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 34.47\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2125:\n",
      "Patient ID: MTS-T0232\n",
      "Age at Diagnosis: 69.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 9.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2126:\n",
      "Patient ID: MTS-T0233\n",
      "Age at Diagnosis: 64.19\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 133.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2127:\n",
      "Patient ID: MTS-T0234\n",
      "Age at Diagnosis: 59.48\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 197.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 4.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2128:\n",
      "Patient ID: MTS-T0235\n",
      "Age at Diagnosis: 63.01\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.38\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 90.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2129:\n",
      "Patient ID: MTS-T0236\n",
      "Age at Diagnosis: 59.61\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.42\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 150.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2130:\n",
      "Patient ID: MTS-T0237\n",
      "Age at Diagnosis: 67.36\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.66\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 37.99\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 33.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2131:\n",
      "Patient ID: MTS-T0238\n",
      "Age at Diagnosis: 49.98\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.92\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 71.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 46.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2132:\n",
      "Patient ID: MTS-T0239\n",
      "Age at Diagnosis: 54.15\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 145.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2133:\n",
      "Patient ID: MTS-T0240\n",
      "Age at Diagnosis: 63.93\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 35.13\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2134:\n",
      "Patient ID: MTS-T0241\n",
      "Age at Diagnosis: 61.83\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 98.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2135:\n",
      "Patient ID: MTS-T0242\n",
      "Age at Diagnosis: 62.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 26.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2136:\n",
      "Patient ID: MTS-T0243\n",
      "Age at Diagnosis: 70.24\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 121.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2137:\n",
      "Patient ID: MTS-T0244\n",
      "Age at Diagnosis: 63.07\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.74\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 120.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2138:\n",
      "Patient ID: MTS-T0245\n",
      "Age at Diagnosis: 57.43\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2139:\n",
      "Patient ID: MTS-T0246\n",
      "Age at Diagnosis: 86.4\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.74\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 43.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2140:\n",
      "Patient ID: MTS-T0247\n",
      "Age at Diagnosis: 35.01\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 121.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2141:\n",
      "Patient ID: MTS-T0248\n",
      "Age at Diagnosis: 76.34\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.64\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 103.09\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2142:\n",
      "Patient ID: MTS-T0249\n",
      "Age at Diagnosis: 46.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 111.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2143:\n",
      "Patient ID: MTS-T0250\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2144:\n",
      "Patient ID: MTS-T0251\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2145:\n",
      "Patient ID: MTS-T0252\n",
      "Age at Diagnosis: 68.83\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.48\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 106.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2146:\n",
      "Patient ID: MTS-T0253\n",
      "Age at Diagnosis: 40.86\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.82\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 138.65\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 41.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2147:\n",
      "Patient ID: MTS-T0254\n",
      "Age at Diagnosis: 69.75\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.34\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 36.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2148:\n",
      "Patient ID: MTS-T0255\n",
      "Age at Diagnosis: 69.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.62\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 98.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2149:\n",
      "Patient ID: MTS-T0256\n",
      "Age at Diagnosis: 63.58\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 17.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2150:\n",
      "Patient ID: MTS-T0257\n",
      "Age at Diagnosis: 62.61\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 0.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2151:\n",
      "Patient ID: MTS-T0258\n",
      "Age at Diagnosis: 50.58\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.7\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 56.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2152:\n",
      "Patient ID: MTS-T0259\n",
      "Age at Diagnosis: 63.6\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 64.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2153:\n",
      "Patient ID: MTS-T0260\n",
      "Age at Diagnosis: 56.95\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 75.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2154:\n",
      "Patient ID: MTS-T0261\n",
      "Age at Diagnosis: 50.95\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.06\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 124.87\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 6.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2155:\n",
      "Patient ID: MTS-T0262\n",
      "Age at Diagnosis: 51.33\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 100.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2156:\n",
      "Patient ID: MTS-T0266\n",
      "Age at Diagnosis: 56.39\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 167.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.87\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2157:\n",
      "Patient ID: MTS-T0273\n",
      "Age at Diagnosis: 86.17\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.34\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 111.12\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2158:\n",
      "Patient ID: MTS-T0275\n",
      "Age at Diagnosis: 53.21\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 112.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2159:\n",
      "Patient ID: MTS-T0276\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.13\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 11.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2160:\n",
      "Patient ID: MTS-T0279\n",
      "Age at Diagnosis: 63.51\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.7\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 69.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2161:\n",
      "Patient ID: MTS-T0281\n",
      "Age at Diagnosis: 74.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 127.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2162:\n",
      "Patient ID: MTS-T0285\n",
      "Age at Diagnosis: 54.8\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.22\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 164.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2163:\n",
      "Patient ID: MTS-T0286\n",
      "Age at Diagnosis: 61.07\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.38\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 84.08\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2164:\n",
      "Patient ID: MTS-T0299\n",
      "Age at Diagnosis: 56.76\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 18.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.72\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 2.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2165:\n",
      "Patient ID: MTS-T0303\n",
      "Age at Diagnosis: 51.34\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 4.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2166:\n",
      "Patient ID: MTS-T0304\n",
      "Age at Diagnosis: 68.08\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.2\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 100.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2167:\n",
      "Patient ID: MTS-T0305\n",
      "Age at Diagnosis: 86.21\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 6.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 39.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2168:\n",
      "Patient ID: MTS-T0312\n",
      "Age at Diagnosis: 67.5\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 105.07\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2169:\n",
      "Patient ID: MTS-T0313\n",
      "Age at Diagnosis: 37.79\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.48\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 156.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2170:\n",
      "Patient ID: MTS-T0325\n",
      "Age at Diagnosis: 38.26\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.8\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 8.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2171:\n",
      "Patient ID: MTS-T0327\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.44\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 9.87\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2172:\n",
      "Patient ID: MTS-T0328\n",
      "Age at Diagnosis: 36.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.24\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 200.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2173:\n",
      "Patient ID: MTS-T0329\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 190.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2174:\n",
      "Patient ID: MTS-T0330\n",
      "Age at Diagnosis: 44.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 2.96\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2175:\n",
      "Patient ID: MTS-T0331\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.4\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 189.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2176:\n",
      "Patient ID: MTS-T0332\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 13.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2177:\n",
      "Patient ID: MTS-T0333\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 16.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2178:\n",
      "Patient ID: MTS-T0334\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.2\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 52.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2179:\n",
      "Patient ID: MTS-T0335\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.32\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 195.39\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2180:\n",
      "Patient ID: MTS-T0336\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.28\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 22.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2181:\n",
      "Patient ID: MTS-T0337\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 201.32\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2182:\n",
      "Patient ID: MTS-T0338\n",
      "Age at Diagnosis: 70.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 60.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2183:\n",
      "Patient ID: MTS-T0339\n",
      "Age at Diagnosis: 67.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.32\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 190.46\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2184:\n",
      "Patient ID: MTS-T0340\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 31.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 95.72\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2185:\n",
      "Patient ID: MTS-T0341\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.14\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 189.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 7.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2186:\n",
      "Patient ID: MTS-T0342\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.28\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 208.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2187:\n",
      "Patient ID: MTS-T0343\n",
      "Age at Diagnosis: 50.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.24\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 41.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2188:\n",
      "Patient ID: MTS-T0344\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.22\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 100.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2189:\n",
      "Patient ID: MTS-T0345\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.28\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 200.33\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2190:\n",
      "Patient ID: MTS-T0346\n",
      "Age at Diagnosis: 54.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.7\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 47.37\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2191:\n",
      "Patient ID: MTS-T0347\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 189.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2192:\n",
      "Patient ID: MTS-T0348\n",
      "Age at Diagnosis: 50.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 189.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2193:\n",
      "Patient ID: MTS-T0349\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.38\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 80.92\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2194:\n",
      "Patient ID: MTS-T0350\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.2\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 197.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2195:\n",
      "Patient ID: MTS-T0351\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.26\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 21.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2196:\n",
      "Patient ID: MTS-T0352\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 194.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2197:\n",
      "Patient ID: MTS-T0353\n",
      "Age at Diagnosis: 62.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.02\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 191.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 1.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2198:\n",
      "Patient ID: MTS-T0354\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.2\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 83.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2199:\n",
      "Patient ID: MTS-T0355\n",
      "Age at Diagnosis: 68.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.44\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 141.12\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2200:\n",
      "Patient ID: MTS-T0356\n",
      "Age at Diagnosis: 56.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.34\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 186.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2201:\n",
      "Patient ID: MTS-T0357\n",
      "Age at Diagnosis: 41.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 18.75\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2202:\n",
      "Patient ID: MTS-T0358\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.44\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 165.79\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2203:\n",
      "Patient ID: MTS-T0359\n",
      "Age at Diagnosis: 66.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.18\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 63.16\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2204:\n",
      "Patient ID: MTS-T0360\n",
      "Age at Diagnosis: 42.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.32\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 11.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2205:\n",
      "Patient ID: MTS-T0361\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.36\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 22.7\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2206:\n",
      "Patient ID: MTS-T0362\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 197.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2207:\n",
      "Patient ID: MTS-T0363\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.36\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 152.96\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2208:\n",
      "Patient ID: MTS-T0364\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 2.34\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 168.75\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2209:\n",
      "Patient ID: MTS-T0365\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 179.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2210:\n",
      "Patient ID: MTS-T0366\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.48\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2211:\n",
      "Patient ID: MTS-T0367\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 185.53\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2212:\n",
      "Patient ID: MTS-T0368\n",
      "Age at Diagnosis: 54.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 202.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2213:\n",
      "Patient ID: MTS-T0369\n",
      "Age at Diagnosis: 32.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 89.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2214:\n",
      "Patient ID: MTS-T0370\n",
      "Age at Diagnosis: 56.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.44\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 109.54\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2215:\n",
      "Patient ID: MTS-T0371\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 190.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2216:\n",
      "Patient ID: MTS-T0372\n",
      "Age at Diagnosis: 67.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 73.03\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2217:\n",
      "Patient ID: MTS-T0373\n",
      "Age at Diagnosis: 55.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.74\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 27.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 37.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2218:\n",
      "Patient ID: MTS-T0374\n",
      "Age at Diagnosis: 66.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.26\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 29.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2219:\n",
      "Patient ID: MTS-T0375\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Tubular/ cribriform\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 2.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 181.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2220:\n",
      "Patient ID: MTS-T0376\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 6.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 6.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2221:\n",
      "Patient ID: MTS-T0377\n",
      "Age at Diagnosis: 68.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.34\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 173.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2222:\n",
      "Patient ID: MTS-T0378\n",
      "Age at Diagnosis: 40.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 196.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2223:\n",
      "Patient ID: MTS-T0379\n",
      "Age at Diagnosis: 40.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.34\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 153.95\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2224:\n",
      "Patient ID: MTS-T0380\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 96.71\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2225:\n",
      "Patient ID: MTS-T0381\n",
      "Age at Diagnosis: 67.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 190.46\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2226:\n",
      "Patient ID: MTS-T0382\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 186.51\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2227:\n",
      "Patient ID: MTS-T0383\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.42\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 179.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2228:\n",
      "Patient ID: MTS-T0384\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.34\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 112.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2229:\n",
      "Patient ID: MTS-T0385\n",
      "Age at Diagnosis: 66.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.28\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 176.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2230:\n",
      "Patient ID: MTS-T0386\n",
      "Age at Diagnosis: 69.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.54\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 156.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2231:\n",
      "Patient ID: MTS-T0387\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.2\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 140.13\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2232:\n",
      "Patient ID: MTS-T0388\n",
      "Age at Diagnosis: 63.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 4.12\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 175.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 6.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2233:\n",
      "Patient ID: MTS-T0389\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 98.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2234:\n",
      "Patient ID: MTS-T0390\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.9\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 19.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2235:\n",
      "Patient ID: MTS-T0391\n",
      "Age at Diagnosis: 69.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.52\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 162.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2236:\n",
      "Patient ID: MTS-T0392\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 177.63\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2237:\n",
      "Patient ID: MTS-T0393\n",
      "Age at Diagnosis: 62.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 171.71\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2238:\n",
      "Patient ID: MTS-T0394\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 2.2\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 183.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2239:\n",
      "Patient ID: MTS-T0395\n",
      "Age at Diagnosis: 66.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 2.2\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 187.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2240:\n",
      "Patient ID: MTS-T0396\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 191.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2241:\n",
      "Patient ID: MTS-T0397\n",
      "Age at Diagnosis: 69.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 3.6\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 131.25\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2242:\n",
      "Patient ID: MTS-T0398\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 176.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2243:\n",
      "Patient ID: MTS-T0399\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 179.61\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2244:\n",
      "Patient ID: MTS-T0400\n",
      "Age at Diagnosis: 69.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 178.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2245:\n",
      "Patient ID: MTS-T0401\n",
      "Age at Diagnosis: 62.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 153.95\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2246:\n",
      "Patient ID: MTS-T0402\n",
      "Age at Diagnosis: 59.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.54\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 182.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2247:\n",
      "Patient ID: MTS-T0403\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 54.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2248:\n",
      "Patient ID: MTS-T0404\n",
      "Age at Diagnosis: 68.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.3\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 182.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2249:\n",
      "Patient ID: MTS-T0405\n",
      "Age at Diagnosis: 55.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 115.46\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2250:\n",
      "Patient ID: MTS-T0406\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 71.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2251:\n",
      "Patient ID: MTS-T0407\n",
      "Age at Diagnosis: 55.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 6.44\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 54.28\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2252:\n",
      "Patient ID: MTS-T0408\n",
      "Age at Diagnosis: 68.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 8.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.18\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 79.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2253:\n",
      "Patient ID: MTS-T0409\n",
      "Age at Diagnosis: 41.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2254:\n",
      "Patient ID: MTS-T0456\n",
      "Age at Diagnosis: 53.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 3.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 188.62\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2255:\n",
      "Patient ID: MTS-T0466\n",
      "Age at Diagnosis: 47.88\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 6.22\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 31.61\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 61.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2256:\n",
      "Patient ID: MTS-T0468\n",
      "Age at Diagnosis: 81.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 106.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2257:\n",
      "Patient ID: MTS-T0479\n",
      "Age at Diagnosis: 57.07\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 14.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.48\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 16.58\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2258:\n",
      "Patient ID: MTS-T0490\n",
      "Age at Diagnosis: 74.13\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.42\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 185.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2259:\n",
      "Patient ID: MTS-T0508\n",
      "Age at Diagnosis: 74.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 39.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2260:\n",
      "Patient ID: MTS-T0510\n",
      "Age at Diagnosis: 32.87\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 7.2\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 233.95\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2261:\n",
      "Patient ID: MTS-T0515\n",
      "Age at Diagnosis: 70.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.24\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 185.23\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2262:\n",
      "Patient ID: MTS-T0516\n",
      "Age at Diagnosis: 65.66\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 188.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2263:\n",
      "Patient ID: MTS-T0525\n",
      "Age at Diagnosis: 51.66\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 189.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2264:\n",
      "Patient ID: MTS-T0528\n",
      "Age at Diagnosis: 81.33\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 134.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 65.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2265:\n",
      "Patient ID: MTS-T0558\n",
      "Age at Diagnosis: 72.01\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 123.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2266:\n",
      "Patient ID: MTS-T0600\n",
      "Age at Diagnosis: 67.42\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 201.22\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2267:\n",
      "Patient ID: MTS-T0602\n",
      "Age at Diagnosis: 56.88\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 41.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2268:\n",
      "Patient ID: MTS-T0646\n",
      "Age at Diagnosis: 63.54\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: 4.68\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 181.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2269:\n",
      "Patient ID: MTS-T0652\n",
      "Age at Diagnosis: 59.27\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 201.58\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2270:\n",
      "Patient ID: MTS-T0673\n",
      "Age at Diagnosis: 65.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.28\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 42.24\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2271:\n",
      "Patient ID: MTS-T0685\n",
      "Age at Diagnosis: 63.25\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.7\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 8.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2272:\n",
      "Patient ID: MTS-T0689\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2273:\n",
      "Patient ID: MTS-T0690\n",
      "Age at Diagnosis: 54.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2274:\n",
      "Patient ID: MTS-T0691\n",
      "Age at Diagnosis: 39.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2275:\n",
      "Patient ID: MTS-T0692\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2276:\n",
      "Patient ID: MTS-T0693\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2277:\n",
      "Patient ID: MTS-T0694\n",
      "Age at Diagnosis: 35.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2278:\n",
      "Patient ID: MTS-T0695\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2279:\n",
      "Patient ID: MTS-T0696\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2280:\n",
      "Patient ID: MTS-T0697\n",
      "Age at Diagnosis: 53.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2281:\n",
      "Patient ID: MTS-T0698\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2282:\n",
      "Patient ID: MTS-T0699\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2283:\n",
      "Patient ID: MTS-T0700\n",
      "Age at Diagnosis: 36.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2284:\n",
      "Patient ID: MTS-T0701\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2285:\n",
      "Patient ID: MTS-T0702\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2286:\n",
      "Patient ID: MTS-T0703\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2287:\n",
      "Patient ID: MTS-T0704\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2288:\n",
      "Patient ID: MTS-T0705\n",
      "Age at Diagnosis: 34.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2289:\n",
      "Patient ID: MTS-T0706\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2290:\n",
      "Patient ID: MTS-T0707\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2291:\n",
      "Patient ID: MTS-T0708\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2292:\n",
      "Patient ID: MTS-T0709\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2293:\n",
      "Patient ID: MTS-T0710\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2294:\n",
      "Patient ID: MTS-T0711\n",
      "Age at Diagnosis: 56.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2295:\n",
      "Patient ID: MTS-T0712\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2296:\n",
      "Patient ID: MTS-T0713\n",
      "Age at Diagnosis: 50.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2297:\n",
      "Patient ID: MTS-T0714\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2298:\n",
      "Patient ID: MTS-T0715\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2299:\n",
      "Patient ID: MTS-T0716\n",
      "Age at Diagnosis: 36.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2300:\n",
      "Patient ID: MTS-T0717\n",
      "Age at Diagnosis: 42.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2301:\n",
      "Patient ID: MTS-T0718\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2302:\n",
      "Patient ID: MTS-T0719\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2303:\n",
      "Patient ID: MTS-T0720\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2304:\n",
      "Patient ID: MTS-T0721\n",
      "Age at Diagnosis: 39.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2305:\n",
      "Patient ID: MTS-T0722\n",
      "Age at Diagnosis: 45.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2306:\n",
      "Patient ID: MTS-T0723\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2307:\n",
      "Patient ID: MTS-T0724\n",
      "Age at Diagnosis: 43.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2308:\n",
      "Patient ID: MTS-T0725\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2309:\n",
      "Patient ID: MTS-T0726\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2310:\n",
      "Patient ID: MTS-T0737\n",
      "Age at Diagnosis: 59.18\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2311:\n",
      "Patient ID: MTS-T0788\n",
      "Age at Diagnosis: 62.72\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 81.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2312:\n",
      "Patient ID: MTS-T0824\n",
      "Age at Diagnosis: 74.7\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.64\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.42\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 32.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2313:\n",
      "Patient ID: MTS-T0877\n",
      "Age at Diagnosis: 78.94\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 7.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 24.41\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 55.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2314:\n",
      "Patient ID: MTS-T0883\n",
      "Age at Diagnosis: 74.41\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 223.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2315:\n",
      "Patient ID: MTS-T0911\n",
      "Age at Diagnosis: 64.33\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.29\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2316:\n",
      "Patient ID: MTS-T0927\n",
      "Age at Diagnosis: 73.15\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 107.66\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2317:\n",
      "Patient ID: MTS-T0951\n",
      "Age at Diagnosis: 61.18\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 202.3\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2318:\n",
      "Patient ID: MTS-T1000\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2319:\n",
      "Patient ID: MTS-T1020\n",
      "Age at Diagnosis: 62.45\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 196.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2320:\n",
      "Patient ID: MTS-T1047\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2321:\n",
      "Patient ID: MTS-T1088\n",
      "Age at Diagnosis: 52.12\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.52\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 123.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2322:\n",
      "Patient ID: MTS-T1134\n",
      "Age at Diagnosis: 62.97\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 19.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 6.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 7.11\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 130.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2323:\n",
      "Patient ID: MTS-T1138\n",
      "Age at Diagnosis: 69.63\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 86.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.6\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2324:\n",
      "Patient ID: MTS-T1161\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2325:\n",
      "Patient ID: MTS-T1185\n",
      "Age at Diagnosis: 76.32\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.22\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 92.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 11.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2326:\n",
      "Patient ID: MTS-T1189\n",
      "Age at Diagnosis: 70.6\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 176.15\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 24.05\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2327:\n",
      "Patient ID: MTS-T1191\n",
      "Age at Diagnosis: 55.07\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 35.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2328:\n",
      "Patient ID: MTS-T1203\n",
      "Age at Diagnosis: 36.95\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.18\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 38.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2329:\n",
      "Patient ID: MTS-T1213\n",
      "Age at Diagnosis: 50.92\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 18.22\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 1.7\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2330:\n",
      "Patient ID: MTS-T1223\n",
      "Age at Diagnosis: 50.01\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 74.51\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.3\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2331:\n",
      "Patient ID: MTS-T1240\n",
      "Age at Diagnosis: 57.94\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.68\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 2.2\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 34.0\n",
      "Tumor Stage: 4.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2332:\n",
      "Patient ID: MTS-T1248\n",
      "Age at Diagnosis: 32.69\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Medullary\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 14.87\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.4\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2333:\n",
      "Patient ID: MTS-T1259\n",
      "Age at Diagnosis: 42.39\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 210.1\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2334:\n",
      "Patient ID: MTS-T1264\n",
      "Age at Diagnosis: 46.5\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 7.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 162.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2335:\n",
      "Patient ID: MTS-T1269\n",
      "Age at Diagnosis: 86.16\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 28.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2336:\n",
      "Patient ID: MTS-T1270\n",
      "Age at Diagnosis: 79.9\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 4.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 7.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 11.94\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2337:\n",
      "Patient ID: MTS-T1272\n",
      "Age at Diagnosis: 53.69\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 113.36\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2338:\n",
      "Patient ID: MTS-T1273\n",
      "Age at Diagnosis: 73.89\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.02\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 139.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2339:\n",
      "Patient ID: MTS-T1275\n",
      "Age at Diagnosis: 82.84\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.28\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 101.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2340:\n",
      "Patient ID: MTS-T1276\n",
      "Age at Diagnosis: 82.49\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 7.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 6.5\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 27.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2341:\n",
      "Patient ID: MTS-T1277\n",
      "Age at Diagnosis: 59.91\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 4.28\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 90.1\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2342:\n",
      "Patient ID: MTS-T1278\n",
      "Age at Diagnosis: 69.47\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.46\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 123.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2343:\n",
      "Patient ID: MTS-T1279\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2344:\n",
      "Patient ID: MTS-T1280\n",
      "Age at Diagnosis: 59.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2345:\n",
      "Patient ID: MTS-T1281\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2346:\n",
      "Patient ID: MTS-T1282\n",
      "Age at Diagnosis: 31.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2347:\n",
      "Patient ID: MTS-T1283\n",
      "Age at Diagnosis: 65.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2348:\n",
      "Patient ID: MTS-T1284\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 35.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2349:\n",
      "Patient ID: MTS-T1285\n",
      "Age at Diagnosis: 62.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2350:\n",
      "Patient ID: MTS-T1286\n",
      "Age at Diagnosis: 51.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 16.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2351:\n",
      "Patient ID: MTS-T1287\n",
      "Age at Diagnosis: 57.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2352:\n",
      "Patient ID: MTS-T1288\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2353:\n",
      "Patient ID: MTS-T1289\n",
      "Age at Diagnosis: 46.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2354:\n",
      "Patient ID: MTS-T1290\n",
      "Age at Diagnosis: 64.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2355:\n",
      "Patient ID: MTS-T1291\n",
      "Age at Diagnosis: 47.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2356:\n",
      "Patient ID: MTS-T1292\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2357:\n",
      "Patient ID: MTS-T1293\n",
      "Age at Diagnosis: 56.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2358:\n",
      "Patient ID: MTS-T1294\n",
      "Age at Diagnosis: 37.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2359:\n",
      "Patient ID: MTS-T1295\n",
      "Age at Diagnosis: 37.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2360:\n",
      "Patient ID: MTS-T1296\n",
      "Age at Diagnosis: 37.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2361:\n",
      "Patient ID: MTS-T1297\n",
      "Age at Diagnosis: 55.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2362:\n",
      "Patient ID: MTS-T1298\n",
      "Age at Diagnosis: 37.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2363:\n",
      "Patient ID: MTS-T1299\n",
      "Age at Diagnosis: 60.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2364:\n",
      "Patient ID: MTS-T1300\n",
      "Age at Diagnosis: 49.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2365:\n",
      "Patient ID: MTS-T1301\n",
      "Age at Diagnosis: 40.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2366:\n",
      "Patient ID: MTS-T1302\n",
      "Age at Diagnosis: 42.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2367:\n",
      "Patient ID: MTS-T1303\n",
      "Age at Diagnosis: 30.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2368:\n",
      "Patient ID: MTS-T1304\n",
      "Age at Diagnosis: 42.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2369:\n",
      "Patient ID: MTS-T1305\n",
      "Age at Diagnosis: 41.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2370:\n",
      "Patient ID: MTS-T1306\n",
      "Age at Diagnosis: 58.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2371:\n",
      "Patient ID: MTS-T1307\n",
      "Age at Diagnosis: 55.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2372:\n",
      "Patient ID: MTS-T1308\n",
      "Age at Diagnosis: 40.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2373:\n",
      "Patient ID: MTS-T1309\n",
      "Age at Diagnosis: 27.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2374:\n",
      "Patient ID: MTS-T1310\n",
      "Age at Diagnosis: 32.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2375:\n",
      "Patient ID: MTS-T1311\n",
      "Age at Diagnosis: 36.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2376:\n",
      "Patient ID: MTS-T1312\n",
      "Age at Diagnosis: 59.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2377:\n",
      "Patient ID: MTS-T1313\n",
      "Age at Diagnosis: 61.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2378:\n",
      "Patient ID: MTS-T1314\n",
      "Age at Diagnosis: 69.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 7.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: nan\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2379:\n",
      "Patient ID: MTS-T1326\n",
      "Age at Diagnosis: 70.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.42\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 84.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2380:\n",
      "Patient ID: MTS-T1329\n",
      "Age at Diagnosis: 68.48\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.28\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 171.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 14.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2381:\n",
      "Patient ID: MTS-T1366\n",
      "Age at Diagnosis: 73.78\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.42\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 72.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2382:\n",
      "Patient ID: MTS-T1454\n",
      "Age at Diagnosis: 60.98\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.2\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 252.53\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2383:\n",
      "Patient ID: MTS-T1501\n",
      "Age at Diagnosis: 86.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.19\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2384:\n",
      "Patient ID: MTS-T1502\n",
      "Age at Diagnosis: 54.82\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 40.49\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2385:\n",
      "Patient ID: MTS-T1503\n",
      "Age at Diagnosis: 44.11\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 5.8\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 297.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2386:\n",
      "Patient ID: MTS-T1504\n",
      "Age at Diagnosis: 51.7\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 259.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2387:\n",
      "Patient ID: MTS-T1514\n",
      "Age at Diagnosis: 76.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.2\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 67.4\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2388:\n",
      "Patient ID: MTS-T1515\n",
      "Age at Diagnosis: 40.94\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 15.59\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2389:\n",
      "Patient ID: MTS-T1516\n",
      "Age at Diagnosis: 43.89\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.6\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 10.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2390:\n",
      "Patient ID: MTS-T1517\n",
      "Age at Diagnosis: 61.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 302.83\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2391:\n",
      "Patient ID: MTS-T1522\n",
      "Age at Diagnosis: 81.59\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 73.91\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 60.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2392:\n",
      "Patient ID: MTS-T1525\n",
      "Age at Diagnosis: 76.18\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 137.5\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2393:\n",
      "Patient ID: MTS-T1526\n",
      "Age at Diagnosis: 35.45\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 269.34\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2394:\n",
      "Patient ID: MTS-T1527\n",
      "Age at Diagnosis: 64.51\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.42\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 289.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2395:\n",
      "Patient ID: MTS-T1537\n",
      "Age at Diagnosis: 71.88\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 118.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2396:\n",
      "Patient ID: MTS-T1548\n",
      "Age at Diagnosis: 37.09\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 11.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 230.49\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2397:\n",
      "Patient ID: MTS-T1549\n",
      "Age at Diagnosis: 57.41\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.36\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 277.47\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2398:\n",
      "Patient ID: MTS-T1560\n",
      "Age at Diagnosis: 53.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 53.42\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2399:\n",
      "Patient ID: MTS-T1561\n",
      "Age at Diagnosis: 65.04\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 71.78\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2400:\n",
      "Patient ID: MTS-T1571\n",
      "Age at Diagnosis: 78.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: 5.8\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 108.98\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2401:\n",
      "Patient ID: MTS-T1576\n",
      "Age at Diagnosis: 46.14\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 20.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.26\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 162.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2402:\n",
      "Patient ID: MTS-T1582\n",
      "Age at Diagnosis: 71.74\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 8.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 6.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 11.74\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2403:\n",
      "Patient ID: MTS-T1583\n",
      "Age at Diagnosis: 78.27\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 5.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 42.5\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2404:\n",
      "Patient ID: MTS-T1605\n",
      "Age at Diagnosis: 70.68\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.9\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 7.6\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2405:\n",
      "Patient ID: MTS-T1616\n",
      "Age at Diagnosis: 71.2\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 45.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2406:\n",
      "Patient ID: MTS-T1633\n",
      "Age at Diagnosis: 29.96\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 12.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2407:\n",
      "Patient ID: MTS-T1659\n",
      "Age at Diagnosis: 73.84\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 14.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 56.05\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2408:\n",
      "Patient ID: MTS-T1706\n",
      "Age at Diagnosis: 63.02\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.44\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 192.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2409:\n",
      "Patient ID: MTS-T1774\n",
      "Age at Diagnosis: 60.55\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 113.52\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.5\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2410:\n",
      "Patient ID: MTS-T1800\n",
      "Age at Diagnosis: 54.27\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 15.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 172.99\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2411:\n",
      "Patient ID: MTS-T1829\n",
      "Age at Diagnosis: 78.29\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 26.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2412:\n",
      "Patient ID: MTS-T1847\n",
      "Age at Diagnosis: 75.92\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 91.48\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2413:\n",
      "Patient ID: MTS-T1865\n",
      "Age at Diagnosis: 82.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 61.02\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2414:\n",
      "Patient ID: MTS-T1872\n",
      "Age at Diagnosis: 37.22\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 12.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2415:\n",
      "Patient ID: MTS-T1922\n",
      "Age at Diagnosis: 42.85\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.9\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 320.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2416:\n",
      "Patient ID: MTS-T1945\n",
      "Age at Diagnosis: 63.72\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.8\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 118.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2417:\n",
      "Patient ID: MTS-T1954\n",
      "Age at Diagnosis: 67.7\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2418:\n",
      "Patient ID: MTS-T1962\n",
      "Age at Diagnosis: 54.02\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.24\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 12.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2419:\n",
      "Patient ID: MTS-T1971\n",
      "Age at Diagnosis: 76.7\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 71.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2420:\n",
      "Patient ID: MTS-T1973\n",
      "Age at Diagnosis: 75.3\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.78\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 94.74\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 39.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2421:\n",
      "Patient ID: MTS-T1983\n",
      "Age at Diagnosis: 86.69\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.56\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 30.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2422:\n",
      "Patient ID: MTS-T1985\n",
      "Age at Diagnosis: 62.8\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.9\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 25.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2423:\n",
      "Patient ID: MTS-T1991\n",
      "Age at Diagnosis: 73.51\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.32\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 58.68\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 16.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2424:\n",
      "Patient ID: MTS-T2018\n",
      "Age at Diagnosis: 71.97\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Other\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BREAST\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 88.78\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 12.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2425:\n",
      "Patient ID: MTS-T2030\n",
      "Age at Diagnosis: 32.95\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.6\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 46.41\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2426:\n",
      "Patient ID: MTS-T2031\n",
      "Age at Diagnosis: 50.69\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 104.14\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2427:\n",
      "Patient ID: MTS-T2043\n",
      "Age at Diagnosis: 47.47\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 81.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 43.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2428:\n",
      "Patient ID: MTS-T2044\n",
      "Age at Diagnosis: 81.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 2.54\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 91.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2429:\n",
      "Patient ID: MTS-T2047\n",
      "Age at Diagnosis: 51.29\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.26\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 179.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2430:\n",
      "Patient ID: MTS-T2053\n",
      "Age at Diagnosis: 62.91\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 27.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2431:\n",
      "Patient ID: MTS-T2054\n",
      "Age at Diagnosis: 42.08\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 3.7\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 74.21\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2432:\n",
      "Patient ID: MTS-T2055\n",
      "Age at Diagnosis: 45.99\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 332.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2433:\n",
      "Patient ID: MTS-T2064\n",
      "Age at Diagnosis: 48.49\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.8\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 359.08\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2434:\n",
      "Patient ID: MTS-T2065\n",
      "Age at Diagnosis: 59.35\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 384.21\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2435:\n",
      "Patient ID: MTS-T2066\n",
      "Age at Diagnosis: 40.87\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.34\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 52.3\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2436:\n",
      "Patient ID: MTS-T2068\n",
      "Age at Diagnosis: 70.92\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.16\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 11.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 58.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2437:\n",
      "Patient ID: MTS-T2073\n",
      "Age at Diagnosis: 67.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 3.4\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 63.91\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2438:\n",
      "Patient ID: MTS-T2074\n",
      "Age at Diagnosis: 69.72\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 26.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2439:\n",
      "Patient ID: MTS-T2075\n",
      "Age at Diagnosis: 69.58\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 1.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2440:\n",
      "Patient ID: MTS-T2076\n",
      "Age at Diagnosis: 47.87\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 370.03\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2441:\n",
      "Patient ID: MTS-T2083\n",
      "Age at Diagnosis: 59.42\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 120.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2442:\n",
      "Patient ID: MTS-T2084\n",
      "Age at Diagnosis: 46.21\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.7\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 9.34\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2443:\n",
      "Patient ID: MTS-T2085\n",
      "Age at Diagnosis: 77.97\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 56.84\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2444:\n",
      "Patient ID: MTS-T2086\n",
      "Age at Diagnosis: 28.83\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.42\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 326.32\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 21.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2445:\n",
      "Patient ID: MTS-T2087\n",
      "Age at Diagnosis: 44.04\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 26.45\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2446:\n",
      "Patient ID: MTS-T2090\n",
      "Age at Diagnosis: 81.42\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 5.0\n",
      "Mutation Count: 18.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 75.59\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2447:\n",
      "Patient ID: MTS-T2094\n",
      "Age at Diagnosis: 52.11\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.5\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 9.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2448:\n",
      "Patient ID: MTS-T2095\n",
      "Age at Diagnosis: 55.17\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: 5.0\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 98.85\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2449:\n",
      "Patient ID: MTS-T2096\n",
      "Age at Diagnosis: 57.19\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 13.82\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2450:\n",
      "Patient ID: MTS-T2097\n",
      "Age at Diagnosis: 66.83\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 9.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 6.9\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 17.43\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 45.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2451:\n",
      "Patient ID: MTS-T2104\n",
      "Age at Diagnosis: 66.74\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 4.8\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 119.01\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2452:\n",
      "Patient ID: MTS-T2105\n",
      "Age at Diagnosis: 77.09\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 11.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 9.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2453:\n",
      "Patient ID: MTS-T2106\n",
      "Age at Diagnosis: 53.73\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.4\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 65.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2454:\n",
      "Patient ID: MTS-T2107\n",
      "Age at Diagnosis: 67.01\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 118.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2455:\n",
      "Patient ID: MTS-T2115\n",
      "Age at Diagnosis: 57.83\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.6\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 27.83\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2456:\n",
      "Patient ID: MTS-T2116\n",
      "Age at Diagnosis: 60.02\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 166.64\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2457:\n",
      "Patient ID: MTS-T2117\n",
      "Age at Diagnosis: 52.25\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 19.57\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2458:\n",
      "Patient ID: MTS-T2118\n",
      "Age at Diagnosis: 50.39\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Mixed Ductal and Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mixed\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 12.0\n",
      "Mutation Count: 13.0\n",
      "Nottingham prognostic index: 6.4\n",
      "Oncotree Code: MDLC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 8.45\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2459:\n",
      "Patient ID: MTS-T2126\n",
      "Age at Diagnosis: 72.64\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.3\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 54.97\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2460:\n",
      "Patient ID: MTS-T2127\n",
      "Age at Diagnosis: 72.9\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.6\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 33.19\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 30.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2461:\n",
      "Patient ID: MTS-T2128\n",
      "Age at Diagnosis: 45.24\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 54.8\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2462:\n",
      "Patient ID: MTS-T2129\n",
      "Age at Diagnosis: 62.36\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 1.02\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2463:\n",
      "Patient ID: MTS-T2150\n",
      "Age at Diagnosis: 64.69\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 6.44\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 130.26\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 3.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2464:\n",
      "Patient ID: MTS-T2153\n",
      "Age at Diagnosis: 67.57\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 4.44\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 25.92\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2465:\n",
      "Patient ID: MTS-T2167\n",
      "Age at Diagnosis: 73.59\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 198.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2466:\n",
      "Patient ID: MTS-T2178\n",
      "Age at Diagnosis: 61.47\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 3.46\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 192.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2467:\n",
      "Patient ID: MTS-T2189\n",
      "Age at Diagnosis: 52.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.44\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 30.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 22.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2468:\n",
      "Patient ID: MTS-T2190\n",
      "Age at Diagnosis: 47.6\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.46\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.07\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2469:\n",
      "Patient ID: MTS-T2191\n",
      "Age at Diagnosis: 35.78\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.46\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 200.33\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2470:\n",
      "Patient ID: MTS-T2206\n",
      "Age at Diagnosis: 43.39\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 6.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 194.87\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2471:\n",
      "Patient ID: MTS-T2212\n",
      "Age at Diagnosis: 73.45\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 149.77\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 70.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2472:\n",
      "Patient ID: MTS-T2291\n",
      "Age at Diagnosis: 55.06\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.8\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.68\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 40.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2473:\n",
      "Patient ID: MTS-T2304\n",
      "Age at Diagnosis: 33.96\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.5\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 198.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2474:\n",
      "Patient ID: MTS-T2320\n",
      "Age at Diagnosis: 47.28\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 3.5\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 225.99\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2475:\n",
      "Patient ID: MTS-T2391\n",
      "Age at Diagnosis: 45.33\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.026\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 34.05\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 13.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2476:\n",
      "Patient ID: MTS-T2392\n",
      "Age at Diagnosis: 43.04\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 5.16\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 201.55\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 80.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2477:\n",
      "Patient ID: MTS-T2393\n",
      "Age at Diagnosis: 59.5\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 160.23\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2478:\n",
      "Patient ID: MTS-T2398\n",
      "Age at Diagnosis: 58.7\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 10.0\n",
      "Nottingham prognostic index: 4.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 52.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2479:\n",
      "Patient ID: MTS-T2402\n",
      "Age at Diagnosis: 72.88\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 95.79\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2480:\n",
      "Patient ID: MTS-T2403\n",
      "Age at Diagnosis: 77.31\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 15.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 5.1\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 57.53\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 50.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2481:\n",
      "Patient ID: MTS-T2404\n",
      "Age at Diagnosis: 55.77\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 249.57\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2482:\n",
      "Patient ID: MTS-T2405\n",
      "Age at Diagnosis: 68.08\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 2.3\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 92.93\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2483:\n",
      "Patient ID: MTS-T2406\n",
      "Age at Diagnosis: 71.38\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 155.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2484:\n",
      "Patient ID: MTS-T2407\n",
      "Age at Diagnosis: 28.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 5.07\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 23.26\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 35.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2485:\n",
      "Patient ID: MTS-T2408\n",
      "Age at Diagnosis: 66.53\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.04\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 240.95\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2486:\n",
      "Patient ID: MTS-T2409\n",
      "Age at Diagnosis: 73.81\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 120.89\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2487:\n",
      "Patient ID: MTS-T2410\n",
      "Age at Diagnosis: 36.04\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 12.0\n",
      "Nottingham prognostic index: 5.05\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 42.7\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 25.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2488:\n",
      "Patient ID: MTS-T2412\n",
      "Age at Diagnosis: 65.45\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 5.052\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 85.86\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 26.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2489:\n",
      "Patient ID: MTS-T2413\n",
      "Age at Diagnosis: 64.94\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 3.03\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 123.42\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2490:\n",
      "Patient ID: MTS-T2414\n",
      "Age at Diagnosis: 63.22\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Lobular Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Lobular\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 9.0\n",
      "Nottingham prognostic index: 4.04\n",
      "Oncotree Code: ILC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 176.38\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2491:\n",
      "Patient ID: MTS-T2415\n",
      "Age at Diagnosis: 83.32\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Mixed Mucinous Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Mucinous\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 2.04\n",
      "Oncotree Code: IMMC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 146.84\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 20.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2492:\n",
      "Patient ID: MTS-T2416\n",
      "Age at Diagnosis: 64.08\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 4.006\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 31.38\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 3.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2493:\n",
      "Patient ID: MTS-T2417\n",
      "Age at Diagnosis: 46.52\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 188.88\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 10.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2494:\n",
      "Patient ID: MTS-T2418\n",
      "Age at Diagnosis: 52.93\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 1.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 155.76\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 17.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2495:\n",
      "Patient ID: MTS-T2419\n",
      "Age at Diagnosis: 63.16\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 1.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: 3.3\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 60.36\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 15.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2496:\n",
      "Patient ID: MTS-T2420\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2497:\n",
      "Patient ID: MTS-T2421\n",
      "Age at Diagnosis: 82.56\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 3.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: 5.36\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 182.37\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 18.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2498:\n",
      "Patient ID: MTS-T2422\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2499:\n",
      "Patient ID: MTS-T2423\n",
      "Age at Diagnosis: 76.22\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 8.0\n",
      "Nottingham prognostic index: 4.62\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 46.88\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 31.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2500:\n",
      "Patient ID: MTS-T2424\n",
      "Age at Diagnosis: 69.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 2.0\n",
      "Mutation Count: 3.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 55.63\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2501:\n",
      "Patient ID: MTS-T2425\n",
      "Age at Diagnosis: 72.0\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Breast Invasive Ductal Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 9.0\n",
      "ER status measured by IHC: Negative\n",
      "ER Status: Negative\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: Ductal/NST\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: IDC\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 54.9\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 23.0\n",
      "Tumor Stage: nan\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2502:\n",
      "Patient ID: MTS-T2426\n",
      "Age at Diagnosis: 64.35\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 3.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 4.38\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 72.76\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 19.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2503:\n",
      "Patient ID: MTS-T2427\n",
      "Age at Diagnosis: 67.58\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: nan\n",
      "Nottingham prognostic index: 2.18\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 62.43\n",
      "Relapse Free Status: Not Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 9.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2504:\n",
      "Patient ID: MTS-T2428\n",
      "Age at Diagnosis: 70.05\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 1.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 2.0\n",
      "Nottingham prognostic index: 2.54\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 4.93\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 27.0\n",
      "Tumor Stage: 1.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2505:\n",
      "Patient ID: MTS-T2429\n",
      "Age at Diagnosis: 63.6\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: 1.0\n",
      "ER status measured by IHC: Positve\n",
      "ER Status: Positive\n",
      "Neoplasm Histologic Grade: 2.0\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 4.0\n",
      "Nottingham prognostic index: 4.56\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): 16.18\n",
      "Relapse Free Status: Recurred\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: 28.0\n",
      "Tumor Stage: 2.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2506:\n",
      "Patient ID: MTS-T2430\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 6.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2507:\n",
      "Patient ID: MTS-T2431\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 7.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n",
      "Row 2508:\n",
      "Patient ID: MTS-T2432\n",
      "Age at Diagnosis: nan\n",
      "Type of Breast Surgery: nan\n",
      "Cancer Type: Breast Cancer\n",
      "Cancer Type Detailed: Invasive Breast Carcinoma\n",
      "Cellularity: nan\n",
      "Chemotherapy: nan\n",
      "Pam50 + Claudin-low subtype: nan\n",
      "Cohort: nan\n",
      "ER status measured by IHC: nan\n",
      "ER Status: nan\n",
      "Neoplasm Histologic Grade: nan\n",
      "HER2 status measured by SNP6: nan\n",
      "HER2 Status: nan\n",
      "Tumor Other Histologic Subtype: nan\n",
      "Hormone Therapy: nan\n",
      "Inferred Menopausal State: nan\n",
      "Integrative Cluster: nan\n",
      "Primary Tumor Laterality: nan\n",
      "Lymph nodes examined positive: 0.0\n",
      "Mutation Count: 5.0\n",
      "Nottingham prognostic index: nan\n",
      "Oncotree Code: BRCA\n",
      "Overall Survival (Months): nan\n",
      "Overall Survival Status: nan\n",
      "PR Status: nan\n",
      "Radio Therapy: nan\n",
      "Relapse Free Status (Months): nan\n",
      "Relapse Free Status: nan\n",
      "Sex: Female\n",
      "3-Gene classifier subtype: nan\n",
      "Tumor Size: nan\n",
      "Tumor Stage: 0.0\n",
      "Patient's Vital Status: nan\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Iterate through the rows and print column names with their corresponding values\n",
    "for index, row in df.iterrows():\n",
    "    print(f\"Row {index}:\")\n",
    "    for col_name, value in row.items():\n",
    "        print(f\"{col_name}: {value}\")\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "ab0f99ce",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of NaN values in 'Age' column: 721\n"
     ]
    }
   ],
   "source": [
    "# Count NaN values in a specific column, e.g., 'Age'\n",
    "nan_count = df['Tumor Stage'].isna().sum()\n",
    "\n",
    "print(f\"Number of NaN values in 'Age' column: {nan_count}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "a6283463",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The first unique value in 'Age' is: 75.65\n"
     ]
    }
   ],
   "source": [
    "# Remove duplicates and get the first unique value from the 'Age' column\n",
    "first_age_value = df['Age at Diagnosis'].drop_duplicates().iloc[0]\n",
    "\n",
    "print(f\"The first unique value in 'Age' is: {first_age_value}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "837268e3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0    75.65\n",
      "1    43.19\n",
      "2    48.87\n",
      "3    47.68\n",
      "4    76.97\n",
      "Name: Age, dtype: object\n"
     ]
    }
   ],
   "source": [
    "# Split the 'Age' values by comma and keep only the first value\n",
    "df['Age'] = df['Age at Diagnosis'].apply(lambda x: str(x).split(',')[0])\n",
    "\n",
    "# Now, get the first 5 rows of 'Age' to verify\n",
    "print(df['Age'].head())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "3fbb9947",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Convert 'Age' to numeric (if it's still string after split)\n",
    "df['Age at Diagnosis'] = pd.to_numeric(df['Age at Diagnosis'], errors='coerce')\n",
    "\n",
    "# Drop rows with NaN ages\n",
    "df = df.dropna(subset=['Age at Diagnosis'])\n",
    "\n",
    "# Create age bins (20-30, 30-40, ..., up to the max age in your data)\n",
    "bins = list(range(20, int(df['Age at Diagnosis'].max()) + 10, 10))\n",
    "labels = [f\"{i}-{i+10}\" for i in bins[:-1]]\n",
    "df['AgeGroup'] = pd.cut(df['Age at Diagnosis'], bins=bins, labels=labels, right=False)\n",
    "\n",
    "# Count values (number of people) in each age group\n",
    "age_group_counts = df['AgeGroup'].value_counts().sort_index()\n",
    "\n",
    "# Calculate percentages\n",
    "total = age_group_counts.sum()\n",
    "percentages = (age_group_counts / total) * 100\n",
    "\n",
    "# Plot bar chart with thinner bars (width=0.5)\n",
    "plt.figure(figsize=(10, 6))\n",
    "bars = plt.bar(age_group_counts.index.astype(str), percentages, color='skyblue', width=0.5)\n",
    "plt.title('Age Group Distribution')\n",
    "plt.ylabel('Percentage')\n",
    "plt.xlabel('Age Group')\n",
    "plt.xticks(rotation=45)\n",
    "\n",
    "# Add percentage text on top of each bar\n",
    "for bar, pct in zip(bars, percentages):\n",
    "    height = bar.get_height()\n",
    "    plt.text(bar.get_x() + bar.get_width() / 2, height + 0.5, f'{pct:.1f}%', \n",
    "             ha='center', va='bottom', fontsize=9)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "2dfa5699",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Md Shoaib\\AppData\\Local\\Temp\\ipykernel_15980\\976248869.py:13: FutureWarning: The default of observed=False is deprecated and will be changed to True in a future version of pandas. Pass observed=False to retain current behavior or observed=True to adopt the future default and silence this warning.\n",
      "  grouped = df.groupby(['AgeGroup', 'Tumor Stage']).size().unstack(fill_value=0)\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAdUAAAHqCAYAAABSldSPAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy88F64QAAAACXBIWXMAAA9hAAAPYQGoP6dpAABjcUlEQVR4nO3dd3xUVd4G8OdOn0kmvVNC6CABQhNQBEGIFCuiu6sCru6KDdHdtaCrq6+rq6676q7KroplFWzYEEWQJghI76GHEEpI721m7nn/CIkMaZMwM2fK8/XDx+Tmzr2/mczNM+fce89RhBACREREdME0sgsgIiIKFAxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJn4dqoqiuPRv9erVsku9IEIIfPTRRxg1ahTi4uJgMpnQsWNHpKen46233mpYr7KyEn/5y1/84vkeO3bM6Xek1+sRHR2NoUOH4oEHHsDevXsbPWb16tXt+n2+/vrrePfdd9v0mKb2NXPmTISGhrZpO61Zv349/vKXv6C4uLjRz8aMGYMxY8a4dX+uqP/dtPU1c9X1118PRVFw7733emT7bZWZmYnZs2ejT58+CAkJgclkQpcuXXDLLbdg1apVCJRB59566y0oitLse3jbtm244oorEBoaioiICFx//fU4evSoy9vv0qVLk39/Z82a1Wjd8vJyzJkzB0lJSTCZTBg4cCA++uijdj83nyL82IYNG5z+TZo0SZjN5kbLS0pKZJd6QR5++GEBQPzud78TX331lVi5cqV45513xK233iqmTJnSsF5eXp4AIJ588kl5xbooMzNTABD33Xef2LBhg/jpp5/EkiVLxDPPPCO6du0qtFqteOGFF5weU1JS0q7f50UXXSRGjx7dpsc0ta8ZM2aIkJCQNm2nNS+++KIAIDIzMxv9bO/evWLv3r1u3Z8rqqurxYYNG0Rubq7bt33mzBmh1+sFABERESGqqqrcvo+2+Oqrr0RISIhITk4Wzz33nPj+++/F6tWrxVtvvSWuvPJKAUD88MMPUmt0hxMnTojw8HCRlJTU5Hs4IyNDWK1WMWrUKLFkyRKxaNEicdFFF4mkpCSX3wfJycnikksuafT39+jRo43WHT9+vIiIiBDz5s0TK1euFHfccYcAID788MMLfq6y+XWons8Tf/S8pbKystnlRqNRTJ8+vcmfOxyOhq/9MVRffPHFRj+rrKxs+IP27bffXvC+2hKqtbW1wmazNfkzb4dqIKp/vpMnT5b+R/Tw4cPCYrGIoUOHNvtBbdWqVWLHjh0tbqeiosIT5bnVlClTxFVXXdXse3jatGkiJibG6XU4duyY0Ov14qGHHnJpH8nJyWLy5MmtrrdkyRIBQCxYsMBp+fjx40VSUpKw2+0u7c9XBXyoJicnixkzZjRad/To0U5/aFetWtVwkD/00EMiISFBhISEiClTpoicnBxRWloqfve734no6GgRHR0tZs6cKcrKypy2WVVVJR555BHRpUsXodfrRVJSkrj77rtFUVFRo5omT54sFi1aJAYOHCiMRqN4+OGHm3xO9UHZ3M/r1YfU+f/qn/uhQ4fEzJkzRffu3YXZbBZJSUliypQpYteuXY22tWfPHjF+/HhhNptFTEyMuPvuu8U333wjAIhVq1Y5rbt8+XIxduxYYbVahdlsFiNHjnTpk31LoSqEECdPnhR6vV5cfvnlDcvqf0fn1nDkyBFx0003icTERGEwGERcXJwYO3as2L59uxCi7rU+/zVJTk522t77778vHnzwQZGUlCQURREZGRlN7qv+/bVnzx4xduxYYbFYRExMjLjnnnuc/rDWP7d33nmn0fM690PPk08+2eTvrH6f579HhRCioKBA3HXXXSIpKUno9XqRkpIi5s6dK6qrqxvt55577hHvv/++6N27tzCbzaJ///5i8eLFzf9SWqi/vtY9e/aIX/3qVyIsLEzExcWJ2267TRQXF7e6zXp9+vQR8fHxIj8/X5jNZjFu3Lgm11u7dq0YPny4MBqNIikpSTz++OPizTffbPIDyEcffSSGDx8uLBaLCAkJERMmTBDbtm1rtZa7775bABCbN292uf7612Hr1q1i6tSpIiIiQiQkJAghXD/+m/vge/7fqnfeeUcAEMuWLRMzZ84UkZGRwmKxiClTpogjR464XPP//vc/YbVaRXZ2dpN/I202mzCbzeLOO+9s9NgJEyaIHj16uLQfV0P1jjvuEKGhoY0+vC5YsEAAED/99JNL+/NVOk90KfuzuXPn4vLLL8e7776LY8eO4Y9//CN+/etfQ6fTYcCAAVi4cCG2b9+OuXPnwmq14tVXXwVQd97z2muvxYoVK/Doo49i1KhR2LVrF5588kls2LABGzZsgNFobNjPtm3bkJGRgccffxwpKSkICQlpsp6YmBh0794dr7/+OuLi4jBp0iT06tULiqI4rZeYmIilS5fiyiuvxO2334477rgDABAbGwsAOHXqFKKjo/G3v/0NsbGxKCwsxHvvvYeLL74Y27dvR69evQAAp0+fxujRoxESEoI33ngDcXFxWLhwYZPnvz744ANMnz4d11xzDd577z3o9Xr85z//QXp6Or7//nuMGzeu3b+HpKQkDB48GOvXr4fdbodO1/RbddKkSXA4HHjhhRfQuXNn5OfnY/369Q3nKL/44gvccMMNCA8Px+uvvw4ATr8HAHj00UcxYsQIzJs3DxqNBnFxccjJyWlyfzabDZMmTcKdd96JRx55BOvXr8czzzyDrKwsLF68uE3P8Y477kBhYSH+9a9/4fPPP0diYiIAoG/fvk2uX11djcsvvxxHjhzBU089hf79+2Pt2rV47rnnsGPHDixZssRp/SVLlmDz5s14+umnERoaihdeeAHXXXcdDhw4gK5du7ap1npTp07FTTfdhNtvvx27d+/Go48+CgCYP39+q49dv349MjIy8Kc//QnR0dGYOnUqPvzwQ2RmZiIlJaVhvV27dmH8+PHo2bMn3nvvPVgsFsybNw8ffPBBo20+++yzePzxx3Hbbbfh8ccfR21tLV588UWMGjUKmzZtava1BIDly5cjMTERQ4YMafPrcP311+NXv/oVZs2ahYqKijYf/21x++23Y/z48ViwYAGys7Px+OOPY8yYMdi1axciIiJafGxubi7mzJmDv/3tb+jYsWOT6xw5cgRVVVXo379/o5/1798fy5cvR3V1NUwmU6u1/vjjj7BaraiurkaPHj1w++23Y86cOdBqtQ3r7NmzB3369Gl0TNfvf8+ePRg5cmSr+/JZslPdndzRUr3qqquc1pszZ44AIGbPnu20/NprrxVRUVEN3y9dulQAaHQe8OOPPxYAxH//+1+nmrRarThw4IBLz2vTpk2ic+fODS0Zq9UqpkyZIt5//32hqmrDem3p/rXb7aK2tlb06NFDPPDAAw3L//SnPwlFURqdy0tPT3dqRVVUVIioqKhGr5fD4RADBgwQw4YNa3H/rbVUhRDipptuEgDEmTNnhBCNW6r5+fkCgHj55Zdb3Fdz3b/127vsssua/dn5LVUA4pVXXnFa969//asAINatW+f03FprqQrRcvfv+e/RefPmCQDik08+cVrv+eefb2jRnLuf+Ph4UVpa2rAsJydHaDQa8dxzzzXa17laaqme//6+++67hclkcnofNue3v/2tACAyMjKEEL+8xn/+85+d1ps2bZoICQkReXl5DcscDofo27ev02t1/PhxodPpxH333ef0+LKyMpGQkCBuvPHGFusxmUxi+PDhjZY7HA5hs9ka/p17iqX+dXjiiSecHtOW47+5Y7S5lup1113ntN5PP/0kAIhnnnmmxecnhBBTp04VI0eObPj9NPU3sn57CxcubPT4Z599VgAQp06danVfd999t5g/f75Ys2aN+PLLL8XNN98sAIhbbrnFab0ePXqI9PT0Ro8/deqUACCeffbZVvfly/z66l9PmDJlitP3ffr0AQBMnjy50fLCwkKUl5cDAFauXAmg7grRc02bNg0hISFYsWKF0/L+/fujZ8+eLtU0dOhQHD58GEuXLsXcuXMxYsQIrFixAtOnT8fVV1/t0tWJdrsdzz77LPr27QuDwQCdTgeDwYBDhw4hIyOjYb01a9agX79+jT7h//rXv3b6fv369SgsLMSMGTNgt9sb/qmqiiuvvBKbN29GRUWFS8+vOa09r6ioKHTr1g0vvvgi/vGPf2D79u1QVbXN+5k6dWqb1r/55pudvv/Nb34DAFi1alWb990WK1euREhICG644Qan5fXvufPfY5dffjmsVmvD9/Hx8YiLi0NWVla7a7j66qudvu/fvz+qq6uRm5vb4uPKy8vxySefYOTIkejduzcAYPTo0ejWrRveffddp9/bmjVrMHbsWMTExDQs02g0uPHGG522+f3338Nut2P69OlO70GTyYTRo0e3+yr466+/Hnq9vuHf7NmzG61z/numrcd/W5z/fhs5ciSSk5Nbfb8tWrQIixcvxptvvtmoZ6spLa1T/zOHw9HoeK/32muv4bbbbsNll12Ga665Bh988AHuvfdefPDBB9i+fXub9+WvGKrniYqKcvreYDC0uLy6uhoAUFBQAJ1O19DdWk9RFCQkJKCgoMBpeX1Xn6v0ej3S09Px17/+Fd9//z2ys7MxZswYfPPNN/juu+9affyDDz6IP//5z7j22muxePFi/Pzzz9i8eTMGDBiAqqqqhvUKCgoQHx/f6PHnLztz5gwA4IYbbnD6A6TX6/H8889DCIHCwsI2PcfzZWVlwWg0Nnrt6ymKghUrViA9PR0vvPACBg0ahNjYWMyePRtlZWUu76ctvwudTofo6GinZQkJCQDQ6HfsbgUFBUhISGj0RycuLg46na7R/s+vE6jr+j73991W52+zvkuztW1+/PHHKC8vx4033oji4mIUFxejpKQEN954I7Kzs7F8+fKGddv6Hhw6dGij9+DHH3+M/Pz8Fmvq3Llzkx8wXnrpJWzevBmbN29u9rHnv2faevy3Rf376/xlLW2zvLwc99xzD+677z4kJSU1vOa1tbUAgOLi4oYPvfW/06a2V1hYCEVRGrqZu3Xr5vQ6P/300y3WfssttwAANm7c2LAsOjq62X0Bjf/W+puAP6dqMplQU1PTaHl+fr7TJ+ELFR0dDbvdjry8PKcDSwiBnJwcDB061Gn9C/00Fh0djTlz5mD16tXYs2cPJk2a1OL69ec/n332Wafl+fn5TudloqOjG/5Ynev8c4z1r92//vUvDB8+vMl9NvWH0VUnT57E1q1bMXr06GbPpwJAcnIy3n77bQDAwYMH8cknn+Avf/kLamtrMW/ePJf21Zbfhd1uR0FBgVO41L829cvqzz2d/7670NCNjo7Gzz//DCGEU825ubmw2+1ufT+7W/3vaM6cOZgzZ06TP09PTwfQ9vfgZ599huTk5DbXNH78eLz22mvYsmWL03nVbt26tfrY898zbTn+jUZjk3+Tmnt/NHV+PycnB927d2+2vvz8fJw5cwYvvfQSXnrppUY/j4yMxDXXXIMvv/wS3bp1g9lsxu7duxutt3v3bnTv3r3hPb148WKn2pOSkpqtAfilt0mj+aX9lpqaioULFza6VqJ+//369Wtxm74u4FuqXbp0wa5du5yWHTx4EAcOHHDrfuovyjn/YopFixahoqKi3Rft2Gy2Zg+2+m7b+jd2S60GRVEaXSixZMkSnDx50mnZ6NGjsWfPHuzbt89p+fk3Zl9yySWIiIjAvn37MGTIkCb/1bfm26qqqgp33HEH7HY7HnroIZcf17NnTzz++ONITU3Ftm3bGpZfaOvsfB9++KHT9wsWLACAhoEa4uPjYTKZGr3vvvrqq0bbcrWlB9S9x8rLy/Hll186LX///fcbfu6LMjIysGHDBkydOhWrVq1q9G/cuHH46quvGt7no0ePxsqVK51amqqq4tNPP3Xabnp6OnQ6HY4cOdLse7AlDzzwACwWC+6555429Ww0pS3Hf1N/k1auXNlwKul857/f1q9fj6ysrBYHBklISGjytU5PT4fJZMKqVavwzDPPAKjrfbnqqqvw+eefO70Ox48fx6pVq3D99dc3LEtNTXV6fVsL1fr35rkfvK+77jqUl5dj0aJFTuu+9957SEpKwsUXX9ziNn1dwLdUb731Vtxyyy24++67MXXqVGRlZeGFF15o1E1zocaPH4/09HQ8/PDDKC0txSWXXNJw9V9aWhpuvfXWdm23pKQEXbp0wbRp03DFFVegU6dOKC8vx+rVq/HKK6+gT58+DW96q9WK5ORkfPXVVxg3bhyioqIQExODLl26YMqUKXj33XfRu3dv9O/fH1u3bsWLL77Y6IrAOXPmYP78+Zg4cSKefvppxMfHY8GCBdi/fz+AXz5xhoaG4l//+hdmzJiBwsJC3HDDDYiLi0NeXh527tyJvLw8vPHGG60+v+PHj2Pjxo1QVRUlJSXYvn075s+fj6ysLLz00kuYMGFCs4/dtWsX7r33XkybNg09evSAwWDAypUrsWvXLjzyyCMN66WmpuKjjz7Cxx9/jK5du8JkMiE1NbXNvwugrtv/pZdeQnl5OYYOHdpw9e/EiRNx6aWXAqj7AHPLLbdg/vz56NatGwYMGIBNmzY1hO+56ut45ZVXMGPGDOj1evTq1cvpXGi96dOn47XXXsOMGTNw7NgxpKamYt26dXj22WcxadIkXHHFFe16Tp5W30p96KGHMGzYsEY/Lysrw4oVK/DBBx/g/vvvx2OPPYbFixdj3LhxeOyxx2A2mzFv3ryG7sr692CXLl3w9NNP47HHHsPRo0dx5ZVXIjIyEmfOnMGmTZsQEhKCp556qtm6unXrhoULF+LXv/41UlNTcdddd2HQoEEwGo3Izc3FsmXLAABhYWGtPse2HP+33nor/vznP+OJJ57A6NGjsW/fPvz73/9GeHh4k9vesmUL7rjjDkybNg3Z2dl47LHH0KFDB9x9993N1mMymZoM3XfffRdarbbRz5566ikMHToUU6ZMwSOPPILq6mo88cQTiImJwR/+8IdWn/+CBQvw+eefY/LkyUhOTkZxcTE+/fRTfPTRR5g5cyYGDBjQsO7EiRMxfvx43HXXXSgtLUX37t2xcOFCLF26FB988IHTlcJ+SeJFUm7X1JVtqqqKF154QXTt2lWYTCYxZMgQsXLlymav/v3000+dHl9/Bd7597LVXwV47hWKVVVV4uGHHxbJyclCr9eLxMREcddddzV7n6orampqxN///ncxceJE0blzZ2E0GoXJZBJ9+vQRDz30kCgoKHBa/4cffhBpaWnCaDQ63adaVFQkbr/9dhEXFycsFou49NJLxdq1a5u8F3LPnj3iiiuuECaTSURFRYnbb79dvPfeewKA2Llzp9O6a9asEZMnTxZRUVFCr9eLDh06iMmTJzd6Hc93/n21Wq1WREZGisGDB4s5c+Y0OZLQ+VfknjlzRsycOVP07t1bhISEiNDQUNG/f3/xz3/+0+kG8mPHjokJEyYIq9Xa5H2qTdXa0n2qu3btEmPGjBFms1lERUWJu+66S5SXlzs9vqSkRNxxxx0iPj5ehISEiKuuukocO3asySs/H330UZGUlCQ0Go1L96nOmjVLJCYmCp1OJ5KTk8Wjjz7a7H2q52vuavhztXT177nvdyF+OT6aG7yitrZWxMXFiYEDBza7P7vdLjp27ChSU1Mblq1du1ZcfPHFwmg0ioSEBPGnP/2p4Srn8++L/fLLL8Xll18uwsLChNFoFMnJyeKGG25weSSkI0eOiPvuu0/06tVLmM3mhm1MmzZNfPHFF05XNjf3Ogjh+vFfU1MjHnroIdGpUydhNpvF6NGjxY4dO1q8T/XWW28VERERwmw2i0mTJolDhw659NzO19IAJlu2bBHjxo0TFotFhIWFiWuvvVYcPnzYpe1u2LBBjBs3TiQkJAi9Xt8wqMbrr7/udPV0vbKyMjF79myRkJAgDAaD6N+/f5NXH/sjRYgAGdiSPOr3v/89Fi5ciIKCgnZ36xJdiAkTJuDYsWM4ePCg7FK84t1338Vtt92GzZs3t+teWpIj4Lt/qe2efvppJCUloWvXrigvL8c333yDt956C48//jgDlbziwQcfRFpaGjp16oTCwkJ8+OGHWL58eUNXMpGvYqhSI3q9Hi+++CJOnDgBu92OHj164B//+Afuv/9+2aVRkHA4HHjiiSeQk5MDRVHQt29f/O9//2u4RYPIV7H7l4iIyE0C/pYaIiIib2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoErnJ66+/jpSUFJhMJgwePBhr165tcf01a9Zg8ODBMJlM6Nq1K+bNm9fufT/33HNQFAVz5szx2j6JqDGGKpEbfPzxx5gzZw4ee+wxbN++HaNGjcLEiRNx/PjxJtfPzMzEpEmTMGrUKGzfvh1z587F7NmzsWjRojbve/Pmzfjvf/+L/v37t7ieO/dJRE1ThBBCdhFE/u7iiy/GoEGD8MYbbzQs69OnD6699lo899xzjdZ/+OGH8fXXXyMjI6Nh2axZs7Bz505s2LDB5f2Wl5dj0KBBeP311/HMM89g4MCBePnll5tc1137JKLmsaVKdIFqa2uxdetWTJgwwWn5hAkTsH79+iYfs2HDhkbrp6enY8uWLbDZbC7v+5577sHkyZNxxRVXtLquu/ZJRM3TyS6AyN/l5+fD4XAgPj7eaXl8fDxycnKafExOTk6T69vtduTn5yMxMbHV/X700UfYtm0bNm/e7FKd7tgnEbWMoUrkJoqiOH0vhGi0rLX1m1relOzsbNx///1YtmwZTCbTBdXo6j6JqHUMVaILFBMTA61W26hVmpub26hlWC8hIaHJ9XU6HaKjo1vd59atW5Gbm4vBgwc3LHM4HPjxxx/x73//GzU1NdBqtW7dJxG1judUiS6QwWDA4MGDsXz5cqfly5cvx8iRI5t8zIgRIxqtv2zZMgwZMgR6vb7VfY4bNw67d+/Gjh07Gv4NGTIEN998M3bs2NEoUN2xT3d644030L9/f4SFhSEsLAwjRozAd9991+JjeDsQ+QVBRBfso48+Enq9Xrz99tti3759Ys6cOSIkJEQcO3ZMCCHEI488Im699daG9Y8ePSosFot44IEHxL59+8Tbb78t9Hq9+Oyzz9pdw+jRo8X999/f8L039tleX3/9tViyZIk4cOCAOHDggJg7d67Q6/Viz549Ta5fX/v9998v9u3bJ958801ptRO1hKFK5CavvfaaSE5OFgaDQQwaNEisWbOm4WczZswQo0ePdlp/9erVIi0tTRgMBtGlSxfxxhtvXND+zw9Vb+zTnSIjI8Vbb73V5M8eeugh0bt3b6dld955pxg+fLg3SiNyGe9TJSKpHA4HPv30U8yYMQPbt29H3759G61z2WWXIS0tDa+88krDsi+++AI33ngjKisrvd59TdQcXqhERFLs3r0bI0aMQHV1NUJDQ/HFF180GagAbwci/8ELlYhIil69emHHjh3YuHEj7rrrLsyYMQP79u1rdn3eDkT+gC1VIpLCYDCge/fuAIAhQ4Zg8+bNeOWVV/Cf//yn0bq8HYj8BVuqROQThBCoqalp8me+dDsQUUsYqkTkdXPnzsXatWtx7Ngx7N69G4899hhWr16Nm2++GQDw6KOPYvr06Q3rz5o1C1lZWXjwwQeRkZGB+fPn4+2338Yf//hHWU+BqEns/iUirztz5gxuvfVWnD59GuHh4ejfvz+WLl2K8ePHAwBOnz7tNG1eSkoKvv32WzzwwAN47bXXkJSUhFdffRVTp06V9RSImsRbaoiIiNyE3b9ERERuwlAlIiJyE4YqERGRmzBUiYiI3IShSkRE5CYMVSIiIjfhfapEXiIqyoCqSqC6GqKmGqipBqrr/m8XKjakdIVNOOBQBRxChUMIqEJAAIjRV+NS6yYACgANbLYIHFzTCxqtBhq9FhqdBhqdBjqjDgaLHnqLHvoQQ8PXOiMPdSJv4JFG5CaiogwoLoIoLgSKCuv+X3L2++IiwG5r9rGK2YKtYebmf26pBkx7f/ne0QE5uyJcrk2j1ZwNWj0MFj0MIQaYIs2wRJlhjjTDHGWBMdTg8vaIqGkMVaI2EIX5EDmngKKCX0KzqO7/sNW2e7tKGx8rhLZN66sOFTVlNagpa3psXQDQGrRnA9YMy9n/m6MssMaHQm/h+LpErmCoEjVDlJVAnMyGOHkcOJUNcSobqK7yzM7sdihCQLg8jZn7L4dw1DpQfqYc5WfKG/3MFG6CNcmKsEQrrIlWWJOsMFjYsiU6H0OVCICoqqwLzVN1ISpOZQNlpV6twaIKVGhdC1Whtq2leqGqS6pRXVKNvIy8hmWmcCOsiWGwJloRlmRFWIcw6M1s0VJwY6hSUBK5pyGOHoI4dRziZDZQWABA7jDYZlVFhda1FqgQ8i/cry6pQXVJHvL2nw1aBQiNC0VklwhEdolERHIEQ5aCDkOVgoKw2SAyD0EcyoA4lFF3DtTHmFXV5XV9IVQbEWjoPs7++QSgANb4UER1jUJUtyhEdI6ARueDdRO5EUOVApYoLmwIUZF5uMWrb32BydGGUFX9IJwEUJZTjrKccmStPw6NToOI5AhEd49GXJ9YmMJNsiskcjuGKgUMoapA9jGoB/fVtUbzcmSX1CamtrRUvXxO1R1Uu4rCI4UoPFKIQ98fQliHMMT1iUVsn1hYoiyyyyNyC4Yq+TVRWwNxYC/Ewb0Qhw947upcLzA6HC6v65Pdv21UerIUpSdLcfiHIwiND0Vsn1jE9YlFaFyo7NKI2o2hSn5JZGdC3b4JYu9OoLb5ey/9SZtCVXX11hv/UH8uNnN1JizRFsT2iUVCajwDlvwOQ5X8higvhdi5BeqOzUB+ruxy3K4toar6YfevqyoLKpG1LgtZ67IQ1iEMSWmJiO8Xz6EWyS/wXUo+TTgcEAf3QezYBHF4P9CG847+xhDELdXm1HcRH/r+MOIuikVSWhIiOkfILouoWQxV8kkiN6eue3f3VqCi8Qg/gUhvb0OoOvz/nGpbOGwOnN6Rg9M7cmCJsSBpYCISBybCEMJRnci3MFTJZ4jaGohd26Du2AScPC67HK/TO+wur6v6wy01HlKZX4nDPxzBkZVHEdMrBp0u7ojI5EjZZREBYKiSDxBVlVA3/gix+ae6qdGClN7ueqj6xX2qHiZUgbyMPORl5CGsQxg6j+yMuD6xUFweP5nI/RiqJI0oK4G6fg3Eto0BcwXvhdC1IVRVB4PjXKUnS7Hn0z0wR5rReUQnJA5MhFYfuBdzke9iqJLXiaICqOtWQuzcArShyzPQtS1U2VJtSlVRFQ58exBHV2ei49AO6DisI2fTIa9iqJLXiNzTUNetgNizExCBexVve2nbMIxisF2o1Fa2Shsy1xxD1k/HkTgwEckjO8Mc2fwk8ETuwlAljxMnsurC9MA+yJ4Jxpdpbez+dTfVruLklpM4te0UEgcmIuWyLhxzmDyKoUoeox49CLFuRd1g9tSqtrRUGaptI1SBU9tOIWdnDpIGJ6HLqGQYQ42yy6IAxFAltxO5p6Eu/Qoi85DsUvyKxsZQ9TTVoeLEphMoPp2P8Gvz0C1iAvQadguT+zBUyW1EVSXUld9BbN3Ic6btoLHVurwuL1S6MPbUDBwu2YqssnXoEXElksMug1bhhOp04RiqdMGEqkJsWQ919fdBfZ/phVLa0lK1s6XaXqHJBuTFbAUA2NQK7CtchMzSVegTdT2SQgZJro78HUOVLoh69CDU778Ccv1r7lKf1KaWKkO1vWoG7my0rMpeiG25b+G4qTcuip4GqyFRQmUUCBiq1C6iqADqsq8h9u+RXUrAUNoQqg62VNvF2kOP3PC9zf48v3o/fjz5LFLCxqBn5GToNLxSmNqGoUptImproP74A8TGHzlwg7upKvSqCpum9fOlgqHaZooCVKT+3Op6Ag4cLV2BkxVb0CfqOnQMHeaF6ihQMFTJJUIIiF1boa5YApSVyi4nYFlUgRIXrkHiOdW2s/bV4kzoUZfXr3GUYEfeuzheug79Ym5EmKGjB6ujQMFQpVaJwnw4vlwIZB+TXUrAM6sqStD6mLXs/m0bRaug9KK17XpsYc1hrD35N3SPSEePiInQKPyzSc3ju4NapG7ZAHXZ1226iIbaz+TiJOwO1y8UJgDWVIEzplPtfryAikPF3yGnYicGxE5HhLGzG6ujQMJQpSaJ8lKoX38CcShDdilBxdVQZfev67QGDYp6L3fLtspsp/DTqRfQLXw8ekZOZquVGuE7ghpR9+2E+s1nvOdUApPd4dJ6Kq8Rc1nIwFqUG4rctj0BFYdLvseZyt1stVIjDFVqIKqroH73BcSurbJLCVpGF1uqdhtbqq7QWXQo6LbUI9tmq5WawncBAQDUzENQv/wIKC2WXUpQMzpcbKkyVF1iTitFmb7cY9uvb7XmVWVgUNxvEaKP89i+yD9wANEgJ+w2OJZ+BfX9/zBQfYDBxVDlhUqtM4TpkZ+ywiv7Kqk9jrUn/4aT5Zu9sj/yXWypBjFx+gQcXywA8s7ILoXOMrh6TpUt1VYZBuVB1dR4bX92UY3tee8gv+oA+kXfCK3G4LV9k+9gqAYpdd1KqKuWAqprf8TJO/QujlLVhqlXg5IpyoD8jiul7Du7fD2KajIxKO52hBmSpNRA8rD7N8iI2ho4PnmvbmQkBqrP0dtbD1UBBRBsqbZEM/g4hEbe9IPlttNYd+p5ZJWuk1YDycGWahARBXlwfPwOu3t9mN6lc6qtj7gUzCwJRhQk/CS7DKjCht0FC1BYcxj9o2+GVsP5WoMBQzVIqAf3Qf38Q6CmWnYp1AKdS/26PGxbog7aDyhCdhkNTpZvQnntGQyNvxMmXYTscsjD2P0b4IQQUFd/D3XhfAaqH9DZXDmnysO2OaGdjSiK8b37rEtqs7D21PMoqs6UXQp5GI/OACZstVA/fR/qmmUAfOeTOzVP61JLld2/zalJ2yG7hGbVOEqwIeefOFG2UXYp5EHsRwpQoqwEjoXzgdMnZJdCbaB16UIlhmpTrN1bnoDcF6jCjh3576O09iT6RF0HRWG7JtAwVAOQOH2iLlDLSmSXQm2kcWU2IMFQbUQBKvq3PgG5rzhaugJlttMYFHc79Bqz7HLIjfgxKcCoGbvheOc1Bqqf0tha7/5lS7WxsD5aVLRhAnJfkFe1D+tPvYRqe7HsUsiNGKoBRP1pJdRP3uPcp35MceWcquBhey5Fq6C0X/smIJetzHYKP53+O8preZtboODRGSAcK76F+sMS8IIk/6bUtv6BiC1VZ9ZUgaoLmIBctip7IdaffolXBgcIhmoAcCz9EmKddwYOJw9z6ZwqD9t6WoMGRb1WyS7jgtWq5diY8ypyK337QitqHY9OPyaEgGPxpxA/+2fXFzWm2OyAaLm3QfBCpQYhA2tRayyQXYZbOEQNNp+ZhxNl/nPBFTXGUPVTQlWhfvURxDbe8xZYBMyi5TFrBVuqAACdWYeCbj/ILsOtBBzYkf8+jpQE1vMKJjw6/ZBwOKAu+gBi5xbZpZAHWNRWWqoqW6oAYB5UCrsHJyCXRyCj8HMcKvpOdiHUDrxP1c8Iux3qZ+9DHOC5l0BlcqgtHplsqQIGq/cmIJflQPFiAECPyImSK6G2YKj6EWGzQf14PsSRg7JLIQ8yO9j92xrDYO9OQC4Lg9X/MFT9hKitgWPB20DWEdmlkIcZ1VZCVQ3uUJU5AbkMDFb/wlD1A6K6Co4P3wROZMkuhbzA1FpLNchDVTMkW+oE5DIwWP0HQ9XHiapKOP73Hw6MH0SMrUxUHsyhakkwoiB+newypGCw+ofgPTr9gLDb4fjoHQZqkDGoDNXmqIMO+NQE5N52oHgxb7fxccF7dPo4IQTULxYAx/1rkHC6cIZWWqpqkIZqaGcDimJ4G1lG4Rc4Uc4BInxVcB6dfkD9/muIfTtll0ESGFqZUzVYW6o1aTwe6gjszPuAQxr6qOA8On2cumENxM8/yi6DJNG3ek5V8VIlvsPaXY9SH5+A3JsEHNia+xaKao7JLoXOw1D1MerenVCXLZZdBkmkb6WlqjqC7LBVgEo/moDcWxyiBptzXke5jdPG+ZIgOzp9m8g6WnceldO3BTWGqrOwPlqU+9kE5N5Sq5bj55x/caJzHxJcR6cPE3ln4PhoPuBo+Q8qBT5dKxOVq47g6f715wnIvaXKXoifc/4Nm1oluxQCQ9UniLLSusEdqnlQEKDlhUoN/H0Ccm8ps53Ctty3IVqZ4Yg8L3iOTh8laqrhWPAmUFIkuxTyEVpbyy1VESQt1UCZgNxb8qr2YW/hZ7LLCHoMVYmEwwH10/eAHH4Sp1+01lJ1BMk51ZABgTMBubccK12NrNLgHHHKVyhCCF4VI4nj608gtvOqxmDwxqYd+Mf6LThdVoHYEDPsqkBRVTX6xkXjH1eOwaXJHRvWvW3pj/hgY+NBDrp0siL7VDl6pSRjxoi78OqSV1FUUYzeHXrhTPEZFFUU45LeI/H7CXdiztv344XpLyLEFIJ7/ns3Xpj+IuIj4r35lC+IzqxD1bXfBOh8qZ6lQIvhCfch2txTdilBiaEqibpjE9SvPpZdBnnBJ3sOYObn3+Ffk8ehtKYGjyxfC51Gg8U3X4tvDhzF/G17sOueGegcEQYAKDSH4vVhwxoer9od+OcNt0Cv1GJoWjyyj2tw+nQxfnXprzCo22DMmncnRvYaiZljb8PTnzyFMHMYLu1zKW4YOQ0vL/4nOkZ3xA0jp8l6+u1ivaQKud2WyC7Dbxk0oRjV4RGYdVGySwk6wdGP5GNEbg7Ub7+QXQZ5ycsbtuK2Qf1w++BUfLr3IO4YnIqukeFYcfQ4/jHxcnQKt+I/W34ZLShCp0VYTHTDv+y9GSgvKcMt03pjxNBE2O0qiiuLcfXQaxAZEglVqAgPCUeXuC7ontgD2QXZuG749dhzfA8OnjqI64ZfL/HZt13dBOQc3/ZC1Krl2HLmP3CotbJLCToMVS8TtTVwfPo+YOObPRjU2h3YduoMxndLdvr6im7J2JBddy793K8BQDnvvbHsjbdgDrXgH89cBgDQarWIDo3GliNbYDaYodPooFE0KK8qx08Z6zBx0CSoqopXvnkZ90+ZA61G670n7AbBMgG5p5XUZmNX/gLZZQQdTv3mZeq3nwP5HAElWORXVsEhBOJCQpy+jg+x4Ex5JQA4fQ0ASu0voZq5fRdOHTiM3z5+D3S6s5+BBfD4tD/jje/fwOtLX8PFPS/G/pMHcMsrN6NDdAcs2/E9Plq3EABwz5t3N2wrtXMq/vnbl1usd8/xPXjwnQeQEpeC/9z134blW49saTiHe0nvkXjwqj9Ar9MDAMqry9123rZuAnJe8esuJys2Iaq0O5LDLpVdStBgS9WL1O2bIHZylo1gpCjOXwsA9YvO/RoAoDqgEwKqw4H//fFx6M0mTLz5ml9+LhSkJqfi9d+/jg/mfIinfvU0Hps6F+GWcLzy21dhMVgQbgnHq3f8CxpFgwkDJwAAjuZm4mjOkWZrLK8ux/Nf/A1pXQc5LVdVFc8teg5XDbkKr97+Kg6cPIBvt/1yvvOt5W/iqiFXueVCKM3gbAhNy2MfU9vsLfwUpbW8w8BbGKpeInJzoH7H86jBJsZihlZRcKa8wunr3IpKxIVaAMDp63pmh4rq8gqU5ObBVl2Dm/pdCV3cq3j6xZ+x/9hRTHhqPLYf3Q6gbprAfyz+J+6cMAsO1YEThScwe9JsJMckQxUqThWcRlJkEgZ1HYSdWbuarfXlxf/E2NRx6Nuxr9PyksqShnO4XeK6YESvEcjKywIAt563tcQbUZDA20HcTRU2bMt9m+dXvYSh6gU8jxq8DDotBiXF44cjx52+XnEkCyM6JQGA09f1zKrAyf0HAQAz/vEs/rn4LexY8xvMmpmKLkkd8Z9Z/0Xvjr0BAN9t+xZhljCM7D0Sy3YuAwAM7j4E6tnRdQ6dPogr066Ew2GHqjY94s7S7Utxqug0po+e3uhnESERDedwa2w12J21G13ju8Jmt7n1vK06+GBQT0DuSeW209hT8InsMoICQ9UL1CWLeB41iM0ZMRjzt+3GO9v2YNpFPfHm1l04UlSCsV074w9LV+NwYTEO5NeNqPXYD2sx8/PvYFYd2PzlEnTufxH6XzEGyb1S0K9PDOJiLTDoDEiJT4HZYEZReRE+/PFD3DvxHhSVF2HRhs+QFJmEzzd+juz84wCAWnstusSlYHvmdlzU6aJG9Z0oOIG3fngTc69/FFpt43BUFAWPT/szPvjxA9z+2m/RPbE7rkybiI/WLURa10Ew6o24/+3ZmPmvGfjy5y/b9RqFdDKiKGZzux5LrskuX4+T5XyNPY0XKnmYuv1niF1bZZdBEt3YrxcKKqvw1zUbcbq8AknWENgcKq7+8EtcFBeNy1M6oaiqGgBwuqwC2SVlcJSWYdcPq3Dtww803uA5jbnXl76GaSNvRExYLP762TOYNvJG9O7QGy98+Ty++PlzxFhjUF5Tjhe/egE3jryxoXVbz6E68OyiZzFjzEx0jOnU7HOoP4db70R+Nn7Y9QPm3fkfPPDOHFw/fCqGdh+K371+B/onp6JrQrc2vUa1nIDcK3bnL0SEMRkh+jjZpQQsDv7gQSL3NBxvvgK0MusI0fnWTJiEndaQhu+7WapxTcSXAIAtiyaj5FTr3a1nis/g1lduwZM3/QWX9L6kyXXKq8px7fPXQKP80mklhICAgEbR4PlbX0Ba1zSnxwgh8Id3/4AbRtyAAV0G4Jq/XY1v5i6ByWDC0588hdTk/rju4utcfq7WbnrkXrLQ5fXpwoQbOuGSpD9Bo7BN5Ql8VT2k4TwqA5XawehofrYRh4tvqaXblyIiJALDewxvdh2L0YI373rLadnXm7/GjszteOLGJ5EQmdDoMeeewy2rKgMA2NW68YrtLZy3bZICVA7gUJ3eVFKbjYNFS9A76prWV6Y24zlVD1F/WALk58oug/yUUW3+thKHvfVZalRVxfc7lmL8gAmNzpO+9cNb+NvnfwMAaDQapMSnOP2LCIlwOm97rnPP4QKA1WxF55jO+Hzj59iXvbfZ87bNCevNCchlOFKyHMU1WbLLCEgMVQ8QJ7IgtqyXXQb5MUMLM9W40lLddnQbcktyMTHtykY/KywrQG5J+z7wnXsOt95D1z6M1XtW4bEFjzV53rY5dROQ8xYaGQRU7Mz7H1TR8oxI1HY8p+pmwuGA47//BHJPyy6F/NihkZfhu8RfBlM495zqmv9eBXuN/8+pGjYAODOA83/K1D38SvSOulp2GQGFLVU3E+tXM1DpgukdLXT/2vw/UDV6DYp6czhC2Y6ULENJzXHZZQQUhqobicJ8qD8uk10GBQB9M92/AgpEG64D8lWhAzkBuS8QULEj732ogkNDugtD1Y3Ubz4DWjgXRuSq5kIV8K8ZZ5qiM+tQ0GOF7DLorDLbKRwq/k52GQGDoeom6s4tEJmHZJdBAULnCNxQNQ8qg11XJrsMOsfh4u9RWntSdhkBgaHqBqKyHOqyr2WXQQFEZwvMUOUE5L5JwIE9BR/LLiMgMFTdQP3+a6CyQnYZFEC0zQ4a4uehOjifE5D7qMLqwxwb2A0YqhdIPXqQY/uS22kD8Jxq3QTkK2WXQS3YV/g57Gq17DL8GkP1Agibre7iJCI30zYzTaDw40NWO/gEJyD3cTWOEhws/lZ2GX7Nf49QH6Cu+R4o4m0B5H6KrZnuX+GfLVVLvBH5CWtll0EuyCxZhfLaHNll+C2GajuJwnyIDWtkl0EBStNMqAo/DVV1ECcg9xd1Fy1xQvP2Yqi2k7pqKdCW2TiI2kBppvvXHw/ZkE4GFMXyAhh/kl+9H6crtssuwy/53xHqA8SZUxB7dsgugwJZc+dU/bClakvbJbsEaod9hZ9zwP12YKi2g7ryOwDsyiLPae6cqr+FqrWbASURe2SXQe1QZS9AVhlnEWorhmobiexMiIP7ZJdBgU4ImJqYqFwIPzpkFaCy/ybZVdAFOFy8FHaV9xW3hR8dob7BsYKXm5N3mJs6Z+9HoRrWW4ty62HZZdAFqHGUIrOE9xa3hf8coT5APbwfyDoquwwKEma18SkGVfWP7l9FwwnIA8WR0h9Q6+CIca5iqLpICHH2XCqRd5j8uKVqTRWoMnOA9kBgV6twuOR72WX4Df84Qn2A2LcLOH1CdhkURExq49GHVNX3D1mNXoPiPqtll0FudKx0DarsxbLL8Au+f4T6AKGqUFexlUreZfTTC5VCB9aixpAvuwxyI1XYcKh4iewy/ILvH6E+QOzcDBTkyS6Dgoyxie5f4eMtVU5AHriyyzag0sZhWVvj20eoDxB2O9TVy2SXQUHI2MRMNb4equY0TkAeqARUHC3lB6bW+PYR6gPElvVAabHsMigIGZro/lUdvnvIGkI5AXmgyy5bj1pHuewyfJrvHqE+QKgqVA6aT5IYHE21VBUJlbjGMDgfqpYDBQQyh6hFZulq2WX4NIZqC8T+3WylkjR6P+r+NUUZkN+JgwQEg2Ola+BQm5vwgXzzCPUR6ibevE7yGBz+c0uNdhAnIA8WNrWCYwK3wDePUB8gck5x9CSSStdUS9UHz6la4o3IT+QE5MEks2QlVMEPUU3xvSPUR6ib+EeC5NLZG89Uozp875yqOugQJyAPMlWOQpwq5xy5TWGoNkFUVkDs5gS9JJe2iZaqr139G9LRiKJYzkQTjI6W8hx6U3zrCPURYtvPQBOtBCJv0tma6v71rZaqbRAnIA9WpbUnUFSdKbsMn8NQPY9QVahb1ssugwgae+MrLB0+dKGStZseJRG7ZZdBEmWV8TTZ+XznCPUR4sAeoKRIdhlE0DTVUrX7SEtVASr785xasDtVsRW1jkrZZfgUhup51J95qTj5Bo2tcUvVVy5UsnICckLdQPsnyjfILsOnMFTPIc6cBrKOyC6DCACg2Jq4+tcu/5BVNArKLvpJdhnkI9gF7Ez+EepD1J/55iDfoTTZUpVQyHmsqUCVhXMLU50KWy7yqw7ILsNnMFTPElWVELu3yS6DqEGToSq5parRa1Dce5XUGsj3ZJX+KLsEn8FQPUvs3sbbaMi32O3QCOdBFZoYY9+rQgfYUGPkBOTkLKdyF2ocnPIPYKg2UPfulF0CUSNm1TlUZbZUdSYtCntwajdqTMCBUxVbZZfhExiqAERZCZDNm5jJ95hV5zlVVYktVfOgctj0bI1Q0zhsYR2GKgCxbxcgOHYp+Z7zQ9Uh6T5VTkBOrSmqyUSljacGGKoA1L07ZJdA1CST4/yWqqRQ5QTk5IJTFVtklyBd0IeqKC0BsrNkl0HUJFOjlqqEGiI5ATm55mQ5Q5Whum8nAHb9km8ynjdRuWrzfktVO/gkJyAnl5TZTqG09qTsMqQK+lBl1y/5svND1eHlUDXHGZGfyHsQyXUng/yCpaAOVVFSBJw4LrsMomY1DlXv7l8M5gTk1DbBfl41uEN13y6w65d8mUFiqHICcmqPKnshimuCt7HisVD98ccfcdVVVyEpKQmKouDLL79s9TFr1qzB4MGDYTKZ0LVrV8ybN89T5QFg1y/5Pr3Ec6q2NM6VSu1zpjJ4J6/3WKhWVFRgwIAB+Pe//+3S+pmZmZg0aRJGjRqF7du3Y+7cuZg9ezYWLVrkkfpEcSFwMng/TZF/0Nt/udxXQPHa1G/WbgaURAbvH0a6MMEcqjpPbXjixImYOHGiy+vPmzcPnTt3xssvvwwA6NOnD7Zs2YK///3vmDp1qtvrq7vql8i3nRuq3jxbwwnI6UKU1p5Alb0QZl2U7FK8zmfOqW7YsAETJkxwWpaeno4tW7bA1sS8khdK3Re8n6TIfziHqsc+Azux9tah3HrIK/uiwHWmco/sEqTwmVDNyclBfHy807L4+HjY7Xbk57t36CtRWQ6czHbrNok8QevllqqiUVDWb53H90OBL5ehKp+iOJ8vEmfH4z1/+YUSmYfBq37JH+icpiPUenx/1n6cgJzco6D6IBwi+KbT9JlQTUhIQE5OjtOy3Nxc6HQ6REdHu3Vf4ii7tsg/aG3ntlQ9G6oavQbFfTgBObmHQ9SisCr4/tb6TKiOGDECy5cvd1q2bNkyDBkyBHq93q37EpnB94sm/6Q5p6UqPByqnICc3C23ap/sErzOY6FaXl6OHTt2YMeOHQDqbpnZsWMHjh+vu43l0UcfxfTp0xvWnzVrFrKysvDggw8iIyMD8+fPx9tvv40//vGPbq1LFBcCRQVu3SaRp2hstb98IzwXqpyAnDyhsDr4GjAeC9UtW7YgLS0NaWlpAIAHH3wQaWlpeOKJJwAAp0+fbghYAEhJScG3336L1atXY+DAgfi///s/vPrqq26/nYZdv+RPNDbvtFTNaRWcgJzcrrT2JGxqlewyvMpj1+iPGTOm4UKjprz77ruNlo0ePRrbtm3zVEkA2PVL/kU593Yy4ZnPwPpQPfK7LvbItim4Cagoqj6KOMtFskvxGp85p+otIuuo7BKIXGf7ZWJw4aHuX+PgAk5ATh5TEGRdwEEVqqKoACgrkV0GkcuU2nO6fz3QUjVyAnLysMLqw7JL8KrgCtXjmbJLIGoboUKvqnVfeiBUdYNOQmjsra9I1E4lNcfhUGtbXzFAMFSJfJxFPXttgpu7f81xRuQncQJy8iwVdhTVBM/f3uAK1ezg+cVS4DB7qqU66DAnICevCKYu4KAJVVFVCeTlyi6DqM1M9aGquu9wDeloRGHcz27bHlFL2FINQCL7GDjeL/kjs6M+VN3X/csJyMmbSmqCZwKToAlVnOYg4eSfjG7u/rV25QTk5F21ahmq7cFx50XQhKrIOyO7BKJ2MTocAABVdc9sTZUDOAE5eV9JbXC0VhmqRD7OeHZOVXecUw3jBOQkSSlDNXAIVQUK8mSXQdQuBtU951QVjYLSfj+5oySiNiupCY5TcB4b+9enFBUAjsC9wf35tZvw+Ip1uO/iNPxj4uUA6iZ4/7/VG/DW1t0oqq7GsA6JeHXyWFwUF9Pitl7ZsA3/3bITx0tKEWMx4/q+PfHXcZfCpK97qyzYlYHHfliLilobbhvUD89PGN3w2GNFJZj0v0XY+PubEWYyeu4JBxmDva77V1xg96+1H3DGEhytBfI9pbXBEarB0VIN4K7fzSdz8NbWXUiNdw7Lv/+0GS9v2IZXJo3Fht/djITQEEx8fxHKapof2aQ+MB8fPRy775mJ/149AZ/uOYDHVqwDAORXVOHOr5fh+QmjseTWqfjfjn349uAvYynfu2QF/nrFKAaqm+nPfiBUHe0/XOsmIF/tpoqI2q7Snh8UM9YERagiQEO1vKYWMxZ9i3lXjUekydSwXAiBVzdux6OXDcN1fXugX3wM5l+XjkqbHQt37292exuzT2Fk5yT8un8fdIkMx/juXXBTam9sPVX3+h0tKka40Ygb+/XC0A4JGJPSCRl5dXPTLtyVAYNWi+v69vDskw5C9S1V9QLOqYb2t6HGyFMgJJNAaRB0AQdFqIr8wAzV+75diYk9u2Jct2Sn5ZlFJcgpr8AV3bo0LDPqdLisS0dsyD7V7PYu6dwB207lYtOJ0wCAo4XFWHooE5N6pAAAekRHotJmx/bTuSisrMKWk2eQGh+LwsoqPLVqPV6ZNNb9T5KgO9tSFY72df/qTFoU9uQE5CRfuS1HdgkeFxTnVAOx+/fj3fux/fQZbPzdzY1+llNeCQCID7E4LY8LseB4SWmz27wptTfyKqswZv7HEADsqoo7hwzAQ6OGAQAizSbMvy4dt33xHaptdtwyoA8mdO+CO778HndfnIZjRSW4buGXsDtU/HnMCEy9qKf7nnAQ052dU7W93b/mtAqUcQJy8gEV9sDvLQn4UBVCAPmBNTxhdkkZHly6Gt/eOrXhAqKmKOc1bAQEWmrrrMnMxt9+/Bn/mjwOwzom4EhhMR78bjX+uiYEj40eDgC4tk8PXNunh9Nj9uTm49VJY9H71fn44IZJiA8Nwcg3F2BUckfEhVqa2x25SHcBt9ToQ3Qo6LrC3SURtUuljaHq/4oLAVtgTTu07dQZ5FZU4uL/fNCwzCEE1madwOubdmDvfbcBqGuxJlpDG9bJq6hCXGhIs9t9ctV63DygD24fnAoASI2PRUWtDXct/gGPjroYGo1zJNfY7bhvyQq8e/1EHC4shl1VcVmXTgDquoo3nTyNKb26ue15Byutvb6l2vbuX+PgQpRqA//iEPIPFQxV/xeIXb9ju3bG9rumOy2746vv0SsmCn+6ZCi6RoYjITQEK45kIS0xDgBQa3fgx2Mn8Oz4Uc1ut9Jmg+a85q1Wo4E4+x/Oa+f+dc3PSO+RgkFJ8dh+Ohf2s/dTAoDNocKhcqxld2hvqBojDMjvzAnIyXdU2vNll+BxAR+qgXjlr9VoQL/zbqEJ0esRbTY1LJ89PA1/W7sJ3aMj0D0qEs+v/RkWvQ6/Tu3d8JiZn3+HDmGh+OsVdUE7pWdXvLxhGwYmxGFYx0QcKSzGX1b+hKt6dYNW49z1uDc3H5/uPYAts24FAPSOiYRGUTB/224khIbgQH4hhnSI9+TLEDQ07Tynqh18ihOQk09xiFpU20tg0oXLLsVjAj5UA/XK39b88ZKhqLLZcd+SlSiqqsawjgn49tapsBoNDetkl5Q5tUznXjYciqLgyZU/4WRZOWItFkzu1RX/N/YSp20LIXDX4h/w9/QxCDHoAQBmvR5vX3slZn+7AjV2B16ZNBYdwqzeebIB7pdQdb2lao4zoCBpjadKImq3CnteQIeqIoQI6D46+7uvAVlHW1+RyEep4ZH47upL0T+zDEfXNX9O/FzmK7M5Xyr5pAExt6KTdYTsMjwm8O9TrSiXXQHRBVHOXmin2l07XEM6cAJy8l2BfrESQ5XI19WHqsPF1QdxAnLyXdWOYtkleFRAh6pQVaCKtxOQf1NsdkAAqr31c6qhnICcfFytI7AHIgnoUEVlBYCAPmVMQUHAqKpwuBCq1QO2eKEeovarYaj6sUp2/VJgMArRaks1rLcOZdaDXqqIqH1qHM0PlRoIAjpURUWF7BKI3MLgaLmlygnIyV/UOgK7sRPQocqWKgUKg6pCtTUfqtZ+QBUnICc/oMKOWkel7DI8JrBDlVf+UoAwqCoczQyOpNFxAnLyL4F8sVJAh6qoZPcvBQaDw9FsSzV0gJ0TkJNfCeTzqgEdqmypUqAwqI4mW6qcgJz8UY3Klqp/4jlVChA6R9PnVC1plbDpA/dTPwUmu1otuwSPCehQ5dW/FCh0DjvOzgDXQB+iQ35XtlLJ/zhEYM1xfa6ADlW2VClQ6Jo4p2ocXAQHJyAnP+RQGar+qTJwL9um4KJzOJwGf6ibgHyFxIqI2o8tVX/l6gjkRD5OqVGdvtdxAnLyY6qwtb6SnwrsUCUKEJraX0LVHGtAPicgJz/GlioRSaXYzul1GXQUUDhRBPkvnlP1V4J/eCgw1Hf/hnQwojB+o+RqiC6Mg92/RCTV2e5fW9oeyYUQXTh2/xKRVKLWgdAUA0qidsouhYhaENihyu5fChQ1dlQP5ATkFBiUAI6ewH1mRAGkuK+DE5BTwFCUwI2ewH1mRAHCbjHgYMpp2WUQuQ1bqkQkzdEr4wN6Vg8KRk1PYxgIAjtUeU6V/FxF5wgcCz0iuwwit1IUhioRSbB/tAEqONwmBRZ2/xKR1+UOS0KekiW7DCK3Y6gSkVepei329y2SXQaRR/DqX3+l18uugKhdjqV3QKVaKLsMIo/QaUyyS/CYwA5VS4jsCojarDo2FEeiM2WXQeQxesUsuwSPYagS+ZgDV4QF9NioRDotQ9UvKQxV8jOFqfE4rectNBTY2FL1V2aGKvkPoVGwf1CV7DKIPE7PlqqfYkuV/Ej2uE4oFWdkl0HkcTq2VP0Tu3/JX9SGmXAoKVt2GURewZaqv2Kokp84nB4Dm6iUXQaRV7Cl6q8YquQHSrtHI9vMi5MoeOi1FtkleExAhyq7f8kf7B8JCKiyyyDyCq1igF7Dlqp/YqiSjzs9qiMKcUJ2GUReY9SGyy7BowI7VM2B28VA/s9u0uNAt1zZZRB5lUnHUPVbiskMaLSyyyBqUuaViahWS2SXQeRVJm2E7BI8KqBDFQBgYWuVfE9lh3BkhvHiJAo+Jl2E7BI8KvBD1RrYXQ3kn/ZfboIKu+wyiLzOrIuSXYJHBXyoKjGxsksgcpI/JAm5mmOyyyCSwsJQ9W9KTLzsEogaqFoNMvoVyy6DSBq2VP0dQ5V8SNaEjqhQC2SXQSSNWRctuwSPCvhQVWLiZJdABACojgnBkbhjsssgksaoDQ/ogR+AIAhVRMcASuA/TfJ9h64Ih13UyC6DSJpQfYLsEjwu4NNG0eqAyMDuwyffV9Q3DicNR2WXQSSV1cBQDQhKLM+rkjxCAfYPrQEgZJdCJBVbqoGC51VJopOXd0KJyJFdBpF0DNUAwYuVSBab1YiDnU7KLoPIJ1gNibJL8LggCVV2/5IcR9LjUCsqZJdBJJ1eEwKjNkx2GR4XFKEKnlMlCcq6RiHLclh2GUQ+IRi6foEgCVXFaAJCA/8TEvmW/ZdqOPk40VnB0PULBEmoAoASy/Oq5D05l3RAAbJll0HkMyKMXWSX4BVBE6qIC45PSSSfw6jDgR75sssg8imRDNXAonRKkV0CBYnM9CRUqcWyyyDyGTrFxHOqgUZJZqiS51UmhuFoJEdOIjpXuLEzlCAZLjY4niUAJTQMiIqRXQYFuANjLVCFTXYZRD4lWM6nAkEUqgCgJHeVXQIFsIK0BJzRZsoug8jnBMv5VCDoQrWb7BIoQKlaBRkDymWXQeSTIozBc/otyEKVLVXyjOPjO6FczZNdBpHPMWkjYNKFyy7Da4IrVCOigPBI2WVQgKmJsuBwfJbsMoh8UpSpu+wSvCqoQhUAlM7B0w1B3nFofCTsolp2GUQ+KcbcS3YJXhV8ocouYHKjkt6xOGE8IrsMIp8Va+4juwSvYqgStZMAkHGxDZx8nKhpFl0szLoo2WV4VfCFakw8EBIquwwKAKcu74RicVp2GUQ+K9bcW3YJXqeTXYAMSueuEBm7ZJdBfsweYsTBzqfYSPUxC17ejIWvbnFaFhFjxv82zQQACCGw8JUt+P6jfSgvqUHPgfGY9dQoJPdsvjX16K+/wp6fTzVaPmRMZzw5fzIAYPWXB/HeixtRXWnH+Bt747ePjmxY78yJUjwx/Rv886sbYLEa3PAs/UcMQzU4KMkMVbowR9LjUCMOyi6DmtC5ZySe+d/VDd9rNErD14v+swNfzt+JOS+MRYeUcHz82jY8MX0x3vjh17CENh14c99Ih932yxR+pUXVmD35E1wyqe6+95LCKvzr0dWY8+JYxHcKw9N3LEHqxR0wdGwyAOD1P/+IGQ8ND7pABRREm4LrIiUgCLt/AUBJCa5LvMm9ypMjcSyUFyf5Kq1Wg8hYS8O/8GgzgLpW6tfv7MKNdw/GyCu7IrlXNB54cSxqquxY8/WhZrdnjTA5bW/HumwYzTpcejZUz2SXwmI1YNSU7ug5IA6pwzsg+3AhAGD1Vweh12sx8srgu5Yj3NAJBq1FdhleF5yhGpfIcYCp3fZfpoOAQ3YZ1IxTx0owY/h7uP2yD/DC7OXIOV4KADiTXYaivEqkjerYsK7eqEW/i5Owf1uOy9tf/sl+XDalO0wWPQAgqUsEaqrtOLI3D2XF1Ti0KxddekejrLgaC17ejDv/Msq9T9BPBNtVv/WCsvsXAJQ+/SF+Wim7DPIzucOTkK+wleqreg6MwwN/H4sOKREozq/Cx69txZ9u+Byvff8rFOVVAgAiYpxbTxExZuSedG2IyYM7zyDrYCFmPz+mYVlouBEPvDgW//zDStTW2DH2ul4YdFlnvPLQKkyZnoozJ0rxzO+/g93uwG9mD23oNg508Zb+skuQImhDVdO3PxwMVWoDh0GLjN6FgNr6uiTHkDHJTt/3HhSP3435ECsXHUCvtHgAgKI4P0aIxsuas+yT/UjuGYWeA+Kdlo9I74oR6b908e7eeBLHDhTgzqcuxZ2XL8AfXxmPyFgz/nDt57hoWGKjYA80Jm1EUM1Mc66g7P4FACWpExARXPdP0YU5lt4BVWqR7DKoDUwWPbr0isapY8WIjK0LsvoWa72SgipExJhb3VZ1lQ1rFx/GhJta7ta01TjwxhNrcc9fR+P0sVI4HCpSL05Cx66RSEoJx8Gdue1/Qn4i3jIAiqufVAJM0IYqUNcFTOSKqngrjkZxWjd/Y6txIPtIESLjQhDfyXr2QqMTv/y81oE9P59C70EJrW5r3ZIjsNU6MObani2u99G/t2Dw6M7o3i8WqqrCYf/lviuHXYXDEfj3YSWGDJRdgjRB2/0LAJqLBsCxYbXsMsgPHBwXCocI/BaGv3v72fUYNq4LYpNCUVJQhY//vRWV5bUYN7UXFEXB1bf1x6evb0NSl3AkdQnHJ69vg9Gsw+irezRs4x9/WIHo+BDMeGi407aXf5KB4RNSEBZpanb/WQcLsfabI3h1yTQAQMdukVA0CpZ9nIHIWAtOHClGz/6xnnnyPkKvCUG0qUfrKwaooA5VpUPnullrStilR80rHBCP07qjsssgFxTkVODv9y9HaVE1wqLM6DUwDn9fdD3iOlgBAFPvHIjaajveeGLt2cEf4vD0e1Oc7lHNO1UORePcdXnyaDH2bcnB0+9NaXbfQgi89tga3PH4yIYrg40mHea8cDnmPbkWtloH7nzqUkQnBPaIbgmW/lCU4O0EVYQQgd8X0QLH919BbPxRdhnko4RGwfpbQ1HGViqRS4bG34V4S6rsMqQJ3o8TZ2n68rwqNS/7ik4MVCIX6RRTUA5NeK6gD1V07AJYg2dWenJdbYQZhxKPyy6DyG/EW1KhVfSyy5Aq6ENVURQofYK3q4Kad2hCNGyiSnYZRH6jo3WE7BKkC/pQBdgFTI2V9IxBtumw7DKI/IZZG4UYU8u3GwUDhioAdE4BQq2yqyAfsn+4A5zXjch1HUKHBfVVv/X4CgBQFA2UfmmyyyAfceqyjihC4/kziah5nazDW18pCDBUz9IM5huCALvFgANdz8gug8ivRBm7IUQfJ7sMn8BQPUuJiQeSg2P2CGre0fR41Kilsssg8isd2UptwFA9h2YIr1wLZhWdwnHMymndiNpCqxiQFDJYdhk+g6F6DqVPKhAS2EOIUfP2jzZC5eTjRG2SGJIGnab58ZCDDUP1HIpWB2XgUNllkAR5Q5OQp8mSXQaR3+kSNlp2CT6FoXoezeARAIJzHsBgpeo1yLiIkyoQtVWkMSVoJyNvDkP1PEpkNJQewT12ZbA5NqEjKtVC2WUQ+Z2UsMtll+BzGKpNUC4eJbsE8pLq2BAciTkmuwwiv2PSRiAhhPf3n4+h2gRNt15AbILsMsgLDl4RDoeokV0Gkd/pEnYZNIpWdhk+h6HaDA1bqwGvqF8cTul5Cw1RW2kUPTpbL5Vdhk9iqDZDGTAYsITILoM8RChAxuBq2WUQ+aUOIcNg0PL2w6YwVJuh6PRQBnGUkEB1YlxnlAoOR0jUHinhY2SX4LMYqi3QDLsE0Opkl0FuZrMacbBDtuwyiPxSnLkfwgwdZJfhsxiqLVCs4VA40H7AOXxlLGyiUnYZRH6pZ+Rk2SX4NIZqKzSjrgD0BtllkJuUdYvCcTMvTiJqj1jzRYgwJssuw6cxVFuhhFqhDLtEdhnkJhmXKBBQZZdB5Jd6RkySXYLPY6i6QHPJWMDIAaP9Xc6lHVGIE7LLIPJLseY+iDSlyC7D5zFUXaCYLdAMv0x2GXQBHCY99nfPlV0Gkd/qwVaqSxiqLlJGjAbMFtllUDsdTU9EtVoiuwwivxRj6oUoUzfZZfgFhqqLFKOprhuY/E5lh3BkhvPiJKL26sErfl3GUG0DZdilQGiY7DKojfaPMUGFXXYZRH4p1nwRok3dZZfhNxiqbaDo9dCMGie7DGqD/MGJyNUek10GkZ9S0CfqOtlF+BWGahspg4cD4ZGyyyAXqFoNMlJ5HpWovTqFDkeYIUl2GX6FodpGilYHzegJsssgF2RN6IgKtUB2GUR+SaPo0TPyKtll+B2GajsoA4YA0bGyy6AW1ERbcCTumOwyiPxWt/DxMOsiZJfhdxiq7aBoNNCM5T1bvuzg+EjYOfk4UbuYtBHoFj5edhl+iaHaTpq+/aH06CO7DGpCcd84nDTwFhqi9uodeTV0GqPsMvwSQ/UCaCZdz8H2fYwAkDG05uxXRNRW4YZkdAi92G3be+655zB06FBYrVbExcXh2muvxYEDB1p93Jo1azB48GCYTCZ07doV8+bNc1tNnsRQvQBKRBQvWvIxJ8d2QonIkV0GkV9SoEFqzK+hKIrbtrlmzRrcc8892LhxI5YvXw673Y4JEyagoqKi2cdkZmZi0qRJGDVqFLZv3465c+di9uzZWLRokdvq8hRFCMGP9BdAqA44/vsycOaU7FKCni3UiLVTbagVzR+sRNS8lLDLcVH0NI/uIy8vD3FxcVizZg0uu6zpMdUffvhhfP3118jIyGhYNmvWLOzcuRMbNmzwaH0Xii3VC6RotNBOuQFw4yc7ap8j6XEMVKJ2Mmkj0MsLt9CUlNTdOx4VFdXsOhs2bMCECc69gOnp6diyZQtsNptH67tQDFU3UDomQxkyUnYZQa0sJQpZIYdll0Hkt/pF3widxrNTXAoh8OCDD+LSSy9Fv379ml0vJycH8fHxTsvi4+Nht9uRn5/v0RovFEPVTTTjJgFWjgssy/5LNZx8nKid4i39kRAy0OP7uffee7Fr1y4sXLiw1XXPP69bf6bSned7PYGh6iaK0QTNldfKLiMonRnZAQVKtuwyiPySVjGiX/RNHt/Pfffdh6+//hqrVq1Cx44dW1w3ISEBOTnOFxzm5uZCp9MhOjrak2VeMIaqG2n6DoDSs6/sMoKKw6jD/p6+3R1E5Mt6RV4Fs85z45kLIXDvvffi888/x8qVK5GSktLqY0aMGIHly5c7LVu2bBmGDBkCvV7vqVLdgqHqZpqJ1/HeVS/KTE9ClVosuwwivxRh7IKUsDEe3cc999yDDz74AAsWLIDVakVOTg5ycnJQVVXVsM6jjz6K6dOnN3w/a9YsZGVl4cEHH0RGRgbmz5+Pt99+G3/84x89Wqs7MFTdTImIgmZMuuwygkJVghVHI4/KLoPIL2kVIwbGzoSieDYG3njjDZSUlGDMmDFITExs+Pfxxx83rHP69GkcP3684fuUlBR8++23WL16NQYOHIj/+7//w6uvvoqpU6d6tFZ34H2qHiBUFY63XgFOn5BdSkDbcXMicrQMVaL2SI3+NZLDRskuI+CwpeoBikYD7dRbAAPHzvSUgrQEBipRO8WZ+zFQPYSh6iFKdCw0U26QXUZAUrUKMvqXyy6DyC8ZNKEYEHuL7DICFkPVgzSpg6CkDZNdRsDJvqITykWe7DKI/FL/mN/AqOU99Z7CUPUwzcTrgdgE2WUEjNoICw4lZMkug8gvdQod4ZVBHoIZQ9XDFL0e2mm38jYbNzmYHgm7qJZdBpHfsehiPD5YPjFUvUKJTai7f5UuSEmvWJwwcvJxorbSKHoMjvudx8f2JYaq12jShkHpP1h2GX5LAMgYbgcnHydqu9ToXyHc2El2GUGBoepFmslTgehY2WX4pVNjOqFYcM5aorbqFDoSnawjZJcRNBiqXqQYjNBOmw7odLJL8Sv2ECMOdjktuwwivxNu6OSVwfLpFwxVL1Pik6BJv0Z2GX7lSHocatQy2WUQ+RW9xoLBcb+DVuPbA9AHGoaqBJohI6FcNEB2GX6hvHMEjoXy4iSitlEwMHYGLPoY2YUEHYaqJJqrbgTiE2WX4fP2j9ZDwCG7DCK/0iPiSsRbUmWXEZQYqpIoRhO0v7kDsIbLLsVn5Q5PQr5yvPUViahBoiUNPSOmyC4jaDFUJVLCIqC9+Q7AyHvHzqfqtdjfu1B2GUR+JcLYBQNjZ0BRFNmlBC2GqmRKfBI006YDGq3sUnxKZnoHVKpFsssg8htmXRSGxs+CVsPR22RiqPoATbde0FzFGW3qVceF4mh0puwyiPyGTmPGsPi7OVC+D2Co+gjNwGFQRk+QXYZPOHCFFQ5RK7sMIr+gQIPBcXfAakiSXQqBoepTtGPSoQwcKrsMqQr7J+C0jpOPE7mqX/SvEGvuI7sMOouh6mM0U6ZB6dpTdhlSCI2CjLQK2WUQ+Y1u4ROQHHap7DLoHAxVH6NotdDcOAOID76unOxxHVEmcmWXQeQXOlsvRZ+oa2WXQedhqPqghntYw4LnHtbacBMOJZ2QXQaRX+gQMhSp0b+SXQY1gaHqo5SwcGh/87uguYf1UHoMbKJSdhlEPi/eMgADYqdDUfjn2xfxt+LDlPhEaG8O/GAt7RGNbNNh2WUQ+bwYU28MivstNArva/dVDFUfp3TqAu30WYDJLLsUj8kYIcDJx4laFmnsVje4g8JZZ3wZQ9UPKEmdoJ1xF2AJkV2K252+rCOKcFJ2GUQ+LczQCcMS7uZoSX6AoeonlIQOdcEaYpVditvYLQbs73pGdhlEPi3c0BnDE2ZDrwnc3qpAwlD1I0pcIrQz7wKsgTEU2dEJCahRS2WXQeSzIo3dMDzxfhi0gddLFagYqn5GiYmHduY9QFiE7FIuSEXHcBwL48VJRM2JMfXCxQn3soXqZxiqfkiJioF25t1ARJTsUtpt/xgjVE4+TtSkOHM/DI2/GzqNUXYp1EYMVT+lREbXBWtUjOxS2ixvaBLyNFmyyyDySYmWNAyJvxNaDa/y9UcMVT+mhEfWBWt0rOxSXKbqNdh/UbHsMoh8UsfQizEo7nbeh+rHGKp+TrGG151jjU2QXYpLjo3viAq1QHYZRD4nJWwsBsRwpCR/x99eAFBCrdDedg+UlB6yS2lRdUwIjsQek10GkU9RoMFF0TfiougboCiK7HLoAjFUA4RitkBzy++gDBkpu5RmHRwfDoeokV0Gkc/QKkYMif89UsLGyC6F3EQRQnB8uACjbl4PdekXgKrKLqVB0UVx+HkwL04iqmfUhmNY/F0IN3aWXQq5kU52AeR+mqEjgZg4qJ++B1TJn/lFKEDGkBoO70t0llWfhGEJd8Os89/b4qhpbKkGMFGYD8fC+UC+3KEAs8d1xt4OB6TWQOQrYky9MTj+dxzUIUAxVAOcqKmG+tn/IA7vl7J/m9WItdfbUCsqpOyfyJd0CRuDvlFTectMAGOoBgEhVKjLvoHYuMbr+864oSOyLIe8vl8iX6JR9Ogf/Rt0tF4suxTyMIZqEFG3b4K65DPA4Z3hAcu6RmP9pacg4DsXTBF5m1kXhSFxv+cFSUGCFyoFEU3aMCjRsXB8/C5QWe7x/WVcCgYqBbVY80VIi53JWWaCCFuqQUiUFMHxxUIg64jH9pFzSUfs6MZuXwpWCnpGTEaPiIkc0CHIMFSDlBAqxE+roa5e6vbuYIdJj7W/UlCtlrh1u0T+wKgNw8DYGYg195FdCknAUA1yIuckHJ9/COS577abw9d0xuFw3kJDwSfekor+MbfAqLXKLoUkYagShN0GdfkSiE3rcKEjNFQmhWHd+EKowuae4oj8gFYxoG/UVCSHjZJdCknGUKUG6pEDUL/6CCgrbfc2tt+cgDPaTDdWReTbwg2dkRZ3G0L18bJLIR/AUCUnoqoS6uJPITJ2tfmx+YMTseWiox6oisj3KNCgW/gE9IyczMEcqAFDlZqk7tgM9bsvgFrXZpVRtRr8dKsZFWq+hysjks+ii8HA2OmIMnWXXQr5GIYqNUsUFcDx5ULgeOvduceu7Iz9cbw4iQKbAg1SwseiV8QUaDUG2eWQD2KoUosabr1ZswywN33xUU1UCNZeVQ67qPZydUTeE27ojP4xNyPc2El2KeTDGKrkElFcCHXplxAH9jb62e6bOuCk8bCEqog8T6sY0SvyKqSEjYGiaGSXQz6OoUptoh7cV3eutbgQAFDcJxYbh2aDk6VSIIoz90NqzK847ym5jKFKbSZsNqjrVkBdvwobbw5FiTgtuyQitzJpI9E3eiqSQgbJLoX8DEOV2q22PA87Kz7DmcrdskshcgutYkT38AnoGj6OFyJRuzBU6YLlVWVgX8FnKLOxxUr+SkGn0OHoFXk1TLpw2cWQH2OokluowoHjZetwqPg71DjaPyITkbdFm3qgb9QNvKqX3IKhSm5lV2uQWboKR0uWw6ZWyS6HqFkhujj0iboOCSEDZJdCAYShSh5hc1TiSMlyZJauhkO4NioTkTdYdNHoHnElOoYO5/CC5HYMVfKoGkcZDhcvRVbZWqjCLrscCmIMU/IGhip5RZW9EIeKv8OJsp+hguFK3mPWRaMHw5S8hKFKXlVtL0Fm6Upkla2DnedcyYMYpiQDQ5WksKlVOF62Dpklq1DtKJZdDgWQCGMKuoaNRULIQIYpeR1DlaRShQMnyzfhaMkPvM+V2k2BBokhaUgJG4tIU4rsciiIMVTJJwghkFu1B1mlPyK3ah84ljC5Qq8xo5P1EqSEjeH4vOQTGKrkcyptBcguX4/jZetR4yiRXQ75IKuhAzpbL0Gn0BHQaYyyyyFqwFAln6UKB3IrdyOrbB3yqjLA1mtw02vMSAoZik7WEYgwJssuh6hJDFXyC5W2Ahwv+wknyn9GtaNIdjnkNQpiTL3QyToCCZaB0Gr0sgsiahFDlfyKEAJFNUdwsnwLTldsR61aJrsk8gCLLhYdQ4ehY+hwWPTRssshchlDlfyWECryqw/gVPkW5FTu4FjDfi5Un4DEkDQkWtIQZuwouxyidmGoUkBQhR25lftwumIrcqv2waZWyC6JXBBm6IgEy0AkhqTBakiUXQ7RBWOoUsARQkVRTSZyK/cit2ovSmuzZZdEZynQINLUFXHmfkgMGYgQfZzskojciqFKAa/aXozcqr3IrdyL/Kr9sItq2SUFFYsuGjHmPog190WMuRf0GrPskog8hqFKQUUVDhTXHENh9WEUVh9BUc0Rnot1M4PGihhzT0SbeiHW3BsWfYzskoi8hqFKQU0IFWW2UyisPnL232GORdwGCrQIM3REpCkFkcYURBhTEMIQpSDGUCU6T6WtACW1x1FaewKltSdRWnMCVY5C2WX5AAUWXQzCjZ3OBmgXhBs6895RonMwVIlcUOuoRFntCZTUnkBZ7UmU1p5EhS03QM/PKrDoohGqT4DVkASrPhFWQyJC9QnQagyyiyPyaQxVogtQ4yhFhS0PFbY8VNrzUGkvQJWtEJX2grPdyL55eBk0oTDpImHWRcKsi6r7vzYKFn0srAxPonZjqBJ5iBAqatVy1DjKUesoQ62jDDVqOWrPfl/jKIdNLYdD2OAQNqjCBod69v9nvxdQz9uqAgUaKIoGGmihKFoo0ECr6KHTmqHXWGDQWKCv/6f95WuD1gqzti5IGZpEnsFQJfJhqnBACAegKGdDVCO7JCJqAUOViIjITfixl4iIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjchKFKRETkJgxVIiIiN2GoEhERuQlDlYiIyE0YqkRERG7CUCUiInIThioREZGbMFSJiIjc5P8B8HCsWxkI4kUAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAdUAAAHqCAYAAABSldSPAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy88F64QAAAACXBIWXMAAA9hAAAPYQGoP6dpAABi3klEQVR4nO3dd3yU9eEH8M/tu1xy2RNC2JuwBRRkE4jYoojWKsOKiqIUacVVbfXX2hbUqnXQqoioDBVREUWQJULYewUCCYGQvS/J5cbz/f0RknIZJIFLnhuf96u8ap48d/e55O4++T7rqxBCCBAREdENU8odgIiIyFuwVImIiFyEpUpEROQiLFUiIiIXYakSERG5CEuViIjIRViqRERELsJSJSIichGWKhERkYt4dKkqFIom/du2bZvcUW+IEAKrVq3CiBEjEBERAb1ej7Zt2yIhIQEffPBBzXrl5eX4y1/+4hHPNy0tzel3pNFoEBoaisGDB+PJJ5/EiRMn6txm27Zt1/X7fPfdd7Fs2bJm3aa+x5o1axb8/f2bdT+N2bVrF/7yl7+gqKiozvdGjRqFUaNGufTxmqL6d9Pcn1lT3XnnnVAoFHj88cdb5P6bKzU1FfPmzUOPHj1gNBqh1+vRvn173H///di6dSs8+aJzhw4dwpQpUxATEwM/Pz90794dL7/8MsrLy+use/DgQYwbNw7+/v4ICgrCnXfeifPnzzf5sUpLSzFv3jy0adMGOp0OXbt2xaJFi+BwOOqsazabMX/+fMTExECv16Nfv35YtWrVDT1XtyE8WFJSktO/xMREYTAY6iwvLi6WO+oNefrppwUA8dBDD4lvvvlGbNmyRXz00Udi+vTpYvLkyTXr5ebmCgDiz3/+s3xhmyg1NVUAEE888YRISkoSO3fuFOvXrxd//etfRceOHYVKpRKLFi1yuk1xcfF1/T579eolRo4c2azb1PdYM2fOFEajsVn305jFixcLACI1NbXO906cOCFOnDjh0sdrCovFIpKSkkROTo7L7zs7O1toNBoBQAQFBYmKigqXP0ZzfPPNN8JoNIq4uDjx97//Xfz4449i27Zt4oMPPhATJ04UAMRPP/0ka8brdeLECaHX60Xfvn3F6tWrxebNm8Wf//xnoVKpxK9+9SundU+dOiUCAgLEiBEjxPr168WaNWtEr169RExMTJNeBzabTQwZMkQEBweLt99+W2zcuFEsWLBAKBQK8cQTT9RZf/z48SIoKEgsWbJEbNmyRcyePVsAEJ999pnLnr9cPLpUa2uJD73WUl5e3uBynU4nZsyYUe/3HQ5HzX97YqkuXry4zvfKy8trPtC+//77G36s5pSq1WoVNput3u+1dql6o+rne9ttt8n+IZqSkiL8/PzE4MGDG/xDbevWreLw4cPXvJ+ysrKWiHfDnn/+eQFApKSkOC1/+OGHBQBRUFBQs2zatGkiLCzM6eeQlpYmNBqNWLhwYaOPtXLlSgFArFmzps5jKZVKcfr06Zpl69evFwDEihUrnNYdP368iImJEXa7vVnP0914fanGxcWJmTNn1ll35MiRTh+0W7durXmTL1y4UERFRQmj0SgmT54ssrKyRElJiXjooYdEaGioCA0NFbNmzRKlpaVO91lRUSGeeeYZ0b59e6HRaERMTIx47LHHRGFhYZ1Mt912m1izZo3o16+f0Ol04umnn673OVUXZUPfr1ZdUrX/VT/3s2fPilmzZonOnTsLg8EgYmJixOTJk8XRo0fr3Nfx48fF+PHjhcFgEGFhYeKxxx4T3333nQAgtm7d6rTupk2bxJgxY0RAQIAwGAzi5ptvbtJf9tcqVSGEyMjIEBqNRowePbpmWfXv6OoM586dE/fcc4+Ijo4WWq1WREREiDFjxohDhw4JIap+1rV/JnFxcU73t3z5crFgwQIRExMjFAqFOHXqVL2PVf36On78uBgzZozw8/MTYWFhYu7cuU4frNXP7aOPPqrzvK7+o+fPf/5zvb+z6ses/RoVQoj8/Hzx6KOPipiYGKHRaESHDh3Ec889JywWS53HmTt3rli+fLno3r27MBgMIj4+Xqxbt67hX8o18ldnPX78uPjNb34jTCaTiIiIEA888IAoKipq9D6r9ejRQ0RGRoq8vDxhMBjE2LFj611vx44dYujQoUKn04mYmBjxpz/9Sbz//vv1/gGyatUqMXToUOHn5yeMRqOYMGGCOHjwYKNZHnvsMQFA7Nu3r8n5q38OBw4cEFOnThVBQUEiKipKCNH0939Df/jW/qz66KOPBACxceNGMWvWLBEcHCz8/PzE5MmTxblz5xrN+pe//EUAELm5uU7LFy5cKJRKpTCbzUKIqlGmwWAQjzzySJ37mDBhgujSpUujj/X4448LhUJRZ3Dw7bffCgDi73//e82y2bNnC39//zp/vK5YsUIAEDt37mz08dyZR+9TbQnPPfcccnJysGzZMrz22mvYtm0b7r33XkydOhWBgYFYuXIlFi5ciE8++QTPPfdcze2EEJgyZQpeffVVTJ8+HevXr8eCBQvw8ccfY8yYMaisrHR6nIMHD+Kpp57CvHnzsGHDBkydOrXePGFhYejcuTPeffddvP766zh9+nS9+3iio6OxYcMGAMCDDz6IpKQkJCUl4YUXXgAAXL58GaGhofjHP/6BDRs24J133oFarcaQIUOQnJxccz+ZmZkYOXIkkpOT8d5772H58uUoLS2td//Xp59+igkTJsBkMuHjjz/G559/jpCQECQkJGDz5s3N/+FfJSYmBgMHDsSuXbtgt9sbXC8xMREHDhzAokWLsGnTJrz33nvo379/zT7KtWvXomPHjujfv3/Nz2Tt2rVO9/Hss88iPT0dS5Yswbp16xAREdHg49lsNiQmJmLs2LH4+uuv8fjjj+M///kP7rnnnmY/x9mzZ+OJJ54AAHz11Vc1+QYMGFDv+haLBaNHj8by5cuxYMECrF+/Hvfffz8WLVqEO++8s87669evx9tvv42XX34Za9asQUhICO64445m7SerberUqejatSvWrFmDZ555BitWrMCTTz7ZpNvu2rULp06dwowZMxAaGoqpU6diy5YtSE1NdVrv6NGjGD9+PMrLy/Hxxx9jyZIlOHjwIP72t7/Vuc9XXnkF9957L3r27InPP/8cn3zyCUpLSzFixAicPHnymnk2bdqE6OhoDBo0qOk/gCvuvPNOdO7cGV988QWWLFnS7Pd/czz44INQKpVYsWIF3njjDezduxejRo2qdz/81WbOnImgoCA8+uijOH/+PEpLS/Hdd9/hP//5D+bOnQuj0QgAOHfuHCoqKhAfH1/nPuLj45GSkgKLxXLNx7JarVAqldBoNE7LdTodgKrfabXjx4+jR48eUKvVdR6r+vseTeZSdylXjFRvv/12p/Xmz58vAIh58+Y5LZ8yZYoICQmp+XrDhg0CQJ39gKtXrxYAxH//+1+nTCqVSiQnJzfpee3du1e0a9euZiQTEBAgJk+eLJYvXy4kSapZrzmbf+12u7BaraJLly7iySefrFn+1FNPCYVCUWdfXkJCgtMoqqysTISEhNT5eTkcDtG3b19x0003XfPxGxupCiHEPffcIwCI7OxsIUTdkWpeXp4AIN54441rPlZDm3+r7+/WW29t8Hu1R6oAxJtvvum07t/+9jcBQPzyyy9Oz62xkaoQ1978W/s1umTJEgFAfP75507r/fOf/6wZ0Vz9OJGRkaKkpKRmWVZWllAqlU6jhvpca6Ra+/X92GOPCb1e7/Q6bMjvfvc7AUCcOnVKCPG/n/ELL7zgtN60adOE0Wh0GmE5HA7Rs2dPp59Venq6UKvVdfbZlZaWiqioKHH33XdfM49erxdDhw6ts9zhcAibzVbz7+pdLNU/hxdffNHpNs15/zf0Hm1opHrHHXc4rbdz504BQPz1r3+95vMTompfaffu3Z22hMybN8/p91V9fytXrqxz+1deeUUAEJcvX77m47zxxhsCgNixY4fT8hdeeEEAEBMmTKhZ1qVLF5GQkFDnPi5fviwAiFdeeaXR5+XOOFKtZfLkyU5f9+jRAwBw22231VleUFAAs9kMANiyZQuAqiNErzZt2jQYjcY6I7f4+Hh07dq1SZkGDx6MlJQUbNiwAc899xyGDRuGzZs3Y8aMGfjVr37VpKMT7XY7XnnlFfTs2RNarRZqtRparRZnz57FqVOnatbbvn07evfujZ49ezrd/t5773X6eteuXSgoKMDMmTNht9tr/kmShIkTJ2Lfvn0oKytr0vNrSGPPKyQkBJ06dcLixYvx+uuv49ChQ5AkqdmP09BWgobcd999Tl//9re/BQBs3bq12Y/dHFu2bIHRaMRdd93ltLz6NVf7NTZ69GgEBATUfB0ZGYmIiAhcuHDhujP86le/cvo6Pj4eFosFOTk517yd2WzG559/jptvvhndu3cHAIwcORKdOnXCsmXLnH5v27dvx5gxYxAWFlazTKlU4u6773a6zx9//BF2ux0zZsxweg3q9XqMHDnyuo+Cv/POO6HRaGr+zZs3r846tV8zzX3/N0ft19vNN9+MuLi4Rl9vaWlpuP322xEaGoovv/wS27dvx6JFi7Bs2TLMnj27zvoKhaLB+6r+nsPhqPN+r84YEhKChx9+GHv27EFRURFWrlyJt956C0DV76+5j+WpWKq1hISEOH2t1Wqvubx6s0h+fj7UajXCw8Od1lMoFIiKikJ+fr7T8ujo6Gbl0mg0SEhIwN/+9jf8+OOPuHjxIkaNGoXvvvsOP/zwQ6O3X7BgAV544QVMmTIF69atw549e7Bv3z707dsXFRUVNevl5+cjMjKyzu1rL8vOzgYA3HXXXU4fQBqNBv/85z8hhEBBQUGznmNtFy5cgE6nq/Ozr6ZQKLB582YkJCRg0aJFGDBgAMLDwzFv3jyUlpY2+XGa87tQq9UIDQ11WhYVFQUAdX7Hrpafn4+oqKg6HzoRERFQq9V1Hr92TqBqc9zVv+/mqn2f1Zv3GrvP1atXw2w24+6770ZRURGKiopQXFyMu+++GxcvXsSmTZtq1m3ua3Dw4MF1XoOrV69GXl7eNTO1a9eu3j8wXnvtNezbtw/79u1r8La1XzPNff83R/Xrq/ayxu7zmWeeQUlJCX788UdMnToVt956K5566im88cYbWLp0KbZv3w7gf7/T+u6voKAACoUCQUFBAIBOnTo5/ZxffvllAFW7qap3Pw0dOhTBwcF44okn8PrrrwMA2rRpU3OfoaGhDT4WUPez1tOoG1/Fs+n1+nr3Z+Tl5Tn9JXyjQkNDYbfbkZub6/TGEkIgKysLgwcPdlr/Rv8aCw0Nxfz587Ft2zYcP34ciYmJ11z/008/xYwZM/DKK684Lc/Ly6t5w1Tfb/WH1dWysrKcvq7+2f373//G0KFD633M+j4YmyojIwMHDhzAyJEj6+x7uVpcXBw+/PBDAMCZM2fw+eef4y9/+QusViuWLFnSpMdqzu/CbrcjPz/fqVyqfzbVy/R6PQDUed3daOmGhoZiz549EEI4Zc7JyYHdbnfp69nVqn9H8+fPx/z58+v9fkJCAoDmvwa//PJLxMXFNTvT+PHj8c4772D//v1O+1U7derU6G1rv2aa8/7X6XT1fiY19Pqo/byrl3Xu3PmaGQ8fPoyePXvW7DutVp3l+PHjNVsLDAYDjh07Vuc+jh07hs6dO9e8ptetW+eUPSYmxul+T548ibS0NJSVlaFLly44cOAAAODWW2+tWa9Pnz5YuXIl7Ha703u7+vF79+59zefl7rx+pNq+fXunneRA1Yfv1QfnuMLYsWMBVJXX1dasWYOysrKa7zeXzWZr8M1Wvdm2+oV9rVGDQqGo+X619evXIyMjw2nZyJEjcfz48ToHedQ+MfuWW25BUFAQTp48iUGDBtX7r3o031wVFRWYPXs27HY7Fi5c2OTbde3aFX/605/Qp08fHDx4sGb5jY7Oavvss8+cvl6xYgUA1FyoITIyEnq9vs7r7ptvvqlzX00d6QFVrzGz2Yyvv/7aafny5ctrvu+OTp06haSkJEydOhVbt26t82/s2LH45ptval7nI0eOxJYtW5xGmpIk4YsvvnC634SEBKjVapw7d67B1+C1PPnkk/Dz88PcuXObtWWjPs15/9f3mbRly5aaXUm11X697dq1CxcuXGj0wiAxMTE4ceJEnftNSkoCALRt2xZA1daX22+/HV999ZXTzyE9PR1bt251OgiuT58+Tj/fq0v16ufXq1cvaDQavPbaa4iJicG0adNqvn/HHXfAbDZjzZo1Trf7+OOPERMTgyFDhlzzebk7rx+pTp8+Hffffz8ee+wxTJ06FRcuXMCiRYvqbKa5UePHj0dCQgKefvpplJSU4JZbbsHRo0fx5z//Gf3798f06dOv636Li4vRvn17TJs2DePGjUNsbCzMZjO2bduGN998Ez169Kh50QcEBCAuLg7ffPMNxo4di5CQEISFhaF9+/aYPHkyli1bhu7duyM+Ph4HDhzA4sWLa95Y1ebPn4+lS5di0qRJePnllxEZGYkVK1bg9OnTAP63b8Tf3x///ve/MXPmTBQUFOCuu+5CREQEcnNzceTIEeTm5uK9995r9Pmlp6dj9+7dkCQJxcXFOHToEJYuXYoLFy7gtddew4QJExq87dGjR/H4449j2rRp6NKlC7RaLbZs2YKjR4/imWeeqVmvT58+WLVqFVavXo2OHTtCr9ejT58+zf5dAFWb/V977TWYzWYMHjwYu3btwl//+ldMmjQJw4cPB1D1B8z999+PpUuXolOnTujbty/27t1bU75Xq87x5ptvYubMmdBoNOjWrZvTvtBqM2bMwDvvvIOZM2ciLS0Nffr0wS+//IJXXnkFiYmJGDdu3HU9p5ZWPUpduHAhbrrppjrfLy0txebNm/Hpp5/i97//PZ5//nmsW7cOY8eOxfPPPw+DwYAlS5bU7KOvfg22b98eL7/8Mp5//nmcP38eEydORHBwMLKzs7F3714YjUa89NJLDebq1KkTVq5ciXvvvRd9+vTBo48+igEDBkCn0yEnJwcbN24EAJhMpkafY3Pe/9OnT8cLL7yAF198ESNHjsTJkyfx9ttvIzAwsN773r9/P2bPno1p06bh4sWLeP7559GmTRs89thj18w0f/58TJkyBePHj8eTTz6JsLAw7N69G3//+9/Rs2dPTJo0qWbdl156CYMHD8bkyZPxzDPPwGKx4MUXX0RYWBj+8Ic/NPr8AeD5559Hnz59EB0djfT0dCxduhR79uzB+vXrYTAYatabNGkSxo8fj0cffRQlJSXo3LkzVq5ciQ0bNuDTTz+FSqVq0uO5LTmPknK1+o7+lSRJLFq0SHTs2FHo9XoxaNAgsWXLlgaP/v3iiy+cbl99BF7tc9mqjwK8+gjFiooK8fTTT4u4uDih0WhEdHS0ePTRRxs8T7UpKisrxauvviomTZok2rVrJ3Q6ndDr9aJHjx5i4cKFIj8/32n9n376SfTv31/odDqn81QLCwvFgw8+KCIiIoSfn58YPny42LFjR73nQh4/flyMGzdO6PV6ERISIh588EHx8ccfCwDiyJEjTutu375d3HbbbSIkJERoNBrRpk0bcdttt9X5OdZW+7xalUolgoODxcCBA8X8+fPrvZJQ7SNys7OzxaxZs0T37t2F0WgU/v7+Ij4+XvzrX/9yOoE8LS1NTJgwQQQEBNR7nmp9Wa91nurRo0fFqFGjhMFgECEhIeLRRx+tOeevWnFxsZg9e7aIjIwURqNR3H777SItLa3eIz+fffZZERMTI5RKZZPOU50zZ46Ijo4WarVaxMXFiWeffbbB81Rra+ho+Ktd6+jf2uc8Vr8/Grp4hdVqFREREaJfv34NPp7dbhdt27YVffr0qVm2Y8cOMWTIEKHT6URUVJR46qmnao5yrn1e7Ndffy1Gjx4tTCaT0Ol0Ii4uTtx1111NvhLSuXPnxBNPPCG6desmDAZDzX1MmzZNrF271ulI2YZ+DkI0/f1fWVkpFi5cKGJjY4XBYBAjR44Uhw8fvuZ5qtOnTxdBQUHCYDCIxMREcfbs2SY9ty1btogJEyaIqKgoYTAYRNeuXcUf/vAHkZeXV2fd/fv3i7Fjxwo/Pz9hMpnElClT6lw44loeffRR0a5dO6HVakVYWJiYOnVqvefBC1F1hPa8efNEVFSU0Gq1Ij4+vt6jjz2RQggPvrAltZqHH34YK1euRH5+/nVv1iW6ERMmTEBaWhrOnDkjd5RWsWzZMjzwwAPYt2/fdZ1LS/Lw+s2/1Hwvv/wyYmJi0LFjR5jNZnz33Xf44IMP8Kc//YmFSq1iwYIF6N+/P2JjY1FQUIDPPvsMmzZtqtmUTOSuWKpUh0ajweLFi3Hp0iXY7XZ06dIFr7/+On7/+9/LHY18hMPhwIsvvoisrCwoFAr07NkTn3zyCe6//365oxFdEzf/EhERuYjXn1JDRETUWliqRERELsJSJSIichGWKhERkYuwVImIiFyEpUpEROQiLFUiIiIXYakSERG5CEuViIjIRViqRERELsJSJSIichGWKhERkYuwVImIiFyEpUpEROQiLFUiIiIXYakSERG5CEuViIjIRViqRERELsJSJSIichGWKhERkYuwVImIiFyEpUpEROQiLFUiIiIXYakSERG5CEuViIjIRViqRF7o73//OxQKBebPn3/N9bZv346BAwdCr9ejY8eOWLJkSesEJPJSLFUiL7Nv3z7897//RXx8/DXXS01NRWJiIkaMGIFDhw7hueeew7x587BmzZpWSkrkfViqRF7EbDbjvvvuw/vvv4/g4OBrrrtkyRK0a9cOb7zxBnr06IHZs2fjd7/7HV599dVWSkvkfViqRF5k7ty5uO222zBu3LhG101KSsKECROcliUkJGD//v2w2WwtFZHIq6nlDkBErrFq1SocPHgQ+/bta9L6WVlZiIyMdFoWGRkJu92OvLw8REdHt0RMIq/GUiXyAhcvXsTvf/97bNy4EXq9vsm3UygUTl8LIepdTkRNw1Il8gIHDhxATk4OBg4cWLPM4XDg559/xttvv43KykqoVCqn20RFRSErK8tpWU5ODtRqNUJDQ1slN5G3YakSeYGxY8fi2LFjTsseeOABdO/eHU8//XSdQgWAYcOGYd26dU7LNm7ciEGDBkGj0bRoXiJvxVIl8gIBAQHo3bu30zKj0YjQ0NCa5c8++ywyMjKwfPlyAMCcOXPw9ttvY8GCBXjooYeQlJSEDz/8ECtXrmz1/ETegkf/EvmIzMxMpKen13zdoUMHfP/999i2bRv69euH//u//8Nbb72FqVOnypiSyLMpRPWRCURERHRDOFIlIiJyEZYqERGRi7BUiYiIXISlSkRE5CIsVSIiIhdhqRIREbkIS5WIiMhFWKpEREQuwlIlIiJyEZYqERGRi7BUiYgAvPfee4iPj4fJZILJZMKwYcPwww8/XPM227dvx8CBA6HX69GxY0csWbKkldKSu2KpEhEBaNu2Lf7xj39g//792L9/P8aMGYNf//rXOHHiRL3rp6amIjExESNGjMChQ4fw3HPPYd68eVizZk0rJyd3wgvqExE1ICQkBIsXL8aDDz5Y53tPP/00vv32W5w6dapm2Zw5c3DkyBEkJSW1ZkxyI5xP1Qf8/PPPWLx4MQ4cOIDMzEysXbsWU6ZMueZttm/fjgULFuDEiROIiYnBwoULMWfOnNYJ7KWEzQpYKmr+CYvlyn9brnx95Xu2SkASgJAAIQBJAsL0UA0pA6Co+qdQAVADCvWV/9de+acHFHpYysNQURwKjUEDjZ8GGoMGSjU3TDWVw+HAF198gbKyMgwbNqzedZKSkjBhwgSnZQkJCfjwww9hs9k40buPYqn6gLKyMvTt2xcPPPBAk+bKrN6s9dBDD+HTTz/Fzp078dhjjyE8PJxzbTZASA6guAiiuBAoKoAoKgSu/u/SYsDhuP4HsIcAttwmr16ZPxAHV7RxWqbWq6EP1ENn0kEfqIf+yv/rAq/8f4AOSpVvF++xY8cwbNgwWCwW+Pv7Y+3atejZs2e962ZlZSEyMtJpWWRkJOx2O/Ly8hAdHd0akcnNsFR9wKRJkzBp0qQmr79kyRK0a9cOb7zxBgCgR48e2L9/P1599VWfL1VRVgqRdRnIyoDIzYYoLACKCoDSkqqRpZuwV9YdJdktdpgtZpizzfXfSAEYggwwhhthDPe78v9V/1QaVQsndg/dunXD4cOHUVRUhDVr1mDmzJnYvn17g8WqUCicvq7em1Z7OfkOlirVwc1agBASkJ8LkXW5qkSzL0NkZQDmUrmjNYnNch2/IwFUFFagorACeWecv6UP0sMYboR/hBGmGBNMbQOhN+lcE9aNaLVadO7cGQAwaNAg7Nu3D2+++Sb+85//1Fk3KioKWVlZTstycnKgVqsRGhraKnnJ/bBUqQ5f3KwlSksg0lIg0lMhMi8BOVmAzSp3rOtmq3DtW9tSZIGlyIL8s/k1y3QBOpjamhDYxgRTWxNMMSavG9EKIVBZWVnv94YNG4Z169Y5Ldu4cSMGDRrkE394Uv1YqlQvb9+sVVOiaecgLpwD8pu+v9ITVJa1/Fu7srQSuadykXuq6menUCpgjDAiKDYIIZ2CEdw+GGqd53zEPPfcc5g0aRJiY2NRWlqKVatWYdu2bdiwYQMA4Nlnn0VGRgaWL18OoOpI37fffhsLFizAQw89hKSkJHz44YdYuXKlnE+DZOY5r3hqNd64WUuYS6oKNO0cRFqK15Vobday1h8xCknAnGWGOcuMS/suQaFUwNTGhJAOwQjpFAJTWxOUSvc9ECo7OxvTp09HZmYmAgMDER8fjw0bNmD8+PEAgMzMTKSnp9es36FDB3z//fd48skn8c477yAmJgZvvfWWzx934OtYqlSHt2zWElkZkE4dgzh9HMjJlDtOq6o0y19eQhIovliM4ovFSP05DSqtCsHtgxDSMQTh3cOhD9TLHdHJhx9+eM3vL1u2rM6ykSNH4uDBgy2UiDwRS9UHmM1mpKSk1HydmpqKw4cPIyQkBO3atfOazVpCSEB6GqTTV4q0qEDuSLKxlMhfqrU5rA7knclH3pl8nNlwFgHRAYjoEY7wHuEwhhnljkfkEixVH7B//36MHj265usFCxYAAGbOnIlly5Z59GYtYbdDpJ6FOHUM4swJoKyB00V8jKXY/fd9l2aWojSzFOe2nIcx3Ijw7uGI6BGOgOgAuaMRXTdeppA8jhASREoyxNH9EGdOAdb6j870Kp1CoE5s2n5gAR22/DuhhQO1HH2QHpG9IxHTLxp+oX5yxyFqFo5UyWOIwnxIh/ZCHNkHlBTLHceNude+yuayFFlw4ZcLuPDLBQTGBiK6bxQie0d61JHE5Lv4KiW3Jmw2iFNHIQ7thUg7B4AbVhojCc8u1atVH+h05seziOgejuh+0QjuEOw1p3aR92GpklsSly9WjUqPH6q6yDw1meTwnlKtJtkkZB3LRtaxbOgDdYjuF4M2g9pA56+VOxqRE5YquQ1ht0Mc3Q9p704g+7LccTyW5PC+ywdezVJcidTtqUj7JQ2RvSIRO6QtTDEmuWMRAWCpkhsQFeUQ+3dB2vuLx1xb1505bL4xehMOgayjWcg6moXA2EDEDolFeI8wt77ABHk/lirJRhQXQkr6GeLQHt84greV2K2+UapXq973qjPp0HZwG7QZ2AYag+dcqIS8B0uVWp3IyoC0ayvEiSNVE3CTS9mtvlsmlSWVOLf5PNJ+voA2g2LQ7uZ20Pl79+Zwci8sVWo10rlkiF1bIc6flTuKV7uuad+8jMPmQHrSRVzal4HoftFoPzzO7S6LSN6JpUotTjp/BtKWH4CM9MZXphvm6mnfPJlkl5CxPwOXD11GTL8YtB/BcqWWxXcftRhxMQ3Slh+qZoWhVmMt59u6NuEQyDiQgcuHLyOmfwzaj2jvlZOsk/z47iOXEzmZkDZ/D3HmpNxRfJIc0755CuEQyNifgczDmWg3LBZxw+Og1vJjkFyHryZyGVFSDGnrDxBH9gO8pLRsKs0s1cZIdglpOy7g8sFMdBjVAW0GxECh5FWa6MaxVOmGiUoLpF+2QOz+GbDb5I7j8ypKWA5NZS2zInl9Mi7tvYTO4zohrGuY3JHIw7FU6YZIh/ZC+mk9UM4p19xFpRvOperuynLLcGTlUQR3CEaXCZ0REMXp5+j6sFTpuojcLDjWrwEunJc7Cl1FQA17JUeq16swtRB7/7sPbQbEoNO4TtDoeXoSNQ9LlZpF2KyQtm+ESPoZkBxyx6E6DHIH8HwCyDhwGbmn89AloTOi+kTJnYg8CEuVmkw6cxLSD2uBogK5o1ADhBdN+yY3a5kVJ746iczDmeh2Wzf4hXDCdGocS5UaJUqKIP3wNcTpY3JHoUZIEkvV1QrOF2LPe3vRfkQc4m6Jg1LFfdbUMJYqNUhIDojdOyBt38gL3nsIb5/2TS6SXcL5ranIOpaN7pO7IzguSO5I5KZYqlQvkZ8Lx9oVvLSgh3HYWKotqTyvHAeXHUS7obHoNLYTlGqOWskZS5XqkA4kQfrxW8BmlTsKNZPdR+ZSlVv67ovIP1eAXnf25Ok35IR/ZlENUW6GY9VSSN99yUL1UPZKngLSWspyy7Dv/f1I25EGIfEKYlSFI1UCAEhnT0H6djVgLpU7Ct0AG0u1VQlJ4NyW88g7m4+eU3rwCGHiSNXXCZsNju+/grTiAxaqF7BZ+HeyHIovFmPvkn3IOJAhdxSSGd+BPkxkXoLjqxVAXrbcUchFbJz2TTYOmwOnv0tGYVohut/enbPf+Cj+1n2UtPtnSD99Bzh4VSRvUslp32SXfTwHpVlm9Lm7D/zDjXLHoVbGzb8+RthscKxdAenHb1ioXojTvrmH8rxy7H9/P7KOZckdhVoZR6o+RBQXwrF6GZB5Se4o1EIsnKHGbThsDpz46iSKLhSj68QuPKfVR7BUfYSUmgLpy+VAeZncUagFVZZyhhp3k3EgAyWZJegzrTcMQZzwwNvxTycfIO3+GdKn/2GhejkBJaxlfEu7o9LLpdj7330oTCuUOwq1ML4DvZjT/lNJkjsOtTiOgtyZvcKOQ58cxuVDl+WOQi2Im3+9FPef+h5O++b+hCRw6tvTKM8vR6exnaBQcHO9t2GpeiGRkQ7Hig+BcrPcUagVSSxVj3FhZzrKCyrQ646eUGl4xLY34eZfLyOlnIbj4/dYqD6I0755ltxTuTiw7CAqSzmtojdhqXoR6egBSCuX8mL4Pkqys1Q9TenlUuz7YD9Ks3iJUG/BUvUSUtJ2SGtXAhIv6OCrOO2bZ6osqcTBZYdQeKFI7ijkAixVDyeEgGPjOkgbvwXA6ad8mb2Speqp7JV2HP70MPLO5ssdhW4QS9WDCckB6ZtVEEnb5I5CboBzqXo2yS7h6KqjyD7BCS48GY/+9VDCZoX0xXKIs6fkjkJugtO+eT4hCRxfcwJ2ix1tBraROw5dB74LPZCwVMDx2fvApQtyRyE3Yq3g29krCOD0d8mwW+yIuyVO7jTUTNz862FEpQWOT/7DQqU6rGaWqjdJ+ekczm0+J3cMaiaWqgcR1ko4Pv0vcPmi3FHIDVXyur9eJ+2XC0j5KUXuGNQMfBd6CGGzwvHZBxyhUoMqzXw7e6MLO9Nxfluq3DGoifgu9ADCZoO08kMg/bzcUciNWYr5dvZWqdtTkfYL/6D2BHwXujlht0Na/RFEKjcBUcMEFLBwLlWvdm7zOaTv5q4fd8dSdWPCYYf0+TKIc8lyRyG3pwcES9Xbnf3xLC7tz5A7Bl0DS9VNCckB6ctPeB4qNYkAZ6jxFcnrkzknqxtjqbohIQSkr1ZAnD4udxTyEEJiqfqSU+tOI/tkjtwxqB4sVTckbfoO4sRhuWOQB5EkzlDjUwRw8quTKLxQKHcSqoWl6mak/bt4LV9qNgenffM5kkPC0VXHYM7h3MnuhKXqRqSzpyB9v1buGOSBHJz2zSfZLXYcX3scFnuR3FHoCpaqmxBZlyF9+QkgJLmjkAeyW1mqvkgfrEXZ8K3Ym/0e7JJF7jgElqpbECXFcKz4ALBWyh2FPBSnffM9xhgdyhJ+QIXfRZRYL+JgzlII/lEuO5aqzIS1Eo6VHwClxXJHIQ9ms7BUfUlAZw0KRn8Jq/Z/ByrlVBzHiYIvZUxFAEtVVkKSIH2xHMjiOWd0Y2yc9s1nmPoBOcNWQVLV3bKVVrINqcVbWz8U1VAIIYTcIXyVY/0aiP275I5Brei9vYfx+q79yCgxw6BRQ6NUIr/Cgi/v+RV+3aNznfV/TruIP/64HSfzChAcooVGrUROXgViooxY+MRAdGofiLlPb0NmphVdo7ojuygbhWVFuKX7zXh4wiOY/+HvsWjGYhj1Rsz972NYNGMxIoMiZXjm5AoBt5Qjp9P311xHASVuinwM4X49WykVXY0jVZlIh/awUH3M58eT8YcN2/DMiCF4I3E0uoYGw2y1Nbh+amExbv9sLYa3a4O1T96HgkILMjLN+OeLt+C5Jwdj3rPbcdcD32POrD745P9exeHUw+gQ0QFvPfgWkjOS8dKqv+D2QbcjMigSH2x6v+a/yfMoVAr4TchutFABQEDCodxlqLDzHFY5sFRlILIv89QZH/RG0gE8MKA3HhzYBw8P6oukh+9Dh+DABtf/7/4jaBdowuuTRmPLifPoGBeIh2b0xqq1ZzB7em/ce2dXlJRa8djv4hGgCYUkJAQaA9E+oj06R3fBxfyLuGPonTiefhxnLp/BHUPvbMVnS66iNqihSUxGftSOJt/GKplxMOdDSMLRgsmoPizVViYqLXB8/jFgb3iEQt7Hanfg4OVsjO8U57R8XK2vr7b7YmbN93enpGPC6DgkjI7D/sM5sNkc+HViJwDA95vSoKz0g1qphlKhhLnCjJ2nfsGkAYmQJAlvfvcGfj95PlRKVcs9QWoRuiAtHIm7URx8tNm3Law8j9MFX7s+FF0Tj25oZdK3q4GCPLljUCvLK6+AQwhEGI1OyyONfg3eJttcVvP97GIzIsNjEBnhB7tdQl6+BVERVd97afFu5GQcwJCuQ3A6Ixn3v3kf2oS2waheozDjremosFbgl1O/4N0N76C4vBhTbroDU4ZMabHnSq7hF61D6a0bYNXlX/d9nC/ZjBB9J0QZ+7kuGF0TS7UVSXt2QJxs/l+c5D0UtWZna+woQcVVN1AoFKg+rFChQM1/b/jibpz8/C4AwKW8i3h+xfN483dvYe77j8HmsOPdh9/DA/+ehRmjZiBx4G146N3ZiI/rg45RnVz0rMjVAjppkT/0KzhUFTd8X0fyPkGAti2MmjAXJKPGcPNvKxEZ6ZA2rZM7BskkzM8AlUKBbHOZ0/KcsvIGbxPpb0TWlfUjA/2RlVOOnNxyqNVKhIbor/rvEABVsxu9vu5feGTCHDgkB9Lz0vHEpMcR6BcIh3BAo9Ei2D8Y8e3jceQC/7hzV6Z4BXKHrXJJoQKATarAwZz34RDc5dQaWKqtQFSUw/HFcsDBgwZ8lVatwoCYSPx0Lt1p+eZzFxq8zdDY6JrvD+3cDpu2pWPj1nQM6hcBjUZV898qddUm5R8Ofg+Tnwk3d78ZG49sBAAM7DwI0pWr7Njt9qr/d9ghSbzyjjsKuLkC2f2+gFC69vdTbL2Ik/m8MERrYKm2MCEEpLUrgGIe3u7r5g8biKUHj+Gjg8dxICMLM9Z8j9SiEgBAalExZn/9I6at+hYA8PxPO3A2vwgXikvwxw3bMKZXR5xLK8J/lx/Db+7oiqWfncCHn53AH+cOgOTQo9BciM9+/gyPT5qLQnMh1iR9iZjgGHy1+ytczEuHAgpkFWXi5MUTOJR6CL1ie8n5o6BaFCoFjONykdN5fYs9xoXSHcgw72ux+6cqvPhDC5N+2QJpc8u9UcizvLf3MF7buR8ZpWbY6xktRhr9cOmpOfjd2g24UFSCP48ehj9s2I6TefkICdFBo1EiO7fq4g9PzxuIOQ/Eo7KyCyZNWINesb0xZcgU/O3Lv6JXbG90b9Mdi77+JwrLCjGixwgcTz+OwrJC3DnkTkwfNUOGZ0/1UetVUI47jeKQIy3+WCqFDiNinoa/NqrFH8tXsVRbkMi8BMcHbwESN/vSDeoUAnVibr3fKjf3RtJHHVs5ELmCLlAD27jdKDOmttpjBmhiMKLNM1AqeJxqS+BPtYUIhx2Or1eyUKnF2VtgLtWjaUfx+a7VOHv5LPLN+XjpnpdwS4/hVY/nsOOjLUux5+xeZBVmwqgzon/HAZg9bjbCTA0fYfrjoQ1Y/M3iOsu/f/4HaDVVz2Hz0Z/wwU8fwGK1YOKASXhkwiM162UVZuHpTxbi3Yffg1FvrHM/nsYvUgfzqI2o1NX/x1JLKbVdxtmiH9At+PZWfVxfwVJtIdLWDUBOltwxyAe0xLRvFlsFOkZ2QkK/iXjp87/U+p4FZzPP4v5b70enqE4orSjFuxvexYsrX8C7j7x3zfv10xmx7PFlTsuqC7W4rBivffsanpqyENHB0fjTZ8+jb/u+GNp1KADgzfVvYPa4h7yiUP07aFEwbC0c6oaP/m5JKUUbEe3XHyZdW1ke35uxVFuAuJgKsWub3DE8zo60S3ht134cvJyNTHNZnYvM/27tBnxy5KTTbW5qE4WdD/32mvdbVGHBC1t24utTKSissKBDcCAWTbgVk7pWbTJdcfQUnv9pB8qsNjwwoDf+OWFkzW3TCouR+Mka7H74Ppj0Ohc+W9dpiWnfbuoyBDd1GVLv9/z1/lg0w3nE+Xji43j8/bnILsq+5vWFFQBCAkLq/V7mlVHv6N6jAQB9O/TDhdwLGNp1KDYf3Qy1SoMRPUdc3xNyI6beSuT0Ww2hlG8rloADR/I+wS0xC6FU8EpbrsRSdTGHZEVyxU/oYNRCY+ak481RZrMhPjIcM/v1wt2f139Ob0Ln9vjg1wk1X2tV1z6A3Wp3YOInaxBh9MOquyejrSkAF4tLEaCrGh3llVXgkW834sMpE9EhOBC//mwtRraPReKVwn18/Wb8bdwIty1UwD2mfSuzlEEBBfz1/tdcr8Jagd/+615IkoROUZ0wa8wD6BLdBQDQJrQNKm2VOJt5FpGBkUjOSMbE/hNRUl6Cj7cuw6uzXmuNp9KiTEMrkd3VPc5XL7ZexLniTegSNFHuKF5F/nejl0ku+g7nNYdw+a5A9D4WjbADmXJH8hgTu3TAxC4drrmOTqVCVEDTN/99dOg4Ciss2PHgb6BRVf1FHhdkqvn++cIiBOp0uLt3NwDAqA6xOJWbj8SuHbHy6CloVSrc0bPLdTyb1mOVuVStNis+/OkDjOkz5pqbZmPD2mHhlIXoENkR5ZVl+Gr3V5j/4e/xn0f/i7ahbRFgCMDCO57GP9f+E1ZbJcb3HY/BnQdj8deLMWXIFGQVZuGFlS/A4bBjxqgZuLXXyAYfy90olAr4jc5Fdpttckdxcrboe0T59UWANlruKF6DpepCRZUXkFq8BQBgkYqxv1cx2nbugu7f5UJdxlGrK2xPu4SYRe8hSK/DiPZt8X9jhiPCv+Hr536XfA5D2kbjifVbsC75HML9DPhNn+54avhgqJRKdAkNRrnNjkOZOYgLDMD+jGzM6t8bBeUVeGnrLmyadXcrPrvrYzXLt/nO7rDjr1/+HyQhYd5tv7/muj1je6Jn7P/m+OwV2xuP/mcOvt7zNR5PfBwAMLzHcAy/ckAUABxOPYzUnFQ8kfgEZr41A8/d9TxC/EMw9/256BMXj2D/4JZ5Yi6k0qmgHncWeaEH5Y5ShyTsOJL3KW6J/gMUCl62wBVYqi4iCQeO5H4CAedzDy/pziJvGketrjCxSwfc1asr2gWakFZUjD9v2YUJH3+BPY/cB526/pdyamExtqZexL3x3fHtfXcgJb8Q877fArsk4U+jhiHYoMfSOxLwwNofYLHZcX/fHpjQuT1mf/0jHhvSH2mFxbhj5dewOyS8MGoYpvbq2srPunGVMpWq3WHH/33xMrKKsrB45qvNPoBIqVSia5tuyCi4VO/3rXYr3lr/Jp6981lcLsiAQ3Kgb/u+AIC2oW1xOuMUhnW7+YafR0vSmjRwjN2HooAUuaM0qKgyFaklW9ExcKzcUbwCS9VFUoo2oNR2ud7vVY9aYzt3Rrfv8jhqvU7Vm2gBoHdkGAbGRKLTvz7A92dSG9xEKwmBCKMfltw+HiqlEgNjInG5tAyv79qPP40aBgCY0qMLpvT43+23p17E8Zw8vJU4Bt3fWopP70pEpL8RN7+/AiPi2l5zZCwHS4mi8ZVcrLpQM/Iz8Oqs1xDo1/C8sA0RQuBc1jl0iKh/k/+n2z/FTV1uQpeYrjibeRaOq05Pc3jApRYNETqUjd6ESl2O3FEadbrwW0T69YFREyF3FI/H8b4LlFozkVL0Y6PrXdSl4JdpAvkDuP/CFaID/BEXZEJKQcOXgIwKMKJLaDBUyv+91HuEhyDLXAarve7Rl5V2O55YvxnvTh6HlIIi2CUJt7aPRbewEHQJDcbeDPfb2mApcf3buKKyAimZKUjJrBphZRZlISUzBdlF2XA4HHjp85dw5vIZPDv1OUiShILSAhSUFsB21TzB//jqH/jgpw9qvl6+bTn2pezD5YLLSMlMwavfvIpzWSm4fVDd8yXTctKw/cQ2zBw9CwDQLqwdFAoFfjj4PXaf2Y30vHR0a9Otzu3chX97LUrGfe0RhQoAkrDhSN5n4LWAbhxHqi5wsmANJNibtK5FKsa+3sWI7dwF3b7Lgbrc2sLpvFd+eQUuFpciyr/hI05vjm2DVcdOQ5IElMqqEd2Z/EJE+xuhVdfdbPq37XuQ0KUDBsRE4lBmjtOlBG0OCQ7JvT50BNSwV7p+pJp8ORl//PgPNV8v+bHq/NMJfSdgxqiZSEreBQB4ZMnDTrd7deZr6NehHwAgpzgHyqumrjNbzPjXutdRaC6EUWdEp+jO+NcD/0L3tt2dn5MQ+Ne61/FowqMwaA0AAJ1Gh4VTFuKt79+CzW7DE4lPIMwU7vLn7QqmXirk9Jf3lJnrUWA5iwulO9DedKvcUTwaL1N4g7LLj2Ff9rVPeG+IQRmE3keCEXqIF4kAAHOlFSkFRQCAwf/5FIsTRmJU+1iEGPQIMejx8rYk3NGzC6L9jbhQVII/bf4FF4tLcezxWTWnyMz66ge0Mfnjb+Oqzme8WFyK+HeWYUa/Xph7U3+kFBTioW824vEh/fHsrc7nYZ7IycNdq77F/jnTYdRqUGGzocPr7+OV8SMQ5W/E3avXIfn3v0MbU0Cr/lwANHiZQoEAbPn36NbPQ/UyDbEiu9u3cse4bhqlH0a3fQlaledfYEMuHKneAEk4cLLgq+u+fYVUhH19ihDbhaNWADhwORvjPv6i5uunftwOAJjetyfemTwWx3Py8OmRkyiyVCI6wIiR7WOxYtrkmkIFqkr06tFRbGAAvp8+FX/csA0D3luONiZ/PDGkP54aPtjpsYUQeHTdT3g1YRSM2qqLKRg0Gnw4ZSLmfb8ZlXYH3kwcI0+hXoMQerkjEK6cMjMqH9ltt8gd5YbYpHKcLfoevUKnyR3FY3GkegPOF2/ByQLXzFHIUStdUwMjVbsjFtvf7S9DIKqm0qqgGZeCwrADckdxCQVUGNn2BfjzoKXrwgOVrpPVYcbZou9ddn9Vo9Y0nLy7Lex+rr9AOnknyeG+V3ryBdoADRS3HfKaQgWqLmF4qmCt3DE8Fkv1OiUXrodNcvXFsAXS9Wex824F8vtzvkNqnMPGUpWLIVyLyklbUBpwRu4oLpddfgT5FWfljuGRWKrXodSaifTSHS12/zWj1mmxHLXSNbXEtG/UOP84LUrGr4NFny13lBZzsmANT7G5DizV63CyYE2dKye5nkC64Qx23q1AQV+OWql+dqvrZ6ihazP1VCFvxOewq0vljtKiiq3pyDDvlTuGx2GpNlN2+THkVpxsfEUXqZCKsLdvGk5Oawu7nh+g5MzeAtO+UcNMg+3IHrQaQtm089I93enCb+CQfPushOZiqTbDjZ5Cc/0E0g1nsfM3KhT0bXiuSvI9VgvPimsNCqUC/qOKkN3ja7mjtCqLowjnizfLHcOjsFSbIb30F5TZ5NuHUiEVYm/fCzjFUStdYStnqbY0lVYJXUIactv9JHcUWaQUb4TFXix3DI/BUm0iSTiQUrRR7hgABC4YzmLXb1QoiOe+Vl9XWSbftG++QOOvgSLxCArD98kdRTYOUYkzRd/JHcNjsFSb6JJ5NyyOhi/c3trKpULs7ZeGU3fFwsFRq8+Scy5Vb2cI08I2aRtKTclyR5HdxdLdqLAXyB3DI7BUm0AIyU1GqbUJXPA7g52/UaMgnvtafZHFzLdwSzDG6lA6fh0qDO43K5EcBBw4V+ybm7+bi+/IJsgo249ye91LxLmLcqkAe/td4KjVB1mKW38uVW9n6q5Gwa2fw6bx7lNmmuti6S5YHWa5Y7g9lmojhBBNmitVfleNWvtw1OoLBJSwlvEt7EqmQQ5kD14NSWVrfGUf4xBWpJZslTuG2+M7shFZ5YdhtnnOJqByqQB7+1/A6akctXo/g9wBvIZCAQSMLEF2z7WAglcRakhayTbYJYvcMdwaS7URKUUb5I5wHQTSjFWj1kKOWr0Wp31zDaVGCX3CReTEueNxE+7FJlXgQknLXaLVG7BUryG7/DiKrRfljnHdyqUC7Kketep4PqO3YaneOI1RDWXiMRRE7JE7isc4X7IZDsHN4w1hqV6DZ45Sa6sate66V4vC3pwf0Zs4OO3bDdGHamFL3IHSwFNyR/EolY4SXCpNkjuG22KpNiCvIhmFlefljuEyZVI+9gxI56jVi0h2lur1MrbVwTzhe1QYMuSO4pHOFf8EIVp6UhHPxFJtgGcc8dtcV41ae3HU6uk47dv1MXVTo2DUF7BpiuSO4rHK7Xm4XOY9E7O7Eku1HmZbNvIsp+WO0WLKpHzsGZiOZI5aPRqnfWs+0wAJ2TethqTkzCs3KqXoR863Wg+Waj3SS36RO0IrEEitHrX25KjVE9ktHKk2mQLwv7UU2b2/4ikzLlJqu4x8yxm5Y7gdlmotDmHDJbPvHAlYJuVjz6B0JN8ZC4eW15H1JDZO+9YkSo0ShoQM5Lb3xl068kov3SV3BLfDUq0lq+wwrJKvXYpLINX/DHb9Vocijlo9hrWCpdoYjZ8aqsQTKIjg0aotIav8MKyOcrljuBWWai3ppb6w6bd+ZVI+dg9Kx5k723HU6gGsnPbtmvQhWtgSd6Ik8ITcUbyWJGzIKNsrdwy3wlK9itmWjXzLWbljyEzgvH8ydv1Wj6Ie4XKHoWuo5LRvDTK2uXLKjJ/nXrzFU1zkJmAnLNWr+MYBSk1TJuVhz+BLOHNHLCQNP7zdUSWnfatXQBcNCkZ/CZu2SO4oPqHEeglFlRfkjuE2+K68QhJ2nzpAqSkEJJwPOMNRq5uyFPPtW5upP5AzdBUkZaXcUXxKeulOuSO4Db4rr8j0yQOUmsYsqket7ThqdRMCClhKOZdqDQUQMLwM2X2+5CkzMrhs3g+HxHN/AZZqDV8+QKkpqkatydh1nwHF3TlqlZ8OECxVAFCqlfAbn4mcjj/IHcVn2YWFV1i6gqUKwGzL4UnMTWSWcrH7Jo5a5SY4lyoAQO2nhjrxJPKjuPlRbjxntQpLFcCl0t1yR/AoNaPW3xpQ3I2jVjkIidO+6YK1cEzaheKg43JHIQCFledgtmbJHUN2LFUAmeWH5I7gkcwiF7uHXMLZKe0gafhSak2S5Nsz1PhF61Ce8APKjelyR6GrpJs5WvX5T8JSaybKbNlyx/BYAhLOmZKx67d+HLW2IocPT/sW0FmDwjFfwqotlDsK1ZJVdljuCLLz+VLli8A1akatv+aotTU4fHTaN1M/IGfYKkgqnjLjjsrteSixXpI7hqx8/tOPm35dR0DCucBkJP3WiOKuYXLH8Wp2q++VasDN5ciO5ykz7i6r7KjcEWTl06VabuNfVS2hVORg99AMpHDU2mLslb4zl6pCpYDf+GzkdP5e7ijUBFnlR+SOICuf/sTLLD8sdwSvJSAhhaPWFmOz+Eapqg1qaBKTkR+9Q+4o1EQl1ouosBfIHUM2Pl2qWWXc9NvSnEatKp9+ubmUzQemfdMFaSEl7kZxsG9vTvREWWW+O1r12U85i70YhZVpcsfwCTWj1vuNKOnCUasrWMu9+8IbflE6VEzciDJjmtxR6Dr48iZgny3VrPLDAHjAQ2sqFTlIGsZRqytUmr13pBrQSYuiMWtRqc2TOwpdpwJLCqyOMrljyMJnP9kyeSqNLKpHrbvv90dJl1C543gsb532zRSvQO6wVXCoy+WOQjdAQEJO+TG5Y8jCO9+ZjbA6zCjw+cnI5VUispE0LBMpv+Ko9XpYSrzvYvoBN1uQ3e8LCKUkdxRyAV/dBOyTn2a5FacgwDeu3AQcSAm6MmrtzFFrc1hKvOetq1ApYByXi5zO38kdhVwot+KUT04H5z3vzGbI5yjVrZSIbCTdnImU2zlqbQoBLSS7d4xU1XoVNJPOIi9mu9xRyMUcwoo8S7LcMVqdT36CcdOv+xFwICW4atRa2ilE7jhuzjumfdOaNJAS96E45LDcUaiF+OIAxudKtdJRAjMvoO+2SkQ2dt2SdWXU6h2jMVeThOdP++YXqYNl0k8o8z8vdxRqQQWWc3JHaHU+V6r5lhS5I1Aj/jdqNaG0I/e11iY5PHuGGv8OWhSNXYtKXa7cUaiFFVem+9x+Vd8r1YozckegJioRWUganolzHLU68eRSNfVWIu+W1TxlxkcIOFBYmSp3jFblc6XK/ameRYIDZ4OTsed+E0o7cl8rADhsnlmqAUMrkT3gcwilQ+4o1Ip8bROwT5Wq1WFGqS1L7hh0HYpFFpKGZ+HcZI5a7R42l6pCqYBxbB5yuq6TOwrJoMDHdrn5VKlWHYnGSxN6KgkOnA25Mmrt4LujVk+a9k2lU0E76Rzy2myTOwrJpLAyFUL4znUBfLBUydMViywkjcjC+cntIJS+N2r1lGnftAEaIPEAikIPyh2FZOQQlSi2XpQ7RqvxqVL1tc0Q3kyCA2dCkrF7uu+NWj1h2jdDhA6Vk7bAHMD3HPnWZ6/PlKrVUY4Sa4bcMcjFqkat2Tg/Oc5nRq1WNy9V//ZalIz7GhY9zwenKixVL1RUmQruT/VOEuw4E3Iau6cHwtwhWO44Lc5qdt+5VE29VMgbvhp2tW9O+0X186UjgH2mVEutl+WOQC2sWGRi14gcnL/Nu/e1VrppqZqGWJE9cDVPmaE6rJIZZqtvbLnwmVItsXHTry+QYMeZ0GTsmR4Ic5x3jlorS93rDwaFUgH/0YXI7vat3FHIjfnKwUo+U6ql1ky5I1ArKhKZ2DUyB6mJ3jdqrSh2n7etSquCbmIqcmM3yx2F3FypjxzT4j7vzhYkhAQzL/rgcyTYkRzmXaNWATXsle7xR4LWXwPFbYdQGLZf7ijkAUptvrELzidKtcyWC0nY5I5BMikSmdg1Krdq1OoefXQD3GOGGkO4DpWTtqI0gNfSpqbxlbMvfKJUuT+VJGGrGrXOCIa5XZDcca6bEPLPperfToeS8d/CYuDWH2q6CnsBbFKF3DFanE+UKo/8pWpF4jJ2jc5D6iTPHLVKkrwjVVMPNfJuXQ27ulTWHOSZfOGzmKVKPkcSNiSHJ2PPdM8btco57ZtpsB3Zg1dBKO2yZSDP5gvHtvhGqfrIDnJqniJUjVrTPGjUKse0bwqlAv6jipDd4+tWf2zyLmab95+r6vWl6pBsKLPlyh2D3JQkbDgdnoy904NR5gGjVrutdS+mr9IqoUu4gNx2P7Xq45J3KmOpej6zLRO8PCE1phCXsXN0HtImuveo1W5tvblUNf4aKBKPoDB8b6s9Jnk3X7iqkteXaqmNF32gppGEDacjkrF3egjKYgPljlMveytN+2YI08KWuB2lpuRWeTzyDeX2PEjCuy9j6fWlWmEvlDsCeZhCZGDnmHy3HLVaLS0/Q40xVovS8etQoeexCORaAhLKvXx3nNeXqsVeLHcE8kBOo9a27jNqtZW37MX0Td3VKLj1S9g0PGWGWka5PV/uCC3K60u10lEkdwTyYIXIwM6x7jNqrSxvuZGqaaAD2YNXQ1JZW+wxiCodJXJHaFFeX6oWB0eqdGOqR637poeivI28o1ZrqetHqgoF4D+yBNm91gIKHtRHLcvbP5O9v1TtRXJHIC9RgEvYOa4AFxLayXY8ucXs2resUqOEPuEicuM2uvR+iRrCkaoHE0Ly+l8gtS6HsOJUZDL2zZBn1Gopdt02aI1RDWXiMRRE7HHZfRI1xts/k726VCsdpRCQ5I5BXkiOUauAEtYy17xl9SFa2BJ3oDTwlEvuj6ipKu0sVY9V6eXb7klerT9qdc3F9I1tdTAnfI8KA2dvotbHkaoH8/Yd4uQeqket6RNadtQqcOPTvgV01aBg1BewaYpuPBDRdWCpejAepEStxSGsOBl1ZdQaY2qRxxA3OO2baYCEnCGrICl5ygzJxy4scEje+xr07lLlSJVaWQEuYef4QqSPj3X5qNVxvdO+KYCAW0uR3fsrnjJDbsHixaNV7y5VXk2JZOAQVpyMPoP9M8JcOmqV7M0vVaVaCcOEDOS0/9FlOYhulDcf7+LVpWqTzHJHIB+Wj4vYOb4I6eNds6/VbmveDDUaPzVUt51AQWSSCx6dyHW8eb+qV5eqQ3jvdnvyDA5RiZPRyVWj1ugbG7XarU2foabqlJmdKAk8cUOPSdQSrA7vvba0V5eqXaqUOwIRgCuj1glFuDju+ketdkvTRqrGGB3KJvyACr+L1/lIRC3LIWxyR2gxXl2qHKmSO3GISpyIScb+6WGoiApo9u1tTZj2LaCLBgWjv4RVyykPyX1585yqXl2qHKmSO8pXXMTOhGJcHNeuWbezVly7VE39gJyhqyCp+Lon9yYJu9wRWoxXl6pD8MOF3JP9yqh13/TwJo9abWUNzFCjAAKGlyE7/kueMkMegaXqobz5BGPyDvmK9KpR69jGR60Wc91SVaqV8BufhZyOP7REPKIWIYGl6pEkeO92e/IedlGJE22Ssb+RUWtlrWnf1AY11ImnkB/1S0tHJHIpwX2qnsmbf3HkffIU6diZUIJLDYxaLSX/e7vqgrVwJO5CcdCx1opH5DLc/OuBhJA47Rt5HLuw4Hj1qDXyf6NWIQBLSdVcqn7ROpQn/IByY7pcMYluCEvVA3HTL3myPEU6dk4swaUxsQAAh1UNCAUCOmtQNOYrnjJDHo2n1HggbvolT2cXFhxvewYHpkegzGCCqa8COcNWwaGqkDsa0Q3x5gOVGj+b3EMJwU2/5B1yFReQP1QDScH9p+QduPnXAykVXvv3AvkgSeG9l3Uj38PNvx5IqdAAUMgdg4iIalF48Wez15aqQqHgaJWIyA2plM2bxtCTeG2pAoBK4b2/OCIiT6VW6OSO0GK8vFSbPv8kERG1DpWSpeqROFIlInI/HKl6KG/ebk9E5Kk4UvVQSm7+JSJyOxypeihu/iUicj/evBXRy0uVI1UiInfDkaqH8ua/hoiIPBX3qXoojlSJiNyPiiNVz6RR+skdgYiIalFzpOqZ9KoguSMQEVEtaqVe7ggtxrtLVR0kdwQiIqrFmwc83l2qXvyLIyLyRBqlHzf/eiq9OljuCEREdBVv/1z28lINlDsCERFdxaBiqXoslUIDrdJf7hhERHSFgSNVz8aDlYiI3AdL1cPpVdwETETkLvTqELkjtCjvL1Uv/6uIiMiTcJ+qh+NpNURE7sPAkapn4z5VIiJ3ofD6z2SvL1Vv/6uIiMhT6FQmKBUquWO0KK8v1QBNlNwRiIgI3n/kL+ADpapXB0GjNModg4jI5/n7wCDH60sVAEzaGLkjEBH5PJO2jdwRWpxPlGqAD/wiiYjcnUnbVu4ILc4nStUX/joiInJ3Jm2s3BFanE+UKkeqRETy0quCoVX5yR2jxflEqZo0MQAUcscgIvJZgTrv3/QL+EipqpRa+KnD5I5BROSzfGF/KuAjpQpwvyoRkZxYql6GpUpEJB+WqpcJ4LmqRESyUCv0PrMLzmdK1Vf+SiIicjcB2jZQKHzjYFGfKVWjJhxaZYDcMYiIfI4vDWp8plQBINTQRe4IREQ+J0gXJ3eEVuNbpapnqRIRtbYwQ1e5I7QaHytV3/nFEhG5A6M6wqfmtfapUg3QRnO/KhFRKwr1oVEq4GOlCnC/KhFRawrTd5M7QqvyvVLlflUiolaiQJiBperVuF+ViKh1BGhjoFX5yx2jVflcqQZoo6FTmeSOQUTk9Xxt0y/gg6UKACH6znJHICLyer50Kk01nyxVbgImImpZCigR4oPHsPhkqYaxVImIWlSgrh00SoPcMVqdT5aqvzbKZ2ZMICKSgy/uTwV8tFQBIMrYT+4IREReK9zQU+4IsvDZUo326y93BCIir6RTmRCi7yR3DFn4bKkG6dpDrwqWOwYRkdeJ8usPhcI368U3nzUAhUKBaG4CJiJyuRjjALkjyMZnSxUAoozcBExE5Eo6VaDPbvoFfLxUQ3QdeXUlIiIXijb289lNv4CPl6pCoUSUX1+5YxAReY1o40C5I8jKp0sVAKJ9eNs/EZEr6VSBCNH57qZfgKWKUH0XaJW+NYsCEVFLiDb2h0KhkDuGrHy+VBUKJSL94uWOQUTk8Xz5qN9qPl+qADcBExHdKL0qCME+vukXYKkCAMIN3aFXBckdg4jIY0UZ+/n8pl+ApQqgahNwu4Bb5I5BROSx2vrfJHcEt8BSvSI24BYo+OMgImo2kzYWQbr2csdwC2yRKwzqIET49ZY7BhGRx4njlr4aLNWrxAWMkDsCEZFHUSl0aMNNvzVYqlcJN/SAnzpU7hhERB4jxjgIaqVe7hhug6V6FR6wRETUPHEmfmZejaVaS2zAzVBAJXcMIiK3F6iN4wFKtbBUa9GpTIgy8iL7RESN6WAaJXcEt8NSrUdcwHC5IxARuTWdyoQYf9+ekaY+LNV6hOq7waiOkDsGEZHbahdwC5QKtdwx3A5LtR4KhQJxplvljkFE5JYUUPEUxAawVBsQFzCcU8IREdUj2tgfenWQ3DHcEku1ASqlFh0Dx8kdg4jIzSjQOWiC3CHcFkv1GtqbboVGaZQ7BhGR24jy6wuTtq3cMdwWS/Ua1Eo9OphGyx2DiMhNKNA1OFHuEG6NpdqIDoGjoVYa5I5BRCS7KL94jlIbwVJthEZp4AnORERQoGvQbXKHcHss1SboYBoNlUIndwwiItlE+cXDpOMotTEs1SbQqvzRnuetEpHPUqBLEPelNgVLtYk6Bo6DSqGVOwYRUauL9ItHoC5W7hgegaXaRDpVAKeFIyIfpEBXjlKbjKXaDJ0Cx0Op0Mgdg4io1UT69eEotRlYqs2gVweho2mM3DGIiFoNj/htHpZqM3UOSoBOZZI7BhFRi4sxDuYotZlYqs2kVurRNWiy3DGIiFqUSqFDz5A75I7hcViq16FdwM0I0MTIHYOIqMV0CZrEmWiuA0v1OigUSvQMuVPuGERELcKojkDHQB4/cj1Yqtcp3K8nIgy95Y5BRORyPUPvglKhljuGR2Kp3oBeodP4wiMirxJh6I1IPw4YrhdL9QYYNeHoaOJE5kTkHZQKNXqFTpM7hkdjqd6gLkETYVCFyB2DiOiGdTSNhVETLncMj8ZSvUEqpRY9QnnQEhF5Nr0qCJ2DJsodw+OxVF0gxjgA4YaecscgIrpuPULuhFrJKS5vFEvVReLDfgu1Qi93DCKiZgvRd0Eb/0Fyx/AKLFUXMahD0DP0LrljEBE1i0qhQ9+w++SO4TVYqi7ULuBmRBh6yR2DiKjJeoTcAaMmQu4YXoOl6mLxYfdBo/STOwYRUaPCDT3R3nSr3DG8CkvVxfTqIPQK4XleROTeNEo/xIfdL3cMr8NSbQFtA4Yg0i9e7hhERA3qHXoPDLxgvsvxGnstJD7st9h26RxsUpncUcjNPDjiU+RklNZZnnh/Lzz68q0QQmDlm/vx46qTMBdXomu/SMx5aQTiul77IiPfLD2CHz47gdzLZphC9Lh5YifMXDgEWl3V23zb12fw8eLdsJTbMf7u7vjdszfX3Db7UglenPEd/vXNXfAL0Lr2CZPbiTYOQBv/wXLH8Eos1RaiU5nQJ/QeHMxdKncUcjOvfz0VkiRqvr6QXIAXZqzD8MROAIA1/zmMr5cewfxFY9CmQyBWv3MQL85Yh/d+uhd+/vUX3ravz+DjRXsw75+j0GNgFDJSi/HmU1sAAA+9cAuKCyrw72e3Yf7iMYiMNeHl2evRZ0gbDB4TBwB494WfMXPhUBaqD9CpAtEn9Ddyx/Ba3PzbgmL8ByHaOEDuGORmAkMNCA73q/m3b0saouNM6D0kBkIIfPvRUdz92EDcPLEj4rqF4snFY1BZYcf2b882eJ+nD2Wjx8AojPp1V0S2NWHAiFjcensXpBzLAQBkXyyBX4AWIyZ3Rte+EegztA0uphQAALZ9cwYajQo3T+zYKs+f5BUfdh+0Kn+5Y3gtlmoL6xP6G+hUJrljkJuyWR3Y+s1ZjLurOxQKBbIvlqIwtxz9R7StWUejU6H3kBicPpjV4P30HBSFc8dzceZINgAgK70E+7ddwKDRVSPRmPZBqLTYce5ELkqLLDh7NAftu4eitMiCFW/swyN/GdGyT5TcQqz/LZyBpoVx828L06r80T98FvZkvQ0BSe445GZ2b0pFWUklxt7VHQBQmFsOAAgKcz4tKyjMgJwMc4P3c+vtXVBcYMHTd38NIQCHXcKk+3ph2qNVW0r8A3V4cvEY/OsPW2CttGPMHd0w4NZ2eHPhVkye0QfZl0rw14d/gN3uwG/nDcYtVzZFk/fwU4eiV+hUuWN4PZZqKwgzdEe34Mk4Xfit3FHIzWz6/DQGjmyH0Eij03KFwnk9Ieouu9qx3Rn4/J0DmPPyCHTrG4nMC8X478s7sSpiP37zRNXl54YldMSwhI5Ot0lLzscjLw3HI6NX4I9vjkdwuAF/mPIVet0UXafYyXMpFWr0j3gQaiUvpdrSuPm3lXQKTECkX1+5Y5AbyckoxZGdlzDhnh41y4LDq4qsesRarTi/AkFhhgbv69PX92L0HV2RcE9PtO8eimEJHTHjqSH44r1DTgdFVbNVOvDeizsw928jkZlWAodDQp8hMWjbMRgxHQJx5kiOi54luYPeofcgWNde7hg+gaXaShQKBfqFz4BRzcuBUZWfvjiNwFADBl/Z7wkAkbEBCA73w+FfLtUss1kdOL7nMroPiGrwviotdihrDWWVSgUgBISoW6qr3t6PgSPboXPvcEiSBIf9f+s47BIcjrq3Ic/ULmA42gXcIncMn8HNv61IozRgYOTD2Hl5MRyiUu44JCNJEvjpy9MYc2c3qNT/+9tWoVDgVw/E44t3DyKmfSBi2gfi83cPQmdQY+SvutSs9/ofNiM00oiZC4cCAG4a0x5fLz2Cjr3C0LVfJDLTivHZv/bipnHtoVI5/+184UwBdnx3Dm+tr7ryV9tOwVAoFdi4+hSCw/1w6VwRusZzompvEKTrgN6hd8sdw6ewVFuZSRuD+LD7cIjnr/q0wzsvIfeyGeOnda/zvamP9IPVYsd7L+64cvGHCLz88WSnc1RzL5uhUP5vZHrP4wOhUFRtBs7PKoMpxICbxsZh+h+HON23EALvPL8ds/90M/R+GgCATq/G/EWjseTPO2CzOvDIS8MRGsVTLjydTmXCoIiHoFTwY741KUR924aoxR3P/xxpJdvkjkFEXkgBFYZF/x4h+s5yR/E53Kcqk54hUxGi42kLROR6PUOnslBlwlKViVKhwoCI2bwwBBG5VFv/oehgGiV3DJ/FUpWRXh2IARGzoYBK7ihE5AUCte3QJ/ReuWP4NJaqzEL1ndE3/H4A1zizn4ioEVqlPwZFPgyVUiN3FJ/GUnUDbf2HoEfIFLljEJGHUil0GBz1GAzqa08PSC2PpeomOgWOR0fTWLljEJGHUUCFQREP8YpJboKl6kZ6hNyJGOMguWMQkcdQoF/4TIT79ZQ7CF3BUnUj1ZcyDNPXvSAAEVFtvULuQht//iHuTliqbkapUGNQ5MMwaWPljkJEbqxL0CR0CBwtdwyqhaXqhtRKPYZEzYWfOkzuKETkhtoFDEe34NvljkH1YKm6KZ3KhCFRj0Or5DVYieh/ovz6o0/ob+SOQQ1gqboxoyYCN0XNhUqhkzsKEbmBUH1X9I+YBYWCH93uir8ZNxeki8NNkY+xWIl8XKA2FoMj50Cl4MUd3BlL1QOEGrpgaNQTUCsNckchIhkEamMxJOoJqJV6uaNQIzj1mwcpqkzHnqx/wyaVyR2FiFpJsK4Tbop6DBr+Ue0RWKoepsR6Cbsz34JVMssdhYhaWJi+GwZFzoFayd0/noKl6oFKrZnYnfUWKh3FckchohYSYeiNgZEPcR+qh2GpeqgyWw6SMt+ExVEodxQicrFo4wD0D38ASgWnhfQ0LFUPVm7Lx+6sN1Buz5c7ChG5SKz/MMSH3cfTZjwUS9XDVdgLsTvrTZTZcuSOQkQ3qL1pJHqF3A2FgvMreyqWqhew2IuxJ+vfKLVdljsKEV2nToETOK+yF2CpegmbVIGDOR8it+Kk3FGIqFkU6B58OzoHTZQ7CLkAS9WLCCHhRMGXSCvZJncUImoCpUKDfmEzEOM/UO4o5CIsVS+UVvIzTuR/DgFJ7ihE1AC9KgiDIucgSNdO7ijkQixVL5VbcQoHcj6AXaqQOwoR1RKka49BEY9Arw6UOwq5GEvVi5VaM7EvewnK7blyRyGiK9oYByM+7H6olLyogzdiqXo5q8OM/Tn/RYElRe4oRD6OByT5ApaqD5CEHUfzVuCSebfcUYh8kkqhQ//wWYgy9pU7CrUwlqoPSSnaiOTCb3kAE1ErMqhDMDhyDkzatnJHoVbAUvUx+RVncSj3I1gcRXJHIfJ6IfrOGBjxEHSqALmjUCthqfogq6MMR/I+QXb5UbmjEHkpBboETULXoERew9fHsFR9WFrJdpws+AqSsMkdhchr6FSB6B/+AMIMXeWOQjJgqfq4EuslHMxZCrMtS+4oRB4vwtAb/cJnQKvylzsKyYSlSnBIVhzP/wIXzTvljkLkkZQKDboH/xodTKM5w4yPY6lSjcvmAziav4JXYSJqBpO2LfqHz0KANkbuKOQGWKrkpNyWj4O5S1FUmSp3FCI3p0CnwPHoFjwZSoVa7jDkJliqVIckHDhfvBlnitbzICaiehjUIegXNhOhhi5yRyE3w1KlBpXb8nAsfxXnaCW6QgElOphGo2vwbVAr9XLHITfEUqVGZZj34UT+l7BKpXJHIZJNkK4D4kPvhUnHKyNRw1iq1CRWRzlOFazFRfMuAHzJkO/QKP3QPXgK2gXcwiN7qVEsVWqWfEsKjuWt4Hmt5BPa+N+EniFTeZlBajKWKjWbJOxIKdqIlOINkIRd7jhELueviUTv0Ht5VSRqNpYqXTezLRvH81Yhz5IsdxQil1AqNOgSNBGdAsfzNBm6LixVumHZ5cdwquBrmG2Zckchum6Rfn3RM2QqjJowuaOQB2OpkksIISG9dBfOFK1HpaNY7jhETRam74ZuIb9GsK693FHIC7BUyaXsUiXOF2/GueJNcIhKueMQNShI1wHdg3+FMEM3uaOQF2GpUouwOsxIKfoRaaU/86pM5FYCNDHoFvwrRBnj5Y5CXoilSi3KYi/C2aIfkF66CwIOueOQD/NTh6Nb8GTEGAdy4nBqMSxVahXltjycKfoeGeZ9LFdqVXpVELoEJSI2YBiUCpXcccjLsVSpVVXYi5BWsg3ppTtg4xRz1IL81OHoYBqFdgHDoVJq5I5DPoKlSrKwS5W4WLoLqSVbUW7PkzsOeZFQfRd0MI1FpF9vbualVsdSJVkJISGr/AjOF29GYeV5ueOQh1Iq1IgxDkJH0xhe8J5kxVIlt1FoScX5ks3IKjsMAUnuOOQBdCoT4gJGIM50K6/PS26BpUpup9yWj9SSrbhoToKd+12pHiZtW3QwjUEb/0G8nCC5FZYquS2HZEN2+RFcMu9BbsUpjl59nFqhR5SxH2L9hyKUF7onN8VSJY9Q6ShBhnkfLpn3oMR6Se441EoUUCHc0ANt/W9CpF88VEqt3JGIromlSh6nxJqBS+Y9yDDv43WGvVSwriPa+A9GjHEgtCp/ueMQNRlLlTyWEBJyK04jw7wHWeVH4BBWuSPRDTBqItHGOBht/G/iTDHksViq5BXskgW5FaeQU34cORUnOYL1EP6aSEQYeiPGfxCCdHFyxyG6YSxV8jpCCJRYLyGn4jhyyk+gsDIVAF/m7kCt0CPU0A0Rhp4IN/SEnyZU7khELsVSJa9ndZhrRrG5FadglcxyR/IhCpi0bRBu6IkIQ08E6zvx+rvk1Viq5FOEkFBUeQE5FcdRYElBUWU65311MY3SiHBDD4QbeiLc0AN6daDckYhaDUuVfJoQEkptl1FoSUNRZRqKKlNRassCNxc3jUqhRaA2FoG6OATp4hCkaw+jJlzuWESyYakS1WKXLCiqvICiylQUVlaVbaWjRO5YslNABZM2xqlAAzTRvGg90VVYqkRNUG7LR6ktA2W2XJTZcqr+356DCnshvG1Uq4QaBk0I/NTh8FOHwV8biSBtHEzatpxCjagRLFWiG+CQbCi351UVrT3nqtLNgcVRDHctXLXSAKM6DH6aquL0U4fBeOW/Depgjj6JrhNLlaiFSMIBm1QGq6MMVqkMNocZ1itfOy+/8v9SGSRhByCqqvjKW7PqK1G9FIC48j8BhUIBtUIPtfLKv6v+W6M0QqsyQqvyh1bpf+X/jTCog3mVIqIWwlIlIiJyEW7jISIichGWKhERkYuwVImIiFyEpUpEROQiLFUiIiIXYakSERG5CEuViIjIRViqRERELsJSJSIichGWKhERkYuwVImIiFyEpUrk5f7+979j8ODBCAgIQEREBKZMmYLk5ORGb7d9+3YMHDgQer0eHTt2xJIlS1ohLZFnY6kSebnt27dj7ty52L17NzZt2gS73Y4JEyagrKyswdukpqYiMTERI0aMwKFDh/Dcc89h3rx5WLNmTSsmJ/I8nKWGyMfk5uYiIiIC27dvx6233lrvOk8//TS+/fZbnDp1qmbZnDlzcOTIESQlJbVWVCKPw5EqkY8pLi4GAISEhDS4TlJSEiZMmOC0LCEhAfv374fNZmvRfESejKVK5EOEEFiwYAGGDx+O3r17N7heVlYWIiMjnZZFRkbCbrcjLy+vpWMSeSy13AGIqPU8/vjjOHr0KH755ZdG11UoFE5fV+8pqr2ciP6HpUrkI5544gl8++23+Pnnn9G2bdtrrhsVFYWsrCynZTk5OVCr1QgNDW3JmEQejZt/ibycEAKPP/44vvrqK2zZsgUdOnRo9DbDhg3Dpk2bnJZt3LgRgwYNgkajaamoRB6PpUrk5ebOnYtPP/0UK1asQEBAALKyspCVlYWKioqadZ599lnMmDGj5us5c+bgwoULWLBgAU6dOoWlS5fiww8/xB//+Ec5ngKRx+ApNURerqF9oB999BFmzZoFAJg1axbS0tKwbdu2mu9v374dTz75JE6cOIGYmBg8/fTTmDNnTiskJvJcLFUiIiIX4eZfIiIiF2GpEhERuQhLlYiIyEVYqkRERC7CUiUiInIRlioREZGLsFSJiIhchKVKRETkIixVIiIiF2GpEhERuQhLlYiIyEVYqkRERC7CUiUiInIRlioREZGLsFSJiIhchKVKRETkIixVIiIiF2GpEhERuQhLlYiIyEVYqkRERC7CUiUiInIRlioREZGLsFSJiIhchKVKRETkIixVIiIiF2GpEhERuQhLlYiIyEVYqkRERC7CUiUiInIRlioREZGLsFSJiIhchKVKRETkIv8PQZjeQnQQ9V0AAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "# Preprocess 'Age at Diagnosis'\n",
    "df['Age at Diagnosis'] = df['Age at Diagnosis'].apply(lambda x: str(x).split(',')[0])\n",
    "df['Age at Diagnosis'] = pd.to_numeric(df['Age at Diagnosis'], errors='coerce')\n",
    "df = df.dropna(subset=['Age at Diagnosis', 'Tumor Stage'])\n",
    "\n",
    "# Define age bins\n",
    "bins = list(range(20, int(df['Age at Diagnosis'].max()) + 10, 10))\n",
    "labels = [f\"{i}-{i+10}\" for i in bins[:-1]]\n",
    "df['AgeGroup'] = pd.cut(df['Age at Diagnosis'], bins=bins, labels=labels, right=False)\n",
    "\n",
    "# Group by AgeGroup and Tumor Stage, then count\n",
    "grouped = df.groupby(['AgeGroup', 'Tumor Stage']).size().unstack(fill_value=0)\n",
    "\n",
    "# Plot: Stacked Bar Chart\n",
    "grouped.plot(kind='bar', stacked=True, figsize=(12, 6), colormap='tab20')\n",
    "plt.title('Tumor Stage Distribution by Age Group')\n",
    "plt.xlabel('Age Group')\n",
    "plt.ylabel('Number of Patients')\n",
    "plt.xticks(rotation=45)\n",
    "plt.legend(title='Tumor Stage')\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Plot: Grouped Bar Chart\n",
    "grouped.plot(kind='bar', stacked=False, figsize=(12, 6), colormap='Set2')\n",
    "plt.title('Tumor Stage Distribution by Age Group')\n",
    "plt.xlabel('Age Group')\n",
    "plt.ylabel('Number of Patients')\n",
    "plt.xticks(rotation=45)\n",
    "plt.legend(title='Tumor Stage')\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "\n",
    "#Seaborn\n",
    "import seaborn as sns\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.heatmap(grouped, annot=True, fmt='d', cmap='YlGnBu', linewidths=0.5)\n",
    "plt.title('Tumor Stage Distribution by Age Group (Heatmap)')\n",
    "plt.xlabel('Tumor Stage')\n",
    "plt.ylabel('Age Group')\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "\n",
    "\n",
    "age_groups = grouped.index\n",
    "\n",
    "for age in age_groups:\n",
    "    plt.figure(figsize=(5, 5))\n",
    "    grouped.loc[age].plot(kind='pie', autopct='%1.1f%%', startangle=90, colormap='Set3')\n",
    "    plt.title(f'Tumor Stage Distribution in Age Group {age}')\n",
    "    plt.ylabel('')\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "145568ff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "# Preprocess 'Age at Diagnosis'\n",
    "df['Age at Diagnosis'] = pd.to_numeric(df['Age at Diagnosis'], errors='coerce')\n",
    "df = df.dropna(subset=['Age at Diagnosis', 'Tumor Stage'])\n",
    "\n",
    "# Define age bins\n",
    "bins = list(range(20, int(df['Age at Diagnosis'].max()) + 10, 10))\n",
    "labels = [f\"{i}-{i+10}\" for i in bins[:-1]]\n",
    "df['AgeGroup'] = pd.cut(df['Age at Diagnosis'], bins=bins, labels=labels, right=False)\n",
    "\n",
    "# Group by AgeGroup and Tumor Stage, then count\n",
    "\n",
    "# Plot: Grouped Bar Chart with percentages\n",
    "ax = grouped.plot(kind='bar', stacked=False, figsize=(12, 6), colormap='Set2', width=0.8)\n",
    "plt.title('Tumor Stage Distribution by Age Group')\n",
    "plt.xlabel('Age Group')\n",
    "plt.ylabel('Number of Patients')\n",
    "plt.xticks(rotation=45)\n",
    "plt.legend(title='Tumor Stage')\n",
    "\n",
    "# Add percentage annotations\n",
    "for i, age_group in enumerate(grouped.index):\n",
    "    total = grouped.loc[age_group].sum()\n",
    "    for j, stage in enumerate(grouped.columns):\n",
    "        count = grouped.loc[age_group, stage]\n",
    "        if count > 0:\n",
    "            percent = (count / total) * 100\n",
    "            x = i + (j - len(grouped.columns) / 2) * 0.15 + 0.08  # adjust x position for bars\n",
    "            ax.text(x, count + 0.5, f'{percent:.1f}%', ha='center', va='bottom', fontsize=8)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "\n",
    "# Heatmap\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.heatmap(grouped, annot=True, fmt='d', cmap='YlGnBu', linewidths=0.5)\n",
    "plt.title('Tumor Stage Distribution by Age Group (Heatmap)')\n",
    "plt.xlabel('Tumor Stage')\n",
    "plt.ylabel('Age Group')\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "375ca59e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+-------+\n",
      "| Tumor Stage | Count |\n",
      "+-------------+-------+\n",
      "|      0      |  13   |\n",
      "|      1      |  630  |\n",
      "|      2      |  979  |\n",
      "|      3      |  144  |\n",
      "|      4      |  11   |\n",
      "+-------------+-------+\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from tabulate import tabulate\n",
    "\n",
    "# Convert 'Tumor Stage' to integers and get counts\n",
    "df['Tumor Stage'] = df['Tumor Stage'].astype(int)\n",
    "stage_counts = df['Tumor Stage'].value_counts().sort_index().reset_index()\n",
    "\n",
    "# Rename columns for clarity\n",
    "stage_counts.columns = ['Tumor Stage', 'Count']\n",
    "\n",
    "# Display the table correctly using tabulate\n",
    "print(tabulate(stage_counts, headers='keys', tablefmt='pretty', showindex=False))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "1dcae0ac",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Filter for female patients and drop rows with missing Tumor Stage\n",
    "female_df = df[df['Sex'].str.lower() == 'female']\n",
    "female_df = female_df.dropna(subset=['Tumor Stage'])\n",
    "\n",
    "# Count occurrences of each tumor stage among females\n",
    "female_stage_counts = female_df['Tumor Stage'].value_counts().sort_index()\n",
    "\n",
    "# Plotting the pie chart\n",
    "plt.figure(figsize=(8, 8))\n",
    "plt.pie(female_stage_counts, labels=female_stage_counts.index.astype(str), autopct='%1.1f%%', startangle=140)\n",
    "plt.title(\"Distribution of Tumor Stages Among Female Patients\")\n",
    "plt.axis('equal')\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "5c187537",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1000x600 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "# Convert Age column and drop NaNs\n",
    "df['Age at Diagnosis'] = pd.to_numeric(df['Age at Diagnosis'], errors='coerce')\n",
    "df = df.dropna(subset=['Age at Diagnosis', 'Neoplasm Histologic Grade'])\n",
    "\n",
    "# Define age bins\n",
    "bins = list(range(20, int(df['Age at Diagnosis'].max()) + 10, 10))\n",
    "labels = [f\"{i}-{i+10}\" for i in bins[:-1]]\n",
    "df.loc[:, 'AgeGroup'] = pd.cut(df['Age at Diagnosis'], bins=bins, labels=labels, right=False)\n",
    "\n",
    "# Group by AgeGroup and Grade\n",
    "grouped_by_grade = df.groupby(['AgeGroup', 'Neoplasm Histologic Grade'], observed=False).size().unstack(fill_value=0)\n",
    "\n",
    "# Bar plot\n",
    "ax = grouped_by_grade.plot(kind='bar', stacked=False, figsize=(12, 6), colormap='Set3', width=0.8)\n",
    "plt.title('Tumor Grade Distribution by Age Group (Percentage View)')\n",
    "plt.xlabel('Age Group')\n",
    "plt.ylabel('Number of Patients')\n",
    "plt.xticks(rotation=45)\n",
    "plt.legend(title='Neoplasm Histologic Grade')\n",
    "\n",
    "# Add percentage labels\n",
    "for i, age_group in enumerate(grouped_by_grade.index):\n",
    "    total = grouped_by_grade.loc[age_group].sum()\n",
    "    for j, grade in enumerate(grouped_by_grade.columns):\n",
    "        count = grouped_by_grade.loc[age_group, grade]\n",
    "        if count > 0:\n",
    "            percent = (count / total) * 100\n",
    "            # Calculate the x position to center the text above the bar\n",
    "            x = i + (j - len(grouped_by_grade.columns) / 2) * 0.15 + 0.08   # Adjust width for better centering\n",
    "            # Adjust the y position to place the text slightly above the center of the bar\n",
    "            ax.text(x, count + 0.5, f'{percent:.1f}%', ha='center', va='bottom', fontsize=8)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "# Heatmap using count\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.heatmap(grouped_by_grade, annot=True, fmt='d', cmap='YlOrBr', linewidths=0.5)\n",
    "plt.title('Number of Patients by Tumor Grade and Age Group (Heatmap)')\n",
    "plt.xlabel('Neoplasm Histologic Grade')\n",
    "plt.ylabel('Age Group')\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a60853cf",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
